molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles,pActivity
CHEMBL134277,CHEMBL1871,Androgen Receptor,IC50,=,215.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccsc1)Oc1ccc(F)cc1-3,6.667561540084394
CHEMBL146794,CHEMBL1871,Androgen Receptor,IC50,=,77.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCOCc1ccc(O)c(C(N)=O)c1,7.113509274827518
CHEMBL2112885,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3OC1C[C@H](NCNC(=O)c2cc(COCC#CCN3C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2O)[C@H](O)[C@H](C)O1,7.045757490560675
CHEMBL336353,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1N(C)C)Oc1ccc(F)cc1-3,5.823908740944319
CHEMBL413309,CHEMBL1871,Androgen Receptor,IC50,=,900.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1c(F)cccc1-3,6.045757490560675
CHEMBL717,CHEMBL1871,Androgen Receptor,IC50,=,6.1,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.214670164989233
CHEMBL348495,CHEMBL1871,Androgen Receptor,IC50,=,332.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCOCCOCc1ccc(O)c(C(N)=O)c1,6.478861916295964
CHEMBL347556,CHEMBL1871,Androgen Receptor,IC50,=,346.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCN1CCN(CCOCc2ccc(O)c(C(N)=O)c2)CC1,6.460923901207224
CHEMBL336169,CHEMBL1871,Androgen Receptor,IC50,=,258.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccco1)Oc1ccc(F)cc1-3,6.58838029403677
CHEMBL806,CHEMBL1871,Androgen Receptor,IC50,=,154.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.8124792791635365
CHEMBL103,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,7.431798275933005
CHEMBL134602,CHEMBL1871,Androgen Receptor,IC50,=,640.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1ccc(F)cc1-3,6.1938200260161125
CHEMBL1274,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,8.045757490560675
CHEMBL151601,CHEMBL1871,Androgen Receptor,IC50,=,49.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CC#CCOCc1ccc(O)c(C(N)=O)c1,7.309803919971486
CHEMBL132363,CHEMBL1871,Androgen Receptor,IC50,=,203.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ncccc1C)Oc1ccc(F)cc1-3,6.692503962086787
CHEMBL336736,CHEMBL1871,Androgen Receptor,IC50,=,820.0,nM,CHEMBL647746,B,Inhibition of human androgen receptor at 10e-12 to 10e-5 M,CHEMBL1145087,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1C)Oc1ccc(F)cc1-3,6.086186147616283
CHEMBL146858,CHEMBL1871,Androgen Receptor,IC50,=,6.0,nM,CHEMBL647749,B,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL1145911,IC50,CC1(C)NC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,8.221848749616356
CHEMBL103,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,7.431798275933005
CHEMBL1908373,CHEMBL1871,Androgen Receptor,IC50,=,269.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1,6.570247719997592
CHEMBL51093,CHEMBL1871,Androgen Receptor,IC50,=,449.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,C=C1CC[C@@H](Br)C(C)(C)[C@H]1Cc1cc(OC)c(Br)cc1O,6.347753658996677
CHEMBL50023,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,C=C1C=C(C)CC(C)(C)C1Cc1ccc([N+](=O)[O-])cc1,6.6020599913279625
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.301029995663981
CHEMBL417729,CHEMBL1871,Androgen Receptor,IC50,=,377.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,C=C1CCCC(C)(C)[C@H]1Cc1cc(OC)c(Br)cc1O,6.423658649794207
CHEMBL51639,CHEMBL1871,Androgen Receptor,IC50,=,238.0,nM,CHEMBL647748,B,Inhibitory activity against human Androgen receptor,CHEMBL1129561,IC50,C=C1CC[C@@H](Br)C(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1O,6.623423042943488
CHEMBL2112311,CHEMBL1871,Androgen Receptor,IC50,=,2.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC[C@H]1c2cc3c(C(F)(F)F)cc(=O)oc3cc2NC[C@H]1C,8.698970004336019
CHEMBL266928,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3C(F)(F)C(F)(F)F,8.301029995663981
CHEMBL6843,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21,9.0
CHEMBL2112312,CHEMBL1871,Androgen Receptor,IC50,=,0.3,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC[C@@H]1c2cc3c(C(F)(F)F)cc(=O)oc3cc2NC[C@H]1C,9.522878745280337
CHEMBL6530,CHEMBL1871,Androgen Receptor,IC50,=,276.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1CCN(C)c2cc3oc(=O)cc(C(F)(F)F)c3cc21,6.559090917934782
CHEMBL415289,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21,9.0
CHEMBL266473,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1,9.0
CHEMBL7289,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC1(C)CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1,9.0
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,117.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.931814138253838
CHEMBL268098,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3,9.0
CHEMBL6654,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1Nc2cc3oc(=O)cc(C(F)(F)F)c3cc2CC1C,8.154901959985743
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,4.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.397940008672037
CHEMBL6721,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1CC(CC)c2cc3c(C(F)(F)F)cc(=O)oc3cc2N1,8.154901959985743
CHEMBL267270,CHEMBL1871,Androgen Receptor,IC50,=,2.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3C(F)(F)F,8.698970004336019
CHEMBL6855,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21,8.301029995663981
CHEMBL2112216,CHEMBL1871,Androgen Receptor,IC50,=,12.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CC[C@H]1C[C@@H](C)Nc2cc3oc(=O)cc(C(F)(F)F)c3cc21,7.920818753952375
CHEMBL269305,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL648082,B,In vitro binding affinity at human androgen receptor transfected into COS cells.,CHEMBL1132082,IC50,CCC1CC(C)c2cc3c(C(F)(F)F)cc(=O)oc3cc2N1,7.958607314841775
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,89.0,nM,CHEMBL648076,B,Displacement of [3H]mibolerone from human Androgen receptor,CHEMBL1147539,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,7.050609993355087
CHEMBL65021,CHEMBL1871,Androgen Receptor,IC50,=,6525.0,nM,CHEMBL648076,B,Displacement of [3H]mibolerone from human Androgen receptor,CHEMBL1147539,IC50,COc1cccc2c1-c1ccc(NS(C)(=O)=O)cc1C(c1ccccc1)O2,5.185419483989682
CHEMBL65221,CHEMBL1871,Androgen Receptor,IC50,=,8727.0,nM,CHEMBL654204,B,Displacement of [3H]mibolerone from human Androgen receptor,CHEMBL1147539,IC50,CS(=O)(=O)Nc1ccc2c(c1)C(c1ccccc1)Oc1cccc(OC(F)F)c1-2,5.059135024033278
CHEMBL137103,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL654136,B,Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells,CHEMBL1131161,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1cc(F)ccc1F)Oc1ccccc1-3,5.795880017344075
CHEMBL342426,CHEMBL1871,Androgen Receptor,IC50,=,916.0,nM,CHEMBL654136,B,Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells,CHEMBL1131161,IC50,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccc(F)c(F)c1)Oc1ccccc1-3,6.03810452633215
CHEMBL70381,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL648074,B,Displacement of [3H]dexamethasone from human androgen receptor,CHEMBL1147558,IC50,Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Cl)cc1F,6.522878745280337
CHEMBL419633,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL648074,B,Displacement of [3H]dexamethasone from human androgen receptor,CHEMBL1147558,IC50,Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccccc1,6.769551078621726
CHEMBL427502,CHEMBL1871,Androgen Receptor,IC50,=,5240.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,Cc1cc(N2C(=O)[C@@H]3C4C=CC([C@H](O)[C@@H]4O)[C@@H]3C2=O)ccc1Br,5.280668713016274
CHEMBL427502,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,Cc1cc(N2C(=O)[C@@H]3C4C=CC([C@H](O)[C@@H]4O)[C@@H]3C2=O)ccc1Br,7.229147988357855
CHEMBL184981,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,6.823908740944319
CHEMBL183173,CHEMBL1871,Androgen Receptor,IC50,=,4030.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,CN1C(=O)C2C=CC1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)[C@H]21,5.39469495385889
CHEMBL183173,CHEMBL1871,Androgen Receptor,IC50,=,631.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,CN1C(=O)C2C=CC1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)[C@H]21,6.199970640755866
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,173.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.761953896871205
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,400.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.3979400086720375
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.585026652029182
CHEMBL182593,CHEMBL1871,Androgen Receptor,IC50,=,307.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,6.512861624522813
CHEMBL182593,CHEMBL1871,Androgen Receptor,IC50,=,41.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,7.3872161432802645
CHEMBL178333,CHEMBL1871,Androgen Receptor,IC50,=,12.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.920818753952375
CHEMBL361445,CHEMBL1871,Androgen Receptor,IC50,=,224.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,6.649751981665837
CHEMBL182412,CHEMBL1871,Androgen Receptor,IC50,=,196.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,6.707743928643524
CHEMBL182412,CHEMBL1871,Androgen Receptor,IC50,=,66.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.180456064458131
CHEMBL369542,CHEMBL1871,Androgen Receptor,IC50,=,49.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC(CCC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,7.309803919971486
CHEMBL183882,CHEMBL1871,Androgen Receptor,IC50,=,658.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3CCCC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,6.181774106386044
CHEMBL183882,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3CCCC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.638272163982407
CHEMBL367375,CHEMBL1871,Androgen Receptor,IC50,=,786.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,6.104577453960593
CHEMBL182993,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,5.769551078621726
CHEMBL182993,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL877304,B,Inhibition of mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,IC50,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.522878745280337
CHEMBL180681,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL831105,B,Inhibition of androgen receptor in human MDA-453 cells,CHEMBL1142826,IC50,Cc1cc(N2C(=O)[C@@H]3C4C=CC(CC4)[C@@H]3C2=O)ccc1Br,7.167491087293763
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,3.9,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.4089353929735
CHEMBL361245,CHEMBL1871,Androgen Receptor,IC50,=,22.0,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CC(=O)O[C@]1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@@]21C,7.657577319177793
CHEMBL361245,CHEMBL1871,Androgen Receptor,IC50,=,4.7,nM,CHEMBL830982,B,Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor,CHEMBL1137214,IC50,CC(=O)O[C@]1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@@]21C,8.327902142064282
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,2.2,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.657577319177793
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,7.8,nM,CHEMBL830982,B,Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor,CHEMBL1137214,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.10790539730952
CHEMBL2311179,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O,9.698970004336019
CHEMBL184228,CHEMBL1871,Androgen Receptor,IC50,=,2.0,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,8.698970004336019
CHEMBL184313,CHEMBL1871,Androgen Receptor,IC50,=,0.1,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,10.0
CHEMBL184313,CHEMBL1871,Androgen Receptor,IC50,=,0.009,nM,CHEMBL830982,B,Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor,CHEMBL1137214,IC50,CCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,11.045757490560675
CHEMBL186467,CHEMBL1871,Androgen Receptor,IC50,=,6.6,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,8.18045606445813
CHEMBL186467,CHEMBL1871,Androgen Receptor,IC50,=,0.9,nM,CHEMBL830982,B,Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor,CHEMBL1137214,IC50,CCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,9.045757490560675
CHEMBL186254,CHEMBL1871,Androgen Receptor,IC50,=,0.8,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CCCCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,9.096910013008056
CHEMBL186254,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL830982,B,Inhibition of AR-dimerization in CHO-K1 cells expressing human androgen receptor,CHEMBL1137214,IC50,CCCCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,7.070581074285707
CHEMBL189306,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL874560,B,Inhibition of human androgen receptor expressed in Escherichia coli,CHEMBL1137214,IC50,CCCCCCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21,9.698970004336019
CHEMBL1274,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,8.045757490560675
CHEMBL146858,CHEMBL1871,Androgen Receptor,IC50,=,6.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)NC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,8.221848749616356
CHEMBL2113034,CHEMBL1871,Androgen Receptor,IC50,=,77.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCCOCCCc1ccc(O)c(C(N)=O)c1,7.113509274827518
CHEMBL2113032,CHEMBL1871,Androgen Receptor,IC50,=,332.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCCOCCOCCCc1ccc(O)c(C(N)=O)c1,6.478861916295964
CHEMBL2113036,CHEMBL1871,Androgen Receptor,IC50,=,49.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCC#CCCc1ccc(O)c(C(N)=O)c1,7.309803919971486
CHEMBL347556,CHEMBL1871,Androgen Receptor,IC50,=,346.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCN1CCN(CCOCc2ccc(O)c(C(N)=O)c2)CC1,6.460923901207224
CHEMBL264131,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)CC3OC1C[C@H](NCNC(=O)c2cc(COCC#CCN3C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2O)[C@H](O)[C@H](C)O1,7.045757490560675
CHEMBL386437,CHEMBL1871,Androgen Receptor,IC50,=,63.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CCCC(=O)Oc1ccc(COCC#CCN2C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1C(=O)NCN[C@H]1CC(OC2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(OC)cccc2C4=O)O[C@@H](C)[C@H]1O,7.200659450546418
CHEMBL806,CHEMBL1871,Androgen Receptor,IC50,=,154.0,nM,CHEMBL828424,B,Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate,CHEMBL1138810,IC50,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.8124792791635365
CHEMBL190225,CHEMBL1871,Androgen Receptor,IC50,=,11700.0,nM,CHEMBL833026,B,Inhibition of human androgen receptor,CHEMBL1141148,IC50,Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Oc2ccc(OCC(=O)O)cc2)cc1,4.931814138253839
CHEMBL190109,CHEMBL1871,Androgen Receptor,IC50,=,3600.0,nM,CHEMBL833026,B,Inhibition of human androgen receptor,CHEMBL1141148,IC50,Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccc(Oc2ccc(Cl)c(OCC(=O)O)c2)cc1)Cc1ccc(F)cc1F,5.443697499232712
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,8.8,nM,CHEMBL833026,B,Inhibition of human androgen receptor,CHEMBL1141148,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.05551732784983
CHEMBL363151,CHEMBL1871,Androgen Receptor,IC50,=,6500.0,nM,CHEMBL833026,B,Inhibition of human androgen receptor,CHEMBL1141148,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(Cc4ccc(C)cc4)C3=CC[C@@]21C,5.187086643357144
CHEMBL185265,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL833026,B,Inhibition of human androgen receptor,CHEMBL1141148,IC50,Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Oc2cccc(OCCCC(=O)NCCCC(=O)O)c2)cc1,5.795880017344075
CHEMBL410683,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL881777,B,Inhibitory concentration against Androgen receptor,CHEMBL1140376,IC50,C/C=C1\C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,6.180456064458131
CHEMBL402063,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL881777,B,Inhibitory concentration against Androgen receptor,CHEMBL1140376,IC50,C/C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,6.657577319177793
CHEMBL373019,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C=C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,7.481486060122112
CHEMBL201517,CHEMBL1871,Androgen Receptor,IC50,=,1769.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CCC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.752272167090277
CHEMBL135,CHEMBL1871,Androgen Receptor,IC50,=,19.1,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,7.718966632752272
CHEMBL203748,CHEMBL1871,Androgen Receptor,IC50,=,7.9,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C=C[C@]12CCC(=O)C=C1CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,8.102372908709558
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,2.7,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.568636235841012
CHEMBL381566,CHEMBL1871,Androgen Receptor,IC50,=,287.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C#C[C@]1(O)CCC2C3CC=C4C[C@@H](O)CC[C@]4(C=C)C3CC[C@@]21C,6.542118103266008
CHEMBL204642,CHEMBL1871,Androgen Receptor,IC50,=,169.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C=C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@]2(C)O,6.772113295386326
CHEMBL440283,CHEMBL1871,Androgen Receptor,IC50,=,212.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,6.673664139071248
CHEMBL203561,CHEMBL1871,Androgen Receptor,IC50,=,1717.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C#CC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.765229704839084
CHEMBL201809,CHEMBL1871,Androgen Receptor,IC50,=,3733.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CC#C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.4279420100736955
CHEMBL437065,CHEMBL1871,Androgen Receptor,IC50,=,1761.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C#C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.754240644032723
CHEMBL382097,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,7.481486060122112
CHEMBL369979,CHEMBL1871,Androgen Receptor,IC50,=,1768.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C=CC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.752517739322945
CHEMBL369991,CHEMBL1871,Androgen Receptor,IC50,=,3767.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CC/C=C\[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.424004379796733
CHEMBL202415,CHEMBL1871,Androgen Receptor,IC50,=,843.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C/C=C/[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,6.074172425375258
CHEMBL383253,CHEMBL1871,Androgen Receptor,IC50,=,718.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C/C=C\[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,6.1438755557577
CHEMBL204389,CHEMBL1871,Androgen Receptor,IC50,=,4617.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CO/C=C/[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.335640125448859
CHEMBL380876,CHEMBL1871,Androgen Receptor,IC50,=,1402.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,CO/C=C\[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O,5.85325198636936
CHEMBL204317,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/Br)C1CC[C@@H]2O,6.920818753952375
CHEMBL379441,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\Br)C1CC[C@@H]2O,7.698970004336019
CHEMBL370236,CHEMBL1871,Androgen Receptor,IC50,=,1436.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/Cl)C1CC[C@@H]2O,5.842845560093719
CHEMBL201569,CHEMBL1871,Androgen Receptor,IC50,=,172.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\Cl)C1CC[C@@H]2O,6.764471553092451
CHEMBL202400,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/F)C1CC[C@@H]2O,7.070581074285707
CHEMBL202007,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL859226,B,Inhibitory activity against AR,CHEMBL1149417,IC50,C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\F)C1CC[C@@H]2O,7.958607314841775
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,1.82,nM,CHEMBL911023,B,Activity against human androgen receptor expressed in HepG2 cells assessed as luciferase reporter gene activation,CHEMBL1137300,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.739928612014925
CHEMBL375107,CHEMBL1871,Androgen Receptor,IC50,=,42.7,nM,CHEMBL911023,B,Activity against human androgen receptor expressed in HepG2 cells assessed as luciferase reporter gene activation,CHEMBL1137300,IC50,BrCC(Br)C1CCC(Br)C(Br)C1,7.369572124974976
CHEMBL376182,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCN(CC)C(=O)CCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.481486060122112
CHEMBL224736,CHEMBL1871,Androgen Receptor,IC50,=,6800.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,5.167491087293763
CHEMBL225147,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CN(C)C(=O)CCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.958607314841775
CHEMBL224047,CHEMBL1871,Androgen Receptor,IC50,=,2100.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCCCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,5.6777807052660805
CHEMBL224734,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,5.795880017344075
CHEMBL387651,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,5.823908740944319
CHEMBL427078,CHEMBL1871,Androgen Receptor,IC50,=,710.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.1487416512809245
CHEMBL224733,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CCC(=O)C[C@@H]1CC(CCCCCCCC(N)=O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.585026652029182
CHEMBL224707,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CCC(=O)C[C@@H]1CC(CCCCCCCC(=O)N1CCCCC1)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.920818753952375
CHEMBL427243,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CCC(=O)C[C@@H]1CC(CCCCCCCC(=O)N1CCCC1)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.455931955649724
CHEMBL224654,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CCC(=O)C[C@@H]1CC(CCCCCCCC(=O)N1CCOCC1)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,5.886056647693163
CHEMBL223355,CHEMBL1871,Androgen Receptor,IC50,=,820.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CN(Cc1ccccc1)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.086186147616283
CHEMBL224352,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCN(CC)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.920818753952375
CHEMBL389277,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.585026652029182
CHEMBL390071,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.180456064458131
CHEMBL224414,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CC(C)N(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.366531544420413
CHEMBL375282,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.522878745280337
CHEMBL224770,CHEMBL1871,Androgen Receptor,IC50,=,280.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.552841968657781
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.698970004336019
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.698970004336019
CHEMBL373460,CHEMBL1871,Androgen Receptor,IC50,=,9900.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,5.00436480540245
CHEMBL375675,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,5.721246399047171
CHEMBL224779,CHEMBL1871,Androgen Receptor,IC50,=,570.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.2441251443275085
CHEMBL389631,CHEMBL1871,Androgen Receptor,IC50,=,550.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.259637310505756
CHEMBL223813,CHEMBL1871,Androgen Receptor,IC50,=,280.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,CCCCN(C)C(=O)CCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.552841968657781
CHEMBL224015,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,6.958607314841775
CHEMBL387850,CHEMBL1871,Androgen Receptor,IC50,=,960.0,nM,CHEMBL914604,B,Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells,CHEMBL1144524,IC50,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)CC4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,6.017728766960431
CHEMBL238365,CHEMBL1871,Androgen Receptor,IC50,=,9.8,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2ccccc2Cl)cc1C(F)(F)F,8.008773924307505
CHEMBL238340,CHEMBL1871,Androgen Receptor,IC50,=,8140.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COCCOCCOc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1,5.089375595110798
CHEMBL238338,CHEMBL1871,Androgen Receptor,IC50,=,1540.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2ccccc2OCCO)cc1C(F)(F)F,5.8124792791635365
CHEMBL266491,CHEMBL1871,Androgen Receptor,IC50,=,2230.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COCCOc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1,5.651695136951839
CHEMBL235784,CHEMBL1871,Androgen Receptor,IC50,=,1310.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COC(=O)COc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1,5.882728704344236
CHEMBL394392,CHEMBL1871,Androgen Receptor,IC50,=,989.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2c(O)cccc2O)cc1C(F)(F)F,6.004803708402821
CHEMBL427678,CHEMBL1871,Androgen Receptor,IC50,=,14.7,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COc1cccc(OC)c1-c1ccc(C#N)c(C(F)(F)F)c1,7.8326826652518236
CHEMBL396656,CHEMBL1871,Androgen Receptor,IC50,=,10.9,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2ccccc2C(F)(F)F)cc1C(F)(F)F,7.962573502059376
CHEMBL392827,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,Cc1ccc(-c2ccc(C#N)c(C(F)(F)F)c2)cc1,6.698970004336019
CHEMBL235601,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,Cc1cccc(-c2ccc(C#N)c(C(F)(F)F)c2)c1,5.721246399047171
CHEMBL235379,CHEMBL1871,Androgen Receptor,IC50,=,146.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,Cc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1,6.835647144215563
CHEMBL235378,CHEMBL1871,Androgen Receptor,IC50,=,61.2,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2ccc(O)cc2)cc1C(F)(F)F,7.213248577854439
CHEMBL391549,CHEMBL1871,Androgen Receptor,IC50,=,229.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2cccc(O)c2)cc1C(F)(F)F,6.6401645176601125
CHEMBL391548,CHEMBL1871,Androgen Receptor,IC50,=,39.9,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F,7.399027104313252
CHEMBL235159,CHEMBL1871,Androgen Receptor,IC50,=,56.7,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COc1ccc(-c2ccc(C#N)c(C(F)(F)F)c2)cc1,7.246416941107094
CHEMBL443579,CHEMBL1871,Androgen Receptor,IC50,=,955.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COc1cccc(-c2ccc(C#N)c(C(F)(F)F)c2)c1,6.019996628416253
CHEMBL238366,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL899495,B,Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells,CHEMBL1137443,IC50,COc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1,7.431798275933005
CHEMBL236699,CHEMBL1871,Androgen Receptor,IC50,=,410.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C[C@@H]1C[C@@H](CCCCCCCCC(CCCC(F)(F)C(F)(F)F)C(=O)O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.3872161432802645
CHEMBL235872,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCCc1cccc(OCCCCCC(=O)O)c1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.920818753952375
CHEMBL235811,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCCc1cccc(OCCCCC(=O)O)c1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.455931955649724
CHEMBL235871,CHEMBL1871,Androgen Receptor,IC50,=,670.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCCc1cccc(OCCCC(=O)O)c1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.173925197299173
CHEMBL238001,CHEMBL1871,Androgen Receptor,IC50,=,96.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCCc1ccc(OCCCCC(=O)O)cc1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,7.017728766960431
CHEMBL237999,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCc1ccc(OCCCCC(=O)O)cc1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.180456064458131
CHEMBL428021,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCc1ccc(OCCCC(=O)O)cc1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.366531544420413
CHEMBL235661,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCc1ccc(OCCC(=O)O)cc1)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.522878745280337
CHEMBL391648,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C=C1C[C@@H](CCCCCCCCCC(=O)O)[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.221848749616356
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.698970004336019
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.698970004336019
CHEMBL393320,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,CN(C)C(=O)CCCCCCC[C@@H]1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12,6.585026652029182
CHEMBL235003,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C[C@@H]1C[C@@H](CCCCCCCC(=O)O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.180456064458131
CHEMBL393319,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL899659,B,Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells,CHEMBL1137463,IC50,C[C@]12CCC(=O)C[C@@H]1C[C@@H](CCCCCCCCCC(=O)O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,6.455931955649724
CHEMBL401458,CHEMBL1871,Androgen Receptor,IC50,=,2.0,nM,CHEMBL903191,B,Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay,CHEMBL1139090,IC50,CC(C)C(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F,8.698970004336019
CHEMBL246800,CHEMBL1871,Androgen Receptor,IC50,=,17.0,nM,CHEMBL903191,B,Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay,CHEMBL1139090,IC50,CCSCC(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F,7.769551078621726
CHEMBL246007,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL903191,B,Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay,CHEMBL1139090,IC50,C=CC(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F,8.154901959985743
CHEMBL250104,CHEMBL1871,Androgen Receptor,IC50,=,7700.0,nM,CHEMBL903387,B,Binding affinity at AR,CHEMBL1139115,IC50,O=C(O)CCc1cc(Br)c(OCc2cccc(Br)c2)c(Br)c1,5.113509274827518
CHEMBL246138,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C=C[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,7.481486060122112
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,2.7,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.568636235841012
CHEMBL135,CHEMBL1871,Androgen Receptor,IC50,=,19.1,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,7.718966632752272
CHEMBL397343,CHEMBL1871,Androgen Receptor,IC50,=,710.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H]5CC[C@@]43CCO5)[C@@H]1CC[C@@H]2O,6.1487416512809245
CHEMBL245575,CHEMBL1871,Androgen Receptor,IC50,=,1120.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC[C@]43CC[C@H]5O)[C@@H]1CC[C@@H]2O,5.950781977329818
CHEMBL245378,CHEMBL1871,Androgen Receptor,IC50,=,1375.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O,5.861697301833718
CHEMBL393278,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CC[C@H]4[C@H]5CCC[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O,7.167491087293763
CHEMBL246341,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC=C[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O,7.070581074285707
CHEMBL392000,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C=CC[C@@H]1C2=CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C=C)CC[C@@H]1O,7.823908740944319
CHEMBL246140,CHEMBL1871,Androgen Receptor,IC50,=,7.9,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C=C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,8.102372908709558
CHEMBL246139,CHEMBL1871,Androgen Receptor,IC50,=,718.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,C/C=C\[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,6.1438755557577
CHEMBL391795,CHEMBL1871,Androgen Receptor,IC50,=,88.0,nM,CHEMBL886327,B,Binding affinity to androgen receptor,CHEMBL1139947,IC50,CC[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.055517327849831
CHEMBL248868,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CCCN(CCC)c1cc(C(F)(F)F)c(C#N)cn1,7.107905397309519
CHEMBL9337,CHEMBL1871,Androgen Receptor,IC50,=,15.9,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO,7.798602875679548
CHEMBL248878,CHEMBL1871,Androgen Receptor,IC50,=,4926.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,C[C@@H](Nc1cc(C(F)(F)F)c(C#N)cn1)c1ccccc1,5.3075055924969154
CHEMBL400098,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,C[C@@H](c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1,5.769551078621726
CHEMBL248690,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,C[C@H](c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1,7.698970004336019
CHEMBL399876,CHEMBL1871,Androgen Receptor,IC50,=,123.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CC(c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1,6.910094888560602
CHEMBL248841,CHEMBL1871,Androgen Receptor,IC50,=,169.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,N#Cc1cnc(N2CCC3CCCCC3C2)cc1C(F)(F)F,6.772113295386326
CHEMBL249072,CHEMBL1871,Androgen Receptor,IC50,=,73.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CC1CCN(c2cc(C(F)(F)F)c(C#N)cn2)CC1,7.136677139879544
CHEMBL398432,CHEMBL1871,Androgen Receptor,IC50,=,209.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,N#Cc1cnc(N2CCCCC2)cc1C(F)(F)F,6.679853713888946
CHEMBL249071,CHEMBL1871,Androgen Receptor,IC50,=,3.8,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CCCCN(C)c1cc(C(F)(F)F)c(C#N)cn1,8.42021640338319
CHEMBL249070,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CCC(C)N(C)c1cc(C(F)(F)F)c(C#N)cn1,8.154901959985743
CHEMBL398431,CHEMBL1871,Androgen Receptor,IC50,=,0.8,nM,CHEMBL940963,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1139813,IC50,CCCN(CC1CC1)c1cc(C(F)(F)F)c(C#N)cn1,9.096910013008056
CHEMBL399439,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL923796,B,Displacement of [3H]DHT from androgen receptor expressed in Sf9 cells,CHEMBL1140457,IC50,N#Cc1ccc(O[C@H]2CCCC[C@@H]2C#N)cc1C(F)(F)F,7.366531544420413
CHEMBL399887,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL923796,B,Displacement of [3H]DHT from androgen receptor expressed in Sf9 cells,CHEMBL1140457,IC50,N#Cc1ccc(O[C@@H]2CCCC[C@H]2C#N)cc1C(F)(F)F,7.221848749616356
CHEMBL251552,CHEMBL1871,Androgen Receptor,IC50,=,58.0,nM,CHEMBL923796,B,Displacement of [3H]DHT from androgen receptor expressed in Sf9 cells,CHEMBL1140457,IC50,N#Cc1ccc(OC2CCCCC2C#N)cc1C(F)(F)F,7.236572006437063
CHEMBL246138,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,7.481486060122112
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,2.7,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.568636235841012
CHEMBL135,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,7.585026652029182
CHEMBL246140,CHEMBL1871,Androgen Receptor,IC50,=,7.9,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,8.102372908709558
CHEMBL250110,CHEMBL1871,Androgen Receptor,IC50,=,2250.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,CC1=CC2=CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1,5.647817481888637
CHEMBL249700,CHEMBL1871,Androgen Receptor,IC50,=,40.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C1C=C2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1,7.3979400086720375
CHEMBL400480,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(=C)C=C1CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,6.481486060122112
CHEMBL440283,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,6.638272163982407
CHEMBL398841,CHEMBL1871,Androgen Receptor,IC50,=,290.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C#C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C=C)[C@H]3CC[C@@]21C,6.537602002101044
CHEMBL250109,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.769551078621726
CHEMBL249904,CHEMBL1871,Androgen Receptor,IC50,=,1615.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C#C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C=C(C)CC[C@]4(C=C)[C@H]3CC[C@@]21C,5.791827473332878
CHEMBL398634,CHEMBL1871,Androgen Receptor,IC50,=,520.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(C)=CC1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,6.2839966563652006
CHEMBL398840,CHEMBL1871,Androgen Receptor,IC50,=,3160.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(c3ccccc3)=CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,5.500312917381596
CHEMBL249903,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(CC)=CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,6.301029995663981
CHEMBL398456,CHEMBL1871,Androgen Receptor,IC50,=,560.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CCC(C)=CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,6.251811972993799
CHEMBL251515,CHEMBL1871,Androgen Receptor,IC50,=,2610.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CC[C@@](C)(O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,5.583359492661719
CHEMBL398455,CHEMBL1871,Androgen Receptor,IC50,=,842.0,nM,CHEMBL925473,B,Binding affinity at AR,CHEMBL1140529,IC50,C=C[C@]12CC[C@](C)(O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12,6.0746879085003505
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,6.9,nM,CHEMBL934261,B,Antagonist activity at human AR ligand binding domain expressed in african green monkey COS7 cells in presence of 5-alpha-dihydrotestosterone by Gal4 hybrid assay,CHEMBL1144664,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.161150909262744
CHEMBL267431,CHEMBL1871,Androgen Receptor,IC50,=,6.1,nM,CHEMBL934261,B,Antagonist activity at human AR ligand binding domain expressed in african green monkey COS7 cells in presence of 5-alpha-dihydrotestosterone by Gal4 hybrid assay,CHEMBL1144664,IC50,COC[C@]1(OC)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(/C=N/O)cc3)C[C@@]21C,8.214670164989233
CHEMBL407848,CHEMBL1871,Androgen Receptor,IC50,=,196.0,nM,CHEMBL934261,B,Antagonist activity at human AR ligand binding domain expressed in african green monkey COS7 cells in presence of 5-alpha-dihydrotestosterone by Gal4 hybrid assay,CHEMBL1144664,IC50,Cn1c(C#N)ccc1-c1cc(F)c2c(c1)C(C)(C)C(=O)N2,6.707743928643524
CHEMBL263660,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL937560,B,Inhibition of wild type androgen receptor expressed in CV1 cells assessed as dihydrotestosterone-stimulated transactivation by CAT reporter gene assay,CHEMBL1145525,IC50,O=C(CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21)c1cccc2ccccc12,6.6020599913279625
CHEMBL263660,CHEMBL1871,Androgen Receptor,IC50,=,251.19,nM,CHEMBL937560,B,Inhibition of wild type androgen receptor expressed in CV1 cells assessed as dihydrotestosterone-stimulated transactivation by CAT reporter gene assay,CHEMBL1145525,IC50,O=C(CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21)c1cccc2ccccc12,6.599997654072045
CHEMBL121626,CHEMBL1871,Androgen Receptor,IC50,=,47000.0,nM,CHEMBL924813,B,Activity at androgen receptor ligand binding domain assessed as inhibition of SRC2-3 interaction after 2 hrs by fluorescence polarization assay,CHEMBL1147068,IC50,Cc1c(Cl)cccc1Nc1ccccc1C(=O)O,4.327902142064283
CHEMBL258241,CHEMBL1871,Androgen Receptor,IC50,=,101.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,Cc1cc(=O)[nH]c2ccc3c4cc(F)ccc4oc(=O)c3c12,6.995678626217357
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,0.05,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,10.301029995663981
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,232.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.634512015109101
CHEMBL402136,CHEMBL1871,Androgen Receptor,IC50,=,477.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1OC2,6.3214816209598865
CHEMBL450334,CHEMBL1871,Androgen Receptor,IC50,=,40.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1ccccc1CO3,7.3979400086720375
CHEMBL257751,CHEMBL1871,Androgen Receptor,IC50,=,22.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,O=c1cc(C(F)(F)F)c2c(ccc3c2oc(=O)c2cccc(O)c23)[nH]1,7.657577319177793
CHEMBL403219,CHEMBL1871,Androgen Receptor,IC50,=,89.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c(=O)oc3c(ccc4[nH]c(=O)cc(C(F)(F)F)c43)c12,7.050609993355087
CHEMBL253535,CHEMBL1871,Androgen Receptor,IC50,=,1.1,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1c(O)cccc1OC3,8.958607314841775
CHEMBL401629,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1CO2,7.853871964321762
CHEMBL253746,CHEMBL1871,Androgen Receptor,IC50,=,112.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(OC)O2,6.950781977329818
CHEMBL258190,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(O)O2,7.301029995663981
CHEMBL427731,CHEMBL1871,Androgen Receptor,IC50,=,1.2,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1c(O)ccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2,8.920818753952375
CHEMBL257151,CHEMBL1871,Androgen Receptor,IC50,=,0.3,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,Cc1cc(=O)[nH]c2ccc3c(c12)COc1cccc(CO)c1-3,9.522878745280337
CHEMBL256947,CHEMBL1871,Androgen Receptor,IC50,=,12.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2,7.920818753952375
CHEMBL256768,CHEMBL1871,Androgen Receptor,IC50,=,2.8,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1c(OC(C)C)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,8.55284196865778
CHEMBL256977,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,CCOc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1OC,8.0
CHEMBL256769,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1c(C(=O)OC(F)(F)F)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,9.698970004336019
CHEMBL427898,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1c(O)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,9.698970004336019
CHEMBL401711,CHEMBL1871,Androgen Receptor,IC50,=,1.9,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,Cc1cc(=O)[nH]c2ccc3c4c(C(=O)OC(C)(C)C)cccc4oc(=O)c3c12,8.721246399047171
CHEMBL450933,CHEMBL1871,Androgen Receptor,IC50,=,21.0,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1cccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,7.6777807052660805
CHEMBL258397,CHEMBL1871,Androgen Receptor,IC50,=,0.8,nM,CHEMBL930493,B,Activity at androgen receptor in human Saos2 cells assessed as IL6 repression,CHEMBL1143080,IC50,COc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1,9.096910013008056
CHEMBL510145,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Sc2ccccc2OC)ccc1C#N,7.698970004336019
CHEMBL453740,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CC(C)Sc1ccc(C#N)c(C(F)(F)F)c1,7.698970004336019
CHEMBL462664,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CCCSc1ccc(C#N)c(C(F)(F)F)c1,7.638272163982407
CHEMBL491493,CHEMBL1871,Androgen Receptor,IC50,=,24.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Oc2ccccc2C)ccc1C#N,7.619788758288394
CHEMBL445429,CHEMBL1871,Androgen Receptor,IC50,=,29.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(SC(C)C)ccc1C#N,7.537602002101044
CHEMBL453623,CHEMBL1871,Androgen Receptor,IC50,=,35.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,N#Cc1ccc(SCC2CC2)cc1C(F)(F)F,7.455931955649724
CHEMBL462022,CHEMBL1871,Androgen Receptor,IC50,=,39.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Sc2c(C)cc(C)cc2C)ccc1C#N,7.4089353929735005
CHEMBL443970,CHEMBL1871,Androgen Receptor,IC50,=,40.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CCCSc1ccc(C#N)c(OC)c1,7.3979400086720375
CHEMBL490956,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1ccccc1Sc1ccc(C#N)cc1Cl,7.366531544420413
CHEMBL448454,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Sc2c(C)cccc2C)ccc1C#N,7.366531544420413
CHEMBL462665,CHEMBL1871,Androgen Receptor,IC50,=,49.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CCCCSc1ccc(C#N)c(C(F)(F)F)c1,7.309803919971486
CHEMBL462026,CHEMBL1871,Androgen Receptor,IC50,=,56.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1ccccc1Sc1ccc(C#N)c(C(F)(F)F)c1,7.251811972993799
CHEMBL490957,CHEMBL1871,Androgen Receptor,IC50,=,57.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Oc2cccc(C)c2)ccc1C#N,7.2441251443275085
CHEMBL453624,CHEMBL1871,Androgen Receptor,IC50,=,63.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,N#Cc1ccc(SCC2CCC2)cc1C(F)(F)F,7.200659450546418
CHEMBL490955,CHEMBL1871,Androgen Receptor,IC50,=,64.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1ccccc1Oc1ccc(C#N)cc1Cl,7.1938200260161125
CHEMBL455566,CHEMBL1871,Androgen Receptor,IC50,=,84.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CCCCSc1ccc(C#N)c(OC)c1,7.075720713938118
CHEMBL449867,CHEMBL1871,Androgen Receptor,IC50,=,115.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(C#N)ccc1Oc1ccccc1C,6.939302159646388
CHEMBL504110,CHEMBL1871,Androgen Receptor,IC50,=,169.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(SCC2CC2)ccc1C#N,6.772113295386326
CHEMBL507671,CHEMBL1871,Androgen Receptor,IC50,=,184.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,N#Cc1ccc(Sc2ccccc2F)cc1C(F)(F)F,6.735182176990463
CHEMBL449371,CHEMBL1871,Androgen Receptor,IC50,=,194.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,N#Cc1ccc(SC2CCC2)cc1C(F)(F)F,6.7121982700697735
CHEMBL501649,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(Oc2ccc(C)cc2)ccc1C#N,6.698970004336019
CHEMBL462025,CHEMBL1871,Androgen Receptor,IC50,=,225.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1ccccc1Sc1ccc(C#N)c(C(F)(F)F)c1,6.647817481888637
CHEMBL448978,CHEMBL1871,Androgen Receptor,IC50,=,315.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CC(C)(C)Sc1ccc(C#N)c(C(F)(F)F)c1,6.501689446210399
CHEMBL447604,CHEMBL1871,Androgen Receptor,IC50,=,353.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(C#N)ccc1Oc1cccc(C)c1,6.452225294612178
CHEMBL462027,CHEMBL1871,Androgen Receptor,IC50,=,411.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1cccc(C)c1Sc1ccc(C#N)c(C(F)(F)F)c1,6.386158178123931
CHEMBL453244,CHEMBL1871,Androgen Receptor,IC50,=,441.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(SCC2CCC2)ccc1C#N,6.355561410532161
CHEMBL503687,CHEMBL1871,Androgen Receptor,IC50,=,519.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,CC(C)CCSc1ccc(C#N)c(C(F)(F)F)c1,6.284832642151542
CHEMBL499137,CHEMBL1871,Androgen Receptor,IC50,=,535.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.2716462179787715
CHEMBL462234,CHEMBL1871,Androgen Receptor,IC50,=,1340.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1cc(C)c(Sc2ccc(C#N)c(C(F)(F)F)c2)c(C)c1,5.872895201635192
CHEMBL464764,CHEMBL1871,Androgen Receptor,IC50,=,1680.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1cccc(Oc2ccc(C#N)c(C(F)(F)F)c2)c1,5.774690718274137
CHEMBL462663,CHEMBL1871,Androgen Receptor,IC50,=,1730.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(SCCC(C)C)ccc1C#N,5.761953896871205
CHEMBL464929,CHEMBL1871,Androgen Receptor,IC50,=,5210.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,COc1cc(C#N)ccc1Oc1ccc(C)cc1,5.283162276700475
CHEMBL465539,CHEMBL1871,Androgen Receptor,IC50,=,5330.0,nM,CHEMBL964136,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells,CHEMBL1153273,IC50,Cc1ccc(Oc2ccc(C#N)c(C(F)(F)F)c2)cc1,5.273272790973428
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,6.9,nM,CHEMBL983681,B,Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL1144156,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.161150909262744
CHEMBL522432,CHEMBL1871,Androgen Receptor,IC50,=,325.0,nM,CHEMBL983681,B,Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL1144156,IC50,Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(c1ccsc1)OCC(=O)N2,6.488116639021126
CHEMBL489788,CHEMBL1871,Androgen Receptor,IC50,=,215.0,nM,CHEMBL983681,B,Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL1144156,IC50,Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(c1ccco1)OCC(=O)N2,6.667561540084394
CHEMBL520169,CHEMBL1871,Androgen Receptor,IC50,=,775.0,nM,CHEMBL983681,B,Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL1144156,IC50,Cn1c(C#N)ccc1-c1ccc2c(c1)C(c1cccs1)(c1cccs1)OCC(=O)N2,6.110698297493689
CHEMBL483246,CHEMBL1871,Androgen Receptor,IC50,=,740.0,nM,CHEMBL983681,B,Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL1144156,IC50,Cn1c(C#N)ccc1-c1ccc2c(c1)C(c1ccco1)(c1ccco1)OCC(=O)N2,6.130768280269024
CHEMBL456237,CHEMBL1871,Androgen Receptor,IC50,=,2300.0,nM,CHEMBL947312,B,Displacement of radiolabeled mibolerone from human androgen receptor by filter paper assay,CHEMBL1152299,IC50,Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1,5.638272163982407
CHEMBL471644,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1cccc(C)c1Oc1ccc(C#N)c(C(F)(F)F)c1,8.0
CHEMBL513195,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CCc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,7.698970004336019
CHEMBL470204,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccccc1Oc1ccc(C#N)c(Cl)c1,7.522878745280337
CHEMBL471645,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,N#Cc1ccc(Oc2ccccc2O)cc1C(F)(F)F,7.468521082957745
CHEMBL490955,CHEMBL1871,Androgen Receptor,IC50,=,64.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccccc1Oc1ccc(C#N)cc1Cl,7.1938200260161125
CHEMBL469334,CHEMBL1871,Androgen Receptor,IC50,=,69.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1cc(C)ccc1Oc1ccc(C#N)c(C(F)(F)F)c1,7.161150909262744
CHEMBL504179,CHEMBL1871,Androgen Receptor,IC50,=,74.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CSc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,7.130768280269024
CHEMBL469380,CHEMBL1871,Androgen Receptor,IC50,=,83.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,7.080921907623926
CHEMBL499137,CHEMBL1871,Androgen Receptor,IC50,=,92.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,7.036212172654444
CHEMBL512837,CHEMBL1871,Androgen Receptor,IC50,=,103.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1ccc(C)cc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.987162775294828
CHEMBL449804,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CCOc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.920818753952375
CHEMBL470629,CHEMBL1871,Androgen Receptor,IC50,=,123.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,N#Cc1ccc(Oc2ccccc2Cl)cc1C(F)(F)F,6.910094888560602
CHEMBL469982,CHEMBL1871,Androgen Receptor,IC50,=,127.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccc(O)c(Oc2ccc(C#N)c(C(F)(F)F)c2)c1,6.896196279044043
CHEMBL469333,CHEMBL1871,Androgen Receptor,IC50,=,157.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1cccc(OC)c1Oc1ccc(C#N)c(C(F)(F)F)c1,6.804100347590767
CHEMBL469983,CHEMBL1871,Androgen Receptor,IC50,=,158.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1cccc(F)c1Oc1ccc(C#N)c(C(F)(F)F)c1,6.801342913045577
CHEMBL513768,CHEMBL1871,Androgen Receptor,IC50,=,198.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1cc(C)c(Oc2ccc(C#N)c(C(F)(F)F)c2)c(C)c1,6.703334809738469
CHEMBL469602,CHEMBL1871,Androgen Receptor,IC50,=,202.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CCCc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.694648630553376
CHEMBL451153,CHEMBL1871,Androgen Receptor,IC50,=,216.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,COc1ccc(CO)cc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.665546248849069
CHEMBL470395,CHEMBL1871,Androgen Receptor,IC50,=,229.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CCSc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.6401645176601125
CHEMBL510289,CHEMBL1871,Androgen Receptor,IC50,=,257.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CCOc1cc(C)ccc1Oc1ccc(C#N)c(C(F)(F)F)c1,6.590066876668706
CHEMBL511145,CHEMBL1871,Androgen Receptor,IC50,=,354.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccc(Oc2ccc(C#N)c(C(F)(F)F)c2)c(O)c1,6.450996737974212
CHEMBL471876,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,N#Cc1ccc(Oc2ccccc2-c2ccccc2)cc1C(F)(F)F,6.366531544420413
CHEMBL464764,CHEMBL1871,Androgen Receptor,IC50,=,770.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1cccc(Oc2ccc(C#N)c(C(F)(F)F)c2)c1,6.113509274827518
CHEMBL507267,CHEMBL1871,Androgen Receptor,IC50,=,2280.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CC(C)c1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1,5.642065152999546
CHEMBL470841,CHEMBL1871,Androgen Receptor,IC50,=,2720.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,N#Cc1ccc(Oc2cccc(Cl)c2)cc1C(F)(F)F,5.565431095965801
CHEMBL465539,CHEMBL1871,Androgen Receptor,IC50,=,4000.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,Cc1ccc(Oc2ccc(C#N)c(C(F)(F)F)c2)cc1,5.3979400086720375
CHEMBL470842,CHEMBL1871,Androgen Receptor,IC50,=,6650.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,N#Cc1ccc(Oc2ccc(Cl)cc2)cc1C(F)(F)F,5.1771783546968955
CHEMBL9337,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL987689,B,Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system,CHEMBL1153981,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO,7.795880017344075
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,6.9,nM,CHEMBL965388,B,Antagonist activity at cloned androgen receptor-ligand binding domain expressed in african green monkey COS7 cells by two hybrid luciferase assay,CHEMBL1157410,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.161150909262744
CHEMBL501080,CHEMBL1871,Androgen Receptor,IC50,=,690.0,nM,CHEMBL965388,B,Antagonist activity at cloned androgen receptor-ligand binding domain expressed in african green monkey COS7 cells by two hybrid luciferase assay,CHEMBL1157410,IC50,CCC1(c2ccco2)OCC(=O)Nc2ccc(-c3cc(F)cc(C#N)c3)cc21,6.161150909262744
CHEMBL9337,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO,7.795880017344075
CHEMBL399887,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,N#Cc1ccc(O[C@@H]2CCCC[C@H]2C#N)cc1C(F)(F)F,7.221848749616356
CHEMBL458084,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,N#Cc1ccc([C@H]2CCCC[C@H]2O)cc1C(F)(F)F,7.431798275933005
CHEMBL458506,CHEMBL1871,Androgen Receptor,IC50,=,1599.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,N#Cc1ccc([C@@H]2CCCC[C@@H]2O)cc1C(F)(F)F,5.796151536253765
CHEMBL501627,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,N#Cc1ccc(C2CCCCC2O)cc1C(F)(F)F,7.585026652029182
CHEMBL248690,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,C[C@H](c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1,7.698970004336019
CHEMBL503575,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,COc1cc(-c2ccccc2O)ccc1C#N,7.431798275933005
CHEMBL391548,CHEMBL1871,Androgen Receptor,IC50,=,39.9,nM,CHEMBL1032459,B,Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells,CHEMBL1142535,IC50,N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F,7.399027104313252
CHEMBL806,CHEMBL1871,Androgen Receptor,IC50,=,2000.0,nM,CHEMBL1023897,B,Antiandrogenic activity in human MDA-MB-453 cells expressing androgen receptor assessed as inhibition of DHT-induced androgen-dependent transcription by luciferase reporter gene assay,CHEMBL1136843,IC50,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.698970004336019
CHEMBL457036,CHEMBL1871,Androgen Receptor,IC50,=,880.0,nM,CHEMBL1022147,B,Binding affinity to human androgen receptor,CHEMBL1152783,IC50,CC#C[C@@]1(O)CC[C@@]2(CC)c3ccc(OCc4cccnc4C)cc3CC[C@@H]2C1,6.055517327849831
CHEMBL10560,CHEMBL1871,Androgen Receptor,IC50,=,420.0,nM,CHEMBL1022147,B,Binding affinity to human androgen receptor,CHEMBL1152783,IC50,CC#C[C@@]1(O)CC[C@@]2(CC)c3ccc(O)cc3CC[C@@H]2C1,6.376750709602099
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.0
CHEMBL559246,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CC[C@@H]12,8.154901959985743
CHEMBL538137,CHEMBL1871,Androgen Receptor,IC50,=,31.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O,7.508638306165727
CHEMBL538877,CHEMBL1871,Androgen Receptor,IC50,=,24.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,COC[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O,7.619788758288394
CHEMBL556229,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)[C@H](Cc5cccc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12,7.638272163982407
CHEMBL562471,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cccc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12,7.568636235841012
CHEMBL556431,CHEMBL1871,Androgen Receptor,IC50,=,41.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cc(F)cc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12,7.3872161432802645
CHEMBL560935,CHEMBL1871,Androgen Receptor,IC50,=,116.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5ccccc5)C[C@H]4[C@@H]3CC[C@@H]12,6.935542010773082
CHEMBL557116,CHEMBL1871,Androgen Receptor,IC50,=,35.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,C/C=C1\C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O,7.455931955649724
CHEMBL559485,CHEMBL1871,Androgen Receptor,IC50,=,292.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5ccccn5)C[C@H]4[C@@H]3CC[C@@H]12,6.534617148551582
CHEMBL556848,CHEMBL1871,Androgen Receptor,IC50,=,129.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5ccncc5)C[C@H]4[C@@H]3CC[C@@H]12,6.889410289700751
CHEMBL562780,CHEMBL1871,Androgen Receptor,IC50,=,62.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cccnc5)C[C@H]4[C@@H]3CC[C@@H]12,7.207608310501746
CHEMBL551269,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cncnc5)C[C@H]4[C@@H]3CC[C@@H]12,7.229147988357855
CHEMBL551270,CHEMBL1871,Androgen Receptor,IC50,=,51.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cnc(C6CC6)nc5)C[C@H]4[C@@H]3CC[C@@H]12,7.292429823902063
CHEMBL559878,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,COc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1,7.958607314841775
CHEMBL549375,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,Cc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1,7.366531544420413
CHEMBL563597,CHEMBL1871,Androgen Receptor,IC50,=,31.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CNc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1,7.508638306165727
CHEMBL562394,CHEMBL1871,Androgen Receptor,IC50,=,715.0,nM,CHEMBL1062413,B,Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells,CHEMBL1153470,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cnc(-c6ccccn6)nc5)C[C@H]4[C@@H]3CC[C@@H]12,6.145693958198919
CHEMBL549725,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL1054363,B,Binding affinity to AR by fluorescence polarization based competition binding assay,CHEMBL1154030,IC50,CC(C(=O)N(C)C)N(CC(F)(F)F)c1ccc(C#N)c(C(F)(F)F)c1,5.795880017344075
CHEMBL558664,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL1054363,B,Binding affinity to AR by fluorescence polarization based competition binding assay,CHEMBL1154030,IC50,CN1CC[C@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1,6.6020599913279625
CHEMBL563341,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL1062687,B,Binding affinity to androgen receptor,CHEMBL1154038,IC50,CN1CC[C@@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1,6.6020599913279625
CHEMBL570708,CHEMBL1871,Androgen Receptor,IC50,=,1995.26,nM,CHEMBL1045527,B,Binding affinity to androgen receptor,CHEMBL1155365,IC50,Cc1c(C#N)c(Cl)nc2c3c(sc12)NC(=O)CC3c1ccccc1Cl,5.700000503883016
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,25.0,nM,CHEMBL1111210,B,Antagonist activity at androgen receptor ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay,CHEMBL1154793,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.6020599913279625
CHEMBL1097751,CHEMBL1871,Androgen Receptor,IC50,=,246.0,nM,CHEMBL1120988,B,Inhibition of androgen receptor,CHEMBL1157753,IC50,CC1=C(C#N)[C@@H](c2ccc(F)cc2Cl)C(C(=O)OC(C)(C)C)=C(C)N1,6.609064892896621
CHEMBL1094797,CHEMBL1871,Androgen Receptor,IC50,=,730.0,nM,CHEMBL1120988,B,Inhibition of androgen receptor,CHEMBL1157753,IC50,CCCC1=C(C(=O)OCC)[C@H](c2ccnc3ccccc23)C(C#N)=C(C)N1,6.136677139879544
CHEMBL1099083,CHEMBL1871,Androgen Receptor,IC50,=,1270.0,nM,CHEMBL1120988,B,Inhibition of androgen receptor,CHEMBL1157753,IC50,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)C)[C@@H]1c1cccc([N+](=O)[O-])c1,5.896196279044043
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.698970004336019
CHEMBL1099140,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C,7.823908740944319
CHEMBL1099141,CHEMBL1871,Androgen Receptor,IC50,=,3900.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)O,5.4089353929735005
CHEMBL1099142,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(N)=O,6.318758762624412
CHEMBL1095223,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCNC(N)=O,6.096910013008056
CHEMBL1095862,CHEMBL1871,Androgen Receptor,IC50,=,400.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCS(N)(=O)=O,6.3979400086720375
CHEMBL1095863,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CNS(=O)(=O)CCCN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C,6.769551078621726
CHEMBL1095864,CHEMBL1871,Androgen Receptor,IC50,=,80.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CN(C)S(=O)(=O)CCCN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C,7.096910013008056
CHEMBL1097855,CHEMBL1871,Androgen Receptor,IC50,=,770.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCS(N)(=O)=O,6.113509274827518
CHEMBL1098174,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,COc1cc(N2C(=O)C(C)(C)N(CCCS(N)(=O)=O)C2=S)ccc1C#N,5.721246399047171
CHEMBL1099086,CHEMBL1871,Androgen Receptor,IC50,=,440.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1CCCS(N)(=O)=O,6.356547323513812
CHEMBL1099087,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL1121343,B,Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting,CHEMBL1158555,IC50,Cc1c(N2C(=O)C(C)(C)N(CCCS(N)(=O)=O)C2=S)ccc(C#N)c1C(F)(F)F,6.585026652029182
CHEMBL1084843,CHEMBL1871,Androgen Receptor,IC50,=,316.0,nM,CHEMBL1118176,B,Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting,CHEMBL1155517,IC50,CSc1ccc(CN2CC(C)(C)[C@@H](Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1,6.500312917381596
CHEMBL507671,CHEMBL1871,Androgen Receptor,IC50,=,184.0,nM,CHEMBL1118176,B,Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting,CHEMBL1155517,IC50,N#Cc1ccc(Sc2ccccc2F)cc1C(F)(F)F,6.735182176990463
CHEMBL1085819,CHEMBL1871,Androgen Receptor,IC50,=,174.0,nM,CHEMBL1118176,B,Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting,CHEMBL1155517,IC50,CC1(C)CN(Cc2ccccc2F)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,6.7594507517174005
CHEMBL1085594,CHEMBL1871,Androgen Receptor,IC50,=,488.0,nM,CHEMBL1118176,B,Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting,CHEMBL1155517,IC50,N#Cc1ccc(Oc2ccc(F)cc2F)cc1C(F)(F)F,6.311580177997289
CHEMBL1085593,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1118176,B,Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting,CHEMBL1155517,IC50,CC1(C)CN(Cc2ccccc2)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,7.0
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,63.1,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,7.199970640755866
CHEMBL1082780,CHEMBL1871,Androgen Receptor,IC50,=,2511.89,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1ccsc1,5.59999938302362
CHEMBL1084013,CHEMBL1871,Androgen Receptor,IC50,=,3162.28,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,COc1cccc(S(=O)(=O)Nc2ccc(-c3ccc4c(cnn4-c4ccc(F)cc4)c3)c(C(F)(F)F)c2)c1,5.499999678657065
CHEMBL1084632,CHEMBL1871,Androgen Receptor,IC50,=,3162.28,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CCCS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.499999678657065
CHEMBL1085853,CHEMBL1871,Androgen Receptor,IC50,=,3162.28,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CCNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.499999678657065
CHEMBL1084014,CHEMBL1871,Androgen Receptor,IC50,=,3981.07,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1cccc(C(F)(F)F)c1,5.40000018605658
CHEMBL1084360,CHEMBL1871,Androgen Receptor,IC50,=,5011.87,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.300000202445418
CHEMBL1085625,CHEMBL1871,Androgen Receptor,IC50,=,5011.87,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CCS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.300000202445418
CHEMBL1083783,CHEMBL1871,Androgen Receptor,IC50,=,6309.57,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1ccccc1,5.200000237109354
CHEMBL1085381,CHEMBL1871,Androgen Receptor,IC50,=,6309.57,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CC(C)CNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.200000237109354
CHEMBL1085380,CHEMBL1871,Androgen Receptor,IC50,=,6309.57,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,CCCNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.200000237109354
CHEMBL1086086,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL1119509,B,Binding affinity to AR,CHEMBL1155531,IC50,O=S(=O)(NCCO)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1,5.0
CHEMBL1163630,CHEMBL1871,Androgen Receptor,IC50,=,2.9,nM,CHEMBL1166105,B,Binding affinity to androgen receptor,CHEMBL1165993,IC50,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1ccco1)c1ccc(Cl)cc1,8.537602002101044
CHEMBL1276308,CHEMBL1871,Androgen Receptor,IC50,=,6.9,nM,CHEMBL1211472,B,Antagonist activity at androgen receptor ligand binding domain by two hybrid assay,CHEMBL1208786,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.161150909262744
CHEMBL1209236,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1211472,B,Antagonist activity at androgen receptor ligand binding domain by two hybrid assay,CHEMBL1208786,IC50,Cn1c(C#N)ccc1-c1ccc(C(=O)C(C)(C)C)cc1,7.0
CHEMBL1209298,CHEMBL1871,Androgen Receptor,IC50,=,165.0,nM,CHEMBL1211472,B,Antagonist activity at androgen receptor ligand binding domain by two hybrid assay,CHEMBL1208786,IC50,Cn1c(C#N)ccc1-c1ccc(/C(=N\O)C(C)(C)C)cc1,6.782516055786093
CHEMBL216272,CHEMBL1871,Androgen Receptor,IC50,=,630.96,nM,CHEMBL1261749,B,Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells,CHEMBL1255506,IC50,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12,6.199998172182031
CHEMBL263091,CHEMBL1871,Androgen Receptor,IC50,=,501.19,nM,CHEMBL1261749,B,Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells,CHEMBL1255506,IC50,COc1ccc(F)cc1C(C)(C)CC(O)(C(=O)Nc1ccc2c(=O)onc(C)c2c1)C(F)(F)F,6.299997602857746
CHEMBL196374,CHEMBL1871,Androgen Receptor,IC50,=,158.49,nM,CHEMBL1261749,B,Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells,CHEMBL1255506,IC50,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cc(F)ccc3O)C(F)(F)F)cc12,6.799998134593398
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,7.522878745280337
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.0
CHEMBL166444,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.154901959985743
CHEMBL1288956,CHEMBL1871,Androgen Receptor,IC50,=,1420.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,Oc1cccc2c1[nH]c1ccc(Br)cc12,5.847711655616943
CHEMBL1288957,CHEMBL1871,Androgen Receptor,IC50,=,4600.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,N#Cc1ccc2[nH]c3c(O)cccc3c2c1,5.337242168318426
CHEMBL1288958,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,Oc1c(Br)ccc2c1[nH]c1cc(Cl)c(Cl)cc12,7.468521082957745
CHEMBL1288959,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,Oc1cccc2c1[nH]c1ccc(Cl)c(Cl)c12,7.823908740944319
CHEMBL1288979,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(Cl)cc21,7.468521082957745
CHEMBL1288980,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)ccc(Cl)c21,7.070581074285707
CHEMBL1290632,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCCc2c1[nH]c1c(Cl)cc(Cl)cc21,6.221848749616356
CHEMBL1288981,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(F)cc21,7.045757490560675
CHEMBL1289012,CHEMBL1871,Androgen Receptor,IC50,=,9200.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,CC1(O)CCCc2c1[nH]c1ccc(C#N)cc21,5.036212172654444
CHEMBL1289013,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,N#Cc1ccc2[nH]c3c(c2c1)CCCC3(O)C(F)(F)F,6.318758762624412
CHEMBL1288321,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,7.568636235841012
CHEMBL1288322,CHEMBL1871,Androgen Receptor,IC50,=,95.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1ccc(Cl)c(Cl)c21,7.022276394711152
CHEMBL1290633,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,7.468521082957745
CHEMBL1290751,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)c2[nH]c3c(Cl)cc(Cl)cc3c2CCC1(F)F,7.0
CHEMBL1288323,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL1291059,B,Binding affinity to androgen receptor by fluorescence binding assay,CHEMBL1287721,IC50,OC1(C(F)(F)F)CCc2c1[nH]c1c(Cl)cc(Cl)cc21,7.886056647693163
CHEMBL591628,CHEMBL1871,Androgen Receptor,IC50,=,31500.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,CCOc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O,4.501689446210399
CHEMBL1527972,CHEMBL1871,Androgen Receptor,IC50,=,30700.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1,4.512861624522814
CHEMBL1302748,CHEMBL1871,Androgen Receptor,IC50,=,32900.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,COc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O,4.482804102050026
CHEMBL1822155,CHEMBL1871,Androgen Receptor,IC50,=,8200.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,COc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O,5.086186147616283
CHEMBL1822156,CHEMBL1871,Androgen Receptor,IC50,=,30580.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O,4.514562518923698
CHEMBL1822157,CHEMBL1871,Androgen Receptor,IC50,=,26000.0,nM,CHEMBL1826238,B,Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay,CHEMBL1821560,IC50,CC1=NN(c2ccccc2)C(=O)/C1=N\Nc1ccc(C(=O)O)c(O)c1,4.585026652029182
CHEMBL591628,CHEMBL1871,Androgen Receptor,IC50,=,11100.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,CCOc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O,4.954677021213342
CHEMBL1527972,CHEMBL1871,Androgen Receptor,IC50,=,5900.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1,5.229147988357855
CHEMBL1302748,CHEMBL1871,Androgen Receptor,IC50,=,4600.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,COc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O,5.337242168318426
CHEMBL1822155,CHEMBL1871,Androgen Receptor,IC50,=,34400.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,COc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O,4.46344155742847
CHEMBL1822156,CHEMBL1871,Androgen Receptor,IC50,=,18640.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O,4.729554091982037
CHEMBL1822157,CHEMBL1871,Androgen Receptor,IC50,=,33400.0,nM,CHEMBL1826239,B,Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity,CHEMBL1821560,IC50,CC1=NN(c2ccccc2)C(=O)/C1=N\Nc1ccc(C(=O)O)c(O)c1,4.476253533188435
CHEMBL1830944,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2cccc(O)c2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.958607314841775
CHEMBL1830943,CHEMBL1871,Androgen Receptor,IC50,=,17.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccc2O)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.769551078621726
CHEMBL1830945,CHEMBL1871,Androgen Receptor,IC50,=,17.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccc(O)cc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.769551078621726
CHEMBL1830789,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.522878745280337
CHEMBL1830952,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2nc3ccccc3s2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.366531544420413
CHEMBL1830941,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2cccc(F)c2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.318758762624412
CHEMBL1830769,CHEMBL1871,Androgen Receptor,IC50,=,70.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)COC(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,7.154901959985743
CHEMBL1830954,CHEMBL1871,Androgen Receptor,IC50,=,84.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2noc(-c3ccccc3)n2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.075720713938118
CHEMBL1830775,CHEMBL1871,Androgen Receptor,IC50,=,91.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,7.040958607678906
CHEMBL1830789,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,7.0
CHEMBL1830938,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COc1cccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)c1,6.958607314841775
CHEMBL1830940,CHEMBL1871,Androgen Receptor,IC50,=,112.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccc2F)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.950781977329818
CHEMBL1830768,CHEMBL1871,Androgen Receptor,IC50,=,113.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)COC(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.94692155651658
CHEMBL1830775,CHEMBL1871,Androgen Receptor,IC50,=,119.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.924453038607469
CHEMBL1830949,CHEMBL1871,Androgen Receptor,IC50,=,128.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccncc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.892790030352131
CHEMBL1830779,CHEMBL1871,Androgen Receptor,IC50,=,132.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCC(C)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.8794260687941495
CHEMBL1830942,CHEMBL1871,Androgen Receptor,IC50,=,144.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccc(F)cc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.84163750790475
CHEMBL1830955,CHEMBL1871,Androgen Receptor,IC50,=,159.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2nc(-c3ccccc3)no2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.798602875679549
CHEMBL1830950,CHEMBL1871,Androgen Receptor,IC50,=,166.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCOC(=O)c1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)o1,6.779891911959945
CHEMBL1830940,CHEMBL1871,Androgen Receptor,IC50,=,174.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccc2F)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.7594507517174005
CHEMBL1830946,CHEMBL1871,Androgen Receptor,IC50,=,187.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CSc1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1,6.7281583934635005
CHEMBL1830774,CHEMBL1871,Androgen Receptor,IC50,=,188.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.7258421507363195
CHEMBL1830778,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCC(C)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.698970004336019
CHEMBL1830951,CHEMBL1871,Androgen Receptor,IC50,=,215.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COC(=O)c1csc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)n1,6.667561540084394
CHEMBL1830774,CHEMBL1871,Androgen Receptor,IC50,=,225.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.647817481888637
CHEMBL1830776,CHEMBL1871,Androgen Receptor,IC50,=,268.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.571865205971211
CHEMBL1830939,CHEMBL1871,Androgen Receptor,IC50,=,284.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COc1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1,6.546681659952963
CHEMBL1830937,CHEMBL1871,Androgen Receptor,IC50,=,298.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COc1ccccc1CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.525783735923745
CHEMBL1830946,CHEMBL1871,Androgen Receptor,IC50,=,316.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CSc1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1,6.500312917381596
CHEMBL1830953,CHEMBL1871,Androgen Receptor,IC50,=,324.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,Cc1nc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cs1,6.489454989793388
CHEMBL1830773,CHEMBL1871,Androgen Receptor,IC50,=,399.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.399027104313252
CHEMBL1830780,CHEMBL1871,Androgen Receptor,IC50,=,444.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCC(CC)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.35261702988538
CHEMBL1830786,CHEMBL1871,Androgen Receptor,IC50,=,494.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.306273051076353
CHEMBL1830782,CHEMBL1871,Androgen Receptor,IC50,=,516.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.287350298372789
CHEMBL1830785,CHEMBL1871,Androgen Receptor,IC50,=,523.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(CCCO)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.281498311132726
CHEMBL1830777,CHEMBL1871,Androgen Receptor,IC50,=,766.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCCCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.115771230367396
CHEMBL1830947,CHEMBL1871,Androgen Receptor,IC50,=,767.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2ccccn2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.115204636051019
CHEMBL1830781,CHEMBL1871,Androgen Receptor,IC50,=,802.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC(C)CCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,6.095825631715837
CHEMBL1830948,CHEMBL1871,Androgen Receptor,IC50,=,880.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CN(Cc2cccnc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,6.055517327849831
CHEMBL1830772,CHEMBL1871,Androgen Receptor,IC50,=,1210.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.917214629683549
CHEMBL1830783,CHEMBL1871,Androgen Receptor,IC50,=,1770.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,COCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.752026733638193
CHEMBL1830784,CHEMBL1871,Androgen Receptor,IC50,=,2450.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CSCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.610833915635467
CHEMBL1830771,CHEMBL1871,Androgen Receptor,IC50,=,2790.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)CNC(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1,5.554395796726403
CHEMBL1830787,CHEMBL1871,Androgen Receptor,IC50,=,3520.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCOC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.453457336521868
CHEMBL1830788,CHEMBL1871,Androgen Receptor,IC50,=,4910.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCNC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.308918507877031
CHEMBL1830779,CHEMBL1871,Androgen Receptor,IC50,=,9790.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CCC(C)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.009217308196862
CHEMBL1830770,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL1833026,B,Binding affinity to human androgen receptor,CHEMBL1828515,IC50,CC1(C)COC(=O)[C@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,5.0
CHEMBL1835807,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL1838302,B,Displacement of [3H]DHT from human recombinant androgen receptor-LBD expressed in Escherichia coli after 18 hrs by liquid scintillation counting,CHEMBL1833942,IC50,CCN(CC)c1cc2oc(=O)ccc2cc1-c1ccccc1,5.0
CHEMBL1835832,CHEMBL1871,Androgen Receptor,IC50,=,9700.0,nM,CHEMBL1838302,B,Displacement of [3H]DHT from human recombinant androgen receptor-LBD expressed in Escherichia coli after 18 hrs by liquid scintillation counting,CHEMBL1833942,IC50,CCN(CC)c1cc2oc(=O)ccc2cc1-c1cccs1,5.013228265733755
CHEMBL1923999,CHEMBL1871,Androgen Receptor,IC50,=,50000.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,O=C(O)c1cccc(CSc2ccc(Cl)cc2Cl)c1,4.301029995663981
CHEMBL1738937,CHEMBL1871,Androgen Receptor,IC50,=,50000.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,Cc1ccc(OCCn2c(SCCC(=O)O)nc3ccccc32)cc1,4.301029995663981
CHEMBL1738936,CHEMBL1871,Androgen Receptor,IC50,=,13100.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,Cc1ccc(OCCn2c(SCCOc3ccccc3)nc3ccccc32)cc1,4.882728704344236
CHEMBL52,CHEMBL1871,Androgen Receptor,IC50,=,38800.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1,4.411168274405793
CHEMBL1924000,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,COC(=O)c1ccc([C@H]2Nc3ccc(C(C)=O)cc3[C@H]3C=CC[C@H]32)cc1,5.920818753952375
CHEMBL1924001,CHEMBL1871,Androgen Receptor,IC50,=,900.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,CCOC(=O)c1ccc2c(c1)[C@H]1C=CC[C@@H]1[C@@H](c1ccccc1)N2,6.045757490560675
CHEMBL1924002,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,NS(=O)(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@@H](c1ccc(Br)cc1)N2,6.301029995663981
CHEMBL240331,CHEMBL1871,Androgen Receptor,IC50,=,50000.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,O=C(CSc1nc(O)c2ccccc2n1)c1ccc(O)c(O)c1,4.301029995663981
CHEMBL1924003,CHEMBL1871,Androgen Receptor,IC50,=,50000.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,Cc1cc(/C=C/C(=O)O)c(C)n1-c1ccc2c(c1)OCO2,4.301029995663981
CHEMBL41632,CHEMBL1871,Androgen Receptor,IC50,=,34800.0,nM,CHEMBL1925688,B,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL1921777,IC50,O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1,4.458420756053419
CHEMBL1928872,CHEMBL1871,Androgen Receptor,IC50,=,3600.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,O=C1COc2ccc(C3=Nn4cnnc4SC3c3ccccc3)cc2N1,5.443697499232712
CHEMBL1928874,CHEMBL1871,Androgen Receptor,IC50,=,5900.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,O=C1COc2ccc(C3=Nn4cnnc4SC3c3ccccc3F)cc2N1,5.229147988357855
CHEMBL1928875,CHEMBL1871,Androgen Receptor,IC50,=,4700.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,O=C1COc2ccc(C3=Nn4cnnc4SC3c3cccc(F)c3)cc2N1,5.327902142064282
CHEMBL1928877,CHEMBL1871,Androgen Receptor,IC50,=,95.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,O=C1COc2ccc(C3=Nn4ccnc4SC3c3ccccc3)cc2N1,7.022276394711152
CHEMBL1928878,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,O=C1COc2ccc(C3=Nc4ccccc4SC3c3ccccc3)cc2N1,5.920818753952375
CHEMBL1929041,CHEMBL1871,Androgen Receptor,IC50,=,4500.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,Cc1cc(F)ccc1-n1nc(C(F)(F)F)cc1-c1cc(Cl)c2c(c1)NC(=O)CO2,5.346787486224656
CHEMBL1393,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL1929758,B,Displacement of [3H]testosterone from AR,CHEMBL1926625,IC50,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,6.920818753952375
CHEMBL1934427,CHEMBL1871,Androgen Receptor,IC50,=,22.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(C)[nH]c(C)c1-c1ccc([N+](=O)[O-])cc1,7.657577319177793
CHEMBL1934428,CHEMBL1871,Androgen Receptor,IC50,=,47.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C)c1C,7.327902142064282
CHEMBL1934429,CHEMBL1871,Androgen Receptor,IC50,=,550.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(-c2ccccc2)c1C,6.259637310505756
CHEMBL1934430,CHEMBL1871,Androgen Receptor,IC50,=,5.5,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,8.259637310505756
CHEMBL1934431,CHEMBL1871,Androgen Receptor,IC50,=,310.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CC2CCCCC2)c1C,6.508638306165727
CHEMBL1933081,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CCc2ccccc2)c1C,6.823908740944319
CHEMBL1934432,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C(=O)c2ccccc2)c1C,6.823908740944319
CHEMBL1934433,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(S(=O)(=O)c2ccccc2)c1C,6.886056647693163
CHEMBL1934434,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,8.301029995663981
CHEMBL1934435,CHEMBL1871,Androgen Receptor,IC50,=,620.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C(=O)O)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,6.207608310501746
CHEMBL1934436,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(CO)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,6.522878745280337
CHEMBL1934437,CHEMBL1871,Androgen Receptor,IC50,=,390.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,6.4089353929735005
CHEMBL1934438,CHEMBL1871,Androgen Receptor,IC50,=,6.7,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1cc(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,8.173925197299173
CHEMBL1934439,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccccc2)c(C)n(Cc2ccccc2)c1C,6.886056647693163
CHEMBL1934440,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc(C#N)cc2)c(C)n(Cc2ccccc2)c1C,7.568636235841012
CHEMBL1934441,CHEMBL1871,Androgen Receptor,IC50,=,3.9,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)n(Cc2ccccc2)c1C,8.4089353929735
CHEMBL1934442,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccccc1,8.853871964321762
CHEMBL1934443,CHEMBL1871,Androgen Receptor,IC50,=,3.4,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cccnc1,8.468521082957745
CHEMBL1934444,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(Cl)nc1,8.045757490560675
CHEMBL1934445,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cncc(CO)c1,7.853871964321762
CHEMBL1934446,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cnc(Cl)c(CO)c1,7.431798275933005
CHEMBL1934447,CHEMBL1871,Androgen Receptor,IC50,=,490.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(-c2ccc(C#N)cc2)c(C#N)cn1Cc1cnc(Cl)c(CO)c1,6.309803919971486
CHEMBL1934448,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)cn1Cc1cnc(Cl)c(CO)c1,7.107905397309519
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.267606240177031
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,2.1,nM,CHEMBL1937839,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.67778070526608
CHEMBL1934427,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(C)[nH]c(C)c1-c1ccc([N+](=O)[O-])cc1,7.468521082957745
CHEMBL1934428,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C)c1C,7.522878745280337
CHEMBL1934429,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(-c2ccccc2)c1C,6.657577319177793
CHEMBL1934430,CHEMBL1871,Androgen Receptor,IC50,=,5.2,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,8.2839966563652
CHEMBL1934431,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CC2CCCCC2)c1C,6.455931955649724
CHEMBL1933081,CHEMBL1871,Androgen Receptor,IC50,=,52.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CCc2ccccc2)c1C,7.2839966563652006
CHEMBL1934432,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C(=O)c2ccccc2)c1C,7.070581074285707
CHEMBL1934433,CHEMBL1871,Androgen Receptor,IC50,=,62.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(S(=O)(=O)c2ccccc2)c1C,7.207608310501746
CHEMBL1934434,CHEMBL1871,Androgen Receptor,IC50,=,3.8,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,8.42021640338319
CHEMBL1934435,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C(=O)O)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,6.721246399047171
CHEMBL1934436,CHEMBL1871,Androgen Receptor,IC50,=,92.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(CO)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,7.036212172654444
CHEMBL1934437,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C,6.886056647693163
CHEMBL1934438,CHEMBL1871,Androgen Receptor,IC50,=,2.2,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1cc(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1,8.657577319177793
CHEMBL1934439,CHEMBL1871,Androgen Receptor,IC50,=,65.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccccc2)c(C)n(Cc2ccccc2)c1C,7.187086643357144
CHEMBL1934440,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc(C#N)cc2)c(C)n(Cc2ccccc2)c1C,7.638272163982407
CHEMBL1934441,CHEMBL1871,Androgen Receptor,IC50,=,4.7,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,COC(=O)c1c(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)n(Cc2ccccc2)c1C,8.327902142064282
CHEMBL1934442,CHEMBL1871,Androgen Receptor,IC50,=,3.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccccc1,8.522878745280337
CHEMBL1934443,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cccnc1,7.638272163982407
CHEMBL1934444,CHEMBL1871,Androgen Receptor,IC50,=,24.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(Cl)nc1,7.619788758288394
CHEMBL1934445,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cncc(CO)c1,6.823908740944319
CHEMBL1934446,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cnc(Cl)c(CO)c1,7.0
CHEMBL1934447,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(-c2ccc(C#N)cc2)c(C#N)cn1Cc1cnc(Cl)c(CO)c1,5.958607314841775
CHEMBL1934448,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)cn1Cc1cnc(Cl)c(CO)c1,6.795880017344075
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.920818753952375
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,2.6,nM,CHEMBL1937840,B,Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs,CHEMBL1932924,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.585026652029182
CHEMBL1957611,CHEMBL1871,Androgen Receptor,IC50,=,91.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)cc2)c(C)c1Cc1ccc(F)cc1,7.040958607678906
CHEMBL1957612,CHEMBL1871,Androgen Receptor,IC50,=,0.47,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(F)cc1,9.327902142064282
CHEMBL1957613,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(F)cc1,8.853871964321762
CHEMBL1957614,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)cc2Cl)c(C)c1Cc1ccc(F)cc1,5.823908740944319
CHEMBL1957615,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(F)cc1,6.958607314841775
CHEMBL1957616,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1-c1ccc(F)cc1,6.7447274948966935
CHEMBL1957617,CHEMBL1871,Androgen Receptor,IC50,=,53.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(F)cc1,7.275724130399211
CHEMBL1957618,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1C(O)c1ccc(F)cc1,7.585026652029182
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.267606240177031
CHEMBL1957619,CHEMBL1871,Androgen Receptor,IC50,=,4200.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccccc1C(N)=O,5.376750709602099
CHEMBL1957620,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1cccc(C(N)=O)c1,6.585026652029182
CHEMBL1957621,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(N)=O)cc1,7.795880017344075
CHEMBL1957622,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CNC(=O)c1ccc(Cc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cc1,7.568636235841012
CHEMBL1957721,CHEMBL1871,Androgen Receptor,IC50,=,920.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N(C)C)cc1,6.036212172654444
CHEMBL1957607,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NC(C)(C)C)cc1,6.958607314841775
CHEMBL1957722,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCCO)cc1,6.795880017344075
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,6.468521082957745
CHEMBL1957609,CHEMBL1871,Androgen Receptor,IC50,=,510.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N2CCOCC2)cc1,6.292429823902063
CHEMBL1957610,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NCC(C)(C)O)cc1,5.958607314841775
CHEMBL1957723,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)N2CCOCC2)cc1,5.886056647693163
CHEMBL1957724,CHEMBL1871,Androgen Receptor,IC50,=,5400.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)nc1,5.267606240177031
CHEMBL1957725,CHEMBL1871,Androgen Receptor,IC50,=,4300.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(NC(=O)C(C)(C)C)cn1,5.366531544420413
CHEMBL1957726,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL1960482,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cn1,5.920818753952375
CHEMBL1957611,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)cc2)c(C)c1Cc1ccc(F)cc1,7.221848749616356
CHEMBL1957612,CHEMBL1871,Androgen Receptor,IC50,=,0.7,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(F)cc1,9.154901959985743
CHEMBL1957613,CHEMBL1871,Androgen Receptor,IC50,=,0.95,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(F)cc1,9.022276394711152
CHEMBL1957614,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)cc2Cl)c(C)c1Cc1ccc(F)cc1,6.455931955649724
CHEMBL1957615,CHEMBL1871,Androgen Receptor,IC50,=,6.3,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(F)cc1,8.200659450546418
CHEMBL1957616,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1-c1ccc(F)cc1,7.481486060122112
CHEMBL1957617,CHEMBL1871,Androgen Receptor,IC50,=,18.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(F)cc1,7.7447274948966935
CHEMBL1957618,CHEMBL1871,Androgen Receptor,IC50,=,8.3,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1C(O)c1ccc(F)cc1,8.080921907623926
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.920818753952375
CHEMBL1957619,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccccc1C(N)=O,5.823908740944319
CHEMBL1957620,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1cccc(C(N)=O)c1,6.698970004336019
CHEMBL1957621,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(N)=O)cc1,8.0
CHEMBL1957622,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CNC(=O)c1ccc(Cc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cc1,7.886056647693163
CHEMBL1957721,CHEMBL1871,Androgen Receptor,IC50,=,460.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N(C)C)cc1,6.337242168318426
CHEMBL1957607,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NC(C)(C)C)cc1,7.0
CHEMBL1957722,CHEMBL1871,Androgen Receptor,IC50,=,99.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCCO)cc1,7.00436480540245
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,6.795880017344075
CHEMBL1957609,CHEMBL1871,Androgen Receptor,IC50,=,700.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N2CCOCC2)cc1,6.154901959985743
CHEMBL1957610,CHEMBL1871,Androgen Receptor,IC50,=,55.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NCC(C)(C)O)cc1,7.259637310505756
CHEMBL1957723,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)N2CCOCC2)cc1,6.7447274948966935
CHEMBL1957724,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)nc1,6.568636235841012
CHEMBL1957725,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(NC(=O)C(C)(C)C)cn1,6.468521082957745
CHEMBL1957726,CHEMBL1871,Androgen Receptor,IC50,=,83.0,nM,CHEMBL1960483,B,Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor T877A mutant expressed in HEK293 cells after 3 hrs,CHEMBL1955860,IC50,CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cn1,7.080921907623926
CHEMBL2159550,CHEMBL1871,Androgen Receptor,IC50,=,13182.57,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1,4.879999913868448
CHEMBL2159549,CHEMBL1871,Androgen Receptor,IC50,=,2818.38,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F,5.550000451689026
CHEMBL2159549,CHEMBL1871,Androgen Receptor,IC50,=,5888.44,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F,5.229999745811778
CHEMBL2159548,CHEMBL1871,Androgen Receptor,IC50,=,776.25,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1,6.109998386815363
CHEMBL2159548,CHEMBL1871,Androgen Receptor,IC50,=,741.31,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1,6.130000141365475
CHEMBL2159547,CHEMBL1871,Androgen Receptor,IC50,=,707.95,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F,6.149997413907538
CHEMBL2159546,CHEMBL1871,Androgen Receptor,IC50,=,1995.26,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1,5.700000503883016
CHEMBL2159546,CHEMBL1871,Androgen Receptor,IC50,=,645.65,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1,6.190002844637807
CHEMBL2159545,CHEMBL1871,Androgen Receptor,IC50,=,295.12,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F,6.530001357781253
CHEMBL2159544,CHEMBL1871,Androgen Receptor,IC50,=,660.69,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1,6.180002266489224
CHEMBL2159544,CHEMBL1871,Androgen Receptor,IC50,=,812.83,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1,6.090000275786018
CHEMBL2159543,CHEMBL1871,Androgen Receptor,IC50,=,10964.78,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F,4.96000007768865
CHEMBL2159542,CHEMBL1871,Androgen Receptor,IC50,=,389.05,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@H]3CCCCC[C@@H]23)c(C(F)(F)F)c1,6.40999458034867
CHEMBL2159541,CHEMBL1871,Androgen Receptor,IC50,=,309.03,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCCCC[C@H]23)c(C(F)(F)F)c1,6.509999358109048
CHEMBL2159540,CHEMBL1871,Androgen Receptor,IC50,=,104.71,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F,6.980011840408714
CHEMBL2159539,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1,6.0
CHEMBL2159539,CHEMBL1871,Androgen Receptor,IC50,=,1148.15,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1,5.940001369850309
CHEMBL2159561,CHEMBL1871,Androgen Receptor,IC50,=,43.65,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F,7.360015751958412
CHEMBL2159573,CHEMBL1871,Androgen Receptor,IC50,=,977.24,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1,6.009998764965339
CHEMBL2159573,CHEMBL1871,Androgen Receptor,IC50,=,1148.15,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1,5.940001369850309
CHEMBL2159572,CHEMBL1871,Androgen Receptor,IC50,=,1096.48,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F,5.95999928552668
CHEMBL2159571,CHEMBL1871,Androgen Receptor,IC50,=,263.03,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@H]3CCCC[C@@H]23)c(C(F)(F)F)c1,6.579994715040948
CHEMBL2159570,CHEMBL1871,Androgen Receptor,IC50,=,128.82,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCCC[C@H]23)c(C(F)(F)F)c1,6.890016705180107
CHEMBL2159569,CHEMBL1871,Androgen Receptor,IC50,=,120.23,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F,6.919987152892072
CHEMBL2159568,CHEMBL1871,Androgen Receptor,IC50,=,64.57,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1cccc(C2=NOC3CCCCC23)c1C(F)(F)F,7.189969213594161
CHEMBL2159568,CHEMBL1871,Androgen Receptor,IC50,=,79.43,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1cccc(C2=NOC3CCCCC23)c1C(F)(F)F,7.100015437450609
CHEMBL2159567,CHEMBL1871,Androgen Receptor,IC50,=,1148.15,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1,5.940001369850309
CHEMBL2159567,CHEMBL1871,Androgen Receptor,IC50,=,1778.28,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1,5.749999855918706
CHEMBL2159566,CHEMBL1871,Androgen Receptor,IC50,=,27.54,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F,7.560036064079095
CHEMBL2159565,CHEMBL1871,Androgen Receptor,IC50,=,1548.82,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1,5.809999051930337
CHEMBL2159565,CHEMBL1871,Androgen Receptor,IC50,=,1348.96,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1,5.8700009280425745
CHEMBL2159564,CHEMBL1871,Androgen Receptor,IC50,=,1479.11,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,Fc1ccc(C2=NOC3CCCC23)cc1C(F)(F)F,5.829999526735649
CHEMBL2159563,CHEMBL1871,Androgen Receptor,IC50,=,269.15,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1,6.570005615848293
CHEMBL2159562,CHEMBL1871,Androgen Receptor,IC50,=,302.0,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCC[C@H]23)cc1C(F)(F)F,6.51999305704285
CHEMBL2159732,CHEMBL1871,Androgen Receptor,IC50,=,2511.89,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,O=[N+]([O-])c1ccc(C2=NO[C@H]3CCC[C@@H]23)cc1C(F)(F)F,5.59999938302362
CHEMBL2159731,CHEMBL1871,Androgen Receptor,IC50,=,446.68,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1,6.350003492533959
CHEMBL2159730,CHEMBL1871,Androgen Receptor,IC50,=,223.87,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NO[C@@H]3CCC[C@H]23)cc1C(F)(F)F,6.650004100737144
CHEMBL2159729,CHEMBL1871,Androgen Receptor,IC50,=,616.6,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,N#Cc1ccc(C2=NO[C@H]3CCC[C@@H]23)cc1C(F)(F)F,6.209996479609511
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,4.571,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.33998877871067
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,223.87,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.650004100737144
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,120.23,nM,CHEMBL2162624,B,Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay,CHEMBL2157978,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.919987152892072
CHEMBL2177238,CHEMBL1871,Androgen Receptor,IC50,=,9.6,nM,CHEMBL2187508,B,Binding affinity to androgen receptor by competitive binding assay,CHEMBL2176865,IC50,CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(C)c1ccc(O)cc1,8.017728766960431
CHEMBL2316547,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL2318840,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12,5.795880017344075
CHEMBL2316542,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL2318840,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,Cc1cccc(C)c1OCCSc1nc2ccccc2[nH]1,5.721246399047171
CHEMBL2316540,CHEMBL1871,Androgen Receptor,IC50,=,3300.0,nM,CHEMBL2318840,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,Cc1cccc(OCCSc2nc3ccccc3[nH]2)c1,5.481486060122112
CHEMBL1563710,CHEMBL1871,Androgen Receptor,IC50,=,4300.0,nM,CHEMBL2318840,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,c1ccc(OCCSc2nc3ccccc3[nH]2)cc1,5.366531544420413
CHEMBL2316547,CHEMBL1871,Androgen Receptor,IC50,=,6400.0,nM,CHEMBL2318839,B,Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12,5.1938200260161125
CHEMBL2316542,CHEMBL1871,Androgen Receptor,IC50,=,6800.0,nM,CHEMBL2318839,B,Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,Cc1cccc(C)c1OCCSc1nc2ccccc2[nH]1,5.167491087293763
CHEMBL2316540,CHEMBL1871,Androgen Receptor,IC50,=,13000.0,nM,CHEMBL2318839,B,Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,Cc1cccc(OCCSc2nc3ccccc3[nH]2)c1,4.886056647693163
CHEMBL1563710,CHEMBL1871,Androgen Receptor,IC50,=,21000.0,nM,CHEMBL2318839,B,Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days,CHEMBL2311268,IC50,c1ccc(OCCSc2nc3ccccc3[nH]2)cc1,4.6777807052660805
CHEMBL2316547,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12,5.823908740944319
CHEMBL2316546,CHEMBL1871,Androgen Receptor,IC50,=,5400.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,c1ccc(OCCSc2cc3ccccc3[nH]2)cc1,5.267606240177031
CHEMBL2316545,CHEMBL1871,Androgen Receptor,IC50,=,62000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,NS(=O)(=O)c1ccc(OCCSc2nc3ccccc3[nH]2)cc1,4.2076083105017466
CHEMBL2316544,CHEMBL1871,Androgen Receptor,IC50,=,4000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Clc1ccc(OCCSc2nc3ccccc3[nH]2)cc1,5.3979400086720375
CHEMBL2316543,CHEMBL1871,Androgen Receptor,IC50,=,5000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Clc1cccc(OCCSc2nc3ccccc3[nH]2)c1,5.301029995663981
CHEMBL2316542,CHEMBL1871,Androgen Receptor,IC50,=,2700.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1cccc(C)c1OCCSc1nc2ccccc2[nH]1,5.568636235841012
CHEMBL2316541,CHEMBL1871,Androgen Receptor,IC50,=,7000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccc(OCCSc2nc3ccccc3[nH]2)cc1,5.154901959985743
CHEMBL2316540,CHEMBL1871,Androgen Receptor,IC50,=,1800.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1cccc(OCCSc2nc3ccccc3[nH]2)c1,5.7447274948966935
CHEMBL2316539,CHEMBL1871,Androgen Receptor,IC50,=,19000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccccc1OCCSc1nc2ccccc2[nH]1,4.721246399047171
CHEMBL2316538,CHEMBL1871,Androgen Receptor,IC50,=,7400.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,c1ccc(CCSc2nc3ccccc3[nH]2)cc1,5.130768280269024
CHEMBL2316535,CHEMBL1871,Androgen Receptor,IC50,=,12000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,c1ccc(CCCSc2nc3ccccc3[nH]2)cc1,4.920818753952375
CHEMBL2316554,CHEMBL1871,Androgen Receptor,IC50,=,12000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCn1c(SCCOc2ccccc2)nc2ccccc21,4.920818753952375
CHEMBL1563710,CHEMBL1871,Androgen Receptor,IC50,=,4200.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,c1ccc(OCCSc2nc3ccccc3[nH]2)cc1,5.376750709602099
CHEMBL1539990,CHEMBL1871,Androgen Receptor,IC50,=,163800.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)O)cc1,3.7856861025756006
CHEMBL2316570,CHEMBL1871,Androgen Receptor,IC50,=,55000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCOC(=O)Cn1c(SCCOc2cccc(CC)c2)nc2ccccc21,4.259637310505756
CHEMBL2316569,CHEMBL1871,Androgen Receptor,IC50,=,45000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1cccc(OCCSc2nc3ccccc3n2C)c1,4.346787486224656
CHEMBL2316568,CHEMBL1871,Androgen Receptor,IC50,=,40300.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCOC(=O)Cn1c(SCCOc2ccc(C)c(C)c2)nc2ccccc21,4.394694953858891
CHEMBL2316567,CHEMBL1871,Androgen Receptor,IC50,=,35000.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCn1c(SCCOc2cccc(C)c2)nc2ccccc21,4.455931955649724
CHEMBL2316566,CHEMBL1871,Androgen Receptor,IC50,=,32900.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,COC(=O)Cn1c(SCCOc2ccc(C)cc2)nc2ccccc21,4.482804102050026
CHEMBL2316565,CHEMBL1871,Androgen Receptor,IC50,=,30600.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)cc1C,4.51427857351842
CHEMBL2316564,CHEMBL1871,Androgen Receptor,IC50,=,24100.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,COCCn1c(SCCOc2cccc(C)c2)nc2ccccc21,4.617982957425132
CHEMBL2316563,CHEMBL1871,Androgen Receptor,IC50,=,22800.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCOc1cccc(OCCSc2nc3ccccc3n2CCOc2ccc(C)cc2)c1,4.642065152999546
CHEMBL2316562,CHEMBL1871,Androgen Receptor,IC50,=,14100.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,CCOC(=O)Cn1c(SCCOc2cccc(C)c2)nc2ccccc21,4.85078088734462
CHEMBL2316561,CHEMBL1871,Androgen Receptor,IC50,=,13700.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1cccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)c1,4.863279432843593
CHEMBL2316560,CHEMBL1871,Androgen Receptor,IC50,=,12700.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,COCCn1c(SCCOc2ccc(C)cc2)nc2ccccc21,4.896196279044043
CHEMBL2316559,CHEMBL1871,Androgen Receptor,IC50,=,11100.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)cc1,4.954677021213342
CHEMBL1738936,CHEMBL1871,Androgen Receptor,IC50,=,13100.0,nM,CHEMBL2318841,B,Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay,CHEMBL2311268,IC50,Cc1ccc(OCCn2c(SCCOc3ccccc3)nc3ccccc32)cc1,4.882728704344236
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.522878745280337
CHEMBL2334724,CHEMBL1871,Androgen Receptor,IC50,=,4000.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OC[C@H](O)CO)c(C)c1,5.3979400086720375
CHEMBL2334345,CHEMBL1871,Androgen Receptor,IC50,=,7400.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OC[C@H](O)CO)c(C)c1)c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1,5.130768280269024
CHEMBL2334344,CHEMBL1871,Androgen Receptor,IC50,=,6700.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OC[C@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1,5.173925197299173
CHEMBL2334343,CHEMBL1871,Androgen Receptor,IC50,=,8300.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1,5.080921907623926
CHEMBL2334342,CHEMBL1871,Androgen Receptor,IC50,=,5800.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1,5.236572006437063
CHEMBL1783642,CHEMBL1871,Androgen Receptor,IC50,=,6200.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OCC(=O)C(C)(C)C)c(C)c1,5.207608310501746
CHEMBL2334339,CHEMBL1871,Androgen Receptor,IC50,=,6800.0,nM,CHEMBL2343831,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay,CHEMBL2331115,IC50,CC[Si](CC)(c1ccc(OCC(O)CO)c(C)c1)c1ccc(OCC(O)C(C)(C)C)c(C)c1,5.167491087293763
CHEMBL2337505,CHEMBL1871,Androgen Receptor,IC50,=,450.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl,6.346787486224656
CHEMBL2337505,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl,6.0
CHEMBL2337506,CHEMBL1871,Androgen Receptor,IC50,=,82.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)C2)cc1Cl,7.086186147616283
CHEMBL2337505,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl,7.229147988357855
CHEMBL2337506,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)C2)cc1Cl,7.522878745280337
CHEMBL2337505,CHEMBL1871,Androgen Receptor,IC50,=,420.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl,6.376750709602099
CHEMBL2337506,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)C2)cc1Cl,6.920818753952375
CHEMBL2337519,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(F)c3)[C@H]2C)cn1,5.769551078621726
CHEMBL2337518,CHEMBL1871,Androgen Receptor,IC50,=,1400.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)cc3)[C@H]2C)cn1,5.853871964321762
CHEMBL2337517,CHEMBL1871,Androgen Receptor,IC50,=,730.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(OC)c3)[C@H]2C)cn1,6.136677139879544
CHEMBL2337516,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(N2CCCC2=O)nc1,6.795880017344075
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,470.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.327902142064282
CHEMBL2337515,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@@H]2C)cn1,5.795880017344075
CHEMBL2337514,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(=O)N(C)C)nc1,5.0
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,99.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,7.00436480540245
CHEMBL2337512,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1,7.0
CHEMBL2337511,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1,8.0
CHEMBL2337510,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1,8.045757490560675
CHEMBL2337508,CHEMBL1871,Androgen Receptor,IC50,=,65.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccc(F)cc3)C2)cc1Cl,7.187086643357144
CHEMBL2337507,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL2339066,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccccc3)C2)cc1Cl,6.6020599913279625
CHEMBL2337519,CHEMBL1871,Androgen Receptor,IC50,=,290.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(F)c3)[C@H]2C)cn1,6.537602002101044
CHEMBL2337518,CHEMBL1871,Androgen Receptor,IC50,=,400.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)cc3)[C@H]2C)cn1,6.3979400086720375
CHEMBL2337517,CHEMBL1871,Androgen Receptor,IC50,=,62.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(OC)c3)[C@H]2C)cn1,7.207608310501746
CHEMBL2337516,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(N2CCCC2=O)nc1,7.958607314841775
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.481486060122112
CHEMBL2337515,CHEMBL1871,Androgen Receptor,IC50,=,6400.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@@H]2C)cn1,5.1938200260161125
CHEMBL2337514,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(=O)N(C)C)nc1,5.769551078621726
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,25.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,7.6020599913279625
CHEMBL2337512,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1,6.920818753952375
CHEMBL2337511,CHEMBL1871,Androgen Receptor,IC50,=,8.6,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1,8.065501548756432
CHEMBL2337510,CHEMBL1871,Androgen Receptor,IC50,=,17.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1,7.769551078621726
CHEMBL2337509,CHEMBL1871,Androgen Receptor,IC50,=,17.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(F)cc1,7.769551078621726
CHEMBL2337508,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccc(F)cc3)C2)cc1Cl,7.167491087293763
CHEMBL2337507,CHEMBL1871,Androgen Receptor,IC50,=,380.0,nM,CHEMBL2339067,B,Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccccc3)C2)cc1Cl,6.42021640338319
CHEMBL2337519,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(F)c3)[C@H]2C)cn1,5.769551078621726
CHEMBL2337518,CHEMBL1871,Androgen Receptor,IC50,=,5300.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)cc3)[C@H]2C)cn1,5.275724130399211
CHEMBL2337517,CHEMBL1871,Androgen Receptor,IC50,=,240.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(OC)c3)[C@H]2C)cn1,6.619788758288394
CHEMBL2337516,CHEMBL1871,Androgen Receptor,IC50,=,87.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(N2CCCC2=O)nc1,7.060480747381382
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,2.6,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.585026652029182
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.920818753952375
CHEMBL2337515,CHEMBL1871,Androgen Receptor,IC50,=,97.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@@H]2C)cn1,7.013228265733755
CHEMBL2337514,CHEMBL1871,Androgen Receptor,IC50,=,3000.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(=O)N(C)C)nc1,5.522878745280337
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,7.0
CHEMBL2337512,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1,7.795880017344075
CHEMBL2337511,CHEMBL1871,Androgen Receptor,IC50,=,18.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1,7.7447274948966935
CHEMBL2337510,CHEMBL1871,Androgen Receptor,IC50,=,42.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1,7.376750709602099
CHEMBL2337509,CHEMBL1871,Androgen Receptor,IC50,=,8.1,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(F)cc1,8.09151498112135
CHEMBL2337508,CHEMBL1871,Androgen Receptor,IC50,=,36.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccc(F)cc3)C2)cc1Cl,7.443697499232712
CHEMBL2337507,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL2339068,B,Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccccc3)C2)cc1Cl,6.886056647693163
CHEMBL2337519,CHEMBL1871,Androgen Receptor,IC50,=,830.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(F)c3)[C@H]2C)cn1,6.080921907623926
CHEMBL2337518,CHEMBL1871,Androgen Receptor,IC50,=,7600.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)cc3)[C@H]2C)cn1,5.119186407719209
CHEMBL2337517,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(OC)c3)[C@H]2C)cn1,6.920818753952375
CHEMBL2337516,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(N2CCCC2=O)nc1,7.886056647693163
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,2.1,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.67778070526608
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.267606240177031
CHEMBL2337515,CHEMBL1871,Androgen Receptor,IC50,=,1600.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@@H]2C)cn1,5.795880017344075
CHEMBL2337514,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(=O)N(C)C)nc1,5.958607314841775
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,44.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,7.356547323513812
CHEMBL2337512,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1,7.167491087293763
CHEMBL2337511,CHEMBL1871,Androgen Receptor,IC50,=,32.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1,7.494850021680094
CHEMBL2337510,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1,7.568636235841012
CHEMBL2337509,CHEMBL1871,Androgen Receptor,IC50,=,8.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(F)cc1,8.096910013008056
CHEMBL2337508,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccc(F)cc3)C2)cc1Cl,6.7447274948966935
CHEMBL2337507,CHEMBL1871,Androgen Receptor,IC50,=,370.0,nM,CHEMBL2339069,B,Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells,CHEMBL2331321,IC50,N#Cc1ccc(N2CCC(O)(c3ccccc3)C2)cc1Cl,6.431798275933005
CHEMBL2346976,CHEMBL1871,Androgen Receptor,IC50,=,1778.28,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,5.749999855918706
CHEMBL2346975,CHEMBL1871,Androgen Receptor,IC50,=,1047.13,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,CC(=O)N1CCN(CCOc2ccc(C3(O)CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1,5.979999397807417
CHEMBL2346974,CHEMBL1871,Androgen Receptor,IC50,=,323.59,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,CC(=O)N1CCN(CCOc2ccc(C3CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1,6.4900049079866005
CHEMBL2346973,CHEMBL1871,Androgen Receptor,IC50,=,234.42,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,Cn1nccc1CCOc1ccc(C2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,6.630005338391571
CHEMBL2346972,CHEMBL1871,Androgen Receptor,IC50,=,5888.44,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,Fc1ccc(CN2CCN(C3=Nn4c(nnc4C(F)(F)F)CC3)CC2)cc1,5.229999745811778
CHEMBL2346971,CHEMBL1871,Androgen Receptor,IC50,=,10715.19,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,OC1(c2cccnc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1,4.970000123715015
CHEMBL2346970,CHEMBL1871,Androgen Receptor,IC50,=,3715.35,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,OC1(c2ccc(F)cc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1,5.430000267796055
CHEMBL2346969,CHEMBL1871,Androgen Receptor,IC50,=,2089.3,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,Fc1cccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)c1F,5.679999195735272
CHEMBL2346968,CHEMBL1871,Androgen Receptor,IC50,=,1584.89,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,Fc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,5.800000874803203
CHEMBL2346967,CHEMBL1871,Androgen Receptor,IC50,=,1513.56,nM,CHEMBL2352673,B,Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis,CHEMBL2346572,IC50,N#Cc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1,5.820000358220838
CHEMBL16972,CHEMBL1871,Androgen Receptor,IC50,=,11100.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,4.954677021213342
CHEMBL2386405,CHEMBL1871,Androgen Receptor,IC50,=,190.55,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(F)cc2)oc2cccc(F)c12,6.719991046891813
CHEMBL2386396,CHEMBL1871,Androgen Receptor,IC50,=,251.19,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,N#Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,6.599997654072045
CHEMBL2386393,CHEMBL1871,Androgen Receptor,IC50,=,331.13,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(F)cc2)oc2cccc(O)c12,6.480001470881152
CHEMBL2386404,CHEMBL1871,Androgen Receptor,IC50,=,363.08,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(Cl)cc2)oc2cccc(F)c12,6.4399976732266335
CHEMBL2386395,CHEMBL1871,Androgen Receptor,IC50,=,363.08,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cccc(O)c12,6.4399976732266335
CHEMBL274471,CHEMBL1871,Androgen Receptor,IC50,=,457.09,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(Cl)cc2)oc2cccc(O)c12,6.339998279897117
CHEMBL2386394,CHEMBL1871,Androgen Receptor,IC50,=,776.25,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccccc2)oc2cccc(F)c12,6.109998386815363
CHEMBL16807,CHEMBL1871,Androgen Receptor,IC50,=,831.76,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccccc2)oc2cccc(O)c12,6.0800019690359814
CHEMBL484662,CHEMBL1871,Androgen Receptor,IC50,=,851.14,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12,6.069998998990925
CHEMBL2386397,CHEMBL1871,Androgen Receptor,IC50,=,851.14,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,CN(C)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,6.069998998990925
CHEMBL2386401,CHEMBL1871,Androgen Receptor,IC50,=,1071.52,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,CSc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.969999718407896
CHEMBL2386406,CHEMBL1871,Androgen Receptor,IC50,=,1202.26,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,N#Cc1ccc(-c2cc(=O)c3c(F)cccc3o2)cc1,5.920001601921648
CHEMBL2386392,CHEMBL1871,Androgen Receptor,IC50,=,1230.27,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(C(F)(F)F)cc2)oc2cccc(O)c12,5.90999956608739
CHEMBL143978,CHEMBL1871,Androgen Receptor,IC50,=,1621.81,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,COc1cccc2oc(-c3ccc(F)cc3)cc(=O)c12,5.790000026071146
CHEMBL2386399,CHEMBL1871,Androgen Receptor,IC50,=,1995.26,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,Nc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.700000503883016
CHEMBL2386408,CHEMBL1871,Androgen Receptor,IC50,=,3548.13,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,NC(=O)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.450000476425332
CHEMBL16972,CHEMBL1871,Androgen Receptor,IC50,=,11220.18,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,4.950000175844591
CHEMBL2386408,CHEMBL1871,Androgen Receptor,IC50,=,3580.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,NC(=O)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.446116973356125
CHEMBL2386399,CHEMBL1871,Androgen Receptor,IC50,=,1990.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,Nc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.701146923590294
CHEMBL143978,CHEMBL1871,Androgen Receptor,IC50,=,1610.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,COc1cccc2oc(-c3ccc(F)cc3)cc(=O)c12,5.79317412396815
CHEMBL2386392,CHEMBL1871,Androgen Receptor,IC50,=,1240.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(C(F)(F)F)cc2)oc2cccc(O)c12,5.906578314837764
CHEMBL2386406,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,N#Cc1ccc(-c2cc(=O)c3c(F)cccc3o2)cc1,5.920818753952375
CHEMBL2386401,CHEMBL1871,Androgen Receptor,IC50,=,1070.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,CSc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,5.97061622231479
CHEMBL484662,CHEMBL1871,Androgen Receptor,IC50,=,860.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12,6.065501548756432
CHEMBL2386397,CHEMBL1871,Androgen Receptor,IC50,=,850.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,CN(C)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,6.070581074285707
CHEMBL16807,CHEMBL1871,Androgen Receptor,IC50,=,840.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccccc2)oc2cccc(O)c12,6.075720713938118
CHEMBL2386394,CHEMBL1871,Androgen Receptor,IC50,=,770.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccccc2)oc2cccc(F)c12,6.113509274827518
CHEMBL274471,CHEMBL1871,Androgen Receptor,IC50,=,460.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(Cl)cc2)oc2cccc(O)c12,6.337242168318426
CHEMBL2386404,CHEMBL1871,Androgen Receptor,IC50,=,360.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(Cl)cc2)oc2cccc(F)c12,6.443697499232712
CHEMBL2386395,CHEMBL1871,Androgen Receptor,IC50,=,360.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cccc(O)c12,6.443697499232712
CHEMBL2386393,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(F)cc2)oc2cccc(O)c12,6.481486060122112
CHEMBL2386396,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,N#Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1,6.6020599913279625
CHEMBL2386405,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL2390352,B,Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay,CHEMBL2385078,IC50,O=c1cc(-c2ccc(F)cc2)oc2cccc(F)c12,6.721246399047171
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.568636235841012
CHEMBL2397337,CHEMBL1871,Androgen Receptor,IC50,=,9760.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc4ccccc4c3)nc2C)c1,5.010550182333308
CHEMBL2397336,CHEMBL1871,Androgen Receptor,IC50,=,5070.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(F)c(Cl)c3)nc2C)c1,5.2949920406666635
CHEMBL2397335,CHEMBL1871,Androgen Receptor,IC50,=,13190.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3cc(Cl)cc(Cl)c3)nc2C)c1,4.879755204453635
CHEMBL2397334,CHEMBL1871,Androgen Receptor,IC50,=,2650.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(Cl)c(Cl)c3)nc2C)c1,5.576754126063192
CHEMBL2397333,CHEMBL1871,Androgen Receptor,IC50,=,6260.0,nM,CHEMBL2399205,B,Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay,CHEMBL2396586,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(C#N)cc3)nc2C)c1,5.20342566678957
CHEMBL2403356,CHEMBL1871,Androgen Receptor,IC50,=,25000.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CCCC(CCC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1,4.6020599913279625
CHEMBL2403350,CHEMBL1871,Androgen Receptor,IC50,=,8200.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CCCC[Si](CCCC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1,5.086186147616283
CHEMBL418971,CHEMBL1871,Androgen Receptor,IC50,=,5900.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CC(C)(c1ccc(O)cc1)c1ccc(O)cc1,5.229147988357855
CHEMBL2403348,CHEMBL1871,Androgen Receptor,IC50,=,5400.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CCC(CC)(c1ccc(N)c(C)c1)c1ccc(O)c(C)c1,5.267606240177031
CHEMBL2403355,CHEMBL1871,Androgen Receptor,IC50,=,4500.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CCC(CC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1,5.346787486224656
CHEMBL2403349,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL2405557,B,Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay,CHEMBL2401681,IC50,CC[Si](CC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1,5.721246399047171
CHEMBL1393,CHEMBL1871,Androgen Receptor,IC50,=,670.0,nM,CHEMBL2411351,B,Antagonist activity at androgen receptor (unknown origin) by NH Pro assay,CHEMBL2407028,IC50,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,6.173925197299173
CHEMBL2407647,CHEMBL1871,Androgen Receptor,IC50,=,12000.0,nM,CHEMBL2411351,B,Antagonist activity at androgen receptor (unknown origin) by NH Pro assay,CHEMBL2407028,IC50,COc1cc(CNC(=O)[C@@]2(Cc3ccccc3)OC(=O)N([C@@H]3CCc4ccccc43)C2=O)cc(OC)c1,4.920818753952375
CHEMBL2441092,CHEMBL1871,Androgen Receptor,IC50,=,5400.0,nM,CHEMBL2446673,B,Displacement of [3H]-DHT from human GST-tagged androgen receptor LBD (627 to 919) expressed in Escherichia coli HB-101 after 15 hrs by liquid scintillation counting analysis,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2cc(C)c(Oc3ccc(O)cc3)c(C)c2)c1,5.267606240177031
CHEMBL2441094,CHEMBL1871,Androgen Receptor,IC50,=,9200.0,nM,CHEMBL2446673,B,Displacement of [3H]-DHT from human GST-tagged androgen receptor LBD (627 to 919) expressed in Escherichia coli HB-101 after 15 hrs by liquid scintillation counting analysis,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)c(C)c2)c1,5.036212172654444
CHEMBL2441107,CHEMBL1871,Androgen Receptor,IC50,=,20000.0,nM,CHEMBL2446673,B,Displacement of [3H]-DHT from human GST-tagged androgen receptor LBD (627 to 919) expressed in Escherichia coli HB-101 after 15 hrs by liquid scintillation counting analysis,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)cc2)c1,4.698970004336019
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,7100.0,nM,CHEMBL2446673,B,Displacement of [3H]-DHT from human GST-tagged androgen receptor LBD (627 to 919) expressed in Escherichia coli HB-101 after 15 hrs by liquid scintillation counting analysis,CHEMBL2439974,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.1487416512809245
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,4600.0,nM,CHEMBL2446445,B,Antagonist activity at androgen receptor H874Y mutant (unknown origin) expressed in human 22Rv1 cells assessed as inhibition of DHT-induced cell growth after 3 days by WST-8 assay,CHEMBL2439974,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.337242168318426
CHEMBL2441092,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL2446445,B,Antagonist activity at androgen receptor H874Y mutant (unknown origin) expressed in human 22Rv1 cells assessed as inhibition of DHT-induced cell growth after 3 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2cc(C)c(Oc3ccc(O)cc3)c(C)c2)c1,5.886056647693163
CHEMBL2441094,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL2446445,B,Antagonist activity at androgen receptor H874Y mutant (unknown origin) expressed in human 22Rv1 cells assessed as inhibition of DHT-induced cell growth after 3 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)c(C)c2)c1,6.657577319177793
CHEMBL2441107,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL2446445,B,Antagonist activity at androgen receptor H874Y mutant (unknown origin) expressed in human 22Rv1 cells assessed as inhibition of DHT-induced cell growth after 3 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)cc2)c1,5.721246399047171
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,940.0,nM,CHEMBL2446446,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in human LNCAP cells assessed as inhibition of DHT-induced cell growth after 6 days by WST-8 assay,CHEMBL2439974,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.026872146400301
CHEMBL2441092,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL2446446,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in human LNCAP cells assessed as inhibition of DHT-induced cell growth after 6 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2cc(C)c(Oc3ccc(O)cc3)c(C)c2)c1,5.619788758288394
CHEMBL2441094,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL2446446,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in human LNCAP cells assessed as inhibition of DHT-induced cell growth after 6 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)c(C)c2)c1,7.366531544420413
CHEMBL2441107,CHEMBL1871,Androgen Receptor,IC50,=,290.0,nM,CHEMBL2446446,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in human LNCAP cells assessed as inhibition of DHT-induced cell growth after 6 days by WST-8 assay,CHEMBL2439974,IC50,COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)cc2)c1,6.537602002101044
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,5600.0,nM,CHEMBL2446110,B,Displacement of Fluormone AL Green from androgen receptor ligand binding domain (unknown origin) after 4 hrs by fluorescence polarization assay,CHEMBL2440058,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.251811972993799
CHEMBL2440233,CHEMBL1871,Androgen Receptor,IC50,=,30100.0,nM,CHEMBL2446110,B,Displacement of Fluormone AL Green from androgen receptor ligand binding domain (unknown origin) after 4 hrs by fluorescence polarization assay,CHEMBL2440058,IC50,O=C(O[C@H]1C(=O)C=CN(C(=O)/C=C/c2ccccc2)[C@@H]1c1ccccc1)c1ccc(F)cc1C(F)(F)F,4.521433504406157
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL3222681,B,Displacement of [3H]mibolerone from human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting analysis,CHEMBL3217624,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.958607314841775
CHEMBL1170,CHEMBL1871,Androgen Receptor,IC50,=,18.0,nM,CHEMBL3222681,B,Displacement of [3H]mibolerone from human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting analysis,CHEMBL3217624,IC50,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,7.7447274948966935
CHEMBL3221237,CHEMBL1871,Androgen Receptor,IC50,=,196.0,nM,CHEMBL3222681,B,Displacement of [3H]mibolerone from human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting analysis,CHEMBL3217624,IC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,6.707743928643524
CHEMBL3238273,CHEMBL1871,Androgen Receptor,IC50,=,99.5,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccccc1)C(=O)N1CCc2c(C#N)cccc21,7.002176919254275
CHEMBL3238274,CHEMBL1871,Androgen Receptor,IC50,=,12.7,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21,7.896196279044043
CHEMBL3238275,CHEMBL1871,Androgen Receptor,IC50,=,34.2,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1cccc(F)c1)C(=O)N1CCc2c(C#N)cccc21,7.465973893943865
CHEMBL3238276,CHEMBL1871,Androgen Receptor,IC50,=,10.1,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccccc1F)C(=O)N1CCc2c(C#N)cccc21,7.995678626217357
CHEMBL3238277,CHEMBL1871,Androgen Receptor,IC50,=,36.5,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(Cl)cc1)C(=O)N1CCc2c(C#N)cccc21,7.437707135543525
CHEMBL3238278,CHEMBL1871,Androgen Receptor,IC50,=,107.0,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1cccc(Cl)c1)C(=O)N1CCc2c(C#N)cccc21,6.97061622231479
CHEMBL3238279,CHEMBL1871,Androgen Receptor,IC50,=,56.3,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccccc1Cl)C(=O)N1CCc2c(C#N)cccc21,7.249491605148654
CHEMBL3238280,CHEMBL1871,Androgen Receptor,IC50,=,2.4,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(Br)cc1)C(=O)N1CCc2c(C#N)cccc21,8.619788758288394
CHEMBL3238281,CHEMBL1871,Androgen Receptor,IC50,=,33.1,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(C(F)(F)F)cc1)C(=O)N1CCc2c(C#N)cccc21,7.480172006224281
CHEMBL3238282,CHEMBL1871,Androgen Receptor,IC50,=,145.5,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1,6.8371370066780734
CHEMBL3238283,CHEMBL1871,Androgen Receptor,IC50,=,133.2,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COC(=O)c1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1,6.875495775165717
CHEMBL3238284,CHEMBL1871,Androgen Receptor,IC50,=,179.4,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(-c2cocn2)cc1)C(=O)N1CCc2c(C#N)cccc21,6.746177561291926
CHEMBL3238285,CHEMBL1871,Androgen Receptor,IC50,=,16.4,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(C#N)cc1)C(=O)N1CCc2c(C#N)cccc21,7.785156151952302
CHEMBL3238286,CHEMBL1871,Androgen Receptor,IC50,=,60.9,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccccc1C(F)(F)F)C(=O)N1CCc2c(C#N)cccc21,7.215382707367125
CHEMBL3238287,CHEMBL1871,Androgen Receptor,IC50,=,14.3,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccccc1C#N)C(=O)N1CCc2c(C#N)cccc21,7.844663962534938
CHEMBL3238288,CHEMBL1871,Androgen Receptor,IC50,=,9.1,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(F)cc1C#N)C(=O)N1CCc2c(C#N)cccc21,8.040958607678906
CHEMBL3238289,CHEMBL1871,Androgen Receptor,IC50,=,11.4,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(F)cc1Br)C(=O)N1CCc2c(C#N)cccc21,7.943095148663527
CHEMBL3238290,CHEMBL1871,Androgen Receptor,IC50,=,10.7,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,Cc1cc(F)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,7.97061622231479
CHEMBL3238291,CHEMBL1871,Androgen Receptor,IC50,=,4.8,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(C#N)cc1Br)C(=O)N1CCc2c(C#N)cccc21,8.318758762624412
CHEMBL3238292,CHEMBL1871,Androgen Receptor,IC50,=,3.2,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(C#N)cc1F)C(=O)N1CCc2c(C#N)cccc21,8.494850021680094
CHEMBL3238293,CHEMBL1871,Androgen Receptor,IC50,=,16.1,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COc1cc(C#N)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,7.79317412396815
CHEMBL3238294,CHEMBL1871,Androgen Receptor,IC50,=,365.8,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COc1cc(Cl)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,6.436756298859602
CHEMBL3238295,CHEMBL1871,Androgen Receptor,IC50,=,426.7,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(F)c1,6.3698773571406875
CHEMBL3233069,CHEMBL1871,Androgen Receptor,IC50,=,3.5,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(Cl)c1,8.455931955649724
CHEMBL3233070,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(Cl)cc1F)C(=O)N1CCc2c(C#N)cccc21,8.301029995663981
CHEMBL3233071,CHEMBL1871,Androgen Receptor,IC50,=,9.1,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(Cl)cc1Cl)C(=O)N1CCc2c(C#N)cccc21,8.040958607678906
CHEMBL3233072,CHEMBL1871,Androgen Receptor,IC50,=,36.8,nM,CHEMBL3243251,B,Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting,CHEMBL3232788,IC50,C[C@](O)(COc1ccc(Br)cc1F)C(=O)N1CCc2c(C#N)cccc21,7.434152181326482
CHEMBL3262343,CHEMBL1871,Androgen Receptor,IC50,=,49000.0,nM,CHEMBL3266739,B,Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days,CHEMBL3259638,IC50,CC(C)(O)c1cn(-c2ccc(Cl)c(C(F)(F)F)c2)nn1,4.309803919971486
CHEMBL3262347,CHEMBL1871,Androgen Receptor,IC50,=,45000.0,nM,CHEMBL3266739,B,Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days,CHEMBL3259638,IC50,CC(C)(O)c1cn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)nn1,4.346787486224656
CHEMBL3262348,CHEMBL1871,Androgen Receptor,IC50,=,40000.0,nM,CHEMBL3266739,B,Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days,CHEMBL3259638,IC50,CC(C)(O)c1cn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1,4.3979400086720375
CHEMBL3263754,CHEMBL1871,Androgen Receptor,IC50,=,9050.0,nM,CHEMBL3266005,B,Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay,CHEMBL3259597,IC50,COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(=O)O,5.043351420794797
CHEMBL3263760,CHEMBL1871,Androgen Receptor,IC50,=,3250.0,nM,CHEMBL3266005,B,Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay,CHEMBL3259597,IC50,COc1nc(C2=NN(c3ccc(C#N)c(C)c3)[C@@H](C3CCCC3)C2)ccc1C(N)=O,5.488116639021126
CHEMBL3263763,CHEMBL1871,Androgen Receptor,IC50,=,7780.0,nM,CHEMBL3266005,B,Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay,CHEMBL3259597,IC50,COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(N)=O,5.109020403010311
CHEMBL3263764,CHEMBL1871,Androgen Receptor,IC50,=,8520.0,nM,CHEMBL3266005,B,Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay,CHEMBL3259597,IC50,CNC(=O)c1ccc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)nc1OC,5.0695604052333
CHEMBL3263767,CHEMBL1871,Androgen Receptor,IC50,=,9940.0,nM,CHEMBL3266005,B,Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay,CHEMBL3259597,IC50,COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(=O)NS(C)(=O)=O,5.002613615602687
CHEMBL1572280,CHEMBL1871,Androgen Receptor,IC50,=,400.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O,6.3979400086720375
CHEMBL3323502,CHEMBL1871,Androgen Receptor,IC50,=,2420.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Cc1ncn(-c2csc(N3CCOCC3)n2)c1C,5.616184634019569
CHEMBL3323498,CHEMBL1871,Androgen Receptor,IC50,=,1740.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Brc1cn(-c2csc(N3CCOCC3)n2)cn1,5.7594507517174005
CHEMBL3323497,CHEMBL1871,Androgen Receptor,IC50,=,4020.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1I,5.39577394691553
CHEMBL3323495,CHEMBL1871,Androgen Receptor,IC50,=,1810.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Ic1ncn(-c2csc(N3CCOCC3)n2)c1I,5.7423214251308154
CHEMBL3323494,CHEMBL1871,Androgen Receptor,IC50,=,1280.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1c(Br)ncn1-c1csc(N2CCOCC2)n1,5.892790030352131
CHEMBL3323493,CHEMBL1871,Androgen Receptor,IC50,=,810.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Oc1cc(F)ccc1-c1csc(N2CCOCC2)n1,6.0915149811213505
CHEMBL3323492,CHEMBL1871,Androgen Receptor,IC50,=,720.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1cn(-c2csc(N3CCOCC3)n2)cn1,6.142667503568731
CHEMBL3323491,CHEMBL1871,Androgen Receptor,IC50,=,700.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Oc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F,6.154901959985743
CHEMBL3323490,CHEMBL1871,Androgen Receptor,IC50,=,570.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1Cl,6.2441251443275085
CHEMBL3323489,CHEMBL1871,Androgen Receptor,IC50,=,440.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1Br,6.356547323513812
CHEMBL3323488,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,COc1cc(F)ccc1-c1csc(N2CCOCC2)n1,6.638272163982407
CHEMBL3323487,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Oc1c(F)cccc1-c1csc(N2CCOCC2)n1,6.823908740944319
CHEMBL3323486,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1cc(-c2csc(N3CCOCC3)n2)cs1,6.657577319177793
CHEMBL3323485,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Cc1scc(-c2csc(N3CCOCC3)n2)c1C,6.366531544420413
CHEMBL3323484,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,COc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F,6.6020599913279625
CHEMBL3323483,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Brc1ncn(-c2csc(N3CCOCC3)n2)c1Br,6.769551078621726
CHEMBL3323482,CHEMBL1871,Androgen Receptor,IC50,=,8430.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,CCc1sc(N2CCOCC2)nc1-c1ccccc1,5.074172425375258
CHEMBL3323481,CHEMBL1871,Androgen Receptor,IC50,=,6460.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Oc1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1,5.189767482004916
CHEMBL3323479,CHEMBL1871,Androgen Receptor,IC50,=,2960.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1ccc(-c2csc(N3CCOCC3)n2)cc1Cl,5.528708288941061
CHEMBL3323478,CHEMBL1871,Androgen Receptor,IC50,=,1320.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Clc1ccc(-c2csc(N3CCOCC3)n2)c(Cl)c1,5.8794260687941495
CHEMBL3323477,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,FC(F)(F)[C@H]1CN(c2nc(-c3ccccc3)cs2)CCO1,6.795880017344075
CHEMBL3323476,CHEMBL1871,Androgen Receptor,IC50,=,890.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,N#Cc1ccc(-c2ccc(N3CCOCC3)s2)cc1,6.050609993355087
CHEMBL3323475,CHEMBL1871,Androgen Receptor,IC50,=,2030.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Nc1ccccc1-c1csc(N2CCOCC2)n1,5.692503962086787
CHEMBL3323474,CHEMBL1871,Androgen Receptor,IC50,=,840.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc(-c2cc(N3CCOCC3)cs2)cc1,6.075720713938118
CHEMBL1416100,CHEMBL1871,Androgen Receptor,IC50,=,630.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc(-c2csc(-c3ccncc3)n2)cc1,6.200659450546418
CHEMBL3323473,CHEMBL1871,Androgen Receptor,IC50,=,690.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCCCC3)n2)cc1,6.161150909262744
CHEMBL1391700,CHEMBL1871,Androgen Receptor,IC50,=,410.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Fc1ccc(-c2csc(N3CCOCC3)n2)cc1,6.3872161432802645
CHEMBL3323472,CHEMBL1871,Androgen Receptor,IC50,=,520.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Cc1ccc(C)c(-c2csc(N3CCOCC3)n2)c1,6.2839966563652006
CHEMBL3323471,CHEMBL1871,Androgen Receptor,IC50,=,580.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,FC(F)(F)c1cccc(-c2csc(N3CCOCC3)n2)c1,6.236572006437063
CHEMBL3323470,CHEMBL1871,Androgen Receptor,IC50,=,510.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc(-c2ccc(N3CCOCC3)s2)cc1,6.292429823902063
CHEMBL1623389,CHEMBL1871,Androgen Receptor,IC50,=,280.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCOCC3)n2)cc1,6.552841968657781
CHEMBL1372017,CHEMBL1871,Androgen Receptor,IC50,=,10600.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Nc1nc(-c2ccc3ccccc3c2)cs1,4.97469413473523
CHEMBL3323468,CHEMBL1871,Androgen Receptor,IC50,=,8080.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,Oc1ccc2nc(N3CCOCC3)sc2c1,5.092588639225414
CHEMBL452153,CHEMBL1871,Androgen Receptor,IC50,=,2260.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,c1ccc2nc(-c3ccncc3)ccc2c1,5.645891560852599
CHEMBL3323467,CHEMBL1871,Androgen Receptor,IC50,=,3910.0,nM,CHEMBL3374324,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days,CHEMBL3352043,IC50,CNc1nc(-c2ccc3ccccc3c2)cs1,5.407823242604133
CHEMBL3323503,CHEMBL1871,Androgen Receptor,IC50,=,1460.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Cc1sc(N2CCOCC2)nc1-c1ccccc1,5.835647144215563
CHEMBL3323502,CHEMBL1871,Androgen Receptor,IC50,=,3560.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Cc1ncn(-c2csc(N3CCOCC3)n2)c1C,5.448550002027124
CHEMBL3323501,CHEMBL1871,Androgen Receptor,IC50,=,3560.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,CS(=O)(=O)c1c(F)cccc1-c1csc(N2CCOCC2)n1,5.448550002027124
CHEMBL3323500,CHEMBL1871,Androgen Receptor,IC50,=,3020.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,COc1c(F)cc(O)cc1-c1csc(N2CCOCC2)n1,5.51999305704285
CHEMBL3323499,CHEMBL1871,Androgen Receptor,IC50,=,2940.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1cc(-c2csc(N3CCOCC3)n2)ccn1,5.531652669587842
CHEMBL3323498,CHEMBL1871,Androgen Receptor,IC50,=,2800.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Brc1cn(-c2csc(N3CCOCC3)n2)cn1,5.552841968657781
CHEMBL3323497,CHEMBL1871,Androgen Receptor,IC50,=,2610.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1I,5.583359492661719
CHEMBL3323496,CHEMBL1871,Androgen Receptor,IC50,=,2580.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCOCC3)n2)nc1,5.58838029403677
CHEMBL3323495,CHEMBL1871,Androgen Receptor,IC50,=,1730.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Ic1ncn(-c2csc(N3CCOCC3)n2)c1I,5.761953896871205
CHEMBL3323494,CHEMBL1871,Androgen Receptor,IC50,=,1450.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1c(Br)ncn1-c1csc(N2CCOCC2)n1,5.838631997765026
CHEMBL3323493,CHEMBL1871,Androgen Receptor,IC50,=,1190.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1cc(F)ccc1-c1csc(N2CCOCC2)n1,5.924453038607469
CHEMBL3323492,CHEMBL1871,Androgen Receptor,IC50,=,960.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1cn(-c2csc(N3CCOCC3)n2)cn1,6.017728766960431
CHEMBL3323491,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F,6.096910013008056
CHEMBL3323490,CHEMBL1871,Androgen Receptor,IC50,=,680.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1Cl,6.167491087293763
CHEMBL3323489,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1ncn(-c2csc(N3CCOCC3)n2)c1Br,6.481486060122112
CHEMBL3323488,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,COc1cc(F)ccc1-c1csc(N2CCOCC2)n1,6.522878745280337
CHEMBL3323487,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1c(F)cccc1-c1csc(N2CCOCC2)n1,6.568636235841012
CHEMBL3323486,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1cc(-c2csc(N3CCOCC3)n2)cs1,6.585026652029182
CHEMBL3323485,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Cc1scc(-c2csc(N3CCOCC3)n2)c1C,6.6020599913279625
CHEMBL3323484,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,COc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F,6.7447274948966935
CHEMBL3323483,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Brc1ncn(-c2csc(N3CCOCC3)n2)c1Br,7.0
CHEMBL3323482,CHEMBL1871,Androgen Receptor,IC50,=,5800.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,CCc1sc(N2CCOCC2)nc1-c1ccccc1,5.236572006437063
CHEMBL3323481,CHEMBL1871,Androgen Receptor,IC50,=,5050.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1,5.296708621881338
CHEMBL3323480,CHEMBL1871,Androgen Receptor,IC50,=,5040.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,OCc1sc(N2CCOCC2)nc1-c1ccccc1,5.297569463554474
CHEMBL3323479,CHEMBL1871,Androgen Receptor,IC50,=,3320.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1ccc(-c2csc(N3CCOCC3)n2)cc1Cl,5.478861916295964
CHEMBL3323478,CHEMBL1871,Androgen Receptor,IC50,=,1660.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Clc1ccc(-c2csc(N3CCOCC3)n2)c(Cl)c1,5.779891911959945
CHEMBL3323477,CHEMBL1871,Androgen Receptor,IC50,=,1650.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,FC(F)(F)[C@H]1CN(c2nc(-c3ccccc3)cs2)CCO1,5.782516055786093
CHEMBL1488607,CHEMBL1871,Androgen Receptor,IC50,=,1590.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Fc1ccc(-c2csc(N3CCSCC3)n2)cc1,5.798602875679549
CHEMBL3323476,CHEMBL1871,Androgen Receptor,IC50,=,1440.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,N#Cc1ccc(-c2ccc(N3CCOCC3)s2)cc1,5.84163750790475
CHEMBL3323475,CHEMBL1871,Androgen Receptor,IC50,=,1380.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Nc1ccccc1-c1csc(N2CCOCC2)n1,5.860120913598763
CHEMBL3323474,CHEMBL1871,Androgen Receptor,IC50,=,1240.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2cc(N3CCOCC3)cs2)cc1,5.906578314837764
CHEMBL1403349,CHEMBL1871,Androgen Receptor,IC50,=,1270.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Fc1ccc(-c2csc(-c3ccncc3)n2)cc1,5.896196279044043
CHEMBL1416100,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2csc(-c3ccncc3)n2)cc1,5.920818753952375
CHEMBL3323473,CHEMBL1871,Androgen Receptor,IC50,=,1030.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCCCC3)n2)cc1,5.987162775294828
CHEMBL1391700,CHEMBL1871,Androgen Receptor,IC50,=,650.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Fc1ccc(-c2csc(N3CCOCC3)n2)cc1,6.187086643357144
CHEMBL3323472,CHEMBL1871,Androgen Receptor,IC50,=,620.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Cc1ccc(C)c(-c2csc(N3CCOCC3)n2)c1,6.207608310501746
CHEMBL3323471,CHEMBL1871,Androgen Receptor,IC50,=,610.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,FC(F)(F)c1cccc(-c2csc(N3CCOCC3)n2)c1,6.214670164989233
CHEMBL1549081,CHEMBL1871,Androgen Receptor,IC50,=,620.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCSCC3)n2)cc1,6.207608310501746
CHEMBL3323470,CHEMBL1871,Androgen Receptor,IC50,=,520.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2ccc(N3CCOCC3)s2)cc1,6.2839966563652006
CHEMBL1623389,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc(-c2csc(N3CCOCC3)n2)cc1,6.481486060122112
CHEMBL3323469,CHEMBL1871,Androgen Receptor,IC50,=,9840.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1ccc(-c2ccc3ccccc3n2)cc1,5.007004901568658
CHEMBL1372017,CHEMBL1871,Androgen Receptor,IC50,=,9160.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Nc1nc(-c2ccc3ccccc3c2)cs1,5.03810452633215
CHEMBL3323468,CHEMBL1871,Androgen Receptor,IC50,=,7410.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,Oc1ccc2nc(N3CCOCC3)sc2c1,5.130181792020672
CHEMBL452153,CHEMBL1871,Androgen Receptor,IC50,=,4200.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,c1ccc2nc(-c3ccncc3)ccc2c1,5.376750709602099
CHEMBL3323467,CHEMBL1871,Androgen Receptor,IC50,=,3170.0,nM,CHEMBL3374323,B,Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay,CHEMBL3352043,IC50,CNc1nc(-c2ccc3ccccc3c2)cs1,5.498940737782249
CHEMBL3326454,CHEMBL1871,Androgen Receptor,IC50,=,0.7,nM,CHEMBL3371986,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-435 cells after 30 mins,CHEMBL3351728,IC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12,9.154901959985743
CHEMBL3318065,CHEMBL1871,Androgen Receptor,IC50,=,1380.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3cc(F)ccc3[nH]2)C(C)C)o1,5.860120913598763
CHEMBL3318064,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc2[nH]c(C(=O)N(Cc3ccco3)C(C)C)cc2c1,5.920818753952375
CHEMBL3318063,CHEMBL1871,Androgen Receptor,IC50,=,1770.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc2[nH]c(C(=O)N(Cc3ccc(C)o3)C(C)C)cc2c1,5.752026733638193
CHEMBL3318062,CHEMBL1871,Androgen Receptor,IC50,=,1650.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc2cc(C(=O)N(Cc3ccc(C)o3)C(C)C)[nH]c2c1,5.782516055786093
CHEMBL3318061,CHEMBL1871,Androgen Receptor,IC50,=,3420.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3ccccc3[nH]2)C(C)C)o1,5.465973893943865
CHEMBL3318060,CHEMBL1871,Androgen Receptor,IC50,=,5450.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CN(Cc1cccs1)C(=O)c1cc2ccc(F)cc2[nH]1,5.2636034977233574
CHEMBL3318059,CHEMBL1871,Androgen Receptor,IC50,=,3060.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CN(Cc1ccc(Br)s1)C(=O)c1cc2ccc(F)cc2[nH]1,5.514278573518419
CHEMBL3317457,CHEMBL1871,Androgen Receptor,IC50,=,5480.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,O=C(c1cc2ccc(F)cc2[nH]1)N(Cc1ccco1)Cc1ccco1,5.261219441515631
CHEMBL3318058,CHEMBL1871,Androgen Receptor,IC50,=,5290.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2cc(C(F)(F)F)ccc2[nH]1,5.276544327964814
CHEMBL3318057,CHEMBL1871,Androgen Receptor,IC50,=,6620.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,COCCN(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1,5.1791420105603
CHEMBL3318056,CHEMBL1871,Androgen Receptor,IC50,=,4580.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,N#CCCN(Cc1ccccc1)C(=O)c1cc2ccccc2[nH]1,5.339134521996131
CHEMBL3318055,CHEMBL1871,Androgen Receptor,IC50,=,6560.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C)C(=O)c2cc3cc(F)ccc3[nH]2)o1,5.1830961606243395
CHEMBL3318054,CHEMBL1871,Androgen Receptor,IC50,=,8090.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CN(Cc1ccc(Br)o1)C(=O)c1cc2ccc(F)cc2[nH]1,5.092051478387727
CHEMBL3318070,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2ccc(F)cc2[nH]1,6.366531544420413
CHEMBL3318069,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1,6.221848749616356
CHEMBL3318068,CHEMBL1871,Androgen Receptor,IC50,=,700.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3ccc(F)cc3[nH]2)C(C)C)o1,6.154901959985743
CHEMBL3318067,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3cccc(F)c3[nH]2)C(C)C)o1,6.0
CHEMBL3318066,CHEMBL1871,Androgen Receptor,IC50,=,1020.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc2cc(C(=O)N(Cc3ccco3)C(C)C)[nH]c2c1,5.991399828238082
CHEMBL3318065,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3cc(F)ccc3[nH]2)C(C)C)o1,5.958607314841775
CHEMBL3318064,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc2[nH]c(C(=O)N(Cc3ccco3)C(C)C)cc2c1,5.886056647693163
CHEMBL3318063,CHEMBL1871,Androgen Receptor,IC50,=,2670.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc2[nH]c(C(=O)N(Cc3ccc(C)o3)C(C)C)cc2c1,5.573488738635424
CHEMBL3318062,CHEMBL1871,Androgen Receptor,IC50,=,2890.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc2cc(C(=O)N(Cc3ccc(C)o3)C(C)C)[nH]c2c1,5.539102157243452
CHEMBL3318061,CHEMBL1871,Androgen Receptor,IC50,=,3320.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3ccccc3[nH]2)C(C)C)o1,5.478861916295964
CHEMBL3318060,CHEMBL1871,Androgen Receptor,IC50,=,3380.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CN(Cc1cccs1)C(=O)c1cc2ccc(F)cc2[nH]1,5.471083299722345
CHEMBL3318059,CHEMBL1871,Androgen Receptor,IC50,=,3530.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CN(Cc1ccc(Br)s1)C(=O)c1cc2ccc(F)cc2[nH]1,5.452225294612178
CHEMBL3317457,CHEMBL1871,Androgen Receptor,IC50,=,4040.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,O=C(c1cc2ccc(F)cc2[nH]1)N(Cc1ccco1)Cc1ccco1,5.393618634889395
CHEMBL3318058,CHEMBL1871,Androgen Receptor,IC50,=,5200.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2cc(C(F)(F)F)ccc2[nH]1,5.2839966563652006
CHEMBL3318057,CHEMBL1871,Androgen Receptor,IC50,=,6470.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,COCCN(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1,5.189095719331299
CHEMBL3318056,CHEMBL1871,Androgen Receptor,IC50,=,7510.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,N#CCCN(Cc1ccccc1)C(=O)c1cc2ccccc2[nH]1,5.124360062995832
CHEMBL3318055,CHEMBL1871,Androgen Receptor,IC50,=,9440.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,Cc1ccc(CN(C)C(=O)c2cc3cc(F)ccc3[nH]2)o1,5.025028005701931
CHEMBL3318054,CHEMBL1871,Androgen Receptor,IC50,=,15670.0,nM,CHEMBL3368856,B,Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days,CHEMBL3351962,IC50,CN(Cc1ccc(Br)o1)C(=O)c1cc2ccc(F)cc2[nH]1,4.80493100353141
CHEMBL3318066,CHEMBL1871,Androgen Receptor,IC50,=,850.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc2cc(C(=O)N(Cc3ccco3)C(C)C)[nH]c2c1,6.070581074285707
CHEMBL3318067,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3cccc(F)c3[nH]2)C(C)C)o1,5.920818753952375
CHEMBL3318068,CHEMBL1871,Androgen Receptor,IC50,=,840.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3ccc(F)cc3[nH]2)C(C)C)o1,6.075720713938118
CHEMBL3318069,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1,6.301029995663981
CHEMBL3318070,CHEMBL1871,Androgen Receptor,IC50,=,530.0,nM,CHEMBL3368857,B,Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,CC(C)N(Cc1ccco1)C(=O)c1cc2ccc(F)cc2[nH]1,6.275724130399211
CHEMBL3318068,CHEMBL1871,Androgen Receptor,IC50,=,2180.0,nM,CHEMBL3369088,B,Inhibition of androgen receptor binding function 3 in human enzalutamide-resistant MR49F cells assessed as reduction in PSA expression after 3 days by prostate surface antigen assay,CHEMBL3351962,IC50,Cc1ccc(CN(C(=O)c2cc3ccc(F)cc3[nH]2)C(C)C)o1,5.661543506395395
CHEMBL3337731,CHEMBL1871,Androgen Receptor,IC50,=,5600.0,nM,CHEMBL3381812,B,Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting,CHEMBL3351638,IC50,Cc1nn(Cc2ccccc2)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2,5.251811972993799
CHEMBL3337823,CHEMBL1871,Androgen Receptor,IC50,=,3600.0,nM,CHEMBL3381812,B,Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting,CHEMBL3351638,IC50,CCCCn1nc(C)c(-c2ccc3c(c2)NC(=O)CO3)c1-c1ccc(F)cc1,5.443697499232712
CHEMBL3337824,CHEMBL1871,Androgen Receptor,IC50,=,3700.0,nM,CHEMBL3381812,B,Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting,CHEMBL3351638,IC50,Cc1nn(CC(C)C)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2,5.431798275933005
CHEMBL3337831,CHEMBL1871,Androgen Receptor,IC50,=,9200.0,nM,CHEMBL3381812,B,Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting,CHEMBL3351638,IC50,Cc1nn(CCC(C)(F)F)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2,5.036212172654444
CHEMBL1393,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL3381812,B,Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting,CHEMBL3351638,IC50,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,6.920818753952375
CHEMBL3343778,CHEMBL1871,Androgen Receptor,IC50,=,83800.0,nM,CHEMBL3382073,B,Binding affinity to androgen receptor (unknown origin),CHEMBL3351221,IC50,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,4.076755981369724
CHEMBL3402223,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,CC1(C)CCCN1c1ccc(C#N)c2ccccc12,8.154901959985743
CHEMBL3402222,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@@H]1CCCN1c1ccc(C#N)c2ccccc12,7.698970004336019
CHEMBL3402221,CHEMBL1871,Androgen Receptor,IC50,=,0.84,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1CCCN1c1ccc(C#N)c2ccccc12,9.075720713938118
CHEMBL570897,CHEMBL1871,Androgen Receptor,IC50,=,2.5,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,O=[N+]([O-])c1ccc(N2CCCC2)c2ccccc12,8.602059991327963
CHEMBL570898,CHEMBL1871,Androgen Receptor,IC50,=,2.5,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,N#Cc1ccc(N2CCCC2)c2ccccc12,8.602059991327963
CHEMBL3402224,CHEMBL1871,Androgen Receptor,IC50,=,1.1,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,CC[C@H]1CCCN1c1ccc(C#N)c2ccccc12,8.958607314841775
CHEMBL3402225,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,CC(C)[C@H]1CCCN1c1ccc(C#N)c2ccccc12,8.853871964321762
CHEMBL3402226,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,N#Cc1ccc(N2CCC[C@@H]2C(N)=O)c2ccccc12,7.468521082957745
CHEMBL3402227,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,N#Cc1ccc(N2CCC[C@@H]2C#N)c2ccccc12,9.0
CHEMBL3402228,CHEMBL1871,Androgen Receptor,IC50,=,2.2,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1[C@@H](O)CCN1c1ccc(C#N)c2ccccc12,8.657577319177793
CHEMBL3402229,CHEMBL1871,Androgen Receptor,IC50,=,2.4,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1[C@H](O)CCN1c1ccc(C#N)c2ccccc12,8.619788758288394
CHEMBL3402230,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1C(=O)CCN1c1ccc(C#N)c2ccccc12,7.431798275933005
CHEMBL3402231,CHEMBL1871,Androgen Receptor,IC50,=,4.1,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1[C@@H](CO)CCN1c1ccc(C#N)c2ccccc12,8.387216143280265
CHEMBL3402232,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,C[C@H]1[C@@H](C(C)(C)O)CCN1c1ccc(C#N)c2ccccc12,8.853871964321762
CHEMBL3402233,CHEMBL1871,Androgen Receptor,IC50,=,7.5,nM,CHEMBL3404787,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs,CHEMBL3399980,IC50,COC(=O)[C@H]1CCN(c2ccc(C#N)c3ccccc23)[C@H]1C,8.1249387366083
CHEMBL3410856,CHEMBL1871,Androgen Receptor,IC50,=,2.11,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,Cc1c(N2C3CCC2CC(C)(O)C3)ccc(C#N)c1Cl,8.675717544702307
CHEMBL3410855,CHEMBL1871,Androgen Receptor,IC50,=,2040.0,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,CCS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,5.690369832574101
CHEMBL3410854,CHEMBL1871,Androgen Receptor,IC50,=,2650.0,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,CS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,5.576754126063192
CHEMBL3410853,CHEMBL1871,Androgen Receptor,IC50,=,233.0,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@H]3CC[C@H]2CC(NCc2ccccc2)C3)cc1C(F)(F)F,6.632644078973981
CHEMBL3410852,CHEMBL1871,Androgen Receptor,IC50,=,66.0,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,N#Cc1ccc(N2C3CCC2CC(=O)C3)cc1C(F)(F)F,7.180456064458131
CHEMBL3410851,CHEMBL1871,Androgen Receptor,IC50,=,29.3,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,CC1(O)C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,7.53313237964589
CHEMBL3410850,CHEMBL1871,Androgen Receptor,IC50,=,39.8,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@H]3CC[C@H]2CC(O)C3)cc1C(F)(F)F,7.400116927926312
CHEMBL3084689,CHEMBL1871,Androgen Receptor,IC50,=,31.7,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@@H]3CC[C@H]2C[C@@H](O)C3)cc1Cl,7.498940737782249
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,86.9,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.060980223551334
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,4.17,nM,CHEMBL3411793,B,Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay,CHEMBL3407333,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.379863945026242
CHEMBL3410856,CHEMBL1871,Androgen Receptor,IC50,=,2.11,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,Cc1c(N2C3CCC2CC(C)(O)C3)ccc(C#N)c1Cl,8.675717544702307
CHEMBL3410855,CHEMBL1871,Androgen Receptor,IC50,=,2040.0,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,CCS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,5.690369832574101
CHEMBL3410854,CHEMBL1871,Androgen Receptor,IC50,=,2650.0,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,CS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,5.576754126063192
CHEMBL3410853,CHEMBL1871,Androgen Receptor,IC50,=,233.0,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@H]3CC[C@H]2CC(NCc2ccccc2)C3)cc1C(F)(F)F,6.632644078973981
CHEMBL3410852,CHEMBL1871,Androgen Receptor,IC50,=,66.0,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,N#Cc1ccc(N2C3CCC2CC(=O)C3)cc1C(F)(F)F,7.180456064458131
CHEMBL3410851,CHEMBL1871,Androgen Receptor,IC50,=,29.3,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,CC1(O)C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1,7.53313237964589
CHEMBL3410850,CHEMBL1871,Androgen Receptor,IC50,=,39.8,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@H]3CC[C@H]2CC(O)C3)cc1C(F)(F)F,7.400116927926312
CHEMBL3084689,CHEMBL1871,Androgen Receptor,IC50,=,31.7,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,N#Cc1ccc(N2[C@@H]3CC[C@H]2C[C@@H](O)C3)cc1Cl,7.498940737782249
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,86.9,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.060980223551334
CHEMBL386630,CHEMBL1871,Androgen Receptor,IC50,=,4.27,nM,CHEMBL3411794,B,Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition,CHEMBL3407333,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.369572124974976
CHEMBL3421871,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL3424580,B,Binding affinity to human AR,CHEMBL3421549,IC50,CC[C@@]12C[C@@](C)(O)[C@](O)(c3ccccc3)C[C@H]1CCc1cc(O)ccc12,6.522878745280337
CHEMBL3421892,CHEMBL1871,Androgen Receptor,IC50,=,40.0,nM,CHEMBL3424580,B,Binding affinity to human AR,CHEMBL3421549,IC50,Cc1noc(=O)c2ccc(NC(=O)C(O)(CC3(c4cc(F)ccc4Cl)CCC3)C(F)(F)F)cc12,7.3979400086720375
CHEMBL3578271,CHEMBL1871,Androgen Receptor,IC50,=,3100.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(Cl)ccc3[nH]2)C1=O,5.508638306165727
CHEMBL3578274,CHEMBL1871,Androgen Receptor,IC50,=,3000.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(C(F)(F)F)ccc3[nH]2)C1=O,5.522878745280337
CHEMBL3578276,CHEMBL1871,Androgen Receptor,IC50,=,13000.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(NS(C)(=O)=O)ccc3[nH]2)C1=O,4.886056647693163
CHEMBL3576885,CHEMBL1871,Androgen Receptor,IC50,=,3100.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(-c4cc[nH]n4)ccc3[nH]2)C1=O,5.508638306165727
CHEMBL3578284,CHEMBL1871,Androgen Receptor,IC50,=,3400.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,Cc1nocc1-c1ccc2[nH]c([C@@]3(Cc4ccccc4)OC(=O)N([C@H](C)c4ccc(F)cc4)C3=O)nc2c1,5.468521082957745
CHEMBL3578285,CHEMBL1871,Androgen Receptor,IC50,=,7700.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(N4CCOCC4)ccc3[nH]2)C1=O,5.113509274827518
CHEMBL3578286,CHEMBL1871,Androgen Receptor,IC50,=,3700.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(-c4cccnc4)ccc3[nH]2)C1=O,5.431798275933005
CHEMBL3578295,CHEMBL1871,Androgen Receptor,IC50,=,11000.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3c(NS(C)(=O)=O)cccc3[nH]2)C1=O,4.958607314841775
CHEMBL1393,CHEMBL1871,Androgen Receptor,IC50,=,670.0,nM,CHEMBL3579176,B,Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay,CHEMBL3576820,IC50,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,6.173925197299173
CHEMBL3590187,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL3592008,B,Displacement of [3H]methyltrienolone from androgen receptor in human prostate cancer cells,CHEMBL3588838,IC50,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,7.301029995663981
CHEMBL3605562,CHEMBL1871,Androgen Receptor,IC50,=,1790.0,nM,CHEMBL3607996,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK2 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.747146969020107
CHEMBL3605560,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL3607996,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK2 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.619788758288394
CHEMBL3605563,CHEMBL1871,Androgen Receptor,IC50,=,620.0,nM,CHEMBL3607996,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK2 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,6.207608310501746
CHEMBL3605564,CHEMBL1871,Androgen Receptor,IC50,=,580.0,nM,CHEMBL3607996,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK2 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,6.236572006437063
CHEMBL3605562,CHEMBL1871,Androgen Receptor,IC50,=,3580.0,nM,CHEMBL3607997,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK3 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.446116973356125
CHEMBL3605560,CHEMBL1871,Androgen Receptor,IC50,=,3520.0,nM,CHEMBL3607997,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK3 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.453457336521868
CHEMBL3605563,CHEMBL1871,Androgen Receptor,IC50,=,1420.0,nM,CHEMBL3607997,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK3 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.847711655616943
CHEMBL3605564,CHEMBL1871,Androgen Receptor,IC50,=,750.0,nM,CHEMBL3607997,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK3 gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,6.1249387366083
CHEMBL3605562,CHEMBL1871,Androgen Receptor,IC50,=,2720.0,nM,CHEMBL3607998,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.565431095965801
CHEMBL3605560,CHEMBL1871,Androgen Receptor,IC50,=,3280.0,nM,CHEMBL3607998,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.484126156288321
CHEMBL3605563,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL3607998,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,5.920818753952375
CHEMBL3605564,CHEMBL1871,Androgen Receptor,IC50,=,770.0,nM,CHEMBL3607998,B,Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay,CHEMBL3603831,IC50,CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1,6.113509274827518
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,13.1,nM,CHEMBL3606495,B,Competitive inhibition of androgen binding to androgen receptor (unknown origin) by invitrogen polar screen assay,CHEMBL3603831,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.882728704344236
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,173.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.761953896871205
CHEMBL3623114,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@@H]1O)[C@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@H]12,8.0
CHEMBL3623116,CHEMBL1871,Androgen Receptor,IC50,=,22.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CC(C)OC(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.657577319177793
CHEMBL3623117,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CN(C(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12)c1ccccc1,7.468521082957745
CHEMBL3623118,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@H]1N)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.221848749616356
CHEMBL3623119,CHEMBL1871,Androgen Receptor,IC50,=,23.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CCC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.638272163982407
CHEMBL3623120,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CNS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.468521082957745
CHEMBL3623121,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CC(C)NC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.221848749616356
CHEMBL3623122,CHEMBL1871,Androgen Receptor,IC50,=,6.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CN1CCN(OC(=O)N[C@@H]2C[C@]3(C)O[C@]2(C)[C@@H]2C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)[C@@H]23)CC1,8.221848749616356
CHEMBL3623123,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@H]1NS(C)(=O)=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.698970004336019
CHEMBL3623124,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1ccccc1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,9.0
CHEMBL3623125,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1ccccc1F)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,8.0
CHEMBL3623126,CHEMBL1871,Androgen Receptor,IC50,=,7.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1cccnc1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,8.154901959985743
CHEMBL3623127,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL3624234,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay,CHEMBL3621143,IC50,CCS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.795880017344075
CHEMBL3623004,CHEMBL1871,Androgen Receptor,IC50,=,30000.0,nM,CHEMBL3624769,B,Binding affinity to androgen receptor (unknown origin),CHEMBL3621041,IC50,C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F,4.522878745280337
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.7447274948966935
CHEMBL66761,CHEMBL1871,Androgen Receptor,IC50,=,5370.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2ccccc2)c2ccccc12,5.270025714300445
CHEMBL3622573,CHEMBL1871,Androgen Receptor,IC50,=,9540.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,Cc1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.020451625295905
CHEMBL3622574,CHEMBL1871,Androgen Receptor,IC50,=,9590.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,COc1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.018181392829336
CHEMBL3622575,CHEMBL1871,Androgen Receptor,IC50,=,10500.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2ccccc2F)c2ccccc12,4.978810700930062
CHEMBL378274,CHEMBL1871,Androgen Receptor,IC50,=,1260.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,Oc1nnc(Cc2ccccc2Cl)c2ccccc12,5.899629454882437
CHEMBL3622576,CHEMBL1871,Androgen Receptor,IC50,=,3670.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2ccccc2C(F)(F)F)c2ccccc12,5.435333935747911
CHEMBL3622578,CHEMBL1871,Androgen Receptor,IC50,=,530.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2ccccc2[N+](=O)[O-])c2ccccc12,6.275724130399211
CHEMBL3622579,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12,6.657577319177793
CHEMBL3622581,CHEMBL1871,Androgen Receptor,IC50,=,1010.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=C(Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12)C(F)(F)F,5.995678626217357
CHEMBL3622583,CHEMBL1871,Androgen Receptor,IC50,=,1660.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,CCN(CC)c1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.779891911959945
CHEMBL3622584,CHEMBL1871,Androgen Receptor,IC50,=,3710.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,CCNc1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.430626090384954
CHEMBL3622585,CHEMBL1871,Androgen Receptor,IC50,=,1950.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,CN(C)c1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.709965388637482
CHEMBL3622586,CHEMBL1871,Androgen Receptor,IC50,=,9020.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,CNc1ccccc1Cc1n[nH]c(=O)c2ccccc12,5.044793462458058
CHEMBL3622587,CHEMBL1871,Androgen Receptor,IC50,=,1380.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,Cc1cccc(C)c1Cc1n[nH]c(=O)c2ccccc12,5.860120913598763
CHEMBL3622588,CHEMBL1871,Androgen Receptor,IC50,=,3760.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(F)cccc2F)c2ccccc12,5.424812155072339
CHEMBL3622589,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)cccc2Cl)c2ccccc12,6.7447274948966935
CHEMBL3622590,CHEMBL1871,Androgen Receptor,IC50,=,920.0,nM,CHEMBL3626368,B,Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)ccc(Cl)c2Cl)c2ccccc12,6.036212172654444
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,7690.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.114073660198569
CHEMBL378274,CHEMBL1871,Androgen Receptor,IC50,=,85400.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,Oc1nnc(Cc2ccccc2Cl)c2ccccc12,4.068542129310995
CHEMBL3622579,CHEMBL1871,Androgen Receptor,IC50,=,45200.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12,4.3448615651886175
CHEMBL3622587,CHEMBL1871,Androgen Receptor,IC50,=,84300.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,Cc1cccc(C)c1Cc1n[nH]c(=O)c2ccccc12,4.074172425375258
CHEMBL3622589,CHEMBL1871,Androgen Receptor,IC50,=,10900.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)cccc2Cl)c2ccccc12,4.962573502059376
CHEMBL3622590,CHEMBL1871,Androgen Receptor,IC50,=,56700.0,nM,CHEMBL3626370,B,Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)ccc(Cl)c2Cl)c2ccccc12,4.246416941107094
CHEMBL378274,CHEMBL1871,Androgen Receptor,IC50,=,860.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,Oc1nnc(Cc2ccccc2Cl)c2ccccc12,6.065501548756432
CHEMBL3622578,CHEMBL1871,Androgen Receptor,IC50,=,1460.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2ccccc2[N+](=O)[O-])c2ccccc12,5.835647144215563
CHEMBL3622579,CHEMBL1871,Androgen Receptor,IC50,=,990.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12,6.00436480540245
CHEMBL3622587,CHEMBL1871,Androgen Receptor,IC50,=,3420.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,Cc1cccc(C)c1Cc1n[nH]c(=O)c2ccccc12,5.465973893943865
CHEMBL3622589,CHEMBL1871,Androgen Receptor,IC50,=,550.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)cccc2Cl)c2ccccc12,6.259637310505756
CHEMBL3622590,CHEMBL1871,Androgen Receptor,IC50,=,920.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,O=c1[nH]nc(Cc2c(Cl)ccc(Cl)c2Cl)c2ccccc12,6.036212172654444
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,850.0,nM,CHEMBL3626371,B,Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay,CHEMBL3621051,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.070581074285707
CHEMBL3667040,CHEMBL1871,Androgen Receptor,IC50,=,12000.0,nM,CHEMBL3705620,B,"Inhibition Assay: To conduct the assays, the 250 uM monasuspiloin solution was further diluted with 10% DMSO to prepare 25 uM, and 5 uM monasuspiloin samples, and the final concentration of DMSO in the cell culture was 1%.The cell line used in glucocorticoid receptor (GR) assay was human A-549 cells (cultured in Ham's F12K medium (Gibco, USA), 10% FBS), the cell line used in progesterone receptor (PR) assay was human T-47D cells (cultured in RPMI 1640 medium (Gibco, USA), 10% FBS), and the cell line used in estrogen receptor (ER) assay was human MCF7 cells (cultured in MEM medium (Gibco, USA), 10% FBS). The cells in the exponential phase of growth were washed off with 1 ml of 0.05% trypsin, centrifuged and collected in a centrifuge tube. 1x107 cells were resuspended in 270 ul BES medium (5 mM BES in medium) and 8 to 10 ug of plasmid [pMMTV-SEAP plasmid was used for GR and PR (see FIG. 7), and pTA-ERE-SEAP plasmid (Clontech, USA) was used for ER (see FIG. 8)] were also added.",CHEMBL3638600,IC50,C/C=C/C1=CC2=C(CO1)C(=O)[C@]1(C)OC(=O)[C@H](C(O)CCCCC)C1C2,4.920818753952375
CHEMBL3787387,CHEMBL1871,Androgen Receptor,IC50,=,5000.0,nM,CHEMBL3788113,B,Antagonist activity against androgen receptor (unknown origin),CHEMBL3784967,IC50,CCOC(=O)C(CC)Oc1ccc2c(C)cc(=O)oc2c1,5.301029995663981
CHEMBL3785926,CHEMBL1871,Androgen Receptor,IC50,=,3760.0,nM,CHEMBL3788113,B,Antagonist activity against androgen receptor (unknown origin),CHEMBL3784967,IC50,Cc1cc(=O)oc2cc(OCC(=O)C(C)(C)C)ccc12,5.424812155072339
CHEMBL3787517,CHEMBL1871,Androgen Receptor,IC50,=,5090.0,nM,CHEMBL3788113,B,Antagonist activity against androgen receptor (unknown origin),CHEMBL3784967,IC50,Cc1cc(=O)oc2cc(OC(C)C(=O)c3ccccc3)ccc12,5.293282217663242
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,490.0,nM,CHEMBL3829948,B,Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay,CHEMBL3826911,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.309803919971486
CHEMBL3828139,CHEMBL1871,Androgen Receptor,IC50,=,710.0,nM,CHEMBL3829948,B,Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay,CHEMBL3826911,IC50,CC(O)(CSc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.1487416512809245
CHEMBL3827008,CHEMBL1871,Androgen Receptor,IC50,=,3100.0,nM,CHEMBL3829948,B,Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay,CHEMBL3826911,IC50,CC(O)(CS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.508638306165727
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,361.0,nM,CHEMBL3829948,B,Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay,CHEMBL3826911,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.442492798094342
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,21.0,nM,CHEMBL3863650,B,Displacement of [18F]-FDHT from androgen receptor in human LNCAP/AR cells,CHEMBL3862016,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.6777807052660805
CHEMBL3948452,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(/C=C/C(=O)Nc2ccccc2N)c(F)c1,6.638272163982407
CHEMBL3955013,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)c(F)c1,6.481486060122112
CHEMBL3966165,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCOCCC(=O)NO)c(F)c1,7.107905397309519
CHEMBL3894825,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)OCCCCCC(=O)NO)c(F)c1,7.366531544420413
CHEMBL3974665,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCNS(N)(=O)=O)c(F)c1,6.455931955649724
CHEMBL3903756,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCNS(N)(=O)=O)c(F)c1,6.958607314841775
CHEMBL3982650,CHEMBL1871,Androgen Receptor,IC50,=,560.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCn2cccc(O)c2=O)c(F)c1,6.251811972993799
CHEMBL3912767,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCn2cccc(O)c2=O)c(F)c1,6.6020599913279625
CHEMBL3908221,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL3863626,B,Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay,CHEMBL3862016,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCc2ccc(C(=O)C(F)(F)F)s2)c(F)c1,7.167491087293763
CHEMBL3039217,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL3864019,B,Antagonist activity at wild type AR in human PC3 cells assessed as suppression of DHT-induced receptor transcriptional activation after 24 hrs by PSA-luciferase reporter gene assay,CHEMBL3862039,IC50,CC(C)c1ccc2c(c1O)CC[C@H]1C3=C(CC[C@]21C)C(=O)OC3,6.585026652029182
CHEMBL3039217,CHEMBL1871,Androgen Receptor,IC50,=,388.0,nM,CHEMBL3864020,B,Antagonist activity at AR T877A mutant (unknown origin) transfected in human PC3 cells assessed as inhibition of DHT-induced receptor transcriptional activation after 24 hrs by PSA-luciferase reporter gene assay,CHEMBL3862039,IC50,CC(C)c1ccc2c(c1O)CC[C@H]1C3=C(CC[C@]21C)C(=O)OC3,6.411168274405792
CHEMBL3039217,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL3864033,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in human PC3 cells assessed as inhibition of DHT-induced receptor transactivation after 24 hrs by PSA-luciferase reporter gene assay,CHEMBL3862039,IC50,CC(C)c1ccc2c(c1O)CC[C@H]1C3=C(CC[C@]21C)C(=O)OC3,6.318758762624412
CHEMBL3927163,CHEMBL1871,Androgen Receptor,IC50,=,5300.0,nM,CHEMBL3867367,B,Antagonist activity at human AR expressed in HEK293 cells measured after 24 hrs by luciferase reporter gene assay,CHEMBL3865849,IC50,O=S(=O)(Nc1ccc(Oc2ccccc2)cc1)c1cccc(C(F)(F)F)c1,5.275724130399211
CHEMBL3902310,CHEMBL1871,Androgen Receptor,IC50,=,57.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,CNC(=O)[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](F)[C@@H]2C1,7.2441251443275085
CHEMBL3921315,CHEMBL1871,Androgen Receptor,IC50,=,44.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,CNC(=O)[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.356547323513812
CHEMBL3893320,CHEMBL1871,Androgen Receptor,IC50,=,55.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@@]3(C(N)=O)S2(=O)=O)cc1C(F)(F)F,7.259637310505756
CHEMBL3949176,CHEMBL1871,Androgen Receptor,IC50,=,91.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](F)[C@@H]2C1,7.040958607678906
CHEMBL3920247,CHEMBL1871,Androgen Receptor,IC50,=,106.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](O)[C@@H]2C1,6.97469413473523
CHEMBL3939272,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@H]3C[C@H]([C@H](O)C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,6.366531544420413
CHEMBL3907304,CHEMBL1871,Androgen Receptor,IC50,=,327.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H]3CC[C@@H](C3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,6.485452247339714
CHEMBL3907304,CHEMBL1871,Androgen Receptor,IC50,=,444.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H]3CC[C@@H](C3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,6.35261702988538
CHEMBL3935242,CHEMBL1871,Androgen Receptor,IC50,=,67.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H]3CC[C@@H](C3=O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.173925197299173
CHEMBL3898284,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H]3C=C[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.522878745280337
CHEMBL3926358,CHEMBL1871,Androgen Receptor,IC50,=,73.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,C[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.136677139879544
CHEMBL3987109,CHEMBL1871,Androgen Receptor,IC50,=,219.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,N#Cc1ccc(N2C[C@@H]3[C@@H]([C@@H]4C=C[C@H]3C4)S2(=O)=O)cc1C(F)(F)F,6.6595558851598815
CHEMBL3917372,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL3869526,B,Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation,CHEMBL3868609,IC50,N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@H]3S2(=O)=O)cc1C(F)(F)F,6.886056647693163
CHEMBL3695596,CHEMBL1871,Androgen Receptor,IC50,=,630.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CCC(=O)C=C1C1CC1[C@@H]1C2CC[C@@]2(C)C1C1CC1[C@@]21CCC(=O)C1,6.200659450546418
CHEMBL3695597,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,5.0
CHEMBL3695598,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21,6.958607314841775
CHEMBL3695599,CHEMBL1871,Androgen Receptor,IC50,=,89.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@H]12,7.050609993355087
CHEMBL3695600,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21,6.886056647693163
CHEMBL3695601,CHEMBL1871,Androgen Receptor,IC50,=,310.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC1(CC1)[C@@]21C=CC(=O)O1,6.508638306165727
CHEMBL3695602,CHEMBL1871,Androgen Receptor,IC50,=,28.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,7.552841968657781
CHEMBL3695603,CHEMBL1871,Androgen Receptor,IC50,=,2600.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,5.585026652029182
CHEMBL3695604,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,7.366531544420413
CHEMBL3695605,CHEMBL1871,Androgen Receptor,IC50,=,76.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CC(=O)O4)[C@H]12,7.119186407719209
CHEMBL3695606,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21,7.301029995663981
CHEMBL3695607,CHEMBL1871,Androgen Receptor,IC50,=,94.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C4CC4)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,7.026872146400302
CHEMBL3695608,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H]([C@H](C4CC4)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,6.522878745280337
CHEMBL3695609,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,6.769551078621726
CHEMBL3695610,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=C(Cl)C(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,6.853871964321762
CHEMBL3695611,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H](C[C@@H](CO)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,6.0
CHEMBL3695612,CHEMBL1871,Androgen Receptor,IC50,=,42.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,CC[C@]12CC[C@H]3[C@@H](CC4(CC4)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,7.376750709602099
CHEMBL3695613,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H](C[C@@H](CO)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,6.0
CHEMBL3695614,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL3705531,B,"Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639292,IC50,C[C@]12CC[C@H]3[C@@H](CC4(CC4)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1,7.431798275933005
CHEMBL1509,CHEMBL1871,Androgen Receptor,IC50,=,630.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12,6.200659450546418
CHEMBL3658376,CHEMBL1871,Androgen Receptor,IC50,=,6.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4CCC3C1C1CC1[C@@]21CCC(=O)O1,8.221848749616356
CHEMBL3658377,CHEMBL1871,Androgen Receptor,IC50,=,61.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,CC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12,7.214670164989233
CHEMBL3658378,CHEMBL1871,Androgen Receptor,IC50,=,74.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,CCC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12,7.130768280269024
CHEMBL3658379,CHEMBL1871,Androgen Receptor,IC50,=,55.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C=CC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12,7.259637310505756
CHEMBL3658380,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4CC(C4CC4)C3C1C1CC1[C@@]21CCC(=O)O1,7.107905397309519
CHEMBL3658381,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4[C@H](CO)CC3C1C1CC1[C@@]21CCC(=O)O1,5.0
CHEMBL3658382,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4C4(CC4)CC3C1C1CC1[C@@]21CCC(=O)O1,7.585026652029182
CHEMBL3915005,CHEMBL1871,Androgen Receptor,IC50,=,420.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4[C@@H]4C[C@@H]4C3C1C1CC1[C@@]21CCC(=O)O1,6.376750709602099
CHEMBL3658384,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL3705748,B,"Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.",CHEMBL3639070,IC50,C[C@]12CCC3C4CCC(=O)C=C4C4CC4C3C1C1CC1[C@@]21CCC(=O)O1,6.481486060122112
CHEMBL1289012,CHEMBL1871,Androgen Receptor,IC50,=,9200.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,CC1(O)CCCc2c1[nH]c1ccc(C#N)cc21,5.036212172654444
CHEMBL1288321,CHEMBL1871,Androgen Receptor,IC50,=,1560.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,5.806875401645538
CHEMBL1289013,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,N#Cc1ccc2[nH]c3c(c2c1)CCCC3(O)C(F)(F)F,6.318758762624412
CHEMBL1288322,CHEMBL1871,Androgen Receptor,IC50,=,40150.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1ccc(Cl)c(Cl)c21,4.3963144503853
CHEMBL1290633,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,7.468521082957745
CHEMBL1288979,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(Cl)cc21,7.468521082957745
CHEMBL3682510,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,O[C@]1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,7.886056647693163
CHEMBL3682511,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,O[C@]1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(Cl)cc21,7.698970004336019
CHEMBL1290632,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCCc2c1[nH]c1c(Cl)cc(Cl)cc21,6.221848749616356
CHEMBL3682512,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)c2[nH]c3cc(Cl)c(Cl)cc3c2CCC1F,6.853871964321762
CHEMBL1288980,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)ccc(Cl)c21,7.070581074285707
CHEMBL3682513,CHEMBL1871,Androgen Receptor,IC50,=,520.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1ccc(F)c(Cl)c21,6.2839966563652006
CHEMBL3682514,CHEMBL1871,Androgen Receptor,IC50,=,70.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1c2[nH]c3ccc(Cl)c(Cl)c3c2C(C(F)(F)F)CC1F,7.154901959985743
CHEMBL3682515,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(F)cc21,7.698970004336019
CHEMBL1288981,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(F)cc21,7.045757490560675
CHEMBL3682517,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)c2[nH]c3cc(Cl)c(Cl)cc3c2CCC1(F)F,6.657577319177793
CHEMBL1290751,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)c2[nH]c3c(Cl)cc(Cl)cc3c2CCC1(F)F,7.0
CHEMBL1288323,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCc2c1[nH]c1c(Cl)cc(Cl)cc21,7.886056647693163
CHEMBL3682519,CHEMBL1871,Androgen Receptor,IC50,=,400.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,CC1CCc2c([nH]c3ccc(Cl)c(Cl)c23)C1(O)C(F)(F)F,6.3979400086720375
CHEMBL3682520,CHEMBL1871,Androgen Receptor,IC50,=,410.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)c(Cl)c21,6.3872161432802645
CHEMBL3682521,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)c(Cl)ccc21,6.886056647693163
CHEMBL3682523,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCc2c1[nH]c1cc(Cl)c(Cl)cc21,6.920818753952375
CHEMBL3682524,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCCc2c1[nH]c1c(F)cc(Cl)cc21,7.267606240177031
CHEMBL3682525,CHEMBL1871,Androgen Receptor,IC50,=,175.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,OC1(C(F)(F)F)CCc2c1[nH]c1ccc(Cl)c(Cl)c21,6.756961951313706
CHEMBL3682526,CHEMBL1871,Androgen Receptor,IC50,=,390.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,N#Cc1cc(C(F)(F)F)c2[nH]c3c(c2c1)CCCC3(O)C(F)(F)F,6.4089353929735005
CHEMBL1288956,CHEMBL1871,Androgen Receptor,IC50,=,1420.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,Oc1cccc2c1[nH]c1ccc(Br)cc12,5.847711655616943
CHEMBL1288957,CHEMBL1871,Androgen Receptor,IC50,=,4600.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,N#Cc1ccc2[nH]c3c(O)cccc3c2c1,5.337242168318426
CHEMBL1288959,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,Oc1cccc2c1[nH]c1ccc(Cl)c(Cl)c12,7.823908740944319
CHEMBL1288958,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL3705681,B,"Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.",CHEMBL3638724,IC50,Oc1c(Br)ccc2c1[nH]c1cc(Cl)c(Cl)cc12,7.468521082957745
CHEMBL3926496,CHEMBL1871,Androgen Receptor,IC50,=,630.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@@]12CCC(=O)C=C1[C@H]1C[C@H]1[C@@H]1[C@H]3[C@H]4C[C@H]4[C@]4(CCC(=O)O4)[C@]3(C)CC[C@H]12,6.200659450546418
CHEMBL3687970,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,7.568636235841012
CHEMBL3692346,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.180456064458131
CHEMBL3692347,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,7.346787486224656
CHEMBL3692348,CHEMBL1871,Androgen Receptor,IC50,=,64.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@H]12,7.1938200260161125
CHEMBL3692349,CHEMBL1871,Androgen Receptor,IC50,=,53.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,7.275724130399211
CHEMBL3692350,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC1(CC1)[C@@]21C=CCO1,6.853871964321762
CHEMBL3692352,CHEMBL1871,Androgen Receptor,IC50,=,1200.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,5.920818753952375
CHEMBL3692353,CHEMBL1871,Androgen Receptor,IC50,=,81.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,7.0915149811213505
CHEMBL3692354,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@H]12,6.958607314841775
CHEMBL3692355,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,5.886056647693163
CHEMBL3692356,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C4CC4)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.721246399047171
CHEMBL3692357,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H](C[C@@H](CO)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.0
CHEMBL3926496,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@@]12CCC(=O)C=C1[C@H]1C[C@H]1[C@@H]1[C@H]3[C@H]4C[C@H]4[C@]4(CCC(=O)O4)[C@]3(C)CC[C@H]12,7.568636235841012
CHEMBL3687970,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,7.585026652029182
CHEMBL3692346,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.886056647693163
CHEMBL3692347,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,6.0
CHEMBL3692348,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@H]12,6.0
CHEMBL3692349,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,6.0
CHEMBL3692350,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC1(CC1)[C@@]21C=CCO1,7.958607314841775
CHEMBL3692351,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.795880017344075
CHEMBL3692352,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.0
CHEMBL3692353,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.0
CHEMBL3692354,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@H]12,6.0
CHEMBL3692355,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@@H]21,6.0
CHEMBL3692356,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H]([C@H](C4CC4)CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.0
CHEMBL3692357,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL3706042,B,"Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.",CHEMBL3638672,IC50,CC[C@]12CC[C@H]3[C@@H](C[C@@H](CO)C4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1,6.853871964321762
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,889.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.051098239029786
CHEMBL3959936,CHEMBL1871,Androgen Receptor,IC50,=,149.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccc3)C2=S)cc1C(F)(F)F,6.826813731587726
CHEMBL3958249,CHEMBL1871,Androgen Receptor,IC50,=,125.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.903089986991944
CHEMBL3985131,CHEMBL1871,Androgen Receptor,IC50,=,137.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F,6.863279432843593
CHEMBL3904234,CHEMBL1871,Androgen Receptor,IC50,=,273.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(N)cc3)C2=S)cc1C(F)(F)F,6.5638373529592435
CHEMBL3903040,CHEMBL1871,Androgen Receptor,IC50,=,131.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(OC(=O)CCl)cc3)C2=S)cc1C(F)(F)F,6.882728704344236
CHEMBL3977051,CHEMBL1871,Androgen Receptor,IC50,=,147.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.8326826652518236
CHEMBL3940023,CHEMBL1871,Androgen Receptor,IC50,=,124.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.906578314837764
CHEMBL3910485,CHEMBL1871,Androgen Receptor,IC50,=,194.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.7121982700697735
CHEMBL3972532,CHEMBL1871,Androgen Receptor,IC50,=,232.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCCCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.634512015109101
CHEMBL3931647,CHEMBL1871,Androgen Receptor,IC50,=,638.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCN(C)CC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.195179321278838
CHEMBL3955747,CHEMBL1871,Androgen Receptor,IC50,=,469.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc(C#N)cc3)C2=S)cc1C(F)(F)F,6.328827157284916
CHEMBL3919228,CHEMBL1871,Androgen Receptor,IC50,=,498.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc([N+](=O)[O-])cc3)C2=S)cc1C(F)(F)F,6.302770657240282
CHEMBL3976056,CHEMBL1871,Androgen Receptor,IC50,=,283.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(-c4ccccc4)cc3)C2=S)cc1C(F)(F)F,6.548213564475709
CHEMBL3947344,CHEMBL1871,Androgen Receptor,IC50,=,162.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F,6.790484985457369
CHEMBL3940304,CHEMBL1871,Androgen Receptor,IC50,=,278.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(O)cc3)C(C)(C)C2=S)cc1C(F)(F)F,6.555955204081924
CHEMBL3973262,CHEMBL1871,Androgen Receptor,IC50,=,369.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)N(c3ccc(O)cc3)C(C)(C)C2=O)cc1C(F)(F)F,6.432973633840939
CHEMBL3963614,CHEMBL1871,Androgen Receptor,IC50,=,523.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccc3C(=O)O)C2=S)cc1C(F)(F)F,6.281498311132726
CHEMBL3938351,CHEMBL1871,Androgen Receptor,IC50,=,143.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(C(F)(F)F)cc3)C2=S)cc1C(F)(F)F,6.844663962534938
CHEMBL3934779,CHEMBL1871,Androgen Receptor,IC50,=,521.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(CCl)(CCl)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.283162276700475
CHEMBL3941698,CHEMBL1871,Androgen Receptor,IC50,=,126.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(CF)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F,6.899629454882437
CHEMBL3932857,CHEMBL1871,Androgen Receptor,IC50,=,258.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccccc3C)C2=S)cc1C(F)(F)F,6.58838029403677
CHEMBL3962284,CHEMBL1871,Androgen Receptor,IC50,=,723.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccn3)C2=S)cc1C(F)(F)F,6.140861702705469
CHEMBL3961165,CHEMBL1871,Androgen Receptor,IC50,=,457.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3cc(C)ccn3)C2=S)cc1C(F)(F)F,6.34008379993015
CHEMBL4114801,CHEMBL1871,Androgen Receptor,IC50,=,222.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C)cc1C(F)(F)F,6.653647025549361
CHEMBL4114736,CHEMBL1871,Androgen Receptor,IC50,=,157.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C(C)(C)/C2=N/C(=S)NCC)cc1C(F)(F)F,6.804100347590767
CHEMBL4115695,CHEMBL1871,Androgen Receptor,IC50,=,176.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C(=S)Nc2ccccc2)cc1C(F)(F)F,6.75448733218585
CHEMBL4114783,CHEMBL1871,Androgen Receptor,IC50,=,144.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C(=S)Nc2ccc(C#N)c(C(F)(F)F)c2)cc1C(F)(F)F,6.84163750790475
CHEMBL3948211,CHEMBL1871,Androgen Receptor,IC50,=,311.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CO)cc3)C2=S)cc1C(F)(F)F,6.507239610973162
CHEMBL3938936,CHEMBL1871,Androgen Receptor,IC50,=,224.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(N)=O)cc3)C2=S)cc1C(F)(F)F,6.649751981665837
CHEMBL3967236,CHEMBL1871,Androgen Receptor,IC50,=,234.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(=O)NC)cc3)C2=S)cc1C(F)(F)F,6.630784142589857
CHEMBL3936716,CHEMBL1871,Androgen Receptor,IC50,=,732.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(=O)NCCO)cc3)C2=S)cc1C(F)(F)F,6.135488918941608
CHEMBL3958745,CHEMBL1871,Androgen Receptor,IC50,=,432.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(=O)OC)cc3)C2=S)cc1C(F)(F)F,6.364516253185088
CHEMBL3965705,CHEMBL1871,Androgen Receptor,IC50,=,112.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(N)=O)cc3)C2=S)cc1C(F)(F)F,6.950781977329818
CHEMBL3895477,CHEMBL1871,Androgen Receptor,IC50,=,92.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(=O)NC)cc3)C2=S)cc1C(F)(F)F,7.036212172654444
CHEMBL3966495,CHEMBL1871,Androgen Receptor,IC50,=,718.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(N4CCNCC4)cc3)C2=S)cc1C(F)(F)F,6.1438755557577
CHEMBL3900828,CHEMBL1871,Androgen Receptor,IC50,=,138.0,nM,CHEMBL3887225,B,"Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.",CHEMBL3886221,IC50,[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)C2=S)cc1C(F)(F)F,6.860120913598763
CHEMBL3917362,CHEMBL1871,Androgen Receptor,IC50,=,240.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccc(F)cc1,6.619788758288394
CHEMBL3967143,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)no1,7.698970004336019
CHEMBL3937441,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1,7.346787486224656
CHEMBL3898984,CHEMBL1871,Androgen Receptor,IC50,=,210.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1nocc1C(=O)NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1,6.6777807052660805
CHEMBL3973563,CHEMBL1871,Androgen Receptor,IC50,=,460.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccno1,6.337242168318426
CHEMBL3905727,CHEMBL1871,Androgen Receptor,IC50,=,740.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccon1,6.130768280269024
CHEMBL3933747,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(F)cccc34)CC2)no1,6.318758762624412
CHEMBL3911299,CHEMBL1871,Androgen Receptor,IC50,=,420.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1cc[nH]n1,6.376750709602099
CHEMBL3916504,CHEMBL1871,Androgen Receptor,IC50,=,105.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1,6.978810700930062
CHEMBL3970563,CHEMBL1871,Androgen Receptor,IC50,=,194.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1,6.7121982700697735
CHEMBL3948034,CHEMBL1871,Androgen Receptor,IC50,=,210.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4ccccc34)CC2)no1,6.6777807052660805
CHEMBL3904554,CHEMBL1871,Androgen Receptor,IC50,=,93.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1cccc(F)c1,7.031517051446065
CHEMBL3929024,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)c(F)c1,6.769551078621726
CHEMBL3913554,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)cc1F,7.167491087293763
CHEMBL3913672,CHEMBL1871,Androgen Receptor,IC50,=,261.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)cc1,6.583359492661719
CHEMBL3927231,CHEMBL1871,Androgen Receptor,IC50,=,463.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(C(F)(F)F)c(F)c1,6.334419008982047
CHEMBL3899806,CHEMBL1871,Androgen Receptor,IC50,=,477.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)cc1,6.3214816209598865
CHEMBL3936931,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)c(Cl)c1,6.721246399047171
CHEMBL3914094,CHEMBL1871,Androgen Receptor,IC50,=,32.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(N[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1,7.494850021680094
CHEMBL3982609,CHEMBL1871,Androgen Receptor,IC50,=,690.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)no1,6.161150909262744
CHEMBL3953928,CHEMBL1871,Androgen Receptor,IC50,=,630.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccon1,6.200659450546418
CHEMBL3921830,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1ccc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4ccccc34)CC2)cc1,6.481486060122112
CHEMBL3920715,CHEMBL1871,Androgen Receptor,IC50,=,52.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cccc(F)c4)CC3)ccnc12,7.2839966563652006
CHEMBL3960255,CHEMBL1871,Androgen Receptor,IC50,=,92.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(F)c4)CC3)ccnc12,7.036212172654444
CHEMBL3932783,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)cc4)CC3)ccnc12,6.853871964321762
CHEMBL3930760,CHEMBL1871,Androgen Receptor,IC50,=,18.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)no1,7.7447274948966935
CHEMBL3907028,CHEMBL1871,Androgen Receptor,IC50,=,67.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(Cl)c4)CC3)ccnc12,7.173925197299173
CHEMBL3966897,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)cc1F,7.346787486224656
CHEMBL3895604,CHEMBL1871,Androgen Receptor,IC50,=,61.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(Cl)c(F)c4)CC3)ccnc12,7.214670164989233
CHEMBL3928026,CHEMBL1871,Androgen Receptor,IC50,=,39.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cc(F)cc(F)c4)CC3)ccnc12,7.4089353929735005
CHEMBL3959058,CHEMBL1871,Androgen Receptor,IC50,=,720.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](CNC(=O)c4ccon4)CC3)ccnc12,6.142667503568731
CHEMBL3893153,CHEMBL1871,Androgen Receptor,IC50,=,650.0,nM,CHEMBL3888981,B,"Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37 C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 g/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Clbe, Germany), 600 g/ml Geneticin (G418-sulphate, Invitrogen) and 10 g/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.1210^12 to 110^5 M in the presence of 110^1 R1881 (methyltrienolone). The test plates were incubated overnight at 37 C. and 5% CO2. After 16 hours, 15 l of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)no1,6.187086643357144
CHEMBL3916504,CHEMBL1871,Androgen Receptor,IC50,=,72.0,nM,CHEMBL3888982,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG, Berlin, Germany), which contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant W741C (Haapala et al., Lab Invest. 81(12): 1647-51, 2001), and with a reporter plasmid based on pGL4.14 (#E6691, Promega) with the luciferase-gene (from Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-8, 1987). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1,7.142667503568731
CHEMBL3970563,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL3888982,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG, Berlin, Germany), which contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant W741C (Haapala et al., Lab Invest. 81(12): 1647-51, 2001), and with a reporter plasmid based on pGL4.14 (#E6691, Promega) with the luciferase-gene (from Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-8, 1987). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1,6.657577319177793
CHEMBL3920715,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL3888982,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG, Berlin, Germany), which contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant W741C (Haapala et al., Lab Invest. 81(12): 1647-51, 2001), and with a reporter plasmid based on pGL4.14 (#E6691, Promega) with the luciferase-gene (from Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-8, 1987). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cccc(F)c4)CC3)ccnc12,7.522878745280337
CHEMBL3960255,CHEMBL1871,Androgen Receptor,IC50,=,72.0,nM,CHEMBL3888982,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG, Berlin, Germany), which contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant W741C (Haapala et al., Lab Invest. 81(12): 1647-51, 2001), and with a reporter plasmid based on pGL4.14 (#E6691, Promega) with the luciferase-gene (from Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-8, 1987). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(F)c4)CC3)ccnc12,7.142667503568731
CHEMBL3916504,CHEMBL1871,Androgen Receptor,IC50,=,56.0,nM,CHEMBL3888983,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG Berlin, Germany) that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant E709Y (Georget et al., Mol. Endocrinol. 20(4): 724-734, 2006), and with the MMTV-luciferase plasmid (see above, transactivation assay for the androgen receptor mutant W741C). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1,7.251811972993799
CHEMBL3970563,CHEMBL1871,Androgen Receptor,IC50,=,175.0,nM,CHEMBL3888983,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG Berlin, Germany) that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant E709Y (Georget et al., Mol. Endocrinol. 20(4): 724-734, 2006), and with the MMTV-luciferase plasmid (see above, transactivation assay for the androgen receptor mutant W741C). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1,6.756961951313706
CHEMBL3920715,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL3888983,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG Berlin, Germany) that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant E709Y (Georget et al., Mol. Endocrinol. 20(4): 724-734, 2006), and with the MMTV-luciferase plasmid (see above, transactivation assay for the androgen receptor mutant W741C). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cccc(F)c4)CC3)ccnc12,8.045757490560675
CHEMBL3960255,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL3888983,B,"Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG Berlin, Germany) that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant E709Y (Georget et al., Mol. Endocrinol. 20(4): 724-734, 2006), and with the MMTV-luciferase plasmid (see above, transactivation assay for the androgen receptor mutant W741C). The cells were treated with the test substances in concentrations from 110^8 to 110^10 M in the presence of 110^10 M R1881 and were incubated overnight at 37 C. and 5% CO2. After 24 hours, 100 l of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).",CHEMBL3886907,IC50,N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(F)c4)CC3)ccnc12,7.853871964321762
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,44260.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,4.353988590408761
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,27710.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,4.557363474217769
CHEMBL4098395,CHEMBL1871,Androgen Receptor,IC50,=,7780.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc([N+](=O)[O-])cc2)cs1,5.109020403010311
CHEMBL4088224,CHEMBL1871,Androgen Receptor,IC50,=,5960.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,N#Cc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1,5.2247537402597635
CHEMBL4059979,CHEMBL1871,Androgen Receptor,IC50,=,8170.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,COc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1,5.087777943467584
CHEMBL4060981,CHEMBL1871,Androgen Receptor,IC50,=,25820.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,Cc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1,4.588043762069598
CHEMBL4082860,CHEMBL1871,Androgen Receptor,IC50,=,27960.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc(Cl)cc2)cs1,4.553462832926356
CHEMBL4069656,CHEMBL1871,Androgen Receptor,IC50,=,21510.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc(F)cc2)cs1,4.667359589612538
CHEMBL4090670,CHEMBL1871,Androgen Receptor,IC50,=,22590.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccccc2)cs1,4.646083769079637
CHEMBL4079171,CHEMBL1871,Androgen Receptor,IC50,=,13170.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccccc2C(=O)N1c1nc(-c2ccc([N+](=O)[O-])cc2)cs1,4.8804142250382165
CHEMBL4103425,CHEMBL1871,Androgen Receptor,IC50,=,10960.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,N#Cc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1,4.96018944585165
CHEMBL4091358,CHEMBL1871,Androgen Receptor,IC50,=,13670.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,COc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1,4.864231485432177
CHEMBL4070425,CHEMBL1871,Androgen Receptor,IC50,=,29040.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,Cc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1,4.537003387971944
CHEMBL2356368,CHEMBL1871,Androgen Receptor,IC50,=,26240.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccccc2C(=O)N1c1nc(-c2ccc(Cl)cc2)cs1,4.581036169296377
CHEMBL2357456,CHEMBL1871,Androgen Receptor,IC50,=,28560.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccccc2C(=O)N1c1nc(-c2ccc(F)cc2)cs1,4.5442417968958635
CHEMBL4073161,CHEMBL1871,Androgen Receptor,IC50,=,36840.0,nM,CHEMBL3997084,B,Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay,CHEMBL3994642,IC50,O=C1c2ccccc2C(=O)N1c1nc(-c2ccccc2)cs1,4.433680378475189
CHEMBL4068008,CHEMBL1871,Androgen Receptor,IC50,=,2800.0,nM,CHEMBL4008020,B,Antagonist activity at GAL4-fused human AR LBD (667 to 919 residues) expressed in CHO-K1 cells assessed as inhibition of dihydrotestosterone-induced transactivation activity after 5 to 6 hrs by luciferase reporter gene assay,CHEMBL4007392,IC50,CCOc1nccc2c1[C@H](c1ccc(C#N)cc1OC)C(C#N)=C(C)N2,5.552841968657781
CHEMBL4096901,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL4008020,B,Antagonist activity at GAL4-fused human AR LBD (667 to 919 residues) expressed in CHO-K1 cells assessed as inhibition of dihydrotestosterone-induced transactivation activity after 5 to 6 hrs by luciferase reporter gene assay,CHEMBL4007392,IC50,CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C#N)=C(C)N2,5.619788758288394
CHEMBL4060271,CHEMBL1871,Androgen Receptor,IC50,=,0.49,nM,CHEMBL4012500,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method,CHEMBL4011613,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1Cl,9.309803919971486
CHEMBL4090028,CHEMBL1871,Androgen Receptor,IC50,=,0.72,nM,CHEMBL4012500,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method,CHEMBL4011613,IC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.142667503568731
CHEMBL4068946,CHEMBL1871,Androgen Receptor,IC50,=,0.52,nM,CHEMBL4012500,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method,CHEMBL4011613,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@]1(C)O,9.2839966563652
CHEMBL4092535,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL4012500,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method,CHEMBL4011613,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.0
CHEMBL4060271,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL4012501,B,Agonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells after 24 hrs by MMTV-promoter driven luciferase reporter gene assay,CHEMBL4011613,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1Cl,9.698970004336019
CHEMBL4090028,CHEMBL1871,Androgen Receptor,IC50,=,0.19,nM,CHEMBL4012501,B,Agonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells after 24 hrs by MMTV-promoter driven luciferase reporter gene assay,CHEMBL4011613,IC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.721246399047171
CHEMBL4068946,CHEMBL1871,Androgen Receptor,IC50,=,0.32,nM,CHEMBL4012501,B,Agonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells after 24 hrs by MMTV-promoter driven luciferase reporter gene assay,CHEMBL4011613,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@]1(C)O,9.494850021680094
CHEMBL4092535,CHEMBL1871,Androgen Receptor,IC50,=,0.29,nM,CHEMBL4012501,B,Agonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells after 24 hrs by MMTV-promoter driven luciferase reporter gene assay,CHEMBL4011613,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.537602002101044
CHEMBL4090028,CHEMBL1871,Androgen Receptor,IC50,=,0.72,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.142667503568731
CHEMBL4092535,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.0
CHEMBL4071751,CHEMBL1871,Androgen Receptor,IC50,=,7.8,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.10790539730952
CHEMBL4100278,CHEMBL1871,Androgen Receptor,IC50,=,11.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,Cc1c(N2C(=O)C[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,7.958607314841775
CHEMBL4085514,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)C(=O)C[C@]1(C)O,7.823908740944319
CHEMBL4072533,CHEMBL1871,Androgen Receptor,IC50,=,3.9,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.4089353929735
CHEMBL4067691,CHEMBL1871,Androgen Receptor,IC50,=,3.4,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.468521082957745
CHEMBL4088914,CHEMBL1871,Androgen Receptor,IC50,=,3.6,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.443697499232712
CHEMBL4059588,CHEMBL1871,Androgen Receptor,IC50,=,9.2,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(OC)c1,8.036212172654444
CHEMBL4087902,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1C,8.045757490560675
CHEMBL4074501,CHEMBL1871,Androgen Receptor,IC50,=,1.3,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O,8.886056647693163
CHEMBL4101232,CHEMBL1871,Androgen Receptor,IC50,=,3.2,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O,8.494850021680094
CHEMBL4101935,CHEMBL1871,Androgen Receptor,IC50,=,6.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@H]1[C@@H](O)[C@H](Cc2ccccc2)C(=O)N1c1ccc(C#N)c(Cl)c1,8.221848749616356
CHEMBL4100995,CHEMBL1871,Androgen Receptor,IC50,=,1.8,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC[C@H]1[C@@H](O)[C@H](C)C(=O)N1c1ccc(C#N)c(Cl)c1,8.744727494896694
CHEMBL4077666,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@H]1[C@@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1,7.853871964321762
CHEMBL4082265,CHEMBL1871,Androgen Receptor,IC50,=,6600.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@@H]1[C@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1,5.180456064458131
CHEMBL4063939,CHEMBL1871,Androgen Receptor,IC50,=,1.1,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@H]1[C@@H](O)C(F)(F)C(=O)N1c1ccc(C#N)c(Cl)c1,8.958607314841775
CHEMBL4093265,CHEMBL1871,Androgen Receptor,IC50,=,5.5,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,CC(C)C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.259637310505756
CHEMBL4083012,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,N#CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,7.853871964321762
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,0.67,nM,CHEMBL4021499,B,Displacement of [3H]mibolerone from human AR after 3 hrs,CHEMBL4020736,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.173925197299173
CHEMBL3183409,CHEMBL1871,Androgen Receptor,IC50,=,16.25,nM,CHEMBL4021779,B,Displacement of [3H]-R1881 from AR in human LNCaP cells preincubated for 30 mins followed by [3H]-R1881 addition measured after 30 mins by microbeta scintillation counter method,CHEMBL4020755,IC50,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,7.789146634685107
CHEMBL4105484,CHEMBL1871,Androgen Receptor,IC50,=,15.41,nM,CHEMBL4021779,B,Displacement of [3H]-R1881 from AR in human LNCaP cells preincubated for 30 mins followed by [3H]-R1881 addition measured after 30 mins by microbeta scintillation counter method,CHEMBL4020755,IC50,[2H]C([2H])([2H])NC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,7.812197361281581
CHEMBL4104046,CHEMBL1871,Androgen Receptor,IC50,=,67.4,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1c(F)cc(O)cc1C#N,7.17134010346468
CHEMBL4069026,CHEMBL1871,Androgen Receptor,IC50,=,36.8,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)c(F)c1F,7.434152181326482
CHEMBL4091403,CHEMBL1871,Androgen Receptor,IC50,=,85.8,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1cc(F)c(O)cc1F,7.066512712151295
CHEMBL4095364,CHEMBL1871,Androgen Receptor,IC50,=,1.6,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1c(F)cc(O)cc1F,8.795880017344075
CHEMBL4074927,CHEMBL1871,Androgen Receptor,IC50,=,1465.9,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1S(C)(=O)=O,5.833895655158384
CHEMBL4087674,CHEMBL1871,Androgen Receptor,IC50,=,330.2,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,COC(=O)c1cc(O)ccc1-c1ccc(C#N)n1C,6.481222931073225
CHEMBL4066319,CHEMBL1871,Androgen Receptor,IC50,=,6.8,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1C#N,8.167491087293763
CHEMBL4100251,CHEMBL1871,Androgen Receptor,IC50,=,65.0,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1[N+](=O)[O-],7.187086643357144
CHEMBL4073399,CHEMBL1871,Androgen Receptor,IC50,=,14.8,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1C(F)(F)F,7.8297382846050425
CHEMBL4088158,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1Cl,8.853871964321762
CHEMBL4062016,CHEMBL1871,Androgen Receptor,IC50,=,47.6,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)c(Cl)c1,7.3223930472795065
CHEMBL4095883,CHEMBL1871,Androgen Receptor,IC50,=,3.2,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1F,8.494850021680094
CHEMBL4068562,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)c(F)c1,7.229147988357855
CHEMBL4103641,CHEMBL1871,Androgen Receptor,IC50,=,7.1,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,CCc1cc(-c2ccc(C#N)n2C)ccc1O,8.148741651280925
CHEMBL4079377,CHEMBL1871,Androgen Receptor,IC50,=,3.7,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cc1cc(O)ccc1-c1ccc(C#N)n1C,8.431798275933005
CHEMBL4065842,CHEMBL1871,Androgen Receptor,IC50,=,2.9,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cc1cc(-c2ccc(C#N)n2C)ccc1O,8.537602002101044
CHEMBL4087256,CHEMBL1871,Androgen Receptor,IC50,=,6.3,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)cc1,8.200659450546418
CHEMBL4061510,CHEMBL1871,Androgen Receptor,IC50,=,8.1,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1ccc(O)c2c1CCC2,8.09151498112135
CHEMBL4074555,CHEMBL1871,Androgen Receptor,IC50,=,28.7,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)ccc1-c1c(Cl)cc(O)cc1Cl,7.542118103266008
CHEMBL4072730,CHEMBL1871,Androgen Receptor,IC50,=,4.9,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cc1c(O)ccc(-c2ccc(C#N)n2C)c1C,8.309803919971486
CHEMBL4073869,CHEMBL1871,Androgen Receptor,IC50,=,166.9,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(C#N)cc(Br)c1-c1ccc(O)cc1,6.777543663320753
CHEMBL4088572,CHEMBL1871,Androgen Receptor,IC50,=,11.1,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,Cn1c(-c2ccc(O)cc2)cc(C(F)(F)F)c1C#N,7.954677021213342
CHEMBL4060340,CHEMBL1871,Androgen Receptor,IC50,=,127.1,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,CCn1c(C#N)ccc1-c1ccc(O)cc1F,6.8958544494459915
CHEMBL4080698,CHEMBL1871,Androgen Receptor,IC50,=,6032.0,nM,CHEMBL4040321,B,Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting,CHEMBL4038318,IC50,N#CCn1c(C#N)ccc1-c1ccc(O)cc1F,5.219538667138282
CHEMBL4092066,CHEMBL1871,Androgen Receptor,IC50,=,794.33,nM,CHEMBL4042895,B,Binding affinity to recombinant human androgen receptor expressed in baculovirus infected sf9 cells,CHEMBL4041544,IC50,CC1(C)C[C@](O)(C(F)(F)F)[C@@H](Nc2cccc3[nH]c(=O)ccc23)c2ccc(F)c(O)c21,6.0999990348465305
CHEMBL4085241,CHEMBL1871,Androgen Receptor,IC50,=,316.23,nM,CHEMBL4042895,B,Binding affinity to recombinant human androgen receptor expressed in baculovirus infected sf9 cells,CHEMBL4041544,IC50,CC1(C)C[C@](O)(C(F)(F)F)[C@@H](Nc2cccc3c(=O)[nH]ccc23)c2ccc(F)c(O)c21,6.499996931948306
CHEMBL4064645,CHEMBL1871,Androgen Receptor,IC50,=,23000.0,nM,CHEMBL4058444,B,Displacement of [3H]-DHT from recombinant human androgen receptor expressed in CHO cells,CHEMBL4052802,IC50,C[C@]12CCC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3ccccc3)CC[C@@H]12,4.638272163982407
CHEMBL4090771,CHEMBL1871,Androgen Receptor,IC50,=,18750.0,nM,CHEMBL4141638,B,Antagonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells assessed as inhibition of R1881-induced protein activation after 24 hrs by luciferase reporter gene assay,CHEMBL4138152,IC50,N#Cc1ccc(N2C(=O)C3Cc4ccccc4N3C2=S)cc1C(F)(F)F,4.726998727936262
CHEMBL4161910,CHEMBL1871,Androgen Receptor,IC50,=,7390.0,nM,CHEMBL4141638,B,Antagonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells assessed as inhibition of R1881-induced protein activation after 24 hrs by luciferase reporter gene assay,CHEMBL4138152,IC50,CCOC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,5.131355561605174
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,1260.0,nM,CHEMBL4141638,B,Antagonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells assessed as inhibition of R1881-induced protein activation after 24 hrs by luciferase reporter gene assay,CHEMBL4138152,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.899629454882437
CHEMBL4174074,CHEMBL1871,Androgen Receptor,IC50,=,83800.0,nM,CHEMBL4147710,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4145518,IC50,CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@@](C)(CNC(=O)c3ccccc3)CCC[C@]21C,4.076755981369724
CHEMBL131,CHEMBL1871,Androgen Receptor,IC50,=,34000.0,nM,CHEMBL4194583,B,Displacement of [3H]methyltrienolone from androgen receptor in human LNCaP cells after 1440 mins by scintillation counting method,CHEMBL4190372,IC50,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,4.468521082957745
CHEMBL4225339,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL4219475,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4219028,IC50,CC(O)(CS(=O)(=O)c1ccc(C(=O)O)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.267606240177031
CHEMBL4227715,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL4219475,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4219028,IC50,Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(C(=O)O)cc1,8.853871964321762
CHEMBL4226844,CHEMBL1871,Androgen Receptor,IC50,=,53.0,nM,CHEMBL4219475,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4219028,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(C(=O)O)cc1,7.275724130399211
CHEMBL4226575,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL4219475,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4219028,IC50,COC(=O)c1ccc(Cc2c(C)n[nH]c2C)cc1,5.823908740944319
CHEMBL4225186,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL4219476,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs,CHEMBL4219028,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1,7.568636235841012
CHEMBL4227287,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL4219476,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs,CHEMBL4219028,IC50,CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)NCCOCCOCCOCCNC(=O)c1ccc(S(=O)(=O)CC(C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)cc1,5.958607314841775
CHEMBL4226899,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL4219476,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs,CHEMBL4219028,IC50,Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1,6.721246399047171
CHEMBL4226314,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL4219476,B,Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs,CHEMBL4219028,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1,6.721246399047171
CHEMBL4226259,CHEMBL1871,Androgen Receptor,IC50,=,1.4,nM,CHEMBL4219475,B,Binding affinity to androgen receptor (unknown origin),CHEMBL4219028,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(C(=O)O)cc1,8.853871964321762
CHEMBL166444,CHEMBL1871,Androgen Receptor,IC50,=,0.302,nM,CHEMBL4263478,B,Agonist activity at GAL4 DNA-binding domain fused androgen receptor (unknown origin) ligand binding domain expressed in UAS-bla GripTite 293 cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay,CHEMBL4261581,IC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.51999305704285
CHEMBL4279841,CHEMBL1871,Androgen Receptor,IC50,=,9110.0,nM,CHEMBL4275653,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry,CHEMBL4270636,IC50,CC(C)Oc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O,5.040481623027002
CHEMBL4283232,CHEMBL1871,Androgen Receptor,IC50,=,4870.0,nM,CHEMBL4275653,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry,CHEMBL4270636,IC50,COc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O,5.3124710387853655
CHEMBL2297673,CHEMBL1871,Androgen Receptor,IC50,=,3740.0,nM,CHEMBL4275653,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1O)c1cc(Cl)ccc1O,5.427128397799519
CHEMBL75897,CHEMBL1871,Androgen Receptor,IC50,=,6400.0,nM,CHEMBL4275653,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2ccccc21,5.1938200260161125
CHEMBL4286655,CHEMBL1871,Androgen Receptor,IC50,=,1720.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1ccccc1/C=C/C(=O)c1cc(I)ccc1O,5.764471553092451
CHEMBL4294564,CHEMBL1871,Androgen Receptor,IC50,=,1640.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1O)c1cc(I)ccc1O,5.785156151952302
CHEMBL4294994,CHEMBL1871,Androgen Receptor,IC50,=,2870.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1O)c1cc(Br)cc(Br)c1O,5.542118103266008
CHEMBL4284351,CHEMBL1871,Androgen Receptor,IC50,=,3960.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,CCCOc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O,5.402304814074488
CHEMBL4287759,CHEMBL1871,Androgen Receptor,IC50,=,5270.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,CCOc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O,5.278189384787453
CHEMBL4293816,CHEMBL1871,Androgen Receptor,IC50,=,8690.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1O)c1cc(Br)ccc1O,5.060980223551334
CHEMBL2297680,CHEMBL1871,Androgen Receptor,IC50,=,5250.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1ccc(/C=C/C(=O)c2cc(Cl)ccc2O)cc1OC,5.279840696594043
CHEMBL4285568,CHEMBL1871,Androgen Receptor,IC50,=,5950.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1cc(/C=C/C(=O)c2cc(Cl)ccc2O)ccc1O,5.22548303427145
CHEMBL4290022,CHEMBL1871,Androgen Receptor,IC50,=,4360.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccc2c(c1)OCO2)c1cc(Cl)ccc1O,5.360513510731414
CHEMBL1981815,CHEMBL1871,Androgen Receptor,IC50,=,5920.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccc(O)cc1)c1cc(Cl)ccc1O,5.22767829327708
CHEMBL2030817,CHEMBL1871,Androgen Receptor,IC50,=,1510.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1)c1cc(Cl)ccc1O,5.821023052706831
CHEMBL4285137,CHEMBL1871,Androgen Receptor,IC50,=,5010.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1ccccc1/C=C/C(=O)c1cc(F)ccc1O,5.300162274132754
CHEMBL4292968,CHEMBL1871,Androgen Receptor,IC50,=,1420.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C(/C=C/c1ccccc1O)c1cc(F)ccc1O,5.847711655616943
CHEMBL594854,CHEMBL1871,Androgen Receptor,IC50,=,3500.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1ccccc1/C=C/C(=O)c1ccccc1O,5.455931955649724
CHEMBL4278241,CHEMBL1871,Androgen Receptor,IC50,=,6190.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,COc1ccc2oc(-c3ccccc3OC)cc(=O)c2c1,5.2083093509798815
CHEMBL4293380,CHEMBL1871,Androgen Receptor,IC50,=,4260.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2ccc(I)cc21,5.370590400897282
CHEMBL4282772,CHEMBL1871,Androgen Receptor,IC50,=,3570.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2c(Br)cc(Br)cc21,5.447331783887806
CHEMBL4290001,CHEMBL1871,Androgen Receptor,IC50,=,1770.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2ccc(Br)cc21,5.752026733638193
CHEMBL4279318,CHEMBL1871,Androgen Receptor,IC50,=,1680.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2ccc(Cl)cc21,5.774690718274137
CHEMBL485349,CHEMBL1871,Androgen Receptor,IC50,=,2730.0,nM,CHEMBL4275646,B,Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay,CHEMBL4270636,IC50,O=C1CC(c2ccccc2O)Oc2ccc(O)cc21,5.5638373529592435
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.301029995663981
CHEMBL1210876,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)cc1O,6.468521082957745
CHEMBL1210959,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c(OC)c1O,6.769551078621726
CHEMBL1210878,CHEMBL1871,Androgen Receptor,IC50,=,730.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1cccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c1O,6.136677139879544
CHEMBL113332,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3ccccc3C(=O)c3ccccc32)c(O)c1,7.0
CHEMBL4278637,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL4275679,B,Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,O=C1c2ccccc2C(=Cc2cccc(O)c2)c2ccccc21,6.455931955649724
CHEMBL1210876,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL4275676,B,Inhibition of R1881-induced transcriptional activity of human AR V7 truncated mutant expressed in human PC3 cells harboring pGL3-ARR3tk-NLuc after 24 hrs by luciferase reporter gene assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)cc1O,5.0
CHEMBL1210959,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL4275676,B,Inhibition of R1881-induced transcriptional activity of human AR V7 truncated mutant expressed in human PC3 cells harboring pGL3-ARR3tk-NLuc after 24 hrs by luciferase reporter gene assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c(OC)c1O,5.0
CHEMBL1210878,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL4275676,B,Inhibition of R1881-induced transcriptional activity of human AR V7 truncated mutant expressed in human PC3 cells harboring pGL3-ARR3tk-NLuc after 24 hrs by luciferase reporter gene assay,CHEMBL4270637,IC50,COc1cccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c1O,5.0
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.045757490560675
CHEMBL1210876,CHEMBL1871,Androgen Receptor,IC50,=,1886.0,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)cc1O,5.72445831159869
CHEMBL1210959,CHEMBL1871,Androgen Receptor,IC50,=,1135.0,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c(OC)c1O,5.945004138470859
CHEMBL1210878,CHEMBL1871,Androgen Receptor,IC50,=,1480.0,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1cccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c1O,5.8297382846050425
CHEMBL113332,CHEMBL1871,Androgen Receptor,IC50,=,231.8,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,COc1ccc(C=C2c3ccccc3C(=O)c3ccccc32)c(O)c1,6.634886568372423
CHEMBL4278637,CHEMBL1871,Androgen Receptor,IC50,=,316.2,nM,CHEMBL4275675,B,Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay,CHEMBL4270637,IC50,O=C1c2ccccc2C(=Cc2cccc(O)c2)c2ccccc21,6.50003813440381
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,5336.0,nM,CHEMBL4348419,B,Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay,CHEMBL4346686,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.2727841790915075
CHEMBL4441215,CHEMBL1871,Androgen Receptor,IC50,=,641.3,nM,CHEMBL4348419,B,Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay,CHEMBL4346686,IC50,Cc1ccc(-c2c(C)noc2C)cc1Nc1ccc(C#N)c(Cl)c1,6.192938760082761
CHEMBL103,CHEMBL1871,Androgen Receptor,IC50,=,13.7,nM,CHEMBL4348419,B,Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay,CHEMBL4346686,IC50,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,7.863279432843593
CHEMBL166444,CHEMBL1871,Androgen Receptor,IC50,=,4.6,nM,CHEMBL4348419,B,Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay,CHEMBL4346686,IC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.337242168318426
CHEMBL4463558,CHEMBL1871,Androgen Receptor,IC50,=,315.0,nM,CHEMBL4354401,B,Inhibition of R1881 induced-AR transcriptional activity in AR-positive human 22Rv1 cells harboring ARE14 construct after 24 hrs by luciferase assay,CHEMBL4351016,IC50,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)c4c(C)nc5[nH]c6ccccc6c5c4C[C@@H]32)C1,6.501689446210399
CHEMBL6874,CHEMBL1871,Androgen Receptor,IC50,=,27.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,IC50,CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.568636235841012
CHEMBL4447539,CHEMBL1871,Androgen Receptor,IC50,=,9.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,IC50,CC1(C)CCc2cc3c(cc2N1)NC(C#N)C=C3C(F)(F)F,8.045757490560675
CHEMBL4548397,CHEMBL1871,Androgen Receptor,IC50,=,22.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,IC50,CC1(C)CCc2cc3c(cc2N1)NC(F)C=C3C(F)(F)F,7.657577319177793
CHEMBL4163069,CHEMBL1871,Androgen Receptor,IC50,=,129.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1,6.889410289700751
CHEMBL4159987,CHEMBL1871,Androgen Receptor,IC50,=,165.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]32)cc1,6.782516055786093
CHEMBL4576596,CHEMBL1871,Androgen Receptor,IC50,=,263.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CCN(CC)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]32)cc1,6.580044251510242
CHEMBL4545820,CHEMBL1871,Androgen Receptor,IC50,=,208.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N4CCOCC4)cc3)C[C@@]21C,6.681936665037238
CHEMBL4591353,CHEMBL1871,Androgen Receptor,IC50,=,1005.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CN1CCN(c2ccc([C@H]3C[C@@]4(C)[C@@H](CC[C@@]4(O)C#CC(C)(C)C)[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@H]43)cc2)CC1,5.997833938243492
CHEMBL4483408,CHEMBL1871,Androgen Receptor,IC50,=,359.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)C[C@@]21C,6.44490555142168
CHEMBL4460554,CHEMBL1871,Androgen Receptor,IC50,=,175.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CCC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,6.756961951313706
CHEMBL4527872,CHEMBL1871,Androgen Receptor,IC50,=,1452.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC3CC3)[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]32)cc1,5.838033383635925
CHEMBL4476493,CHEMBL1871,Androgen Receptor,IC50,=,2955.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CCC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,5.529442514782726
CHEMBL4483697,CHEMBL1871,Androgen Receptor,IC50,=,642.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(F)(F)F)[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]32)cc1,6.192464971931146
CHEMBL4571052,CHEMBL1871,Androgen Receptor,IC50,=,912.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,6.0400051616715835
CHEMBL4452917,CHEMBL1871,Androgen Receptor,IC50,=,2246.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C(C)C)cc3)C[C@@]21C,5.6485902480745604
CHEMBL4562338,CHEMBL1871,Androgen Receptor,IC50,=,1295.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)CCOC)cc3)C[C@@]21C,5.887730231582729
CHEMBL4453035,CHEMBL1871,Androgen Receptor,IC50,=,3146.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N4CCCC4)cc3)C[C@@]21C,5.502241281712732
CHEMBL4448048,CHEMBL1871,Androgen Receptor,IC50,=,354.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(-n4cccc4)cc3)C[C@@]21C,6.450996737974212
CHEMBL4515467,CHEMBL1871,Androgen Receptor,IC50,=,561.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(OC)cc3)C[C@@]21C,6.251037138743839
CHEMBL4534324,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL4407255,B,Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay,CHEMBL4406804,IC50,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](OCc3ccc(Cl)cc3)C[C@@]21C,7.070581074285707
CHEMBL3183409,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,7.795880017344075
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,248.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.605548319173783
CHEMBL1738889,CHEMBL1871,Androgen Receptor,IC50,=,3.8,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.42021640338319
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,216.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.665546248849069
CHEMBL4539953,CHEMBL1871,Androgen Receptor,IC50,=,244.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.61261017366127
CHEMBL4521365,CHEMBL1871,Androgen Receptor,IC50,=,32.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.494850021680094
CHEMBL4527176,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.431798275933005
CHEMBL4449952,CHEMBL1871,Androgen Receptor,IC50,=,835.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.078313524516398
CHEMBL4542153,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.886056647693163
CHEMBL4527241,CHEMBL1871,Androgen Receptor,IC50,=,126.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.899629454882437
CHEMBL4469605,CHEMBL1871,Androgen Receptor,IC50,=,101.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.995678626217357
CHEMBL4436972,CHEMBL1871,Androgen Receptor,IC50,=,39.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.4089353929735005
CHEMBL4438211,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.229147988357855
CHEMBL4443566,CHEMBL1871,Androgen Receptor,IC50,=,142.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(CN1CCc2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.847711655616944
CHEMBL4451795,CHEMBL1871,Androgen Receptor,IC50,=,1032.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1cc(-c2ccccc2)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,5.986320302708807
CHEMBL4447959,CHEMBL1871,Androgen Receptor,IC50,=,203.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.692503962086787
CHEMBL4585987,CHEMBL1871,Androgen Receptor,IC50,=,234.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cccc(F)c21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.630784142589857
CHEMBL4590504,CHEMBL1871,Androgen Receptor,IC50,=,99.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.00436480540245
CHEMBL4474118,CHEMBL1871,Androgen Receptor,IC50,=,94.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.026872146400302
CHEMBL4483663,CHEMBL1871,Androgen Receptor,IC50,=,142.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.847711655616944
CHEMBL4567476,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1cc(F)c2ccccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.346787486224656
CHEMBL4475563,CHEMBL1871,Androgen Receptor,IC50,=,898.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2c(F)cc(-c3ccc(F)cc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.0467236633326955
CHEMBL4520679,CHEMBL1871,Androgen Receptor,IC50,=,1015.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2c(F)c(-c3ccccc3)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.993533957750769
CHEMBL4583465,CHEMBL1871,Androgen Receptor,IC50,=,686.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2nc(C#N)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.163675884293248
CHEMBL4448937,CHEMBL1871,Androgen Receptor,IC50,=,972.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,CCOC(=O)c1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccccc12,6.012333735073725
CHEMBL4542693,CHEMBL1871,Androgen Receptor,IC50,=,985.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(I)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.006563769502389
CHEMBL4456781,CHEMBL1871,Androgen Receptor,IC50,=,918.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.037157318798758
CHEMBL4460567,CHEMBL1871,Androgen Receptor,IC50,=,215.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.667561540084394
CHEMBL4442857,CHEMBL1871,Androgen Receptor,IC50,=,157.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,6.804100347590767
CHEMBL4554646,CHEMBL1871,Androgen Receptor,IC50,=,58.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2ccc([N+](=O)[O-])cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.236572006437063
CHEMBL4586748,CHEMBL1871,Androgen Receptor,IC50,=,88.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc([N+](=O)[O-])ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.055517327849831
CHEMBL4474096,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.070581074285707
CHEMBL4456765,CHEMBL1871,Androgen Receptor,IC50,=,127.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.896196279044043
CHEMBL4446471,CHEMBL1871,Androgen Receptor,IC50,=,64.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL4475765,CHEMBL1871,Androgen Receptor,IC50,=,598.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.223298816011589
CHEMBL4444904,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.070581074285707
CHEMBL4584527,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1,7.318758762624412
CHEMBL4571680,CHEMBL1871,Androgen Receptor,IC50,=,392.0,nM,CHEMBL4411916,B,Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay,CHEMBL4411271,IC50,CC(O)(CCc1ccc(N)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.406713932979542
CHEMBL4528089,CHEMBL1871,Androgen Receptor,IC50,=,310.0,nM,CHEMBL4480101,B,Inhibition of AR transcriptional activity in human ARR2PB-eGFP expressing LNCaP cells after 3 days by fluorescence assay,CHEMBL4477262,IC50,c1ccc2c(c1)CC(c1c[nH]c3ccccc13)N2,6.508638306165727
CHEMBL2023820,CHEMBL1871,Androgen Receptor,IC50,=,4700.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,O=C(O)c1cccc(Nc2ccc([N+](=O)[O-])c3ccccc23)c1,5.327902142064282
CHEMBL491,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.638272163982407
CHEMBL4641012,CHEMBL1871,Androgen Receptor,IC50,=,3600.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,CCc1ccc(NC(=O)c2cc3cccc(O)c3oc2=N)cc1,5.443697499232712
CHEMBL4646593,CHEMBL1871,Androgen Receptor,IC50,=,5800.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,CCc1cccc(NC(=O)c2cc3cccc(O)c3oc2=N)c1,5.236572006437063
CHEMBL4642187,CHEMBL1871,Androgen Receptor,IC50,=,8100.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,CCc1ccccc1NC(=O)c1cc2cccc(O)c2oc1=N,5.0915149811213505
CHEMBL4648793,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,Cc1ccc(NC(=O)c2cc3cccc(O)c3oc2=N)cc1,5.619788758288394
CHEMBL4640248,CHEMBL1871,Androgen Receptor,IC50,=,3300.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1Cl,5.481486060122112
CHEMBL4644092,CHEMBL1871,Androgen Receptor,IC50,=,6500.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,N=c1oc2c(O)cccc2cc1C(=O)Nc1ccc(F)cc1,5.187086643357144
CHEMBL4634960,CHEMBL1871,Androgen Receptor,IC50,=,3300.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(F)c1,5.481486060122112
CHEMBL4642678,CHEMBL1871,Androgen Receptor,IC50,=,4400.0,nM,CHEMBL4622650,B,Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay,CHEMBL4619820,IC50,N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1F,5.356547323513812
CHEMBL4778550,CHEMBL1871,Androgen Receptor,IC50,=,2030.0,nM,CHEMBL4666016,B,Antagonist activity at recombinant androgen receptor (unknown origin) transfected in human LNCaP cells co-transfected with PSA and luciferase incubated for 24 hrs by dual luciferase reporter gene assay,CHEMBL4665623,IC50,CCOC(=O)c1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCc4ccccc43)c2)s1,5.692503962086787
CHEMBL2346976,CHEMBL1871,Androgen Receptor,IC50,=,1780.0,nM,CHEMBL4668335,B,Induction of androgen receptor degradation in human LNCaP cells,CHEMBL4665673,IC50,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,5.7495799976911055
CHEMBL2023820,CHEMBL1871,Androgen Receptor,IC50,=,8000.0,nM,CHEMBL4668502,B,Displacement of [3H]-R1881 from androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 incubated for 2 hrs by scintillation counting,CHEMBL4665678,IC50,O=C(O)c1cccc(Nc2ccc([N+](=O)[O-])c3ccccc23)c1,5.096910013008056
CHEMBL4439327,CHEMBL1871,Androgen Receptor,IC50,=,80000.0,nM,CHEMBL4668502,B,Displacement of [3H]-R1881 from androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 incubated for 2 hrs by scintillation counting,CHEMBL4665678,IC50,Oc1ccc2c(O)ncc(-c3cc(F)c(F)c(F)c3)c2c1,4.096910013008056
CHEMBL2023820,CHEMBL1871,Androgen Receptor,IC50,=,21000.0,nM,CHEMBL4668508,B,Antagonist activity at androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 in presence of DHT by BrightGlo luciferase assay,CHEMBL4665678,IC50,O=C(O)c1cccc(Nc2ccc([N+](=O)[O-])c3ccccc23)c1,4.6777807052660805
CHEMBL4513510,CHEMBL1871,Androgen Receptor,IC50,=,300000.0,nM,CHEMBL4668508,B,Antagonist activity at androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 in presence of DHT by BrightGlo luciferase assay,CHEMBL4665678,IC50,COc1ccc2[nH]c(C(=O)N3CCC(CC(C)(C)O)CC3)cc2c1,3.5228787452803374
CHEMBL4439327,CHEMBL1871,Androgen Receptor,IC50,=,2100.0,nM,CHEMBL4668508,B,Antagonist activity at androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 in presence of DHT by BrightGlo luciferase assay,CHEMBL4665678,IC50,Oc1ccc2c(O)ncc(-c3cc(F)c(F)c(F)c3)c2c1,5.6777807052660805
CHEMBL4746345,CHEMBL1871,Androgen Receptor,IC50,=,84.0,nM,CHEMBL4676559,B,Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Br)c(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.075720713938118
CHEMBL4781335,CHEMBL1871,Androgen Receptor,IC50,=,63.0,nM,CHEMBL4676559,B,Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.200659450546418
CHEMBL4776248,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL4676559,B,Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C#N)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.366531544420413
CHEMBL4783581,CHEMBL1871,Androgen Receptor,IC50,=,219.0,nM,CHEMBL4676559,B,Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.6595558851598815
CHEMBL4782924,CHEMBL1871,Androgen Receptor,IC50,=,901.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@@](Cn1cc(N)cn1)(OC(=O)CCl)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.045275209020938
CHEMBL4800572,CHEMBL1871,Androgen Receptor,IC50,=,1131.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@@]1(Cn2cc(F)cn2)OC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.946537395074545
CHEMBL4747056,CHEMBL1871,Androgen Receptor,IC50,=,2124.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,N#Cc1ccc(NC(=O)CCn2cc(F)cn2)cc1C(F)(F)F,5.6728454875905685
CHEMBL4746960,CHEMBL1871,Androgen Receptor,IC50,=,462.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CC(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.335358024443874
CHEMBL4792938,CHEMBL1871,Androgen Receptor,IC50,=,192.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.71669877129645
CHEMBL4758119,CHEMBL1871,Androgen Receptor,IC50,=,579.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(-c2ccccc2)c(C#N)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.237321436272564
CHEMBL4784244,CHEMBL1871,Androgen Receptor,IC50,=,5481.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C#N)c(Br)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,5.2611401979278
CHEMBL4794467,CHEMBL1871,Androgen Receptor,IC50,=,35.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Br)c(F)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.455931955649724
CHEMBL4757702,CHEMBL1871,Androgen Receptor,IC50,=,138.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Cl)c(Br)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.860120913598763
CHEMBL4752477,CHEMBL1871,Androgen Receptor,IC50,=,332.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)nc1Cl,6.478861916295964
CHEMBL4739997,CHEMBL1871,Androgen Receptor,IC50,=,181.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C#N)c(Br)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.7423214251308154
CHEMBL4782992,CHEMBL1871,Androgen Receptor,IC50,=,285.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(-c2ccc(F)cc2)c(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.54515513999149
CHEMBL4746345,CHEMBL1871,Androgen Receptor,IC50,=,84.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Br)c(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.075720713938118
CHEMBL4800363,CHEMBL1871,Androgen Receptor,IC50,=,5450.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1cc(C(F)(F)F)c(C#N)cc1I,5.2636034977233574
CHEMBL4741021,CHEMBL1871,Androgen Receptor,IC50,=,2470.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccnc(Cl)c1,5.607303046740334
CHEMBL4779527,CHEMBL1871,Androgen Receptor,IC50,=,427.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(Cl)c1,6.369572124974976
CHEMBL4776221,CHEMBL1871,Androgen Receptor,IC50,=,6108.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CC(C)(C)OC(=O)Nc1cnn(C[C@](C)(O)C(=O)Nc2cnc(C#N)c(C(F)(F)F)c2)c1,5.214100971615617
CHEMBL4778795,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C#N)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.229147988357855
CHEMBL4790541,CHEMBL1871,Androgen Receptor,IC50,=,208.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C(F)(F)F)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.681936665037238
CHEMBL4781335,CHEMBL1871,Androgen Receptor,IC50,=,62.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.207608310501746
CHEMBL218490,CHEMBL1871,Androgen Receptor,IC50,=,65.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21,7.187086643357144
CHEMBL3183409,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,6.795880017344075
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,216.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.665546248849069
CHEMBL4740742,CHEMBL1871,Androgen Receptor,IC50,=,248.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,N#Cc1ccc(NC(=O)CS(=O)(=O)c2ccc(F)cc2)cc1C(F)(F)F,6.605548319173783
CHEMBL4741767,CHEMBL1871,Androgen Receptor,IC50,=,827.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,COC(=O)Nc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1,6.082494490447454
CHEMBL4752893,CHEMBL1871,Androgen Receptor,IC50,=,1153.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CC(C)(C)OC(=O)Nc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1,5.938170692705301
CHEMBL4794197,CHEMBL1871,Androgen Receptor,IC50,=,276.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C#Cc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1,6.559090917934782
CHEMBL4793442,CHEMBL1871,Androgen Receptor,IC50,=,1069.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1ccc(-c2ccc(F)cc2)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.971022294791222
CHEMBL4746814,CHEMBL1871,Androgen Receptor,IC50,=,969.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(-c2ccc(F)cc2)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.013676222949234
CHEMBL4778019,CHEMBL1871,Androgen Receptor,IC50,=,4770.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1ccc(-c2ccccc2)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.3214816209598865
CHEMBL4758685,CHEMBL1871,Androgen Receptor,IC50,=,1152.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(-c2ccccc2)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.938547520912807
CHEMBL4747667,CHEMBL1871,Androgen Receptor,IC50,=,8087.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,Cc1cnn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c1,5.092212556889384
CHEMBL4753877,CHEMBL1871,Androgen Receptor,IC50,=,36.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc([N+](=O)[O-])cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.443697499232712
CHEMBL4776248,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C#N)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.346787486224656
CHEMBL4741569,CHEMBL1871,Androgen Receptor,IC50,=,205.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1ccc(C(F)(F)F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.688246138944246
CHEMBL4751646,CHEMBL1871,Androgen Receptor,IC50,=,71.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1487416512809245
CHEMBL4742694,CHEMBL1871,Androgen Receptor,IC50,=,758.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,CC(=O)c1cnn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c1,6.120330794367947
CHEMBL4798843,CHEMBL1871,Androgen Receptor,IC50,=,2038.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(I)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.690795820329592
CHEMBL4797334,CHEMBL1871,Androgen Receptor,IC50,=,427.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Br)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.369572124974976
CHEMBL4752991,CHEMBL1871,Androgen Receptor,IC50,=,136.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(Cl)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.866461091629782
CHEMBL4740374,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1ccc(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.657577319177793
CHEMBL4783581,CHEMBL1871,Androgen Receptor,IC50,=,199.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.701146923590294
CHEMBL4779474,CHEMBL1871,Androgen Receptor,IC50,=,1442.0,nM,CHEMBL4676574,B,Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay,CHEMBL4673256,IC50,C[C@](O)(Cn1cccn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.84103473961659
CHEMBL1274,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,6.221848749616356
CHEMBL4572306,CHEMBL1871,Androgen Receptor,IC50,=,3100.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC(C)(NC(=O)Nc1ccc(F)c(C(F)(F)F)c1)C(=O)O,5.508638306165727
CHEMBL4777133,CHEMBL1871,Androgen Receptor,IC50,=,6900.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)CNC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O,5.161150909262744
CHEMBL4786811,CHEMBL1871,Androgen Receptor,IC50,=,2800.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)C(=O)NC(=O)N1c1ccc(F)c(C(F)(F)F)c1,5.552841968657781
CHEMBL4777511,CHEMBL1871,Androgen Receptor,IC50,=,8100.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)CN(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1,5.0915149811213505
CHEMBL4790269,CHEMBL1871,Androgen Receptor,IC50,=,2100.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)OC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O,5.6777807052660805
CHEMBL4787997,CHEMBL1871,Androgen Receptor,IC50,=,910.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)CC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O,6.040958607678906
CHEMBL4778185,CHEMBL1871,Androgen Receptor,IC50,=,3500.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,O=C1C2CCCN2C(=O)N1c1ccc(F)c(C(F)(F)F)c1,5.455931955649724
CHEMBL4747499,CHEMBL1871,Androgen Receptor,IC50,=,4200.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,O=C1NC2(CCCCC2)C(=O)N1c1ccc(F)c(C(F)(F)F)c1,5.376750709602099
CHEMBL4755665,CHEMBL1871,Androgen Receptor,IC50,=,990.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,O=C1NC2(CCCC2)C(=O)N1c1ccc(F)c(C(F)(F)F)c1,6.00436480540245
CHEMBL4793158,CHEMBL1871,Androgen Receptor,IC50,=,4800.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(CO)NC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O,5.318758762624412
CHEMBL4763136,CHEMBL1871,Androgen Receptor,IC50,=,5300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,O=C1N[C@H](c2ccccc2)C(=O)N1c1ccc(F)c(C(F)F)c1,5.275724130399211
CHEMBL4793070,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,O=C1CNC(=O)N1c1ccc(F)c(C(F)(F)F)c1,6.585026652029182
CHEMBL4743529,CHEMBL1871,Androgen Receptor,IC50,=,4200.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)C1=O,5.376750709602099
CHEMBL4763876,CHEMBL1871,Androgen Receptor,IC50,=,9600.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2cccnc2)C1=O,5.017728766960431
CHEMBL4778298,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccnc3ccccc23)C1=O,5.886056647693163
CHEMBL4748422,CHEMBL1871,Androgen Receptor,IC50,=,4500.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccnc(C(F)(F)F)c2)C1=O,5.346787486224656
CHEMBL4782426,CHEMBL1871,Androgen Receptor,IC50,=,3800.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccncc2)C1=O,5.42021640338319
CHEMBL4746443,CHEMBL1871,Androgen Receptor,IC50,=,9100.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CN(C)C(=O)c1cc(N2C(=O)NC(C)(C)C2=O)ccc1F,5.040958607678906
CHEMBL4799429,CHEMBL1871,Androgen Receptor,IC50,=,3700.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccc(F)c(C#N)c2)C1=O,5.431798275933005
CHEMBL4750103,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O,5.886056647693163
CHEMBL4781708,CHEMBL1871,Androgen Receptor,IC50,=,6000.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2cccc(C(F)(F)F)c2)C1=O,5.221848749616356
CHEMBL4748557,CHEMBL1871,Androgen Receptor,IC50,=,4300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1S(=O)(=O)c1ccccc1,5.366531544420413
CHEMBL4740944,CHEMBL1871,Androgen Receptor,IC50,=,6300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1S(C)(=O)=O,5.200659450546418
CHEMBL4786505,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1CCc1ccccc1,5.619788758288394
CHEMBL4758277,CHEMBL1871,Androgen Receptor,IC50,=,290.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1CC#N,6.537602002101044
CHEMBL4799175,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CCN1C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)C1(C)C,6.853871964321762
CHEMBL4778974,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CN1C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)C1(C)C,5.886056647693163
CHEMBL4465426,CHEMBL1871,Androgen Receptor,IC50,=,4400.0,nM,CHEMBL4681685,B,Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay,CHEMBL4680100,IC50,CC1(C)NC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O,5.356547323513812
CHEMBL4797715,CHEMBL1871,Androgen Receptor,IC50,=,4020.0,nM,CHEMBL4685675,B,Displacement of fluormone-AL green from GST-tagged androgen receptor LBD (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL4680213,IC50,Clc1ccccc1C1Nc2ccc3ccccc3c2C2C=CCC21,5.39577394691553
CHEMBL27769,CHEMBL1871,Androgen Receptor,IC50,=,18.0,nM,CHEMBL4685675,B,Displacement of fluormone-AL green from GST-tagged androgen receptor LBD (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL4680213,IC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.7447274948966935
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,3970.0,nM,CHEMBL4685675,B,Displacement of fluormone-AL green from GST-tagged androgen receptor LBD (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL4680213,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.401209493236885
CHEMBL4798606,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Fc1ccccc1C1Nc2ccc3ccccc3c2C2C=CCC21,6.657577319177793
CHEMBL4760141,CHEMBL1871,Androgen Receptor,IC50,=,150.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Brc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)cc1,6.823908740944319
CHEMBL4790160,CHEMBL1871,Androgen Receptor,IC50,=,820.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,CCOC(=O)C1Nc2ccc3ccccc3c2C2C=CCC12,6.086186147616283
CHEMBL4796332,CHEMBL1871,Androgen Receptor,IC50,=,1920.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Clc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)cc1,5.71669877129645
CHEMBL4797715,CHEMBL1871,Androgen Receptor,IC50,=,2400.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Clc1ccccc1C1Nc2ccc3ccccc3c2C2C=CCC21,5.619788758288394
CHEMBL4798254,CHEMBL1871,Androgen Receptor,IC50,=,20350.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Clc1ccc(C2Nc3ccc4ccccc4c3C3OCCCC23)c(Cl)c1,4.691435586438761
CHEMBL4759623,CHEMBL1871,Androgen Receptor,IC50,=,5600.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,c1ccc(C2Nc3ccc4ccccc4c3C3C4CCC(C4)C23)cc1,5.251811972993799
CHEMBL4782786,CHEMBL1871,Androgen Receptor,IC50,=,7450.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,Clc1ccc(C2Nc3ccc4ccccc4c3C3C4CCC(C4)C23)cc1,5.127843727251707
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,36.0,nM,CHEMBL4685676,B,Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay,CHEMBL4680213,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.443697499232712
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,3030.0,nM,CHEMBL4686004,B,Antagonist activity at Androgen receptor (unknown origin) expressed in COS7 cells by dual luciferase reporter gene assay relative to control,CHEMBL4680224,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.518557371497695
CHEMBL4756936,CHEMBL1871,Androgen Receptor,IC50,=,6170.0,nM,CHEMBL4686004,B,Antagonist activity at Androgen receptor (unknown origin) expressed in COS7 cells by dual luciferase reporter gene assay relative to control,CHEMBL4680224,IC50,CCOC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2,5.209714835966759
CHEMBL4750503,CHEMBL1871,Androgen Receptor,IC50,=,4377.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F,5.358823453386886
CHEMBL4754074,CHEMBL1871,Androgen Receptor,IC50,=,9862.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CNc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F,5.0060350018048805
CHEMBL4788710,CHEMBL1871,Androgen Receptor,IC50,=,18140.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CSc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F,4.741362717275924
CHEMBL4781726,CHEMBL1871,Androgen Receptor,IC50,=,2837.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4ccccc4N3C2=S)cc1C(F)(F)F,5.547140664204148
CHEMBL4750351,CHEMBL1871,Androgen Receptor,IC50,=,3438.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccccc5)ccc4N3C2=S)cc1C(F)(F)F,5.463694127648966
CHEMBL4798945,CHEMBL1871,Androgen Receptor,IC50,=,3906.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cccnc5)ccc4N3C2=S)cc1C(F)(F)F,5.408267761048164
CHEMBL4757852,CHEMBL1871,Androgen Receptor,IC50,=,2183.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccc(C(F)(F)F)nc5)ccc4N3C2=S)cc1C(F)(F)F,5.66094626429086
CHEMBL4759704,CHEMBL1871,Androgen Receptor,IC50,=,8953.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cnc6ccccc6c5)ccc4N3C2=S)cc1C(F)(F)F,5.048031415507089
CHEMBL4755743,CHEMBL1871,Androgen Receptor,IC50,=,8075.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cnc(Cl)nc5)ccc4N3C2=S)cc1C(F)(F)F,5.0928574689968595
CHEMBL4788869,CHEMBL1871,Androgen Receptor,IC50,=,5978.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,Cc1noc(C)c1-c1ccc2c(c1)CCC1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=S)N21,5.223444089296738
CHEMBL4787221,CHEMBL1871,Androgen Receptor,IC50,=,4527.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccn(C6CC6)n5)ccc4N3C2=S)cc1C(F)(F)F,5.3441895055047475
CHEMBL4743145,CHEMBL1871,Androgen Receptor,IC50,=,148.6,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)COC2=O,6.827981190575444
CHEMBL4743302,CHEMBL1871,Androgen Receptor,IC50,=,590.2,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CN1Cc2cc(N3C(=S)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2C1=O,6.229000794836059
CHEMBL4745209,CHEMBL1871,Androgen Receptor,IC50,=,195.5,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)CCOC2=O,6.708853238268114
CHEMBL4759470,CHEMBL1871,Androgen Receptor,IC50,=,941.1,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CC1(C)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)COC2=O,6.026364226582593
CHEMBL4787631,CHEMBL1871,Androgen Receptor,IC50,=,2292.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1cnc2c(c1)COC2=O,5.639785386704648
CHEMBL4759841,CHEMBL1871,Androgen Receptor,IC50,=,216.7,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,6.664141088680182
CHEMBL4752689,CHEMBL1871,Androgen Receptor,IC50,=,80.7,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,7.09312646527793
CHEMBL4794639,CHEMBL1871,Androgen Receptor,IC50,=,95.2,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,7.021363051615525
CHEMBL4745855,CHEMBL1871,Androgen Receptor,IC50,=,26735.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ncc(N2C(=O)C3(COC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,4.572919811563641
CHEMBL4759832,CHEMBL1871,Androgen Receptor,IC50,=,238.8,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,6.6219656775426685
CHEMBL4780549,CHEMBL1871,Androgen Receptor,IC50,=,140.9,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,6.851089006890644
CHEMBL4756685,CHEMBL1871,Androgen Receptor,IC50,=,2219.0,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ncc(N2C(=O)C3(CCCC3)N(c3cnc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,5.653842697767992
CHEMBL4792484,CHEMBL1871,Androgen Receptor,IC50,=,134.6,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)CCOC4=O)C2=S)cc1C(F)(F)F,6.870954940112042
CHEMBL4764992,CHEMBL1871,Androgen Receptor,IC50,=,516.2,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ncc(N2C(=O)C3(CCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,6.28718199979215
CHEMBL4746653,CHEMBL1871,Androgen Receptor,IC50,=,63.8,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ncc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,7.195179321278838
CHEMBL4754309,CHEMBL1871,Androgen Receptor,IC50,=,93.3,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ncc(N2C(=O)C3(CCCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,7.0301183562535
CHEMBL4762417,CHEMBL1871,Androgen Receptor,IC50,=,669.6,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,N#Cc1ccc(N2C(=O)C3(CC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F,6.174184555014796
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,646.9,nM,CHEMBL4689074,B,Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay,CHEMBL4680336,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.189162848859512
CHEMBL4297185,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,IC50,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,7.585026652029182
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,219.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.6595558851598815
CHEMBL3183409,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,IC50,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,6.698970004336019
CHEMBL4783581,CHEMBL1871,Androgen Receptor,IC50,=,2000.0,nM,CHEMBL4726224,B,SARD activity at AR-LBD T877A mutant (unknown origin) after 4 hrs by luciferase assay,CHEMBL4725256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL4783581,CHEMBL1871,Androgen Receptor,IC50,=,2000.0,nM,CHEMBL4726225,B,SARD activity at AR-LBD F876L mutant (unknown origin) after 4 hrs by luciferase assay,CHEMBL4725256,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL4761957,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL4731338,B,Modulation of AR in human LNCAP cells transfected with PSA reporter gene assessed as inhibition of R1881-induced PSA luciferase activity pretreated for 1 hr followed by R1881 addition and measured after 24 hrs by luciferase assay,CHEMBL4725453,IC50,CC(C)S(=O)(=O)Nc1nc(COc2ccc(C(C)(C)c3cc(Cl)c(OCCCl)c(C#N)c3)cc2)co1,6.301029995663981
CHEMBL4757339,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL4731338,B,Modulation of AR in human LNCAP cells transfected with PSA reporter gene assessed as inhibition of R1881-induced PSA luciferase activity pretreated for 1 hr followed by R1881 addition and measured after 24 hrs by luciferase assay,CHEMBL4725453,IC50,CC(C)(c1ccc(OCc2ccnc(NS(C)(=O)=O)n2)cc1)c1cc(F)c(OCCCl)c(Cl)c1,6.301029995663981
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,248.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.605548319173783
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,216.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.665546248849069
CHEMBL4584527,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1,7.318758762624412
CHEMBL4444904,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.070581074285707
CHEMBL4783581,CHEMBL1871,Androgen Receptor,IC50,=,199.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.701146923590294
CHEMBL4875270,CHEMBL1871,Androgen Receptor,IC50,=,1856.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1ccnc1)C(=O)Nc1ccc(C#N)c(Cl)c1,5.731422028117157
CHEMBL4870613,CHEMBL1871,Androgen Receptor,IC50,=,1019.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cncc1Br)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.991825815993574
CHEMBL4857366,CHEMBL1871,Androgen Receptor,IC50,=,1091.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cncn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.962175249411658
CHEMBL4862864,CHEMBL1871,Androgen Receptor,IC50,=,1013.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cnc(C(F)(F)F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.99439055463972
CHEMBL4852427,CHEMBL1871,Androgen Receptor,IC50,=,1018.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(CN1CCOCC1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.99225222199926
CHEMBL4861273,CHEMBL1871,Androgen Receptor,IC50,=,226.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1ccc(-c2ccc(F)cc2)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.645891560852599
CHEMBL4746814,CHEMBL1871,Androgen Receptor,IC50,=,969.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cc(-c2ccc(F)cc2)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.013676222949234
CHEMBL4877240,CHEMBL1871,Androgen Receptor,IC50,=,172.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(CN(c1ccccc1)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.764471553092451
CHEMBL4868501,CHEMBL1871,Androgen Receptor,IC50,=,383.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cc(-c2ccc(F)cc2)nn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.416801226031377
CHEMBL4861278,CHEMBL1871,Androgen Receptor,IC50,=,217.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1cc(-c2ccc(F)cc2)nn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.66354026615147
CHEMBL4853429,CHEMBL1871,Androgen Receptor,IC50,=,317.0,nM,CHEMBL4810288,B,Antagonist activity at human androgen receptor expressed in HEK-293 cells harboring GRE-LUC and CMV-renilla luciferase assessed as inhibition of transactivation incubated for 24 hrs in presence of R1881 by dual luciferase assay,CHEMBL4808211,IC50,C[C@](O)(Cn1nncc1-c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.498940737782249
CHEMBL4852950,CHEMBL1871,Androgen Receptor,IC50,=,6500.0,nM,CHEMBL4819499,B,Antagonist activity at AR in human LNCaP cells transfected with PSA assessed as inhibition of R1881-induced PSA luciferase activity pretreated with compound followed by R1881 addition and measured after 48 hrs by luciferase assay,CHEMBL4818988,IC50,CCC(=O)N[C@H](C[C@H](C)C(Cl)(Cl)Cl)C(=O)N1C(=O)C=C(OC)[C@@H]1C[C@H](C)C(Cl)Cl,5.187086643357144
CHEMBL4861372,CHEMBL1871,Androgen Receptor,IC50,=,10000.0,nM,CHEMBL4819499,B,Antagonist activity at AR in human LNCaP cells transfected with PSA assessed as inhibition of R1881-induced PSA luciferase activity pretreated with compound followed by R1881 addition and measured after 48 hrs by luciferase assay,CHEMBL4818988,IC50,COC1=CC(=O)N(C(=O)[C@@H](CCC(Cl)(Cl)Cl)NC(=O)C(C)(C)C)[C@@H]1CCC(Cl)(Cl)Cl,5.0
CHEMBL4871230,CHEMBL1871,Androgen Receptor,IC50,=,3500.0,nM,CHEMBL4819499,B,Antagonist activity at AR in human LNCaP cells transfected with PSA assessed as inhibition of R1881-induced PSA luciferase activity pretreated with compound followed by R1881 addition and measured after 48 hrs by luciferase assay,CHEMBL4818988,IC50,COC1=CC(=O)N(C(=O)[C@@H](CCC(Cl)(Cl)Cl)NC(=O)C(C)(C)C)[C@@H]1CCC(Cl)Cl,5.455931955649724
CHEMBL4852950,CHEMBL1871,Androgen Receptor,IC50,=,14000.0,nM,CHEMBL4819500,B,Inhibition of R1881-stimulated AR transcription driven human LNCaP cells proliferation preincubated for 1 hr followed by R1881 addition and measured after 4 days by Alamar blue assay,CHEMBL4818988,IC50,CCC(=O)N[C@H](C[C@H](C)C(Cl)(Cl)Cl)C(=O)N1C(=O)C=C(OC)[C@@H]1C[C@H](C)C(Cl)Cl,4.853871964321762
CHEMBL4861372,CHEMBL1871,Androgen Receptor,IC50,=,12000.0,nM,CHEMBL4819500,B,Inhibition of R1881-stimulated AR transcription driven human LNCaP cells proliferation preincubated for 1 hr followed by R1881 addition and measured after 4 days by Alamar blue assay,CHEMBL4818988,IC50,COC1=CC(=O)N(C(=O)[C@@H](CCC(Cl)(Cl)Cl)NC(=O)C(C)(C)C)[C@@H]1CCC(Cl)(Cl)Cl,4.920818753952375
CHEMBL4871230,CHEMBL1871,Androgen Receptor,IC50,=,6900.0,nM,CHEMBL4819500,B,Inhibition of R1881-stimulated AR transcription driven human LNCaP cells proliferation preincubated for 1 hr followed by R1881 addition and measured after 4 days by Alamar blue assay,CHEMBL4818988,IC50,COC1=CC(=O)N(C(=O)[C@@H](CCC(Cl)(Cl)Cl)NC(=O)C(C)(C)C)[C@@H]1CCC(Cl)Cl,5.161150909262744
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,19.0,nM,CHEMBL4820462,B,Displacement of [3H]methyltrienolone from wild-type androgen receptor in human LNCaP cells incubated for 24 hrs by scintillation counting analysis,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,7.721246399047171
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,38.0,nM,CHEMBL4820462,B,Displacement of [3H]methyltrienolone from wild-type androgen receptor in human LNCaP cells incubated for 24 hrs by scintillation counting analysis,CHEMBL4819022,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.42021640338319
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,127.0,nM,CHEMBL4820466,B,Antagonist activity at VP16-AR wild-type (unknown origin) transfected in human HepG2 cells cotransfected with ARE-LUC incubated for 48 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,6.896196279044043
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,98.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,7.008773924307505
CHEMBL4858811,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,7.431798275933005
CHEMBL4859502,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cn2)CC1,7.070581074285707
CHEMBL4876579,CHEMBL1871,Androgen Receptor,IC50,=,145.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)cc3)C2=S)cc1C(F)(F)F,6.838631997765026
CHEMBL4850003,CHEMBL1871,Androgen Receptor,IC50,=,427.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ncc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cn2)CC1,6.369572124974976
CHEMBL4868340,CHEMBL1871,Androgen Receptor,IC50,=,309.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3cnc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,6.510041520575165
CHEMBL4869652,CHEMBL1871,Androgen Receptor,IC50,=,214.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)cc3)C2=S)cnc1C#N,6.669586226650809
CHEMBL4860547,CHEMBL1871,Androgen Receptor,IC50,=,102.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)nc3)C2=S)cnc1C#N,6.991399828238082
CHEMBL4879319,CHEMBL1871,Androgen Receptor,IC50,=,81.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,Cc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cnc1C#N,7.0915149811213505
CHEMBL4849570,CHEMBL1871,Androgen Receptor,IC50,=,47.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1Cl,7.327902142064282
CHEMBL4862827,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)cc3)C2=S)cc1Cl,7.431798275933005
CHEMBL4853754,CHEMBL1871,Androgen Receptor,IC50,=,204.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(CN4CCNCC4)cc3)C2=S)cc1C(F)(F)F,6.690369832574101
CHEMBL4861595,CHEMBL1871,Androgen Receptor,IC50,=,182.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F,6.739928612014925
CHEMBL4850855,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL4820474,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(O)nc3)C2=S)cc1C(F)(F)F,6.0
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,191.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,6.718966632752272
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,117.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.931814138253838
CHEMBL4858811,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,7.267606240177031
CHEMBL4859502,CHEMBL1871,Androgen Receptor,IC50,=,115.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cn2)CC1,6.939302159646388
CHEMBL4876579,CHEMBL1871,Androgen Receptor,IC50,=,240.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)cc3)C2=S)cc1C(F)(F)F,6.619788758288394
CHEMBL4850003,CHEMBL1871,Androgen Receptor,IC50,=,417.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,CN1CCC(Oc2ncc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cn2)CC1,6.379863945026242
CHEMBL4868340,CHEMBL1871,Androgen Receptor,IC50,=,501.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3cnc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,6.300162274132754
CHEMBL4869652,CHEMBL1871,Androgen Receptor,IC50,=,302.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)cc3)C2=S)cnc1C#N,6.51999305704285
CHEMBL4860547,CHEMBL1871,Androgen Receptor,IC50,=,162.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)nc3)C2=S)cnc1C#N,6.790484985457369
CHEMBL4879319,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,Cc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cnc1C#N,6.920818753952375
CHEMBL4849570,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1Cl,7.301029995663981
CHEMBL4862827,CHEMBL1871,Androgen Receptor,IC50,=,76.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)cc3)C2=S)cc1Cl,7.119186407719209
CHEMBL4853754,CHEMBL1871,Androgen Receptor,IC50,=,355.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(CN4CCNCC4)cc3)C2=S)cc1C(F)(F)F,6.449771646944906
CHEMBL4861595,CHEMBL1871,Androgen Receptor,IC50,=,204.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F,6.690369832574101
CHEMBL4850855,CHEMBL1871,Androgen Receptor,IC50,=,2239.0,nM,CHEMBL4820475,B,Antagonist activity at AR wild-type (unknown origin) transfected in human LNCAP cells cotransfected with ARE-LUC incubated for 20 to 24 hrs in presence of AR agonist R1881 by steady-glo luciferase reporter gene assay,CHEMBL4819022,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(O)nc3)C2=S)cc1C(F)(F)F,5.649945906420969
CHEMBL4876467,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Clc1cc(Cl)c2[nH]cc(-c3ccc4ccccc4n3)c2c1,5.823908740944319
CHEMBL4852876,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc2c(-c3ccc4ccccc4n3)c[nH]c2c(F)c1F,7.045757490560675
CHEMBL4877104,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cc(F)cc2c(-c3ccc4ccccc4n3)c[nH]c12,6.638272163982407
CHEMBL4850974,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1ccc2c(-c3ccc4ccccc4n3)c[nH]c2c1F,6.721246399047171
CHEMBL4852542,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1c(F)ccc2c(-c3ccc4ccccc4n3)c[nH]c12,6.769551078621726
CHEMBL4852991,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc(Cl)cc2c(-c3ccc4ccccc4n3)c[nH]c12,6.886056647693163
CHEMBL4870138,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc(Cl)c2[nH]cc(-c3ccc4ccccc4n3)c2c1,7.0
CHEMBL4875734,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Clc1cccc2c(-c3ccc4ccccc4n3)c[nH]c12,7.0
CHEMBL4856070,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1ccc2c(-c3ccc4ccccc4n3)c[nH]c2c1Cl,7.522878745280337
CHEMBL4845915,CHEMBL1871,Androgen Receptor,IC50,=,30.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc(F)c2[nH]cc(-c3ccc4ccccc4n3)c2c1,7.522878745280337
CHEMBL4870389,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4ccccc4n3)c[nH]c12,7.221848749616356
CHEMBL4877237,CHEMBL1871,Androgen Receptor,IC50,=,1590.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cc(C)c2[nH]cc(-c3ccc4ccccc4n3)c2c1,5.798602875679549
CHEMBL4860114,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cc(Cl)c2[nH]cc(-c3ccc4ccccc4n3)c2c1,5.721246399047171
CHEMBL4846981,CHEMBL1871,Androgen Receptor,IC50,=,2170.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1ccc2c(-c3ccc4ccccc4n3)c[nH]c2c1F,5.66354026615147
CHEMBL4868764,CHEMBL1871,Androgen Receptor,IC50,=,240.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4c(C(F)(F)F)cccc4n3)c[nH]c12,6.619788758288394
CHEMBL4868944,CHEMBL1871,Androgen Receptor,IC50,=,230.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CNC(=O)c1cccc2nc(-c3c[nH]c4c(C)cccc34)ccc12,6.638272163982407
CHEMBL4864867,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4ccc(F)cc4n3)c[nH]c12,6.522878745280337
CHEMBL4852702,CHEMBL1871,Androgen Receptor,IC50,=,1650.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4ccc(Cl)cc4n3)c[nH]c12,5.782516055786093
CHEMBL4869391,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2ccc(-c3c[nH]c4c(C)cccc34)nc12,6.7447274948966935
CHEMBL4857183,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4cccc(F)c4n3)c[nH]c12,7.0
CHEMBL4856585,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4cccc(Cl)c4n3)c[nH]c12,6.698970004336019
CHEMBL4871740,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Cc1cccc2c(-c3ccc4cccc(Br)c4n3)c[nH]c12,6.795880017344075
CHEMBL4849023,CHEMBL1871,Androgen Receptor,IC50,=,40.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,O=C(NCC(F)F)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,7.3979400086720375
CHEMBL4872533,CHEMBL1871,Androgen Receptor,IC50,=,70.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,O=C(NC1CC1)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,7.154901959985743
CHEMBL4847082,CHEMBL1871,Androgen Receptor,IC50,=,70.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc2c(-c3ccc4c(-c5cncs5)cccc4n3)c[nH]c2c(F)c1F,7.154901959985743
CHEMBL4876258,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CNC(=O)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,6.958607314841775
CHEMBL4849002,CHEMBL1871,Androgen Receptor,IC50,=,180.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,O=C(NCC1CC1)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,6.7447274948966935
CHEMBL4866292,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CC(C)NC(=O)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,6.721246399047171
CHEMBL4875909,CHEMBL1871,Androgen Receptor,IC50,=,500.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc2c(-c3ccc4c(-c5nccs5)cccc4n3)c[nH]c2c(F)c1F,6.301029995663981
CHEMBL4871449,CHEMBL1871,Androgen Receptor,IC50,=,550.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,Fc1cc2c(-c3ccc4c(C(F)(F)F)cccc4n3)c[nH]c2c(F)c1F,6.259637310505756
CHEMBL4854145,CHEMBL1871,Androgen Receptor,IC50,=,740.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CC(C)(C)NC(=O)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,6.130768280269024
CHEMBL4870661,CHEMBL1871,Androgen Receptor,IC50,=,32000.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,OC(c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12)C(F)(F)F,4.494850021680094
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,75.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.1249387366083
CHEMBL4848581,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL4828552,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB incubated for 3 days by fluorescence method,CHEMBL4825767,IC50,CC(C)NC(=O)c1cccc2nc(-c3cn(COP(=O)([O-])[O-])c4c(F)c(F)c(F)cc34)ccc12.[Na+].[Na+],6.180456064458131
CHEMBL4866292,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL4828554,B,Antagonist activity at androgen receptor in human LNCaP cells harboring eGFP/ARRIPB assessed as reduction in PSA level incubated for 3 days,CHEMBL4825767,IC50,CC(C)NC(=O)c1cccc2nc(-c3c[nH]c4c(F)c(F)c(F)cc34)ccc12,6.795880017344075
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,98.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,7.008773924307505
CHEMBL4877559,CHEMBL1871,Androgen Receptor,IC50,=,5012.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)NC(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,5.299988937677888
CHEMBL4861204,CHEMBL1871,Androgen Receptor,IC50,=,676.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.170053304058364
CHEMBL4866153,CHEMBL1871,Androgen Receptor,IC50,=,525.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.279840696594043
CHEMBL4872153,CHEMBL1871,Androgen Receptor,IC50,=,759.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.11975822410452
CHEMBL4868140,CHEMBL1871,Androgen Receptor,IC50,=,339.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.4698003017969175
CHEMBL4856041,CHEMBL1871,Androgen Receptor,IC50,=,1660.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1C,5.779891911959945
CHEMBL4851052,CHEMBL1871,Androgen Receptor,IC50,=,178.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CN1C(=S)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=O)C12Cc1ccc(OC3CCNCC3)cc1C2,6.7495799976911055
CHEMBL4854295,CHEMBL1871,Androgen Receptor,IC50,=,145.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.838631997765026
CHEMBL4850746,CHEMBL1871,Androgen Receptor,IC50,=,93.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.031517051446065
CHEMBL4857716,CHEMBL1871,Androgen Receptor,IC50,=,102.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1CC(C)C,6.991399828238082
CHEMBL4865876,CHEMBL1871,Androgen Receptor,IC50,=,123.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CC(C)C,6.910094888560602
CHEMBL4871015,CHEMBL1871,Androgen Receptor,IC50,=,257.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CC1,6.590066876668706
CHEMBL4865067,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCC1,6.769551078621726
CHEMBL4852266,CHEMBL1871,Androgen Receptor,IC50,=,132.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCCC1,6.8794260687941495
CHEMBL4871131,CHEMBL1871,Androgen Receptor,IC50,=,174.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCCCC1,6.7594507517174005
CHEMBL4876793,CHEMBL1871,Androgen Receptor,IC50,=,112.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@@]1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.950781977329818
CHEMBL4860814,CHEMBL1871,Androgen Receptor,IC50,=,151.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@@]1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.821023052706831
CHEMBL4879321,CHEMBL1871,Androgen Receptor,IC50,=,65.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@]1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.187086643357144
CHEMBL4865182,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL4837140,B,Antagonist activity at AR F877L mutant (unknown origin) transfected in human LNCAP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@]1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.107905397309519
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,117.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.931814138253838
CHEMBL4865865,CHEMBL1871,Androgen Receptor,IC50,=,191.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,6.718966632752272
CHEMBL4877559,CHEMBL1871,Androgen Receptor,IC50,=,11220.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)NC(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,4.950007143079858
CHEMBL4861204,CHEMBL1871,Androgen Receptor,IC50,=,1380.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C,5.860120913598763
CHEMBL4866153,CHEMBL1871,Androgen Receptor,IC50,=,646.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1ccc2c(c1)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.189767482004916
CHEMBL4872153,CHEMBL1871,Androgen Receptor,IC50,=,1096.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C,5.96018944585165
CHEMBL4868140,CHEMBL1871,Androgen Receptor,IC50,=,398.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C,6.400116927926312
CHEMBL4851052,CHEMBL1871,Androgen Receptor,IC50,=,219.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CN1C(=S)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=O)C12Cc1ccc(OC3CCNCC3)cc1C2,6.6595558851598815
CHEMBL4854295,CHEMBL1871,Androgen Receptor,IC50,=,112.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.950781977329818
CHEMBL4850746,CHEMBL1871,Androgen Receptor,IC50,=,93.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.031517051446065
CHEMBL4857716,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1CC(C)C,7.0
CHEMBL4865876,CHEMBL1871,Androgen Receptor,IC50,=,126.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CC(C)C,6.899629454882437
CHEMBL4871015,CHEMBL1871,Androgen Receptor,IC50,=,191.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CC1,6.718966632752272
CHEMBL4865067,CHEMBL1871,Androgen Receptor,IC50,=,229.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCC1,6.6401645176601125
CHEMBL4852266,CHEMBL1871,Androgen Receptor,IC50,=,148.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCCC1,6.8297382846050425
CHEMBL4871131,CHEMBL1871,Androgen Receptor,IC50,=,209.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)CC1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C1CCCCC1,6.679853713888946
CHEMBL4876793,CHEMBL1871,Androgen Receptor,IC50,=,178.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@@]1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.7495799976911055
CHEMBL4860814,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@@]1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,6.769551078621726
CHEMBL4879321,CHEMBL1871,Androgen Receptor,IC50,=,52.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@]1(C2)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.2839966563652006
CHEMBL4865182,CHEMBL1871,Androgen Receptor,IC50,=,72.0,nM,CHEMBL4837141,B,Antagonist activity at wild type androgen receptor in castration-resistant human LNCaP cells assessed as inhibition of R1881-stimulated receptor transcriptional activation measured after 20 to 24 hrs by Steady-Glo luciferase assay,CHEMBL4834497,IC50,CNC(=O)c1cc2c(cc1F)C[C@]1(C2)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C(C)C,7.142667503568731
CHEMBL5085066,CHEMBL1871,Androgen Receptor,IC50,=,18050.0,nM,CHEMBL5045077,B,Antagonist activity at human AR AF2 assessed as inhibition of fluorescent-labelled D11-FxxLF peptide Co-activator to receptor by TR-FRET assay,CHEMBL5042532,IC50,CN(C)S(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,4.7435227937583235
CHEMBL139835,CHEMBL1871,Androgen Receptor,IC50,=,258.6,nM,CHEMBL5045077,B,Antagonist activity at human AR AF2 assessed as inhibition of fluorescent-labelled D11-FxxLF peptide Co-activator to receptor by TR-FRET assay,CHEMBL5042532,IC50,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,6.587371479455625
CHEMBL5090685,CHEMBL1871,Androgen Receptor,IC50,=,5730.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Cc1ccccc1)Nc1ccc(OCc2ccccc2)cc1,5.24184537803261
CHEMBL5075240,CHEMBL1871,Androgen Receptor,IC50,=,2270.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1ccc(F)cc1,5.6439741428068775
CHEMBL5085212,CHEMBL1871,Androgen Receptor,IC50,=,5020.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1ccc(Cl)cc1,5.29929628285498
CHEMBL5085066,CHEMBL1871,Androgen Receptor,IC50,=,470.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,CN(C)S(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,6.327902142064282
CHEMBL5077404,CHEMBL1871,Androgen Receptor,IC50,=,4160.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=[N+]([O-])c1ccccc1S(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,5.380906669373257
CHEMBL5074175,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1ccccc1,6.958607314841775
CHEMBL5090667,CHEMBL1871,Androgen Receptor,IC50,=,3370.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1cc(Cl)ccc1Cl,5.4723700991286615
CHEMBL1463660,CHEMBL1871,Androgen Receptor,IC50,=,6110.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,CS(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,5.213958789757446
CHEMBL5074767,CHEMBL1871,Androgen Receptor,IC50,=,1550.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1ccc(Br)cc1,5.809668301829708
CHEMBL5081582,CHEMBL1871,Androgen Receptor,IC50,=,1770.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=S(=O)(Nc1ccc(OCc2ccccc2)cc1)c1ccc(C(F)(F)F)cc1,5.752026733638193
CHEMBL5086603,CHEMBL1871,Androgen Receptor,IC50,=,7900.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,CCS(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,5.102372908709558
CHEMBL5078718,CHEMBL1871,Androgen Receptor,IC50,=,11520.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,Cc1ccc(S(=O)(=O)Nc2ccc(OCc3ccccc3)cc2)cc1,4.938547520912807
CHEMBL5074003,CHEMBL1871,Androgen Receptor,IC50,=,2250.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,N#Cc1ccc(S(=O)(=O)Nc2ccc(OCc3ccccc3)cc2)cc1,5.647817481888637
CHEMBL5077543,CHEMBL1871,Androgen Receptor,IC50,=,1590.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,O=[N+]([O-])c1cccc(S(=O)(=O)Nc2ccc(OCc3ccccc3)cc2)c1,5.798602875679549
CHEMBL5075580,CHEMBL1871,Androgen Receptor,IC50,=,7050.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,CCCCS(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,5.151810883008601
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,70.0,nM,CHEMBL5045078,B,Antagonist activity against human androgen receptor expressed in human LNCap cells trasfected with ARR2PB-eGFP cells incubated for 3 days by fluorescence based AR transcription assay,CHEMBL5042532,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.154901959985743
CHEMBL5081630,CHEMBL1871,Androgen Receptor,IC50,=,1660.0,nM,CHEMBL5057873,B,Binding affinity to GST-tagged AR ligand binding domain (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(/N=C/c3ccccc3O)cc2o1,5.779891911959945
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,80.0,nM,CHEMBL5057873,B,Binding affinity to GST-tagged AR ligand binding domain (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL5055679,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.096910013008056
CHEMBL4087723,CHEMBL1871,Androgen Receptor,IC50,=,750.0,nM,CHEMBL5057873,B,Binding affinity to GST-tagged AR ligand binding domain (unknown origin) measured after 4 hrs by fluorescence polarization assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(Br)cc3)cc2o1,6.1249387366083
CHEMBL5079200,CHEMBL1871,Androgen Receptor,IC50,=,1400.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,Cc1cccc(COc2ccc3c(C(F)(F)F)cc(=O)oc3c2)c1,5.853871964321762
CHEMBL5093730,CHEMBL1871,Androgen Receptor,IC50,=,920.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3F)cc2o1,6.036212172654444
CHEMBL5071682,CHEMBL1871,Androgen Receptor,IC50,=,780.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3c(F)cccc3Cl)cc2o1,6.107905397309519
CHEMBL5076873,CHEMBL1871,Androgen Receptor,IC50,=,410.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3Cl)cc2o1,6.3872161432802645
CHEMBL5077637,CHEMBL1871,Androgen Receptor,IC50,=,1470.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3cc4c(cc3Cl)OCO4)cc2o1,5.8326826652518236
CHEMBL5081630,CHEMBL1871,Androgen Receptor,IC50,=,5570.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(/N=C/c3ccccc3O)cc2o1,5.2541448048262716
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,14.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.853871964321762
CHEMBL5088635,CHEMBL1871,Androgen Receptor,IC50,=,940.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3Br)cc2o1,6.026872146400301
CHEMBL5084126,CHEMBL1871,Androgen Receptor,IC50,=,2280.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3cccc(Br)c3)cc2o1,5.642065152999546
CHEMBL4087723,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(Br)cc3)cc2o1,6.769551078621726
CHEMBL5082962,CHEMBL1871,Androgen Receptor,IC50,=,470.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(F)cc3)cc2o1,6.327902142064282
CHEMBL5087976,CHEMBL1871,Androgen Receptor,IC50,=,1040.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(Cl)cc3)cc2o1,5.982966660701219
CHEMBL145403,CHEMBL1871,Androgen Receptor,IC50,=,1180.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccccc3)cc2o1,5.928117992693874
CHEMBL5087488,CHEMBL1871,Androgen Receptor,IC50,=,610.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,Cc1ccc(COc2ccc3c(C(F)(F)F)cc(=O)oc3c2)cc1,6.214670164989233
CHEMBL5079698,CHEMBL1871,Androgen Receptor,IC50,=,890.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(C(F)(F)F)cc3)cc2o1,6.050609993355087
CHEMBL5094619,CHEMBL1871,Androgen Receptor,IC50,=,1620.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,COc1ccc(COc2ccc3c(C(F)(F)F)cc(=O)oc3c2)cc1,5.790484985457369
CHEMBL5078938,CHEMBL1871,Androgen Receptor,IC50,=,25060.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc(OC(F)(F)F)cc3)cc2o1,4.6010189333418685
CHEMBL5091168,CHEMBL1871,Androgen Receptor,IC50,=,9260.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,CC(C)c1ccc(COc2ccc3c(C(F)(F)F)cc(=O)oc3c2)cc1,5.033389013318066
CHEMBL5071912,CHEMBL1871,Androgen Receptor,IC50,=,30740.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,COC(=O)c1ccc(COc2ccc3c(C(F)(F)F)cc(=O)oc3c2)cc1,4.512296136836274
CHEMBL5094528,CHEMBL1871,Androgen Receptor,IC50,=,9370.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccc4c(c3)OCO4)cc2o1,5.028260409112222
CHEMBL5083886,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL5057874,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP incubated for 72 hrs by fluorescence assay,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(OCc3ccncc3)cc2o1,5.721246399047171
CHEMBL5081630,CHEMBL1871,Androgen Receptor,IC50,=,3710.0,nM,CHEMBL5057875,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP assessed as decrease in PSA level,CHEMBL5055679,IC50,O=c1cc(C(F)(F)F)c2ccc(/N=C/c3ccccc3O)cc2o1,5.430626090384954
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,480.0,nM,CHEMBL5057875,B,Inhibition of AR transcriptional activity in human LNCaP cells harboring ARR2PB-eGFP assessed as decrease in PSA level,CHEMBL5055679,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.318758762624412
CHEMBL5182367,CHEMBL1871,Androgen Receptor,IC50,=,760.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CNC(=O)c3ccc(F)cc3)n2)cc1C(F)(F)F,6.119186407719209
CHEMBL5194785,CHEMBL1871,Androgen Receptor,IC50,=,1150.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CNC(=O)c3ccc(Cl)cc3)n2)cc1C(F)(F)F,5.939302159646388
CHEMBL5196306,CHEMBL1871,Androgen Receptor,IC50,=,300.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(C(=O)NCc2ccn(-c3ccc(C#N)c(C(F)(F)F)c3)n2)cc1,6.522878745280337
CHEMBL5195872,CHEMBL1871,Androgen Receptor,IC50,=,1850.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CNC(=O)c3ccc([N+](=O)[O-])cc3)n2)cc1C(F)(F)F,5.732828271596986
CHEMBL5201931,CHEMBL1871,Androgen Receptor,IC50,=,5820.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CNC(=O)c3ccc(F)cn3)n2)cc1C(F)(F)F,5.235077015350111
CHEMBL5194539,CHEMBL1871,Androgen Receptor,IC50,=,780.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CNC(=O)c3ccc(F)nc3)n2)cc1C(F)(F)F,6.107905397309519
CHEMBL5183890,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,Cc1cn(-c2ccc(C#N)c(C(F)(F)F)c2)nc1CNC(=O)c1ccc(F)cc1,6.657577319177793
CHEMBL5172818,CHEMBL1871,Androgen Receptor,IC50,=,14900.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,Cc1cn(-c2ccc(C#N)c(C(F)(F)F)c2)nc1CNC(=O)c1ccc(C#N)cc1,4.826813731587726
CHEMBL5186217,CHEMBL1871,Androgen Receptor,IC50,=,450.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,Cc1cn(-c2ccc(C#N)c(C(F)(F)F)c2)nc1CNC(=O)c1ccc([N+](=O)[O-])cc1,6.346787486224656
CHEMBL5194098,CHEMBL1871,Androgen Receptor,IC50,=,16240.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2cc(C(F)(F)F)c(CNC(=O)c3ccc(F)cc3)n2)cc1C(F)(F)F,4.789413975094844
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,25.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.6020599913279625
CHEMBL5177079,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,6.920818753952375
CHEMBL5206094,CHEMBL1871,Androgen Receptor,IC50,=,50.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(NC(=O)Cc2ccn(-c3ccc(C#N)c(C(F)(F)F)c3)n2)cc1,7.301029995663981
CHEMBL5175077,CHEMBL1871,Androgen Receptor,IC50,=,80.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc([N+](=O)[O-])cc3)n2)cc1C(F)(F)F,7.096910013008056
CHEMBL5186580,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cn3)n2)cc1C(F)(F)F,6.468521082957745
CHEMBL5203294,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,6.853871964321762
CHEMBL5193409,CHEMBL1871,Androgen Receptor,IC50,=,6340.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1cc(NC(=O)Cc2ccn(-c3ccc(C#N)c(C(F)(F)F)c3)n2)ccc1F,5.1979107421182675
CHEMBL5188878,CHEMBL1871,Androgen Receptor,IC50,=,210.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)c(F)c3)n2)cc1C(F)(F)F,6.6777807052660805
CHEMBL5187028,CHEMBL1871,Androgen Receptor,IC50,=,4530.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,Cc1ccc(NC(=O)Cc2ccn(-c3ccc(C#N)c(C(F)(F)F)c3)n2)cc1,5.343901797987169
CHEMBL5197284,CHEMBL1871,Androgen Receptor,IC50,=,9200.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,COc1ccc(NC(=O)Cc2ccn(-c3ccc(C#N)c(C(F)(F)F)c3)n2)cc1,5.036212172654444
CHEMBL5201101,CHEMBL1871,Androgen Receptor,IC50,=,69.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,7.161150909262744
CHEMBL5185396,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,O=C(Cc1ccn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)n1)Nc1ccc(F)cc1,6.468521082957745
CHEMBL5208225,CHEMBL1871,Androgen Receptor,IC50,=,2570.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,O=C(Cc1ccn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)n1)Nc1ccc(F)cn1,5.590066876668706
CHEMBL5185108,CHEMBL1871,Androgen Receptor,IC50,=,360.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,O=C(Cc1ccn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)n1)Nc1ccc(F)nc1,6.443697499232712
CHEMBL5200307,CHEMBL1871,Androgen Receptor,IC50,=,220.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1Cl,6.657577319177793
CHEMBL5174154,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL5106948,B,Antagonist activity at androgen receptor (unknown origin) in human LNCap-ARR2PB-eGFP cells by measuring fluorescence intensity measured after 3 days by transcriptional assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cn3)n2)cc1Cl,6.769551078621726
CHEMBL5177079,CHEMBL1871,Androgen Receptor,IC50,=,910.0,nM,CHEMBL5106957,B,Antagonist activity at androgen receptor F877L mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,6.040958607678906
CHEMBL5203294,CHEMBL1871,Androgen Receptor,IC50,=,1310.0,nM,CHEMBL5106957,B,Antagonist activity at androgen receptor F877L mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,5.882728704344236
CHEMBL5201101,CHEMBL1871,Androgen Receptor,IC50,=,460.0,nM,CHEMBL5106957,B,Antagonist activity at androgen receptor F877L mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,6.337242168318426
CHEMBL4457117,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL5106957,B,Antagonist activity at androgen receptor F877L mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,CC(O)c1cc(C(=O)N[C@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,7.431798275933005
CHEMBL5177079,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL5106958,B,Antagonist activity at androgen receptor F877L/T877A dual mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,6.6020599913279625
CHEMBL5203294,CHEMBL1871,Androgen Receptor,IC50,=,1120.0,nM,CHEMBL5106958,B,Antagonist activity at androgen receptor F877L/T877A dual mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,5.950781977329818
CHEMBL5201101,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL5106958,B,Antagonist activity at androgen receptor F877L/T877A dual mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,6.568636235841012
CHEMBL4457117,CHEMBL1871,Androgen Receptor,IC50,=,64.0,nM,CHEMBL5106958,B,Antagonist activity at androgen receptor F877L/T877A dual mutant (unknown origin) expressed in PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by dual luciferase assay,CHEMBL5104187,IC50,CC(O)c1cc(C(=O)N[C@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,7.1938200260161125
CHEMBL5177079,CHEMBL1871,Androgen Receptor,IC50,=,910.0,nM,CHEMBL5106959,B,Antagonist activity at androgen receptor F877L mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,6.040958607678906
CHEMBL5203294,CHEMBL1871,Androgen Receptor,IC50,=,1310.0,nM,CHEMBL5106959,B,Antagonist activity at androgen receptor F877L mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,5.882728704344236
CHEMBL5201101,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL5106959,B,Antagonist activity at androgen receptor F877L mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,6.769551078621726
CHEMBL5177079,CHEMBL1871,Androgen Receptor,IC50,=,250.0,nM,CHEMBL5106960,B,Antagonist activity at androgen receptor F876L/T877A mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,6.6020599913279625
CHEMBL5203294,CHEMBL1871,Androgen Receptor,IC50,=,1120.0,nM,CHEMBL5106960,B,Antagonist activity at androgen receptor F876L/T877A mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,5.950781977329818
CHEMBL5201101,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL5106960,B,Antagonist activity at androgen receptor F876L/T877A mutant in human PC-3 cells assessed as inhibition of transcriptional activity measured after 24 hrs by luminescence based microplate reader assay,CHEMBL5104187,IC50,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,6.568636235841012
CHEMBL5185742,CHEMBL1871,Androgen Receptor,IC50,=,1551.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](NC(=O)c3ccncc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,5.809388202186395
CHEMBL5173364,CHEMBL1871,Androgen Receptor,IC50,=,1348.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](NC(=O)c3ccnnc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,5.870310107800699
CHEMBL5206638,CHEMBL1871,Androgen Receptor,IC50,=,914.5,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,COc1cncc(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccnnc6)CC[C@]5(C)[C@H]4CC[C@]23C)c1,6.038816290187564
CHEMBL5174715,CHEMBL1871,Androgen Receptor,IC50,=,1641.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,Cc1cncc(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccnnc6)CC[C@]5(C)[C@H]4CC[C@]23C)c1,5.784891418946907
CHEMBL5197724,CHEMBL1871,Androgen Receptor,IC50,=,1285.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,Cc1cn(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6cccnc6)CC[C@]5(C)[C@H]4CC[C@]23C)cn1,5.891096872332687
CHEMBL5201702,CHEMBL1871,Androgen Receptor,IC50,=,511.2,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](NC(=O)c3ccncc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3ccnc3)=CC[C@@H]12,6.2914091548496565
CHEMBL5200292,CHEMBL1871,Androgen Receptor,IC50,=,9145.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](NC(=O)c3ccnnc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3ccnn3)=CC[C@@H]12,5.038816290187564
CHEMBL5200697,CHEMBL1871,Androgen Receptor,IC50,=,244.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,Cc1cn(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccnnc6)CC[C@]5(C)[C@H]4CC[C@]23C)cn1,6.61261017366127
CHEMBL5181000,CHEMBL1871,Androgen Receptor,IC50,=,980.8,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](NC(=O)c3ccnnc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3ccnc3)=CC[C@@H]12,6.00841954282566
CHEMBL5178984,CHEMBL1871,Androgen Receptor,IC50,=,246.6,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,Cc1cn(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)[C@H]4CC[C@]23C)cn1,6.608006927740288
CHEMBL2105738,CHEMBL1871,Androgen Receptor,IC50,=,1108.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,5.955460239607589
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,492.0,nM,CHEMBL5119709,B,Antagonist activity at DHT-induced Androgen receptor transcriptional activity in human HEK293 cells measured after 24 hrs by Steady-Glo reagent based assay,CHEMBL5113526,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.308034897232639
CHEMBL5178984,CHEMBL1871,Androgen Receptor,IC50,=,208.8,nM,CHEMBL5119723,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in HEK293 cells incubated for 24 hrs by luciferase reporter assay,CHEMBL5113526,IC50,Cc1cn(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)[C@H]4CC[C@]23C)cn1,6.680269505669775
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,112.3,nM,CHEMBL5119723,B,Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in HEK293 cells incubated for 24 hrs by luciferase reporter assay,CHEMBL5113526,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.949620243738542
CHEMBL5178984,CHEMBL1871,Androgen Receptor,IC50,=,268.2,nM,CHEMBL5119724,B,Antagonist activity at androgen receptor F876L mutant (unknown origin) expressed in HEK293 cells incubated for 24 hrs by luciferase reporter assay,CHEMBL5113526,IC50,Cc1cn(C2=CC[C@H]3[C@@H]4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)[C@H]4CC[C@]23C)cn1,6.57154122648442
CHEMBL1200436,CHEMBL1871,Androgen Receptor,IC50,=,0.808,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,9.092588639225413
CHEMBL5202640,CHEMBL1871,Androgen Receptor,IC50,=,38.0,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)C(C(=O)Nc5ccccc5C(F)(F)F)CC[C@H]4[C@@H]3CC[C@@H]12,7.42021640338319
CHEMBL1274,CHEMBL1871,Androgen Receptor,IC50,=,5000.0,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O,5.301029995663981
CHEMBL4090028,CHEMBL1871,Androgen Receptor,IC50,=,0.72,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.142667503568731
CHEMBL4092535,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.0
CHEMBL4088914,CHEMBL1871,Androgen Receptor,IC50,=,3.6,nM,CHEMBL5127806,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5126525,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.443697499232712
CHEMBL1393,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL5136125,B,Displacement of [3H]-methyltrienolene from human androgen receptor incubated overnight by liquid scintillation counting analysis,CHEMBL5131538,IC50,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,7.318758762624412
CHEMBL1095097,CHEMBL1871,Androgen Receptor,IC50,=,17000.0,nM,CHEMBL5136125,B,Displacement of [3H]-methyltrienolene from human androgen receptor incubated overnight by liquid scintillation counting analysis,CHEMBL5131538,IC50,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]23O[C@@H]2C[C@@]2(C)[C@@H](CC[C@@]24CCC(=O)O4)[C@H]13,4.769551078621726
CHEMBL3402228,CHEMBL1871,Androgen Receptor,IC50,=,2.4,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,C[C@H]1[C@@H](O)CCN1c1ccc(C#N)c2ccccc12,8.619788758288394
CHEMBL4060271,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1Cl,9.0
CHEMBL3410856,CHEMBL1871,Androgen Receptor,IC50,=,1.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,Cc1c(N2C3CCC2CC(C)(O)C3)ccc(C#N)c1Cl,9.0
CHEMBL3326454,CHEMBL1871,Androgen Receptor,IC50,=,0.7,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12,9.154901959985743
CHEMBL391548,CHEMBL1871,Androgen Receptor,IC50,=,39.9,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F,7.399027104313252
CHEMBL399887,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,N#Cc1ccc(O[C@@H]2CCCC[C@H]2C#N)cc1C(F)(F)F,7.221848749616356
CHEMBL470204,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,Cc1ccccc1Oc1ccc(C#N)c(Cl)c1,7.221848749616356
CHEMBL1085593,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,CC1(C)CN(Cc2ccccc2)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,7.0
CHEMBL5208304,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,CC(c1ccccc1)N(C)c1ccc(C#N)c(C(F)(F)F)n1,7.698970004336019
CHEMBL458084,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,N#Cc1ccc([C@H]2CCCC[C@H]2O)cc1C(F)(F)F,7.585026652029182
CHEMBL490956,CHEMBL1871,Androgen Receptor,IC50,=,43.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,IC50,Cc1ccccc1Sc1ccc(C#N)cc1Cl,7.366531544420413
CHEMBL5183180,CHEMBL1871,Androgen Receptor,IC50,=,59.0,nM,CHEMBL5140900,B,Displacement of [3H]methyltrienolone from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,IC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cncnc5)C[C@H]4[C@@H]3CC[C@@H]12,7.229147988357855
CHEMBL3221237,CHEMBL1871,Androgen Receptor,IC50,=,6.6,nM,CHEMBL5140900,B,Displacement of [3H]methyltrienolone from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,IC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,8.18045606445813
CHEMBL5209205,CHEMBL1871,Androgen Receptor,IC50,=,12.7,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,C[C@](O)(CCOc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21,7.896196279044043
CHEMBL4088914,CHEMBL1871,Androgen Receptor,IC50,=,3.6,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.443697499232712
CHEMBL246006,CHEMBL1871,Androgen Receptor,IC50,=,2.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,N#CCC(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F,8.698970004336019
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,1300.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.886056647693163
CHEMBL1099086,CHEMBL1871,Androgen Receptor,IC50,=,440.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1CCCS(N)(=O)=O,6.356547323513812
CHEMBL221174,CHEMBL1871,Androgen Receptor,IC50,=,140.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC(O)(COC(=O)c1ccccc1C(F)(F)F)c1cc2cc([N+](=O)[O-])c(C(F)(F)F)cc2[nH]1,6.853871964321762
CHEMBL5196915,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC(O)(C[S+]([O-])c1ccc(Cl)c(Cl)c1)c1cc2cc(Cl)c(C(F)(F)F)cc2[nH]1,7.0
CHEMBL5199125,CHEMBL1871,Androgen Receptor,IC50,=,13.0,nM,CHEMBL5140928,B,Partial agonist activity at human Androgen receptor,CHEMBL5137058,IC50,N#Cc1ccc(N2C(=O)N[C@@](CO)(c3ccccc3)C2=O)cc1C(F)(F)F,7.886056647693163
CHEMBL5192412,CHEMBL1871,Androgen Receptor,IC50,=,0.9,nM,CHEMBL5140928,B,Partial agonist activity at human Androgen receptor,CHEMBL5137058,IC50,C[C@@]1(c2ccc(O)cc2)NC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O,9.045757490560675
CHEMBL5204114,CHEMBL1871,Androgen Receptor,IC50,=,10.0,nM,CHEMBL5140931,B,Agonist activity at Androgen receptor in human 22Rv1 cells cotransfected with pARE-LUC measured by luciferase assay,CHEMBL5137058,IC50,CCCN(CC(F)(F)F)c1cc(Br)c(C#N)s1,8.0
CHEMBL5186356,CHEMBL1871,Androgen Receptor,IC50,=,60.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CCCCc1ccc(OC(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc([N+](=O)[O-])c5ccccc45)C(=O)N32)cc1,7.221848749616356
CHEMBL362566,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)cc1C(F)(F)F,6.455931955649724
CHEMBL5186213,CHEMBL1871,Androgen Receptor,IC50,=,19.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,C[C@@]12O[C@@](C)(C[C@H]1O)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12,7.721246399047171
CHEMBL5189989,CHEMBL1871,Androgen Receptor,IC50,=,32.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CC(C)N1C[C@@]2(C)O[C@](C)(C1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.494850021680094
CHEMBL5194764,CHEMBL1871,Androgen Receptor,IC50,=,91.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CNC(=O)[C@]12C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]1[C@H]1C[C@H](F)[C@@H]2C1,7.040958607678906
CHEMBL3932464,CHEMBL1871,Androgen Receptor,IC50,=,16.0,nM,CHEMBL5140936,B,Antagonist activity at Androgen receptor in human MDA-MB-453 cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CCS(=O)(=O)N[C@@H]1C[C@@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.795880017344075
CHEMBL5186356,CHEMBL1871,Androgen Receptor,IC50,=,4750.0,nM,CHEMBL5140937,B,Antagonist activity at Androgen receptor in human LNCaP cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CCCCc1ccc(OC(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc([N+](=O)[O-])c5ccccc45)C(=O)N32)cc1,5.323306390375134
CHEMBL362566,CHEMBL1871,Androgen Receptor,IC50,=,3920.0,nM,CHEMBL5140937,B,Antagonist activity at Androgen receptor in human LNCaP cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)cc1C(F)(F)F,5.406713932979542
CHEMBL5189989,CHEMBL1871,Androgen Receptor,IC50,=,125.0,nM,CHEMBL5140937,B,Antagonist activity at Androgen receptor in human LNCaP cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CC(C)N1C[C@@]2(C)O[C@](C)(C1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,6.903089986991944
CHEMBL3932464,CHEMBL1871,Androgen Receptor,IC50,=,153.0,nM,CHEMBL5140937,B,Antagonist activity at Androgen receptor in human LNCaP cells measured by SEAP reporter gene assay,CHEMBL5137058,IC50,CCS(=O)(=O)N[C@@H]1C[C@@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,6.815308569182401
CHEMBL1946811,CHEMBL1871,Androgen Receptor,IC50,=,131.0,nM,CHEMBL5140943,B,Antagonist activity at Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC1(C)CN(CCC#N)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,6.882728704344236
CHEMBL1947185,CHEMBL1871,Androgen Receptor,IC50,=,68.0,nM,CHEMBL5140943,B,Antagonist activity at Androgen receptor (unknown origin),CHEMBL5137058,IC50,CC1(C)CN(CCC#N)C(=O)[C@@H]1Oc1ccc(C#N)c(Cl)c1,7.167491087293763
CHEMBL5201606,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL5140945,B,Binding affinity to wild-type Androgen receptor (unknown origin),CHEMBL5137058,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1-c1cnc(Cl)c(CO)c1,7.431798275933005
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,34.0,nM,CHEMBL5140945,B,Binding affinity to wild-type Androgen receptor (unknown origin),CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,7.468521082957745
CHEMBL5192915,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL5140945,B,Binding affinity to wild-type Androgen receptor (unknown origin),CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NC(C)(C)C)cn1,6.366531544420413
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,830.0,nM,CHEMBL5140945,B,Binding affinity to wild-type Androgen receptor (unknown origin),CHEMBL5137058,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,6.080921907623926
CHEMBL5201606,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL5140946,B,Binding affinity to bicalutamide-resistant Androgen receptor T877A mutant (unknown origin),CHEMBL5137058,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1-c1cnc(Cl)c(CO)c1,7.0
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL5140946,B,Binding affinity to bicalutamide-resistant Androgen receptor T877A mutant (unknown origin),CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,6.795880017344075
CHEMBL5192915,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL5140946,B,Binding affinity to bicalutamide-resistant Androgen receptor T877A mutant (unknown origin),CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NC(C)(C)C)cn1,6.468521082957745
CHEMBL5201606,CHEMBL1871,Androgen Receptor,IC50,=,25.0,nM,CHEMBL5140947,B,Antagonist activity at wild-type Androgen receptor (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1-c1cnc(Cl)c(CO)c1,7.6020599913279625
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,590.0,nM,CHEMBL5140947,B,Antagonist activity at wild-type Androgen receptor (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,6.229147988357855
CHEMBL5192915,CHEMBL1871,Androgen Receptor,IC50,=,1000.0,nM,CHEMBL5140947,B,Antagonist activity at wild-type Androgen receptor (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NC(C)(C)C)cn1,6.0
CHEMBL5201606,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL5140948,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1-c1cnc(Cl)c(CO)c1,6.958607314841775
CHEMBL1957608,CHEMBL1871,Androgen Receptor,IC50,=,1100.0,nM,CHEMBL5140948,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1,5.958607314841775
CHEMBL5192915,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL5140948,B,Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in African green monkey COS-7 cells measured as gene transcription level,CHEMBL5137058,IC50,Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NC(C)(C)C)cn1,6.721246399047171
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,120.23,nM,CHEMBL5140953,B,Antagonist activity at Androgen receptor (unknown origin) in African green monkey COS-1 cells,CHEMBL5137058,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.919987152892072
CHEMBL5197097,CHEMBL1871,Androgen Receptor,IC50,=,27.54,nM,CHEMBL5140953,B,Antagonist activity at Androgen receptor (unknown origin) in African green monkey COS-1 cells,CHEMBL5137058,IC50,N#Cc1ccc(C2=NO[C@H]3CCCC[C@@H]23)cc1C(F)(F)F,7.560036064079095
CHEMBL202990,CHEMBL1871,Androgen Receptor,IC50,=,200.0,nM,CHEMBL5140955,B,Antagonist activity at human Androgen receptor measured by AR-mediated transcriptional activation assay,CHEMBL5137058,IC50,C[C@@H]1CN(c2ccc(C#N)c(C(F)(F)F)c2)[C@@H](C)CN1C(=O)Nc1ccc(F)cc1F,6.698970004336019
CHEMBL197595,CHEMBL1871,Androgen Receptor,IC50,=,110.0,nM,CHEMBL5140955,B,Antagonist activity at human Androgen receptor measured by AR-mediated transcriptional activation assay,CHEMBL5137058,IC50,C[C@@H]1CN(c2ccc(C#N)c(C(F)(F)F)c2)[C@@H](C)CN1C(=O)Nc1ccc(C(F)(F)F)nc1,6.958607314841775
CHEMBL2337513,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL5140957,B,Binding affinity to bicalutamide-resistant Androgen receptor T878A mutant (unknown origin),CHEMBL5137058,IC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1,5.769551078621726
CHEMBL2316547,CHEMBL1871,Androgen Receptor,IC50,=,530.0,nM,CHEMBL5140966,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of PSA expression,CHEMBL5137058,IC50,NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12,6.275724130399211
CHEMBL4848581,CHEMBL1871,Androgen Receptor,IC50,=,660.0,nM,CHEMBL5140966,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of PSA expression,CHEMBL5137058,IC50,CC(C)NC(=O)c1cccc2nc(-c3cn(COP(=O)([O-])[O-])c4c(F)c(F)c(F)cc34)ccc12.[Na+].[Na+],6.180456064458131
CHEMBL1623389,CHEMBL1871,Androgen Receptor,IC50,=,280.0,nM,CHEMBL5140966,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of PSA expression,CHEMBL5137058,IC50,c1ccc(-c2csc(N3CCOCC3)n2)cc1,6.552841968657781
CHEMBL3323483,CHEMBL1871,Androgen Receptor,IC50,=,170.0,nM,CHEMBL5140966,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of PSA expression,CHEMBL5137058,IC50,Brc1ncn(-c2csc(N3CCOCC3)n2)c1Br,6.769551078621726
CHEMBL391548,CHEMBL1871,Androgen Receptor,IC50,=,0.2,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F,9.698970004336019
CHEMBL399887,CHEMBL1871,Androgen Receptor,IC50,=,12.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,N#Cc1ccc(O[C@@H]2CCCC[C@H]2C#N)cc1C(F)(F)F,7.920818753952375
CHEMBL470204,CHEMBL1871,Androgen Receptor,IC50,=,57.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,Cc1ccccc1Oc1ccc(C#N)c(Cl)c1,7.2441251443275085
CHEMBL1085593,CHEMBL1871,Androgen Receptor,IC50,=,38.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,CC1(C)CN(Cc2ccccc2)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1,7.42021640338319
CHEMBL5208304,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,CC(c1ccccc1)N(C)c1ccc(C#N)c(C(F)(F)F)n1,7.346787486224656
CHEMBL458084,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,N#Cc1ccc([C@H]2CCCC[C@H]2O)cc1C(F)(F)F,7.045757490560675
CHEMBL490956,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL5140971,B,Antagonist activity at Androgen receptor in human MDA-kb2 cells,CHEMBL5137058,IC50,Cc1ccccc1Sc1ccc(C#N)cc1Cl,7.107905397309519
CHEMBL4858811,CHEMBL1871,Androgen Receptor,IC50,=,54.0,nM,CHEMBL5140974,B,Antagonist activity at Androgen receptor in human LNCaP cells measured by transcriptional reporter assay,CHEMBL5137058,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,7.267606240177031
CHEMBL4858811,CHEMBL1871,Androgen Receptor,IC50,=,37.0,nM,CHEMBL5140975,B,Antagonist activity at Androgen receptor F877L mutant in human LNCaP cells measured by transcriptional reporter assay,CHEMBL5137058,IC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)nc3)C2=S)cc1C(F)(F)F,7.431798275933005
CHEMBL4758041,CHEMBL1871,Androgen Receptor,IC50,=,6000.0,nM,CHEMBL5140979,B,Antagonist activity at Androgen receptor (unknown origin) assessed as inhibition of activation function 1 (AF-1) of AR N-terminal transactivation domain (NTD),CHEMBL5137058,IC50,CC(C)(c1ccc(OCC(O)CO)cc1)c1ccc(OCC(O)CCl)cc1,5.221848749616356
CHEMBL4297675,CHEMBL1871,Androgen Receptor,IC50,=,9600.0,nM,CHEMBL5140979,B,Antagonist activity at Androgen receptor (unknown origin) assessed as inhibition of activation function 1 (AF-1) of AR N-terminal transactivation domain (NTD),CHEMBL5137058,IC50,CC(=O)OC[C@H](COc1ccc(C(C)(C)c2ccc(OC[C@@H](CCl)OC(C)=O)cc2)cc1)OC(C)=O,5.017728766960431
CHEMBL2086964,CHEMBL1871,Androgen Receptor,IC50,=,26300.0,nM,CHEMBL5140989,B,Antagonist activity at wild-type human Androgen receptor measured by TR-FRET assay,CHEMBL5137058,IC50,COc1cc(/C=N/NC(=O)c2cc3c(ccc4ccccc43)o2)cc(OC)c1O,4.580044251510242
CHEMBL2086964,CHEMBL1871,Androgen Receptor,IC50,=,33200.0,nM,CHEMBL5140990,B,Antagonist activity at human Androgen receptor T877A mutant measured by TR-FRET assay,CHEMBL5137058,IC50,COc1cc(/C=N/NC(=O)c2cc3c(ccc4ccccc43)o2)cc(OC)c1O,4.478861916295964
CHEMBL5192111,CHEMBL1871,Androgen Receptor,IC50,=,430.0,nM,CHEMBL5140993,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of Binding Function 3 (BF3) of AR measured by enhanced green fluorescent protein transcriptional (eGFPT) assay,CHEMBL5137058,IC50,CC(C)C(NC(=O)c1cc2ccc(F)cc2[nH]1)c1ccco1,6.366531544420413
CHEMBL2316547,CHEMBL1871,Androgen Receptor,IC50,=,1500.0,nM,CHEMBL5140993,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of Binding Function 3 (BF3) of AR measured by enhanced green fluorescent protein transcriptional (eGFPT) assay,CHEMBL5137058,IC50,NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12,5.823908740944319
CHEMBL2397334,CHEMBL1871,Androgen Receptor,IC50,=,6260.0,nM,CHEMBL5140996,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of Binding Function 3 (BF3) of AR measured by luciferase assay,CHEMBL5137058,IC50,CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(Cl)c(Cl)c3)nc2C)c1,5.20342566678957
CHEMBL409,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL5140996,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of Binding Function 3 (BF3) of AR measured by luciferase assay,CHEMBL5137058,IC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.568636235841012
CHEMBL1201303,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL5140997,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of DNA binding domain of AR measured by enhanced green fluorescent protein transcriptional (eGFPT) assay,CHEMBL5137058,IC50,Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1,6.721246399047171
CHEMBL1623389,CHEMBL1871,Androgen Receptor,IC50,=,330.0,nM,CHEMBL5140997,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of DNA binding domain of AR measured by enhanced green fluorescent protein transcriptional (eGFPT) assay,CHEMBL5137058,IC50,c1ccc(-c2csc(N3CCOCC3)n2)cc1,6.481486060122112
CHEMBL3323483,CHEMBL1871,Androgen Receptor,IC50,=,100.0,nM,CHEMBL5140997,B,Antagonist activity at Androgen receptor in human LNCaP cells assessed as inhibition of DNA binding domain of AR measured by enhanced green fluorescent protein transcriptional (eGFPT) assay,CHEMBL5137058,IC50,Brc1ncn(-c2csc(N3CCOCC3)n2)c1Br,7.0
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,350.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.455931955649724
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,450.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.346787486224656
CHEMBL5204177,CHEMBL1871,Androgen Receptor,IC50,=,390.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)NO,6.4089353929735005
CHEMBL5169570,CHEMBL1871,Androgen Receptor,IC50,=,1170.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCCC(=O)NO,5.931814138253838
CHEMBL5194282,CHEMBL1871,Androgen Receptor,IC50,=,1450.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCCCC(=O)NO,5.838631997765026
CHEMBL5173941,CHEMBL1871,Androgen Receptor,IC50,=,390.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCCCCC(=O)NO,6.4089353929735005
CHEMBL5180580,CHEMBL1871,Androgen Receptor,IC50,=,980.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)cc1,6.008773924307505
CHEMBL5206234,CHEMBL1871,Androgen Receptor,IC50,=,2340.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)cn1,5.630784142589857
CHEMBL5169631,CHEMBL1871,Androgen Receptor,IC50,=,750.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)nc1,6.1249387366083
CHEMBL3955013,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)c(F)c1,5.769551078621726
CHEMBL5176010,CHEMBL1871,Androgen Receptor,IC50,=,280.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1Cc1ccc(C(=O)Nc2ccccc2N)cc1,6.552841968657781
CHEMBL5170796,CHEMBL1871,Androgen Receptor,IC50,=,190.0,nM,CHEMBL5144599,B,Anti-androgenic activity at androgen receptor (unknown origin) expressed in HEK293 cells by BRET assay,CHEMBL5143530,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1C12CC(CC(=O)Nc3ccccc3N)(C1)C2,6.721246399047171
CHEMBL5206636,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL5153402,B,Inhibition of full length human AR stably expressed in human HEK293 cells assessed as luciferase activity incubated for 24 hrs by microplate luminometer luciferase assay,CHEMBL5150054,IC50,CC(Cn1ccc(-c2ccc(C#N)c(Cl)c2)n1)NC(=O)c1cc(C(C)O)[nH]n1,7.585026652029182
CHEMBL5289372,CHEMBL1871,Androgen Receptor,IC50,=,3510.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(C(C)(C)C)cc1,5.454692883534176
CHEMBL5287425,CHEMBL1871,Androgen Receptor,IC50,=,4230.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,COC(=O)c1ccc(-c2c(C)c(O)c(O)c(C=O)c2COCc2ccccc2)cc1,5.373659632624958
CHEMBL5274549,CHEMBL1871,Androgen Receptor,IC50,=,3220.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(CO[C@H]2CC[C@@]3(C)C(=CC[C@@H]4[C@@H]3CC[C@]3(C)C(=O)CC[C@@H]43)C2)c1-c1ccccc1,5.492144128304169
CHEMBL5272151,CHEMBL1871,Androgen Receptor,IC50,=,3270.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1ccc(-c2c(C)c(O)c(O)c(C=O)c2COCc2ccccc2)cc1,5.485452247339714
CHEMBL5286695,CHEMBL1871,Androgen Receptor,IC50,=,3470.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(Br)cc1,5.459670525209127
CHEMBL5267283,CHEMBL1871,Androgen Receptor,IC50,=,4900.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(Cl)cc1,5.309803919971486
CHEMBL5276445,CHEMBL1871,Androgen Receptor,IC50,=,3740.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc([N+](=O)[O-])cc1,5.427128397799519
CHEMBL5288892,CHEMBL1871,Androgen Receptor,IC50,=,3320.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(C(F)(F)F)cc2)c1-c1ccccc1,5.478861916295964
CHEMBL5273071,CHEMBL1871,Androgen Receptor,IC50,=,1230.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(C(F)(F)F)cc1,5.910094888560602
CHEMBL5270583,CHEMBL1871,Androgen Receptor,IC50,=,3050.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(C(F)(F)F)c2)c1-c1ccccc1,5.515700160653214
CHEMBL5268639,CHEMBL1871,Androgen Receptor,IC50,=,2380.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(F)cc2)c1-c1ccccc1,5.623423042943488
CHEMBL5288687,CHEMBL1871,Androgen Receptor,IC50,=,4050.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(F)c2)c1-c1ccccc1,5.392544976785332
CHEMBL5284656,CHEMBL1871,Androgen Receptor,IC50,=,4530.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1cccc(COCc2c(C=O)c(O)c(O)c(C)c2-c2ccccc2)c1,5.343901797987169
CHEMBL5271500,CHEMBL1871,Androgen Receptor,IC50,=,4490.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(OC(F)(F)F)cc1,5.347753658996677
CHEMBL5279893,CHEMBL1871,Androgen Receptor,IC50,=,2540.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2C(F)(F)F)c1-c1ccccc1,5.5951662833800615
CHEMBL5277025,CHEMBL1871,Androgen Receptor,IC50,=,2720.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(OC(F)(F)F)cc2)c1-c1ccccc1,5.565431095965801
CHEMBL5276723,CHEMBL1871,Androgen Receptor,IC50,=,2410.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(F)cc2)c1-c1ccc(F)cc1,5.617982957425132
CHEMBL5266054,CHEMBL1871,Androgen Receptor,IC50,=,2140.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(F)cc2)c1-c1ccc(C(F)(F)F)cc1,5.669586226650809
CHEMBL5281425,CHEMBL1871,Androgen Receptor,IC50,=,2090.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(F)c2)c1-c1ccc(C(F)(F)F)cc1,5.679853713888946
CHEMBL5288135,CHEMBL1871,Androgen Receptor,IC50,=,2520.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2F)c1-c1ccc(C(F)(F)F)cc1,5.598599459218455
CHEMBL5290281,CHEMBL1871,Androgen Receptor,IC50,=,2090.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccc(F)cc2)c1-c1cccc(F)c1,5.679853713888946
CHEMBL5281004,CHEMBL1871,Androgen Receptor,IC50,=,2890.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(F)c2)c1-c1cccc(F)c1,5.539102157243452
CHEMBL5267125,CHEMBL1871,Androgen Receptor,IC50,=,2810.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(Cl)c2Cl)c1-c1ccccc1,5.55129368009492
CHEMBL5282215,CHEMBL1871,Androgen Receptor,IC50,=,4080.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(C(F)(F)F)cc1Br,5.3893398369101195
CHEMBL5284847,CHEMBL1871,Androgen Receptor,IC50,=,3390.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(Br)cc1F,5.4698003017969175
CHEMBL5268130,CHEMBL1871,Androgen Receptor,IC50,=,3250.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(C(F)(F)F)cc1Cl,5.488116639021126
CHEMBL5287623,CHEMBL1871,Androgen Receptor,IC50,=,2300.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(F)cc1F,5.638272163982407
CHEMBL5287380,CHEMBL1871,Androgen Receptor,IC50,=,2050.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(F)c(F)c1,5.688246138944246
CHEMBL5286595,CHEMBL1871,Androgen Receptor,IC50,=,2190.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1ccc(Br)c(F)c1,5.6595558851598815
CHEMBL5284251,CHEMBL1871,Androgen Receptor,IC50,=,4390.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2ccccc2)c1-c1cc(C(F)(F)F)cc(C(F)(F)F)c1,5.357535479757878
CHEMBL51483,CHEMBL1871,Androgen Receptor,IC50,=,7160.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1cc2c(C(C)C)c(O)c(O)c(C=O)c2c(O)c1-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,5.145086977692145
CHEMBL5287211,CHEMBL1871,Androgen Receptor,IC50,=,2580.0,nM,CHEMBL5224598,B,Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of AR transcription activity by dual-luciferase reporter assays,CHEMBL5223107,IC50,Cc1c(O)c(O)c(C=O)c(COCc2cccc(F)c2)c1-c1ccc(F)cc1,5.58838029403677
CHEMBL5272485,CHEMBL1871,Androgen Receptor,IC50,=,33.0,nM,CHEMBL5235778,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5233269,IC50,COC(=O)c1ccc(C2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,7.481486060122112
CHEMBL5184863,CHEMBL1871,Androgen Receptor,IC50,=,156.0,nM,CHEMBL5239295,B,Inhibition of AR LBD in human LNCaP cells,CHEMBL5236610,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)NCCOCCOC(=O)CC12CC3CC(CC(C3)C1)C2,6.806875401645538
CHEMBL5279873,CHEMBL1871,Androgen Receptor,IC50,=,293.0,nM,CHEMBL5239295,B,Inhibition of AR LBD in human LNCaP cells,CHEMBL5236610,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)NCCOCCOCCOCCOC12CC3CC(CC(C3)C1)C2,6.53313237964589
CHEMBL1390665,CHEMBL1871,Androgen Receptor,IC50,=,4300.0,nM,CHEMBL5239313,B,Inhibition of Androgen receptor (unknown origin),CHEMBL5236610,IC50,Clc1ccc(-c2cnc3n2CCC3)cc1,5.366531544420413
CHEMBL1596561,CHEMBL1871,Androgen Receptor,IC50,=,214000.0,nM,CHEMBL5243638,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5241120,IC50,CC1(C2CC(C(F)(F)F)n3nc(C(=O)O)cc3N2)CC1,3.669586226650809
CHEMBL5272426,CHEMBL1871,Androgen Receptor,IC50,=,487000.0,nM,CHEMBL5243638,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5241120,IC50,O=C(O)c1nn2c(c1Cl)NC(c1ccccc1)CC2C(F)(F)F,3.3124710387853655
CHEMBL5266585,CHEMBL1871,Androgen Receptor,IC50,=,23400.0,nM,CHEMBL5243638,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5241120,IC50,COc1ccc(C2CC(C(F)(F)F)n3nc(-c4ccc(C(=O)O)cc4)cc3N2)cc1OC,4.6307841425898575
CHEMBL5286150,CHEMBL1871,Androgen Receptor,IC50,=,45800.0,nM,CHEMBL5243638,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5241120,IC50,Cc1ccc(C2CC(C(F)(F)F)n3nc(C(N)=O)cc3N2)cc1,4.339134521996131
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,24600.0,nM,CHEMBL5243638,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL5241120,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,4.609064892896621
CHEMBL399680,CHEMBL1871,Androgen Receptor,IC50,=,1900.0,nM,CHEMBL5245443,B,Binding affinity to AR (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5244231,IC50,C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)CC[C@]12O,5.721246399047171
CHEMBL4448523,CHEMBL1871,Androgen Receptor,IC50,=,690.0,nM,CHEMBL5253349,B,Inhibition of AR (unknown origin),CHEMBL5252522,IC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1Cc1ccc(-c2cn(CCCCCCC(=O)NO)nn2)cc1,6.161150909262744
CHEMBL5393933,CHEMBL1871,Androgen Receptor,IC50,=,1700.0,nM,CHEMBL5334766,B,Displacement of Fluormone AL Green from androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5331127,IC50,N#Cc1ccc(N2CCC3(CCN(C(=O)c4ccccc4)CC3)C2)cc1Cl,5.769551078621726
CHEMBL5421324,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5334766,B,Displacement of Fluormone AL Green from androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5331127,IC50,CN1CCN(c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc(C#N)c(Cl)c3)C4)cc2)CC1,6.096910013008056
CHEMBL5399353,CHEMBL1871,Androgen Receptor,IC50,=,78.0,nM,CHEMBL5334766,B,Displacement of Fluormone AL Green from androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5331127,IC50,CN1CCN(C(=O)c2ccc(N3CCC4(CC3)CCN(c3ccc(C#N)c(Cl)c3)C4)cc2)CC1,7.107905397309519
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5334766,B,Displacement of Fluormone AL Green from androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5331127,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.096910013008056
CHEMBL5407635,CHEMBL1871,Androgen Receptor,IC50,=,612.1,nM,CHEMBL5335602,B,Antagonist activity at wild type androgen receptor expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.2131776205008125
CHEMBL5400213,CHEMBL1871,Androgen Receptor,IC50,=,120.5,nM,CHEMBL5335602,B,Antagonist activity at wild type androgen receptor expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.919012953089113
CHEMBL5413706,CHEMBL1871,Androgen Receptor,IC50,=,235.0,nM,CHEMBL5335602,B,Antagonist activity at wild type androgen receptor expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6F)CC[C@]5(C)C4CC[C@]23C)cn1,6.628932137728263
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,522.0,nM,CHEMBL5335602,B,Antagonist activity at wild type androgen receptor expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.282329496997738
CHEMBL5407635,CHEMBL1871,Androgen Receptor,IC50,=,268.2,nM,CHEMBL5335604,B,Antagonist activity at androgen receptor F876L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.57154122648442
CHEMBL5400213,CHEMBL1871,Androgen Receptor,IC50,=,389.8,nM,CHEMBL5335604,B,Antagonist activity at androgen receptor F876L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.409158165218397
CHEMBL5413706,CHEMBL1871,Androgen Receptor,IC50,=,273.4,nM,CHEMBL5335604,B,Antagonist activity at androgen receptor F876L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6F)CC[C@]5(C)C4CC[C@]23C)cn1,6.563201489768197
CHEMBL5407635,CHEMBL1871,Androgen Receptor,IC50,=,490.2,nM,CHEMBL5335606,B,Antagonist activity at androgen receptor W741L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.309626693083941
CHEMBL5400213,CHEMBL1871,Androgen Receptor,IC50,=,371.3,nM,CHEMBL5335606,B,Antagonist activity at androgen receptor W741L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.430275050773841
CHEMBL5413706,CHEMBL1871,Androgen Receptor,IC50,=,413.1,nM,CHEMBL5335606,B,Antagonist activity at androgen receptor W741L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6F)CC[C@]5(C)C4CC[C@]23C)cn1,6.383944805023414
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,1031.0,nM,CHEMBL5335606,B,Antagonist activity at androgen receptor W741L mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.986741334716483
CHEMBL5407635,CHEMBL1871,Androgen Receptor,IC50,=,208.8,nM,CHEMBL5335608,B,Antagonist activity at androgen receptor T877A mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,6.680269505669775
CHEMBL5400213,CHEMBL1871,Androgen Receptor,IC50,=,79.75,nM,CHEMBL5335608,B,Antagonist activity at androgen receptor T877A mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,7.0982693082707815
CHEMBL5413706,CHEMBL1871,Androgen Receptor,IC50,=,280.9,nM,CHEMBL5335608,B,Antagonist activity at androgen receptor T877A mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6F)CC[C@]5(C)C4CC[C@]23C)cn1,6.551448260798422
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,112.3,nM,CHEMBL5335608,B,Antagonist activity at androgen receptor T877A mutant expressed in HEK293 cells assessed as reduction in DHT-induced transcriptional activation of androgen receptor incubated for 24 hrs by Steady-Glo assay,CHEMBL5331145,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.949620243738542
CHEMBL4444904,CHEMBL1871,Androgen Receptor,IC50,=,85.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.070581074285707
CHEMBL5408162,CHEMBL1871,Androgen Receptor,IC50,=,1079.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccccc2c2ccccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,5.966978555317089
CHEMBL5435897,CHEMBL1871,Androgen Receptor,IC50,=,871.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccccc2c2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.059981844992336
CHEMBL5398983,CHEMBL1871,Androgen Receptor,IC50,=,991.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccccc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.003926345514724
CHEMBL5403067,CHEMBL1871,Androgen Receptor,IC50,=,1243.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccccc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,5.905528871358355
CHEMBL5395016,CHEMBL1871,Androgen Receptor,IC50,=,1025.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccc(F)cc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.989276134608227
CHEMBL5420396,CHEMBL1871,Androgen Receptor,IC50,=,277.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc2ccc(F)cc2n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.557520230935552
CHEMBL5402802,CHEMBL1871,Androgen Receptor,IC50,=,687.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nnc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.16304326294045
CHEMBL5417717,CHEMBL1871,Androgen Receptor,IC50,=,560.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nnc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.251811972993799
CHEMBL5434659,CHEMBL1871,Androgen Receptor,IC50,=,2594.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nnc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.586030028251939
CHEMBL63560,CHEMBL1871,Androgen Receptor,IC50,=,248.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.605548319173783
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,216.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.665546248849069
CHEMBL4297185,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,7.318758762624412
CHEMBL1738889,CHEMBL1871,Androgen Receptor,IC50,=,3.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.522878745280337
CHEMBL5419739,CHEMBL1871,Androgen Receptor,IC50,=,999.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cnc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.000434511774017
CHEMBL5408185,CHEMBL1871,Androgen Receptor,IC50,=,721.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cc1nc2cc(F)c(F)cc2[nH]1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.142064735280571
CHEMBL5408573,CHEMBL1871,Androgen Receptor,IC50,=,1662.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cnc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,5.779368980551908
CHEMBL5435483,CHEMBL1871,Androgen Receptor,IC50,=,371.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cnc2cccc(F)c21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.430626090384954
CHEMBL5408265,CHEMBL1871,Androgen Receptor,IC50,=,1024.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cnc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.9897000433601875
CHEMBL5436377,CHEMBL1871,Androgen Receptor,IC50,=,3616.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cnc2cccc(C(F)(F)F)c21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.441771578196674
CHEMBL5427747,CHEMBL1871,Androgen Receptor,IC50,=,274.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(F)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.562249437179612
CHEMBL5432213,CHEMBL1871,Androgen Receptor,IC50,=,367.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(Cl)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.435333935747911
CHEMBL5409022,CHEMBL1871,Androgen Receptor,IC50,=,21.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.6777807052660805
CHEMBL5422396,CHEMBL1871,Androgen Receptor,IC50,=,746.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(C=O)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.127261172527332
CHEMBL5435387,CHEMBL1871,Androgen Receptor,IC50,=,583.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(/C=N\O)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.234331445240986
CHEMBL5440678,CHEMBL1871,Androgen Receptor,IC50,=,134.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(/C=N\O)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.872895201635192
CHEMBL5423257,CHEMBL1871,Androgen Receptor,IC50,=,3434.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,CC(=O)N/N=C\c1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,5.4641997091751024
CHEMBL5421740,CHEMBL1871,Androgen Receptor,IC50,=,160.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(C#N)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.795880017344075
CHEMBL5422780,CHEMBL1871,Androgen Receptor,IC50,=,488.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(C#N)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.311580177997289
CHEMBL5426070,CHEMBL1871,Androgen Receptor,IC50,=,63.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc([N+](=O)[O-])c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.200659450546418
CHEMBL5438541,CHEMBL1871,Androgen Receptor,IC50,=,173.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ncc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.761953896871205
CHEMBL5429413,CHEMBL1871,Androgen Receptor,IC50,=,209.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc2c(C(F)(F)F)cccc2n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.679853713888946
CHEMBL5393959,CHEMBL1871,Androgen Receptor,IC50,=,102.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(F)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.991399828238082
CHEMBL5417016,CHEMBL1871,Androgen Receptor,IC50,=,26.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(F)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.585026652029182
CHEMBL5421024,CHEMBL1871,Androgen Receptor,IC50,=,165.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.782516055786093
CHEMBL5426016,CHEMBL1871,Androgen Receptor,IC50,=,183.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.73754891026957
CHEMBL5440684,CHEMBL1871,Androgen Receptor,IC50,=,162.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Br)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.790484985457369
CHEMBL5426565,CHEMBL1871,Androgen Receptor,IC50,=,237.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(I)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.625251653989896
CHEMBL5408438,CHEMBL1871,Androgen Receptor,IC50,=,89.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,Cc1nn(C[C@](C)(O)C(=O)Nc2cnc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,7.050609993355087
CHEMBL5398460,CHEMBL1871,Androgen Receptor,IC50,=,48.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2c(C(F)(F)F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.318758762624412
CHEMBL5416166,CHEMBL1871,Androgen Receptor,IC50,=,20.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2c(C(F)(F)F)cccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.698970004336019
CHEMBL5399091,CHEMBL1871,Androgen Receptor,IC50,=,115.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(C=O)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.939302159646388
CHEMBL5410494,CHEMBL1871,Androgen Receptor,IC50,=,796.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.099086932262331
CHEMBL4442857,CHEMBL1871,Androgen Receptor,IC50,=,157.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,6.804100347590767
CHEMBL5421919,CHEMBL1871,Androgen Receptor,IC50,=,45.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1cc(F)c2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.346787486224656
CHEMBL5419937,CHEMBL1871,Androgen Receptor,IC50,=,373.0,nM,CHEMBL5340020,B,Antagonist activity at CMV-tagged full length wild type human AR expressed in HEK293 cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ncc2c(C(F)(F)F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.428291168191312
CHEMBL4444904,CHEMBL1871,Androgen Receptor,IC50,=,6.05,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.21824462534753
CHEMBL5435897,CHEMBL1871,Androgen Receptor,IC50,=,16.9,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1c2ccccc2c2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.772113295386326
CHEMBL5402802,CHEMBL1871,Androgen Receptor,IC50,=,257.0,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nnc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.590066876668706
CHEMBL5409022,CHEMBL1871,Androgen Receptor,IC50,=,6.08,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,8.216096420727265
CHEMBL5438541,CHEMBL1871,Androgen Receptor,IC50,=,94.4,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1ncc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.025028005701931
CHEMBL5417016,CHEMBL1871,Androgen Receptor,IC50,=,62.72,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(F)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,7.202593950323618
CHEMBL5426016,CHEMBL1871,Androgen Receptor,IC50,=,242.2,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.615825861192967
CHEMBL5416166,CHEMBL1871,Androgen Receptor,IC50,=,125.0,nM,CHEMBL5340027,B,Antagonist activity at AR F876L mutant (unknown origin) expressed in COS cells co-transfected with GRE-LUC and CMV-renilla LUC assessed as inhibition of R1881-induced receptor transactivation measured after 24 hrs by luciferase reporter gene assay,CHEMBL5338730,IC50,C[C@](O)(Cn1nc(Cl)c2c(C(F)(F)F)cccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.903089986991944
CHEMBL5435259,CHEMBL1871,Androgen Receptor,IC50,=,1180.0,nM,CHEMBL5347772,B,Antagonist activity at AR transcription in human 22Rv1 cells incubated for 24 hrs in presence of R1881,CHEMBL5346877,IC50,Cc1c2c(nn1-c1ccc(F)cc1)C[C@@H]1CC[C@@H]3[C@H](CC[C@]4(C)[C@@H](O)CC[C@@H]34)[C@@]1(C)C2,5.928117992693874
CHEMBL4870803,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN(c1ccc(C#N)c(Cl)c1)[C@H]1CC[C@H](NC(=O)c2ccc(N3CCN(C4CN(c5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)C4)CC3)cc2)CC1,7.823908740944319
CHEMBL5398752,CHEMBL1871,Androgen Receptor,IC50,=,5000.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N3CCC4(CCN(c5ccc(C#N)c(Cl)c5)CC4)C3)cc2)CC1,5.301029995663981
CHEMBL5421324,CHEMBL1871,Androgen Receptor,IC50,=,3600.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N3CCC4(CC3)CCN(c3ccc(C#N)c(Cl)c3)C4)cc2)CC1,5.443697499232712
CHEMBL5424470,CHEMBL1871,Androgen Receptor,IC50,=,6900.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N3CCC4(CCN(c5ccc(C#N)c(Cl)c5)C4)C3)cc2)CC1,5.161150909262744
CHEMBL5422234,CHEMBL1871,Androgen Receptor,IC50,=,9900.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N3CCC4(C3)CN(c3ccc(C#N)c(Cl)c3)C4)cc2)CC1,5.00436480540245
CHEMBL4861621,CHEMBL1871,Androgen Receptor,IC50,=,15.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](N(C)c4ccc(C#N)c(Cl)c4)CC3)cc2)CC1,7.823908740944319
CHEMBL5398420,CHEMBL1871,Androgen Receptor,IC50,=,55.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](Oc4ccc(C#N)c(Cl)c4)CC3)cc2)CC1,7.259637310505756
CHEMBL5430612,CHEMBL1871,Androgen Receptor,IC50,=,1800.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(C(=O)c2ccc(N3CCC4(CCN(c5ccc(C#N)c(Cl)c5)C4)C3)cc2)CC1,5.7447274948966935
CHEMBL5399353,CHEMBL1871,Androgen Receptor,IC50,=,80.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(C(=O)c2ccc(N3CCC4(CC3)CCN(c3ccc(C#N)c(Cl)c3)C4)cc2)CC1,7.096910013008056
CHEMBL5398564,CHEMBL1871,Androgen Receptor,IC50,=,5400.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CN1CCN(C(=O)c2ccc(N3CCC4(CCN(c5ccc(C#N)c(Cl)c5)CC4)C3)cc2)CC1,5.267606240177031
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.096910013008056
CHEMBL166444,CHEMBL1871,Androgen Receptor,IC50,=,5.0,nM,CHEMBL5367923,B,Binding affinity to GST-tagged androgen receptor LBD (unknown origin) incubated for 4 hrs by fluorescence polarization assay,CHEMBL5365467,IC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.301029995663981
CHEMBL5423482,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1cccs1,6.221848749616356
CHEMBL5439835,CHEMBL1871,Androgen Receptor,IC50,=,4700.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1c(C)noc1C,5.327902142064282
CHEMBL5395364,CHEMBL1871,Androgen Receptor,IC50,=,700.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2[nH]ncc2c1,6.154901959985743
CHEMBL5416202,CHEMBL1871,Androgen Receptor,IC50,=,10300.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2[nH]ccc2c1,4.987162775294828
CHEMBL5440496,CHEMBL1871,Androgen Receptor,IC50,=,2200.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2cn[nH]c2c1,5.657577319177793
CHEMBL5416819,CHEMBL1871,Androgen Receptor,IC50,=,920.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2[nH]cnc2c1,6.036212172654444
CHEMBL5397445,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2c(cnn2C)c1,6.920818753952375
CHEMBL5421312,CHEMBL1871,Androgen Receptor,IC50,=,90.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2c(ccn2C)c1,7.045757490560675
CHEMBL5394445,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2ncccc2c1,6.096910013008056
CHEMBL5395976,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2cnccc2c1,6.096910013008056
CHEMBL5423748,CHEMBL1871,Androgen Receptor,IC50,=,270.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1cncnc1,6.568636235841012
CHEMBL5430613,CHEMBL1871,Androgen Receptor,IC50,=,600.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc2occc2c1,6.221848749616356
CHEMBL5431700,CHEMBL1871,Androgen Receptor,IC50,=,760.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,COc1ccc(-c2cc(C(N)=O)ccc2SC)cc1F,6.119186407719209
CHEMBL5409469,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccc(F)c(O)c1,6.920818753952375
CHEMBL5405109,CHEMBL1871,Androgen Receptor,IC50,=,240.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1c(F)cc(C(N)=O)cc1-c1ccc2c(cnn2C)c1,6.619788758288394
CHEMBL5395092,CHEMBL1871,Androgen Receptor,IC50,=,2200.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,Cn1ncc2cc(-c3cc(C(N)=O)ccc3SCc3ccccc3)ccc21,5.657577319177793
CHEMBL5405995,CHEMBL1871,Androgen Receptor,IC50,=,8600.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,Cn1ncc2cc(-c3cc(C(N)=O)ccc3C(F)(F)F)ccc21,5.065501548756432
CHEMBL5433104,CHEMBL1871,Androgen Receptor,IC50,=,940.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,Cn1ncc2cc(-c3cc(C(N)=O)ccc3NCc3ccccc3)ccc21,6.026872146400301
CHEMBL5416300,CHEMBL1871,Androgen Receptor,IC50,=,800.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,Cn1ncc2cc(-c3cc(C(N)=O)ccc3NCCCN3CCOCC3)ccc21,6.096910013008056
CHEMBL5424031,CHEMBL1871,Androgen Receptor,IC50,=,120.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(=O)O)cc1-c1cncnc1,6.920818753952375
CHEMBL5401872,CHEMBL1871,Androgen Receptor,IC50,=,130.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(=O)N2CCCCC2)cc1-c1cncnc1,6.886056647693163
CHEMBL5394108,CHEMBL1871,Androgen Receptor,IC50,=,260.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(=O)N2CCOCC2)cc1-c1cncnc1,6.585026652029182
CHEMBL1082407,CHEMBL1871,Androgen Receptor,IC50,=,340.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.468521082957745
CHEMBL5429958,CHEMBL1871,Androgen Receptor,IC50,=,7400.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CSc1ccc(C(N)=O)cc1-c1ccno1,5.130768280269024
CHEMBL4758041,CHEMBL1871,Androgen Receptor,IC50,=,37400.0,nM,CHEMBL5375768,B,Inhibition of androgen receptor in human VCaP cells expressing GRE-2-TATA-Luc co-expressing firefly luciferase incubated for 24 hrs in presence of DHT by luciferase reporter gene assay,CHEMBL5370692,IC50,CC(C)(c1ccc(OCC(O)CO)cc1)c1ccc(OCC(O)CCl)cc1,4.42712839779952
CHEMBL134277,CHEMBL1871,Androgen Receptor,Ki,=,669.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccsc1)Oc1ccc(F)cc1-3,6.174573882232177
CHEMBL415524,CHEMBL1871,Androgen Receptor,Ki,=,1589.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CCc1ccccc1/C=C1\Oc2ccc(F)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.798876102792621
CHEMBL336353,CHEMBL1871,Androgen Receptor,Ki,=,819.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1N(C)C)Oc1ccc(F)cc1-3,6.086716098239581
CHEMBL413309,CHEMBL1871,Androgen Receptor,Ki,=,1456.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1c(F)cccc1-3,5.836838625022981
CHEMBL717,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.537602002101044
CHEMBL337856,CHEMBL1871,Androgen Receptor,Ki,=,960.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1C)Oc1c(F)cccc1-3,6.017728766960431
CHEMBL335996,CHEMBL1871,Androgen Receptor,Ki,=,439.0,nM,CHEMBL648842,B,Inhibition of DHT binding to human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,COc1ccccc1/C=C1\Oc2ccc(F)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.357535479757878
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL648375,B,Displacement of DHT from human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL1145087,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL266282,CHEMBL1871,Androgen Receptor,Ki,=,1230.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.910094888560602
CHEMBL440454,CHEMBL1871,Androgen Receptor,Ki,=,2590.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(NC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.586700235918748
CHEMBL268239,CHEMBL1871,Androgen Receptor,Ki,=,1320.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(CO)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.8794260687941495
CHEMBL267231,CHEMBL1871,Androgen Receptor,Ki,=,96.3,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(OC(F)F)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,7.016373712875465
CHEMBL8394,CHEMBL1871,Androgen Receptor,Ki,=,2460.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(SC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.609064892896621
CHEMBL7671,CHEMBL1871,Androgen Receptor,Ki,=,650.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C#Cc1cccc2c1-c1ccc3c(c1C(CC=C)O2)C(C)=CC(C)(C)N3,6.187086643357144
CHEMBL266709,CHEMBL1871,Androgen Receptor,Ki,=,2060.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(O)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.686132779630847
CHEMBL131,CHEMBL1871,Androgen Receptor,Ki,=,2760.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,5.559090917934782
CHEMBL267940,CHEMBL1871,Androgen Receptor,Ki,=,239.0,nM,CHEMBL809267,B,Binding affinity towards testosterone receptor,CHEMBL1144889,KI,C=CCC1Oc2cccc(C=C)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.621602099051863
CHEMBL27297,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1CCNc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C,8.045757490560675
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.698970004336019
CHEMBL281028,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC1(C)CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.920818753952375
CHEMBL281945,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,C[C@H]1CNc2cc3nc(O)cc(C(F)(F)F)c3cc2C1CCC(F)(F)F,8.698970004336019
CHEMBL283449,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC1CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,8.045757490560675
CHEMBL717,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.537602002101044
CHEMBL280865,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCCC1CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.537602002101044
CHEMBL286158,CHEMBL1871,Androgen Receptor,Ki,=,807.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1cccc(C(F)(F)F)c1)Oc1ccccc1-3,6.09312646527793
CHEMBL27413,CHEMBL1871,Androgen Receptor,Ki,=,263.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1CCN(C)c2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C,6.580044251510242
CHEMBL2113261,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC[C@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@H]1C,7.568636235841012
CHEMBL282866,CHEMBL1871,Androgen Receptor,Ki,=,58.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1(CC)CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.236572006437063
CHEMBL2113248,CHEMBL1871,Androgen Receptor,Ki,=,72.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC(C)C[C@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@@H]1C,7.142667503568731
CHEMBL34015,CHEMBL1871,Androgen Receptor,Ki,=,698.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1ccc(Cl)cc1)Oc1ccccc1-3,6.156144577376839
CHEMBL32603,CHEMBL1871,Androgen Receptor,Ki,=,1196.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,CC1C(=O)C(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1ccccc1-3,5.9222688203476075
CHEMBL282204,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@H]1C,8.096910013008056
CHEMBL286684,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NCCC3,7.721246399047171
CHEMBL418198,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@@H]1C,8.096910013008056
CHEMBL284475,CHEMBL1871,Androgen Receptor,Ki,=,732.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1ccccc1)Oc1ccccc1-3,6.135488918941608
CHEMBL282813,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC(C)CC1CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.657577319177793
CHEMBL27812,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NC[C@@H]1CCC[C@H]31,8.096910013008056
CHEMBL431493,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NC[C@@H]1CCCC[C@H]31,8.698970004336019
CHEMBL27945,CHEMBL1871,Androgen Receptor,Ki,=,630.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1CCN(C)c2cc3nc(O)cc(C(F)(F)F)c3cc21,6.200659450546418
CHEMBL390728,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,8.154901959985743
CHEMBL25802,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NC[C@H]1CCCC[C@H]31,7.823908740944319
CHEMBL36564,CHEMBL1871,Androgen Receptor,Ki,=,620.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1cccc(F)c1)Oc1ccccc1-3,6.207608310501746
CHEMBL436344,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@@H]1C,7.795880017344075
CHEMBL35525,CHEMBL1871,Androgen Receptor,Ki,=,504.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1cccc(F)c1)Oc1ccccc1-3,6.297569463554474
CHEMBL285705,CHEMBL1871,Androgen Receptor,Ki,=,1075.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1ccccc1)Oc1ccccc1-3,5.968591535748375
CHEMBL34824,CHEMBL1871,Androgen Receptor,Ki,=,560.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,CC1C(=O)C(C)(C)Nc2ccc3c(c21)/C(=C/c1cccc(F)c1)Oc1ccccc1-3,6.251811972993799
CHEMBL27276,CHEMBL1871,Androgen Receptor,Ki,=,13.0,nM,CHEMBL648839,B,"Binding affinity to the human androgen receptor (hAR), using [3H]DHT as radioligand in a competitive binding assay",CHEMBL1132051,KI,CC(C)C1CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.886056647693163
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL35429,CHEMBL1871,Androgen Receptor,Ki,=,1177.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1ccc(Cl)cc1)Oc1ccccc1-3,5.929223537156565
CHEMBL36065,CHEMBL1871,Androgen Receptor,Ki,=,1091.0,nM,CHEMBL651952,B,Binding affinity against baculovirus expressed human androgen receptor (hAR),CHEMBL1132711,KI,C[C@@H]1C(=O)C(C)(C)Nc2ccc3c(c21)[C@H](c1cccc(C(F)(F)F)c1)Oc1ccccc1-3,5.962175249411658
CHEMBL78646,CHEMBL1871,Androgen Receptor,Ki,=,180.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,O=C1C=C2CCc3cc(O)ccc3[C@]2(Cc2ccccc2)CC1,6.7447274948966935
CHEMBL82307,CHEMBL1871,Androgen Receptor,Ki,=,54.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,COc1ccc2c(c1)CCC1=CC(=O)CC[C@@]12Cc1ccccc1,7.267606240177031
CHEMBL351519,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1Nc2cc3c(cc2C1(C)C)c(C(F)(F)F)cc(=O)n3C,8.045757490560675
CHEMBL77779,CHEMBL1871,Androgen Receptor,Ki,=,130.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,Oc1ccc2c(c1)CC[C@@H]1C[C@@](O)(C#CCl)CC[C@@]21Cc1ccccc1,6.886056647693163
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL648323,B,Binding affinity against Androgen receptor expressed COS cells,CHEMBL1130772,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.698970004336019
CHEMBL352456,CHEMBL1871,Androgen Receptor,Ki,=,194.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CCn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N[C@@H]1CCCC[C@H]31,6.7121982700697735
CHEMBL162569,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C,8.221848749616356
CHEMBL161980,CHEMBL1871,Androgen Receptor,Ki,=,78.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1CC[C@@H]2[C@H](C1)c1cc3c(C(F)(F)F)cc(=O)n(C)c3cc1N2C,7.107905397309519
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.337242168318426
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,82.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.086186147616283
CHEMBL351465,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,8.0
CHEMBL165912,CHEMBL1871,Androgen Receptor,Ki,=,63.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CCCN1c2cc3c(cc2[C@H]2CCCC[C@H]21)c(C(F)(F)F)cc(=O)n3C,7.200659450546418
CHEMBL310180,CHEMBL1871,Androgen Receptor,Ki,=,1300.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,O=C1CC[C@@]2(Cc3ccccc3)c3ccc(O)cc3CC[C@@H]2C1,5.886056647693163
CHEMBL162503,CHEMBL1871,Androgen Receptor,Ki,=,61.0,nM,CHEMBL648325,B,Binding affinity against hAR androgen receptor expressed in COS cells,CHEMBL1130772,KI,Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NCC3,7.214670164989233
CHEMBL162368,CHEMBL1871,Androgen Receptor,Ki,=,79.0,nM,CHEMBL648325,B,Binding affinity against hAR androgen receptor expressed in COS cells,CHEMBL1130772,KI,CC1(C)CCC[C@@H]2c3cc4c(C(F)(F)F)cc(O)nc4cc3N[C@@H]21,7.102372908709558
CHEMBL166323,CHEMBL1871,Androgen Receptor,Ki,=,41.0,nM,CHEMBL648325,B,Binding affinity against hAR androgen receptor expressed in COS cells,CHEMBL1130772,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NCC3,7.3872161432802645
CHEMBL78625,CHEMBL1871,Androgen Receptor,Ki,=,650.0,nM,CHEMBL648838,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,CC#C[C@@]1(O)CC[C@@]2(Cc3ccccc3)c3ccc(O)cc3CC[C@@H]2C1,6.187086643357144
CHEMBL351022,CHEMBL1871,Androgen Receptor,Ki,=,28.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CC1(C)CNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.552841968657781
CHEMBL350932,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)N[C@@H]1CCCC[C@H]31,8.301029995663981
CHEMBL422196,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N[C@@H]1CCCC[C@]31C,8.045757490560675
CHEMBL161892,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CN1c2cc3c(cc2[C@H]2CCCC[C@H]21)c(C(F)(F)F)cc(=O)n3C,8.0
CHEMBL78807,CHEMBL1871,Androgen Receptor,Ki,=,690.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,COc1ccc2c(c1)CCC1=CC(=O)CC[C@]12Cc1ccccc1,6.161150909262744
CHEMBL349631,CHEMBL1871,Androgen Receptor,Ki,=,33.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1N(C)c2cc3c(cc2C1(C)C)c(C(F)(F)F)cc(=O)n3C,7.481486060122112
CHEMBL163143,CHEMBL1871,Androgen Receptor,Ki,=,97.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CN1c2cc3c(cc2[C@@]2(C)CCCC[C@@H]12)c(C(F)(F)F)cc(=O)n3C,7.013228265733755
CHEMBL423620,CHEMBL1871,Androgen Receptor,Ki,=,77.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,CC1(C)CCC[C@]2(C)c3cc4c(C(F)(F)F)cc(O)nc4cc3N[C@H]12,7.113509274827518
CHEMBL163142,CHEMBL1871,Androgen Receptor,Ki,=,59.0,nM,CHEMBL648325,B,Binding affinity against hAR androgen receptor expressed in COS cells,CHEMBL1130772,KI,CN1c2cc3c(cc2[C@H]2CCCC(C)(C)[C@H]21)c(C(F)(F)F)cc(=O)n3C,7.229147988357855
CHEMBL78704,CHEMBL1871,Androgen Receptor,Ki,=,90.0,nM,CHEMBL648837,B,Displacement of [3H]DHT from human Androgen receptor,CHEMBL1135457,KI,CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(Cc4ccc(C)cc4)C3=CC[C@@]21C,7.045757490560675
CHEMBL348918,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@@H]1c2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N[C@@H]1C,8.0
CHEMBL166212,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1CC[C@H]2Nc3cc4nc(O)cc(C(F)(F)F)c4cc3[C@H]2C1,7.638272163982407
CHEMBL163366,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@@H]1Cc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N1,8.045757490560675
CHEMBL165219,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C1(C)C,7.6777807052660805
CHEMBL163425,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N[C@@H]1CCCC[C@H]31,8.397940008672037
CHEMBL162103,CHEMBL1871,Androgen Receptor,Ki,=,167.0,nM,CHEMBL648325,B,Binding affinity against hAR androgen receptor expressed in COS cells,CHEMBL1130772,KI,CN1CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc21,6.777283528852417
CHEMBL349229,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@@H]1CNc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.769551078621726
CHEMBL351447,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@]12CCCC[C@H]1Nc1cc3nc(O)cc(C(F)(F)F)c3cc12,7.6777807052660805
CHEMBL165803,CHEMBL1871,Androgen Receptor,Ki,=,94.0,nM,CHEMBL648322,B,Binding affinity against Androgen receptor transfected into COS cells,CHEMBL1130772,KI,C[C@H]1CC[C@H]2Nc3cc4c(cc3[C@H]2C1)c(C(F)(F)F)cc(=O)n4C,7.026872146400302
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL648331,B,Binding affinity for human Androgen receptor,CHEMBL1129561,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL51669,CHEMBL1871,Androgen Receptor,Ki,=,1099.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCCC(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1O,5.95900230757651
CHEMBL48745,CHEMBL1871,Androgen Receptor,Ki,=,1923.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCC(C)(C)C1Cc1cc(OC)c(Br)cc1O,5.71602071576152
CHEMBL296156,CHEMBL1871,Androgen Receptor,Ki,=,6810.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C[C@H](CO)CC(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1O,5.166852888087215
CHEMBL2113712,CHEMBL1871,Androgen Receptor,Ki,=,6454.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1(O)Cc1ccc([N+](=O)[O-])cc1,5.190171038932114
CHEMBL50454,CHEMBL1871,Androgen Receptor,Ki,=,1139.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C[C@H](C)C[C@@H](C)[C@@H]1Cc1cc(OC)c(Br)cc1O,5.943476275920899
CHEMBL48858,CHEMBL1871,Androgen Receptor,Ki,=,1542.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCCC(C)(C)C1Cc1cc(OC)c(Br)cc1O,5.811915626285062
CHEMBL54270,CHEMBL1871,Androgen Receptor,Ki,=,1942.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1Cc1cc(OC)c(Br)cc1OC(C)=O,5.711750774428014
CHEMBL299512,CHEMBL1871,Androgen Receptor,Ki,=,2698.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1Cc1ccc([N+](=O)[O-])c(C)c1,5.568958054664114
CHEMBL50023,CHEMBL1871,Androgen Receptor,Ki,=,6303.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1Cc1ccc([N+](=O)[O-])cc1,5.200452692874385
CHEMBL50241,CHEMBL1871,Androgen Receptor,Ki,=,1.1,nM,CHEMBL648331,B,Binding affinity for human Androgen receptor,CHEMBL1129561,KI,C=C1CC[C@H](O)C/C1=C/C=C1\CCCC2(C)C1CCC2C(C)/C=C/C(C)C(C)C,8.958607314841775
CHEMBL48358,CHEMBL1871,Androgen Receptor,Ki,=,1518.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=CCC(C)(C)C1Cc1cc(OC)c(Br)cc1O,5.818728228440539
CHEMBL53549,CHEMBL1871,Androgen Receptor,Ki,=,696.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C[C@H](C)CC(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1O,6.157390760389438
CHEMBL299778,CHEMBL1871,Androgen Receptor,Ki,=,1644.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCC[C@H](C)[C@H]1Cc1cc(OC)c(Br)cc1O,5.784098186795968
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,10.6,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,7.97469413473523
CHEMBL417729,CHEMBL1871,Androgen Receptor,Ki,=,737.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCCC(C)(C)[C@H]1Cc1cc(OC)c(Br)cc1O,6.132532512140949
CHEMBL49978,CHEMBL1871,Androgen Receptor,Ki,=,2318.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1C/C=C/c1cc(OC)c(Br)cc1O,5.634886568372423
CHEMBL51933,CHEMBL1871,Androgen Receptor,Ki,=,1497.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)C[C@@H](C)[C@@H]1Cc1cc(OC)c(Br)cc1OC(C)=O,5.824778199656947
CHEMBL50849,CHEMBL1871,Androgen Receptor,Ki,=,3008.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,COc1cc(CC2C(C)(C)CC(C)=CC23CC3)c(OC(C)=O)cc1Br,5.521722168080395
CHEMBL50534,CHEMBL1871,Androgen Receptor,Ki,=,6662.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1[C@@H](Cc2cc(OC)c(Br)cc2O)C(C)(C)CC[C@@]1(C)O,5.176395371644842
CHEMBL51788,CHEMBL1871,Androgen Receptor,Ki,=,570.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1CCC[C@@H](C)[C@@H]1Cc1cc(OC)c(Br)cc1O,6.2441251443275085
CHEMBL48746,CHEMBL1871,Androgen Receptor,Ki,=,1449.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)CC(C)(C)C1Cc1cc(OC)c(Br)cc1O,5.838931614528825
CHEMBL50619,CHEMBL1871,Androgen Receptor,Ki,=,6387.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C(C)=CCC(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1OC(C)=O,5.194703083842015
CHEMBL299828,CHEMBL1871,Androgen Receptor,Ki,=,1591.0,nM,CHEMBL648329,B,Binding affinity determined against human Androgen receptor,CHEMBL1129561,KI,C=C1C=C(C)C(Cc2cc(OC)c(Br)cc2O)C(C)(C)C1,5.798329820353418
CHEMBL156142,CHEMBL1871,Androgen Receptor,Ki,=,76.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.119186407719209
CHEMBL346487,CHEMBL1871,Androgen Receptor,Ki,=,62.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)Nc2cc3nc(O)cc(C)c3cc21,7.207608310501746
CHEMBL156806,CHEMBL1871,Androgen Receptor,Ki,=,189.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1(C)Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C,6.723538195826755
CHEMBL160665,CHEMBL1871,Androgen Receptor,Ki,=,73.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C,7.136677139879544
CHEMBL351148,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.537602002101044
CHEMBL345854,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NC1(CCCCC1)CC3,8.045757490560675
CHEMBL160230,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1(C)CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N1C,8.0
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.568636235841012
CHEMBL160250,CHEMBL1871,Androgen Receptor,Ki,=,102.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1(CC)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,6.991399828238082
CHEMBL160239,CHEMBL1871,Androgen Receptor,Ki,=,670.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NC(C)(C)C=C3C,6.173925197299173
CHEMBL346827,CHEMBL1871,Androgen Receptor,Ki,=,56.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NC(C)(C)CC3,7.251811972993799
CHEMBL350465,CHEMBL1871,Androgen Receptor,Ki,=,251.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C,6.600326278518962
CHEMBL160713,CHEMBL1871,Androgen Receptor,Ki,=,69.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCCC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.161150909262744
CHEMBL157344,CHEMBL1871,Androgen Receptor,Ki,=,358.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC(C)(C)C1(C)C,6.446116973356125
CHEMBL157407,CHEMBL1871,Androgen Receptor,Ki,=,78.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N1CCCC1(C)CC3,7.107905397309519
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,117.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.931814138253838
CHEMBL435651,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CN1c2cc3c(cc2CCC1(C)C)c(C(F)(F)F)cc(=O)n3C,7.769551078621726
CHEMBL160923,CHEMBL1871,Androgen Receptor,Ki,=,874.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)Nc2c1cc1c(C(F)(F)F)cc(=O)n(C)c1c2C,6.058488567365597
CHEMBL347910,CHEMBL1871,Androgen Receptor,Ki,=,85.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,Cc1c2c(cc3c(C(F)(F)F)cc(O)nc13)C(C)CC(C)(C)N2,7.070581074285707
CHEMBL160386,CHEMBL1871,Androgen Receptor,Ki,=,81.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)Nc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C,7.0915149811213505
CHEMBL157703,CHEMBL1871,Androgen Receptor,Ki,=,82.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)Nc2c1cc1c(C(F)(F)F)cc(O)nc1c2C,7.086186147616283
CHEMBL347870,CHEMBL1871,Androgen Receptor,Ki,=,695.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)N(C)c2cc3nc(O)cc(C(F)(F)F)c3cc21,6.158015195409886
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,7.657577319177793
CHEMBL156982,CHEMBL1871,Androgen Receptor,Ki,=,54.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.267606240177031
CHEMBL6874,CHEMBL1871,Androgen Receptor,Ki,=,26.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.585026652029182
CHEMBL422707,CHEMBL1871,Androgen Receptor,Ki,=,69.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CCC1(C)CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N1,7.161150909262744
CHEMBL156751,CHEMBL1871,Androgen Receptor,Ki,=,650.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC(C)C1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,6.187086643357144
CHEMBL160451,CHEMBL1871,Androgen Receptor,Ki,=,115.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,6.939302159646388
CHEMBL349539,CHEMBL1871,Androgen Receptor,Ki,=,268.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=C(C)C(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,6.571865205971211
CHEMBL160257,CHEMBL1871,Androgen Receptor,Ki,=,151.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,C[C@@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC(C)(C)[C@H]1C,6.821023052706831
CHEMBL352002,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,Cc1c2c(cc3c(C(F)(F)F)cc(=O)n(C)c13)C(C)CC(C)(C)N2,7.3979400086720375
CHEMBL345342,CHEMBL1871,Androgen Receptor,Ki,=,39.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1=CC(C)(C)N(C)c2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C,7.4089353929735005
CHEMBL156641,CHEMBL1871,Androgen Receptor,Ki,=,456.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,C[C@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC(C)(C)[C@H]1C,6.341035157335565
CHEMBL156278,CHEMBL1871,Androgen Receptor,Ki,=,46.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1CC(C)(C)Nc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C,7.337242168318426
CHEMBL350877,CHEMBL1871,Androgen Receptor,Ki,=,86.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC1(C)C=Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.0655015487564325
CHEMBL139835,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C,7.853871964321762
CHEMBL156312,CHEMBL1871,Androgen Receptor,Ki,=,169.0,nM,CHEMBL651953,B,Binding affinity for human androgen receptor in transiently-transfected COS-1 cells.,CHEMBL1131477,KI,CC12CCCN1c1cc3nc(O)cc(C(F)(F)F)c3cc1CC2,6.772113295386326
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL648328,B,Binding affinity for human Androgen receptor expressed in COS-1 cells,CHEMBL1132152,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.522878745280337
CHEMBL302870,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL648328,B,Binding affinity for human Androgen receptor expressed in COS-1 cells,CHEMBL1132152,KI,C[C@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,8.397940008672037
CHEMBL390728,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL648328,B,Binding affinity for human Androgen receptor expressed in COS-1 cells,CHEMBL1132152,KI,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.769551078621726
CHEMBL806,CHEMBL1871,Androgen Receptor,Ki,=,1300.0,nM,CHEMBL648324,B,Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL1144953,KI,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.886056647693163
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL114941,CHEMBL1871,Androgen Receptor,Ki,=,903.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCCC1Oc2ccc(C)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.044312249686494
CHEMBL322108,CHEMBL1871,Androgen Receptor,Ki,=,785.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCCC1Oc2ccc(OC)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.105130343254748
CHEMBL326092,CHEMBL1871,Androgen Receptor,Ki,=,1330.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCCC1Oc2ccc(F)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.876148359032914
CHEMBL286446,CHEMBL1871,Androgen Receptor,Ki,=,621.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(C)Oc1ccc(Cl)cc1-3,6.20690839982342
CHEMBL112987,CHEMBL1871,Androgen Receptor,Ki,=,886.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCCC1Oc2ccc(Cl)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.052566278112949
CHEMBL116007,CHEMBL1871,Androgen Receptor,Ki,=,456.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(C)Oc1ccc(F)cc1-3,6.341035157335565
CHEMBL114607,CHEMBL1871,Androgen Receptor,Ki,=,1485.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(CCC(C)C)Oc1ccccc1-3,5.828273546346769
CHEMBL116221,CHEMBL1871,Androgen Receptor,Ki,=,697.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCOC1Oc2ccc(Cl)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.15676722190199
CHEMBL717,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.537602002101044
CHEMBL325221,CHEMBL1871,Androgen Receptor,Ki,=,2046.0,nM,CHEMBL648841,B,Displacement of DHT from human androgen receptor,CHEMBL1131555,KI,CCCCC1Oc2ccccc2-c2ccc3c(c21)C(C)=CC(C)(C)N3,5.689094370623859
CHEMBL717,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.537602002101044
CHEMBL137103,CHEMBL1871,Androgen Receptor,Ki,=,887.0,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1cc(F)ccc1F)Oc1ccccc1-3,6.052076380168273
CHEMBL134421,CHEMBL1871,Androgen Receptor,Ki,=,2660.0,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1ccccc1-3,5.575118363368933
CHEMBL296323,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL648326,B,Binding affinity against human androgen receptor (hAR) in competitive binding assay,CHEMBL1134484,KI,C[C@](O)(CBr)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,9.522878745280337
CHEMBL49615,CHEMBL1871,Androgen Receptor,Ki,=,80.9,nM,CHEMBL648326,B,Binding affinity against human androgen receptor (hAR) in competitive binding assay,CHEMBL1134484,KI,C[C@](O)(CBr)C(=O)Nc1ccc(N)c(C(F)(F)F)c1,7.092051478387727
CHEMBL32812,CHEMBL1871,Androgen Receptor,Ki,=,798.0,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1cccc(F)c1)Oc1ccccc1-3,6.09799710864927
CHEMBL302362,CHEMBL1871,Androgen Receptor,Ki,=,844.0,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1C)Oc1ccccc1-3,6.073657553374344
CHEMBL48159,CHEMBL1871,Androgen Receptor,Ki,=,16.5,nM,CHEMBL648326,B,Binding affinity against human androgen receptor (hAR) in competitive binding assay,CHEMBL1134484,KI,C[C@@](O)(CBr)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.782516055786093
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL651951,B,Binding affinity against human androgen receptor,CHEMBL1131161,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL268326,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@@H]1C[C@H](C)c2cc3c(C(F)(F)F)cc(O)nc3cc2N1,8.221848749616356
CHEMBL7058,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C,7.823908740944319
CHEMBL7455,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C[C@@H]1C,7.920818753952375
CHEMBL7373,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@@H]1C[C@H](C)c2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.6777807052660805
CHEMBL7053,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C,7.958607314841775
CHEMBL7177,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,8.096910013008056
CHEMBL7421,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1CC,7.537602002101044
CHEMBL6983,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C,7.657577319177793
CHEMBL6874,CHEMBL1871,Androgen Receptor,Ki,=,26.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.585026652029182
CHEMBL7089,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C[C@H]1C,7.958607314841775
CHEMBL427957,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1C[C@@H](C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21,7.638272163982407
CHEMBL6959,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1CC,7.795880017344075
CHEMBL6689,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(C)C,7.301029995663981
CHEMBL266269,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C,7.823908740944319
CHEMBL268569,CHEMBL1871,Androgen Receptor,Ki,=,24.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CCC[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.619788758288394
CHEMBL267850,CHEMBL1871,Androgen Receptor,Ki,=,109.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC(C)[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,6.962573502059376
CHEMBL7383,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@@H]1C[C@H](CC)c2cc3c(C(F)(F)F)cc(O)nc3cc2N1,8.045757490560675
CHEMBL267471,CHEMBL1871,Androgen Receptor,Ki,=,42.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(CC)CC,7.376750709602099
CHEMBL267141,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,8.154901959985743
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.698970004336019
CHEMBL267907,CHEMBL1871,Androgen Receptor,Ki,=,82.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,C[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(C)C,7.086186147616283
CHEMBL7231,CHEMBL1871,Androgen Receptor,Ki,=,32.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CCC[C@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1CC,7.494850021680094
CHEMBL2112349,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL648840,B,"Binding affinity towards human androgen receptor (hAR), using dihydrotestosterone as radioligand for competitive binding assay",CHEMBL1132083,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1O,7.568636235841012
CHEMBL132295,CHEMBL1871,Androgen Receptor,Ki,=,96.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CCCC[S+]([O-])c1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3,7.017728766960431
CHEMBL133792,CHEMBL1871,Androgen Receptor,Ki,=,84.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(Cl)nc3cc2N1,7.075720713938118
CHEMBL132427,CHEMBL1871,Androgen Receptor,Ki,=,86.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CN1c2cc3nc(C#N)cc(C(F)(F)F)c3cc2CCC1(C)C,7.0655015487564325
CHEMBL134140,CHEMBL1871,Androgen Receptor,Ki,=,159.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(Br)nc3cc2N1,6.798602875679549
CHEMBL335316,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(C#N)nc3cc2N1,7.657577319177793
CHEMBL134180,CHEMBL1871,Androgen Receptor,Ki,=,572.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(NS(C)(=O)=O)nc3cc2N1,6.242603971206975
CHEMBL6874,CHEMBL1871,Androgen Receptor,Ki,=,26.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.585026652029182
CHEMBL133331,CHEMBL1871,Androgen Receptor,Ki,=,320.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1=CC(C)(C)Nc2cc3nc(Cl)cc(C(F)(F)F)c3cc21,6.494850021680094
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,117.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.931814138253838
CHEMBL133503,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(F)nc3cc2N1,7.958607314841775
CHEMBL338922,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1(C)CCc2cc3c(C(F)(F)F)ccnc3cc2N1,8.301029995663981
CHEMBL133289,CHEMBL1871,Androgen Receptor,Ki,=,294.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CN1c2cc3nc(Cl)cc(C(F)(F)F)c3cc2CCC1(C)C,6.531652669587842
CHEMBL132803,CHEMBL1871,Androgen Receptor,Ki,=,57.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC1=CC(C)(C)Nc2cc3nc(F)cc(C(F)(F)F)c3cc21,7.2441251443275085
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,34.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.468521082957745
CHEMBL134209,CHEMBL1871,Androgen Receptor,Ki,=,20.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,C[S+]([O-])c1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3,7.698970004336019
CHEMBL133465,CHEMBL1871,Androgen Receptor,Ki,=,96.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CN1c2cc3nc(F)cc(C(F)(F)F)c3cc2CCC1(C)C,7.017728766960431
CHEMBL133167,CHEMBL1871,Androgen Receptor,Ki,=,426.0,nM,CHEMBL872368,B,Binding affinity for human androgen receptor transfected into mammalian COS-1 cells,CHEMBL1133046,KI,CN1c2cc3nc(Br)cc(C(F)(F)F)c3cc2CCC1(C)C,6.370590400897282
CHEMBL318409,CHEMBL1871,Androgen Receptor,Ki,=,1400.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccccc1)Oc1ccc(Cl)cc1-3,5.853871964321762
CHEMBL99046,CHEMBL1871,Androgen Receptor,Ki,=,2660.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,COc1cccc2c1-c1ccc3c(c1C(c1ccccc1)O2)C(C)=CC(C)(C)N3,5.575118363368933
CHEMBL131,CHEMBL1871,Androgen Receptor,Ki,=,2762.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,5.558776325757387
CHEMBL95644,CHEMBL1871,Androgen Receptor,Ki,=,3360.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,COc1cccc2c1-c1ccc3c(c1C(c1cccc(C(F)(F)F)c1)O2)C(C)=CC(C)(C)N3,5.4736607226101555
CHEMBL97206,CHEMBL1871,Androgen Receptor,Ki,=,3115.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,COc1cccc2c1-c1ccc3c(c1C(c1cccc(OCSC)c1)O2)C(C)=CC(C)(C)N3,5.506541949004811
CHEMBL317578,CHEMBL1871,Androgen Receptor,Ki,=,3066.0,nM,CHEMBL651954,B,Binding affinity for androgen receptor,CHEMBL1134574,KI,COc1cccc2c1-c1ccc3c(c1C(c1cccc(OC(=O)N(C)C)c1)O2)C(C)=CC(C)(C)N3,5.513427849481644
CHEMBL101914,CHEMBL1871,Androgen Receptor,Ki,=,1856.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccccc1)Oc1ccccc1-3,5.731422028117157
CHEMBL318513,CHEMBL1871,Androgen Receptor,Ki,=,795.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(C(F)(F)F)c1)Oc1ccccc1-3,6.0996328713435295
CHEMBL103092,CHEMBL1871,Androgen Receptor,Ki,=,1581.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(C)c(F)c1)Oc1ccccc1-3,5.801068130067791
CHEMBL320690,CHEMBL1871,Androgen Receptor,Ki,=,1526.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(Cl)c1)Oc1ccccc1-3,5.816445466381138
CHEMBL317921,CHEMBL1871,Androgen Receptor,Ki,=,5831.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(Cl)c1)Oc1ccccc1-3,5.234256958578955
CHEMBL286595,CHEMBL1871,Androgen Receptor,Ki,=,2685.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)cc1)Oc1ccccc1-3,5.571055709964426
CHEMBL101907,CHEMBL1871,Androgen Receptor,Ki,=,3499.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cc(C)cc(Br)c1)Oc1ccccc1-3,5.4560560575170935
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,8.070581074285707
CHEMBL102754,CHEMBL1871,Androgen Receptor,Ki,=,1457.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(F)c1)Oc1ccccc1-3,5.83654044823001
CHEMBL102720,CHEMBL1871,Androgen Receptor,Ki,=,1860.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(C)c1)Oc1ccccc1-3,5.730487055782084
CHEMBL717,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,8.537602002101044
CHEMBL102403,CHEMBL1871,Androgen Receptor,Ki,=,2330.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(C)cc1)Oc1ccccc1-3,5.632644078973981
CHEMBL430855,CHEMBL1871,Androgen Receptor,Ki,=,2138.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(Br)c1)Oc1ccccc1-3,5.669992299127241
CHEMBL102541,CHEMBL1871,Androgen Receptor,Ki,=,2584.0,nM,CHEMBL651955,B,Binding affinity was determined on Human androgen receptor (hAR) using progesterone as radioligand.,CHEMBL1131454,KI,CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cc(Cl)cc(Cl)c1)Oc1ccccc1-3,5.587707490676953
CHEMBL367364,CHEMBL1871,Androgen Receptor,Ki,=,1615.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,5.791827473332878
CHEMBL367364,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,8.698970004336019
CHEMBL368906,CHEMBL1871,Androgen Receptor,Ki,=,55.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.259637310505756
CHEMBL368906,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.301029995663981
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.301029995663981
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.698970004336019
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,117.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.931814138253838
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.698970004336019
CHEMBL361222,CHEMBL1871,Androgen Receptor,Ki,=,46.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Br)c(C(F)(F)F)c1,7.337242168318426
CHEMBL361222,CHEMBL1871,Androgen Receptor,Ki,=,0.6,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Br)c(C(F)(F)F)c1,9.221848749616356
CHEMBL182236,CHEMBL1871,Androgen Receptor,Ki,=,125.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC(C4)[C@@H]3C2=O)ccc1Br,6.903089986991944
CHEMBL182236,CHEMBL1871,Androgen Receptor,Ki,=,3.6,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC(C4)[C@@H]3C2=O)ccc1Br,8.443697499232712
CHEMBL180859,CHEMBL1871,Androgen Receptor,Ki,=,177.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(F)c(Cl)c1,6.752026733638194
CHEMBL180859,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(F)c(Cl)c1,8.698970004336019
CHEMBL366924,CHEMBL1871,Androgen Receptor,Ki,=,400.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,Cc1ccc(N2C(=O)[C@@H]3C4C=CC(C4)[C@@H]3C2=O)cc1C,6.3979400086720375
CHEMBL366924,CHEMBL1871,Androgen Receptor,Ki,=,3.4,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,Cc1ccc(N2C(=O)[C@@H]3C4C=CC(C4)[C@@H]3C2=O)cc1C,8.468521082957745
CHEMBL181571,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,9.0
CHEMBL181571,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,9.301029995663981
CHEMBL178957,CHEMBL1871,Androgen Receptor,Ki,=,401.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cc(C(F)(F)F)cc(C(F)(F)F)c1,6.396855627379818
CHEMBL178957,CHEMBL1871,Androgen Receptor,Ki,=,24.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cc(C(F)(F)F)cc(C(F)(F)F)c1,7.619788758288394
CHEMBL178886,CHEMBL1871,Androgen Receptor,Ki,=,158.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cc(Cl)cc(Cl)c1,6.801342913045577
CHEMBL178886,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cc(Cl)cc(Cl)c1,8.221848749616356
CHEMBL181722,CHEMBL1871,Androgen Receptor,Ki,=,530.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc2cccnc2c1,6.275724130399211
CHEMBL181722,CHEMBL1871,Androgen Receptor,Ki,=,13.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc2cccnc2c1,7.886056647693163
CHEMBL181674,CHEMBL1871,Androgen Receptor,Ki,=,284.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc2ccccc2c1,6.546681659952963
CHEMBL181674,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc2ccccc2c1,7.958607314841775
CHEMBL369509,CHEMBL1871,Androgen Receptor,Ki,=,162.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(O)c2ncccc12,6.790484985457369
CHEMBL369509,CHEMBL1871,Androgen Receptor,Ki,=,32.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(O)c2ncccc12,7.494850021680094
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,35.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.455931955649724
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,43.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.366531544420413
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.698970004336019
CHEMBL359911,CHEMBL1871,Androgen Receptor,Ki,=,284.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc2ccccc2c1,6.546681659952963
CHEMBL359911,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc2ccccc2c1,7.958607314841775
CHEMBL182186,CHEMBL1871,Androgen Receptor,Ki,=,192.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])cc1,6.71669877129645
CHEMBL182186,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])cc1,7.920818753952375
CHEMBL178469,CHEMBL1871,Androgen Receptor,Ki,=,632.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,6.199282921717614
CHEMBL178469,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,8.154901959985743
CHEMBL367364,CHEMBL1871,Androgen Receptor,Ki,=,319.0,nM,CHEMBL830415,B,Inhibition of [3H]DHT binding to androgen receptor of MDA-453 cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,6.496209316942819
CHEMBL367364,CHEMBL1871,Androgen Receptor,Ki,=,3.4,nM,CHEMBL828881,B,Inhibition of [3H]-DHT binding to T877A androgen receptor of LNCaP cells,CHEMBL1144249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,8.468521082957745
CHEMBL427502,CHEMBL1871,Androgen Receptor,Ki,=,33.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC([C@H](O)[C@@H]4O)[C@@H]3C2=O)ccc1Br,7.481486060122112
CHEMBL184981,CHEMBL1871,Androgen Receptor,Ki,=,83.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,7.080921907623926
CHEMBL184981,CHEMBL1871,Androgen Receptor,Ki,=,28.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,7.552841968657781
CHEMBL183173,CHEMBL1871,Androgen Receptor,Ki,=,115.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,CN1C(=O)C2C=CC1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)[C@H]21,6.939302159646388
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,35.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.455931955649724
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,43.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.366531544420413
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.698970004336019
CHEMBL182593,CHEMBL1871,Androgen Receptor,Ki,=,158.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,6.801342913045577
CHEMBL182593,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(C3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,8.221848749616356
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.301029995663981
CHEMBL178333,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.698970004336019
CHEMBL361445,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,7.721246399047171
CHEMBL361445,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,9.301029995663981
CHEMBL182412,CHEMBL1871,Androgen Receptor,Ki,=,100.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.0
CHEMBL182412,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.721246399047171
CHEMBL369542,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CCC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.045757490560675
CHEMBL369542,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC(CCC3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.045757490560675
CHEMBL183882,CHEMBL1871,Androgen Receptor,Ki,=,2810.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3CCCC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,5.55129368009492
CHEMBL183882,CHEMBL1871,Androgen Receptor,Ki,=,20.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3CCCC(CC3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,7.698970004336019
CHEMBL367375,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.522878745280337
CHEMBL182993,CHEMBL1871,Androgen Receptor,Ki,=,3200.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,5.494850021680094
CHEMBL182993,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,O=C1[C@@H]2C3C=CC([C@H]4C[C@@H]34)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,8.045757490560675
CHEMBL180681,CHEMBL1871,Androgen Receptor,Ki,=,171.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC(CC4)[C@@H]3C2=O)ccc1Br,6.767003889607846
CHEMBL180681,CHEMBL1871,Androgen Receptor,Ki,=,0.01,nM,CHEMBL825228,B,Binding affinity for mutant T877A Androgen receptor in human LNCaP cells,CHEMBL1142826,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC(CC4)[C@@H]3C2=O)ccc1Br,11.0
CHEMBL427502,CHEMBL1871,Androgen Receptor,Ki,=,432.0,nM,CHEMBL839595,B,Binding affinity for androgen receptor in human MDA-453 cells,CHEMBL1142826,KI,Cc1cc(N2C(=O)[C@@H]3C4C=CC([C@H](O)[C@@H]4O)[C@@H]3C2=O)ccc1Br,6.364516253185088
CHEMBL414318,CHEMBL1871,Androgen Receptor,Ki,=,34.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,7.468521082957745
CHEMBL407672,CHEMBL1871,Androgen Receptor,Ki,=,8.9,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)NCCS(=O)(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.050609993355087
CHEMBL187605,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21,7.3979400086720375
CHEMBL414845,CHEMBL1871,Androgen Receptor,Ki,=,180.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21,6.7447274948966935
CHEMBL188129,CHEMBL1871,Androgen Receptor,Ki,=,60.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)N21,7.221848749616356
CHEMBL188545,CHEMBL1871,Androgen Receptor,Ki,=,1030.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)N21,5.987162775294828
CHEMBL364393,CHEMBL1871,Androgen Receptor,Ki,=,230.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@H]2C[C@@H]1[C@H]1C(=O)N(c3ccc([N+](=O)[O-])cc3)C(=O)N21,6.638272163982407
CHEMBL188803,CHEMBL1871,Androgen Receptor,Ki,=,240.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc(C#N)cc3)C(=O)N21,6.619788758288394
CHEMBL188857,CHEMBL1871,Androgen Receptor,Ki,=,190.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc(C#N)cc3)C(=O)N21,6.721246399047171
CHEMBL188261,CHEMBL1871,Androgen Receptor,Ki,=,1400.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@]1(C)C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21,5.853871964321762
CHEMBL185880,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,O=C1[C@H]2[C@H]3CC[C@H](C3)N2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,9.0
CHEMBL188297,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,O=C1[C@@H]2[C@@H]3CC[C@@H](C3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.301029995663981
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,65.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.187086643357144
CHEMBL362566,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)cc1C(F)(F)F,8.0
CHEMBL426623,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,O=C1[C@H]2[C@@H]3C[C@@H](CN3C(=O)Oc3ccc(F)cc3)N2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.0
CHEMBL365921,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)c2ccccc12,7.3979400086720375
CHEMBL189600,CHEMBL1871,Androgen Receptor,Ki,=,120.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)c4ccccc4)N3C2=O)cc1C(F)(F)F,6.920818753952375
CHEMBL365650,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,O=C1[C@H]2[C@@H]3C[C@@H](CN3C(=O)c3ccccc3)N2C(=O)N1c1ccc([N+](=O)[O-])cc1,8.0
CHEMBL447184,CHEMBL1871,Androgen Receptor,Ki,=,690.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)N32)cc1,6.161150909262744
CHEMBL365482,CHEMBL1871,Androgen Receptor,Ki,=,70.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc([N+](=O)[O-])cc4)C(=O)N32)cc1,7.154901959985743
CHEMBL371392,CHEMBL1871,Androgen Receptor,Ki,=,100.0,nM,CHEMBL826376,B,Displacement of [3H]DHT from androgen receptor of human MDA-453 cells,CHEMBL1138730,KI,CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc(C#N)cc4)C(=O)N32)cc1,7.0
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,0.65,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,9.187086643357144
CHEMBL364368,CHEMBL1871,Androgen Receptor,Ki,=,8.9,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C(C)=O)cc3)C[C@@]21C,8.050609993355087
CHEMBL436859,CHEMBL1871,Androgen Receptor,Ki,=,34.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C(=O)CC[C@H](NC(=O)CC[C@@H](C)[C@H]4CC[C@H]5[C@@H]6[C@H](O)C[C@@H]7C[C@H](O)CC[C@]7(C)[C@H]6C[C@H](O)[C@]45C)C(=O)O)cc3)C[C@@]21C,7.468521082957745
CHEMBL411185,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C(=O)CNC(=O)OC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,7.6777807052660805
CHEMBL266935,CHEMBL1871,Androgen Receptor,Ki,=,6.2,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCNC(=O)OC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.207608310501746
CHEMBL427568,CHEMBL1871,Androgen Receptor,Ki,=,8.9,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.050609993355087
CHEMBL427568,CHEMBL1871,Androgen Receptor,Ki,=,8.1,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.09151498112135
CHEMBL408376,CHEMBL1871,Androgen Receptor,Ki,=,7.4,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCCC(=O)N(C)C4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.130768280269024
CHEMBL384975,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCNC(=O)N(C)C4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,7.795880017344075
CHEMBL406027,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCCS(=O)(=O)N(C)C4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,7.769551078621726
CHEMBL415621,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCCOC4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.337242168318426
CHEMBL2096804,CHEMBL1871,Androgen Receptor,Ki,=,4.8,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOCCO[C@@H]4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.318758762624412
CHEMBL2096708,CHEMBL1871,Androgen Receptor,Ki,=,3.3,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCOCCO[C@H]4CC[C@@]5(C)[C@@H](C4)C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,8.481486060122112
CHEMBL440251,CHEMBL1871,Androgen Receptor,Ki,=,53.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCC[C@H]4[C@H](O)CC[C@@]5(C)[C@@H]4C[C@@H](O)[C@@H]4[C@@H]5C[C@H](O)[C@]5(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@@H]45)cc3)C[C@@]21C,7.275724130399211
CHEMBL263942,CHEMBL1871,Androgen Receptor,Ki,=,37.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C(=O)CNC(=O)O[C@@H]4C[C@@H]5CC(O)CC[C@]5(C)[C@H]5C[C@H](O)[C@]6(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]6[C@H]45)cc3)C[C@@]21C,7.431798275933005
CHEMBL414041,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL827149,B,Inhibition of human androgen receptor,CHEMBL1138676,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)CCNC(=O)O[C@@H]4C[C@@H]5CC(O)CC[C@]5(C)[C@H]5C[C@H](O)[C@]6(C)[C@@H]([C@H](C)CCC(=O)O)CC[C@H]6[C@H]45)cc3)C[C@@]21C,7.7447274948966935
CHEMBL410683,CHEMBL1871,Androgen Receptor,Ki,=,315.0,nM,CHEMBL884739,B,Inhibitory concentration against Androgen receptor,CHEMBL1140376,KI,C/C=C1\C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,6.501689446210399
CHEMBL402063,CHEMBL1871,Androgen Receptor,Ki,=,240.0,nM,CHEMBL884739,B,Inhibitory concentration against Androgen receptor,CHEMBL1140376,KI,C/C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,6.619788758288394
CHEMBL198037,CHEMBL1871,Androgen Receptor,Ki,=,3380.0,nM,CHEMBL884809,B,Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]testosterone,CHEMBL1141063,KI,CCC(CC)(c1ccc(NCCC(C)(C)O)c(C)c1)c1ccc(NCCC(C)(C)O)c(C)c1,5.471083299722345
CHEMBL197548,CHEMBL1871,Androgen Receptor,Ki,=,2900.0,nM,CHEMBL884809,B,Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]testosterone,CHEMBL1141063,KI,CCC(CC)(c1ccc(NCCC(C)(C)O)c(C)c1)c1ccc(OCC(=O)C(C)(C)C)c(C)c1,5.537602002101044
CHEMBL370567,CHEMBL1871,Androgen Receptor,Ki,=,1508.0,nM,CHEMBL884809,B,Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]testosterone,CHEMBL1141063,KI,CCC(CC)(c1ccc(NCC(O)CO)c(C)c1)c1ccc(OCC(O)C(C)(C)C)c(C)c1,5.821598658466245
CHEMBL199238,CHEMBL1871,Androgen Receptor,Ki,=,1170.0,nM,CHEMBL884809,B,Binding affinity to androgen receptor by incubation with GST-hARLBD and [3H]testosterone,CHEMBL1141063,KI,CCC(CC)(c1ccc(NCC(O)CO)c(C)c1)c1ccc(OCC(=O)C(C)(C)C)c(C)c1,5.931814138253838
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL858790,B,Inhibition of human AR,CHEMBL1147729,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.721246399047171
CHEMBL197595,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL858790,B,Inhibition of human AR,CHEMBL1147729,KI,C[C@@H]1CN(c2ccc(C#N)c(C(F)(F)F)c2)[C@@H](C)CN1C(=O)Nc1ccc(C(F)(F)F)nc1,8.337242168318426
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.698970004336019
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.823908740944319
CHEMBL267260,CHEMBL1871,Androgen Receptor,Ki,=,7.1,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,Oc1cc(C(F)(F)F)c2cc(N(CC3CC3)CC(F)(F)F)ccc2n1,8.148741651280925
CHEMBL217769,CHEMBL1871,Androgen Receptor,Ki,=,7.1,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCN(CC(F)(F)F)c1ccc2nc(O)cc(C(F)(F)F)c2c1,8.148741651280925
CHEMBL217324,CHEMBL1871,Androgen Receptor,Ki,=,6.3,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,Oc1cc(C(F)(F)F)c2cc(N(CC3CC3)CC3CC3)ccc2n1,8.200659450546418
CHEMBL217402,CHEMBL1871,Androgen Receptor,Ki,=,7.4,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCN(c1ccc2nc(O)cc(C(F)(F)F)c2c1)C(C)C,8.130768280269024
CHEMBL216949,CHEMBL1871,Androgen Receptor,Ki,=,222.0,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCCCN(CCCC)c1ccc2nc(O)cc(C(F)(F)F)c2c1,6.653647025549361
CHEMBL442240,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCCN(CCC)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.1938200260161125
CHEMBL277378,CHEMBL1871,Androgen Receptor,Ki,=,4.4,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCN(CC)c1ccc2nc(O)cc(C(F)(F)F)c2c1,8.356547323513812
CHEMBL217168,CHEMBL1871,Androgen Receptor,Ki,=,153.0,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CN(C)c1ccc2nc(O)cc(C(F)(F)F)c2c1,6.815308569182401
CHEMBL217428,CHEMBL1871,Androgen Receptor,Ki,=,58.0,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CC(C)Nc1ccc2nc(O)cc(C(F)(F)F)c2c1,7.236572006437063
CHEMBL405835,CHEMBL1871,Androgen Receptor,Ki,=,54.0,nM,CHEMBL911185,B,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL1137374,KI,CCCNc1ccc2nc(O)cc(C(F)(F)F)c2c1,7.267606240177031
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.522878745280337
CHEMBL425646,CHEMBL1871,Androgen Receptor,Ki,=,5.3,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12,8.275724130399212
CHEMBL425646,CHEMBL1871,Androgen Receptor,Ki,=,3.2,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12,8.494850021680094
CHEMBL218914,CHEMBL1871,Androgen Receptor,Ki,=,5.5,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,N#Cc1ccc(N2C(=O)C3C(O)CCN3C2=O)c2ccccc12,8.259637310505756
CHEMBL220359,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1[C@@H]2[C@H](O)CCN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.823908740944319
CHEMBL220359,CHEMBL1871,Androgen Receptor,Ki,=,2.1,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1[C@@H]2[C@H](O)CCN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.67778070526608
CHEMBL374781,CHEMBL1871,Androgen Receptor,Ki,=,3.5,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1C2C(O)CCN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.455931955649724
CHEMBL2096842,CHEMBL1871,Androgen Receptor,Ki,=,4.3,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1[C@H]2C[C@H](O)CN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.366531544420413
CHEMBL219198,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1[C@H]2C[C@@H](O)CN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.823908740944319
CHEMBL374121,CHEMBL1871,Androgen Receptor,Ki,=,1.7,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1C2CCCN2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.769551078621726
CHEMBL218809,CHEMBL1871,Androgen Receptor,Ki,=,24.0,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4CC[C@@H](C4)N3C2=O)c2ccccc12,7.619788758288394
CHEMBL384533,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL913352,B,Displacement of [3H]DHT from human AR in MDA453 cells,CHEMBL1138210,KI,O=C1[C@H]2[C@@H]3CC[C@@H](C3)N2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,9.0
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.522878745280337
CHEMBL226609,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCC1CCCCN31,7.795880017344075
CHEMBL227749,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H]1CCCN31,7.568636235841012
CHEMBL227695,CHEMBL1871,Androgen Receptor,Ki,=,109.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC(C)C[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,6.962573502059376
CHEMBL226559,CHEMBL1871,Androgen Receptor,Ki,=,51.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC(C)[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,7.292429823902063
CHEMBL226558,CHEMBL1871,Androgen Receptor,Ki,=,2.8,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.55284196865778
CHEMBL390746,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,7.721246399047171
CHEMBL224263,CHEMBL1871,Androgen Receptor,Ki,=,7.1,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,C[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.148741651280925
CHEMBL227088,CHEMBL1871,Androgen Receptor,Ki,=,5.7,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,C[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.244125144327509
CHEMBL388997,CHEMBL1871,Androgen Receptor,Ki,=,9.4,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.0268721464003
CHEMBL227440,CHEMBL1871,Androgen Receptor,Ki,=,7.8,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.10790539730952
CHEMBL389481,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC1CC1,7.638272163982407
CHEMBL227394,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC1CC1,8.397940008672037
CHEMBL224207,CHEMBL1871,Androgen Receptor,Ki,=,5.6,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC,8.2518119729938
CHEMBL227305,CHEMBL1871,Androgen Receptor,Ki,=,4.2,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCN1c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2OCC1C,8.3767507096021
CHEMBL227033,CHEMBL1871,Androgen Receptor,Ki,=,113.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1,6.94692155651658
CHEMBL227408,CHEMBL1871,Androgen Receptor,Ki,=,25.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1CN(CC(F)(F)F)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.6020599913279625
CHEMBL227408,CHEMBL1871,Androgen Receptor,Ki,=,75.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1CN(CC(F)(F)F)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.1249387366083
CHEMBL376360,CHEMBL1871,Androgen Receptor,Ki,=,30.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1CN(CC(F)(F)F)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.522878745280337
CHEMBL388831,CHEMBL1871,Androgen Receptor,Ki,=,34.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1CN(CC)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.468521082957745
CHEMBL227463,CHEMBL1871,Androgen Receptor,Ki,=,58.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1CN(C)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.236572006437063
CHEMBL227408,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1CN(CC(F)(F)F)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.823908740944319
CHEMBL268589,CHEMBL1871,Androgen Receptor,Ki,=,33.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC1CN(C)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1,7.481486060122112
CHEMBL390577,CHEMBL1871,Androgen Receptor,Ki,=,206.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCCN3Cc1ccccc1,6.686132779630847
CHEMBL227784,CHEMBL1871,Androgen Receptor,Ki,=,1.6,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCCN3CC1CC1,8.795880017344075
CHEMBL227783,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCCN3CC(F)(F)F,8.397940008672037
CHEMBL375907,CHEMBL1871,Androgen Receptor,Ki,=,48.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC(C)(C)N1CCOc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.318758762624412
CHEMBL227645,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CC(C)CN1CCOc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.769551078621726
CHEMBL227590,CHEMBL1871,Androgen Receptor,Ki,=,9.6,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCCN1CCOc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,8.017728766960431
CHEMBL224204,CHEMBL1871,Androgen Receptor,Ki,=,1.2,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCN1CCOc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,8.920818753952375
CHEMBL227030,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CN1CCOc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.823908740944319
CHEMBL390728,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.958607314841775
CHEMBL1445,CHEMBL1871,Androgen Receptor,Ki,=,5.7,nM,CHEMBL916638,B,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL1139861,KI,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C,8.244125144327509
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.698970004336019
CHEMBL3706874,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCC1CCc2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2N1,7.958607314841775
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,151.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.821023052706831
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.823908740944319
CHEMBL3706911,CHEMBL1871,Androgen Receptor,Ki,=,56.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(C)(C)CNc1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.251811972993799
CHEMBL3706910,CHEMBL1871,Androgen Receptor,Ki,=,59.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(C)CNc1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.229147988357855
CHEMBL3706909,CHEMBL1871,Androgen Receptor,Ki,=,74.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2cc(NC3CCCC3)ccc2[nH]1,7.130768280269024
CHEMBL3706908,CHEMBL1871,Androgen Receptor,Ki,=,78.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2cc(NCC(F)(F)C(F)(F)F)ccc2[nH]1,7.107905397309519
CHEMBL3706907,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2cc(NCC(F)(F)F)ccc2[nH]1,7.795880017344075
CHEMBL3706903,CHEMBL1871,Androgen Receptor,Ki,=,157.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NCC(F)(F)F,6.804100347590767
CHEMBL3706902,CHEMBL1871,Androgen Receptor,Ki,=,869.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NC,6.060980223551334
CHEMBL3706901,CHEMBL1871,Androgen Receptor,Ki,=,650.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,Cc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NCC(C)C,6.187086643357144
CHEMBL3706900,CHEMBL1871,Androgen Receptor,Ki,=,641.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCCNc1cc2[nH]c(=O)cc(C(F)(F)F)c2cc1C,6.193141970481182
CHEMBL3706899,CHEMBL1871,Androgen Receptor,Ki,=,13.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCC(C)c1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N,7.886056647693163
CHEMBL3706898,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N,8.045757490560675
CHEMBL3706897,CHEMBL1871,Androgen Receptor,Ki,=,20.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N,7.698970004336019
CHEMBL3706896,CHEMBL1871,Androgen Receptor,Ki,=,30.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,Cc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N,7.522878745280337
CHEMBL3706895,CHEMBL1871,Androgen Receptor,Ki,=,241.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCCN(CC(F)(F)F)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.617982957425132
CHEMBL3706894,CHEMBL1871,Androgen Receptor,Ki,=,30.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCN(CC(F)(F)F)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.522878745280337
CHEMBL3706893,CHEMBL1871,Androgen Receptor,Ki,=,463.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCN(CC)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.334419008982047
CHEMBL3706892,CHEMBL1871,Androgen Receptor,Ki,=,761.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CN(C)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.118615343229427
CHEMBL3706891,CHEMBL1871,Androgen Receptor,Ki,=,163.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NCc3ccccc3)cc2[nH]1,6.787812395596042
CHEMBL3706889,CHEMBL1871,Androgen Receptor,Ki,=,36.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NCC(F)(F)C(F)(F)F)cc2[nH]1,7.443697499232712
CHEMBL3706888,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NCC(F)(F)F)cc2[nH]1,7.823908740944319
CHEMBL3706887,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NC3CCCCC3)cc2[nH]1,6.0
CHEMBL3706886,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NC3CCCC3)cc2[nH]1,6.0
CHEMBL3706885,CHEMBL1871,Androgen Receptor,Ki,=,161.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,O=c1cc(C(F)(F)F)c2ccc(NC3CCC3)cc2[nH]1,6.79317412396815
CHEMBL3706884,CHEMBL1871,Androgen Receptor,Ki,=,118.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,C=CC(C)(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.928117992693874
CHEMBL3706883,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCC(C)(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.958607314841775
CHEMBL3706882,CHEMBL1871,Androgen Receptor,Ki,=,134.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(C)(C)CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.872895201635192
CHEMBL3706881,CHEMBL1871,Androgen Receptor,Ki,=,65.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(C)CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.187086643357144
CHEMBL3706880,CHEMBL1871,Androgen Receptor,Ki,=,79.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.102372908709558
CHEMBL3706879,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCCCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.301029995663981
CHEMBL3706878,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.537602002101044
CHEMBL3706877,CHEMBL1871,Androgen Receptor,Ki,=,83.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.080921907623926
CHEMBL3706876,CHEMBL1871,Androgen Receptor,Ki,=,407.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,6.39040559077478
CHEMBL3706875,CHEMBL1871,Androgen Receptor,Ki,=,37.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CCCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1,7.431798275933005
CHEMBL350877,CHEMBL1871,Androgen Receptor,Ki,=,73.0,nM,CHEMBL887363,B,Binding affinity to human androgen receptor expressed in CV1 cells,CHEMBL1144605,KI,CC1(C)C=Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.136677139879544
CHEMBL397274,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ncccc12,7.6777807052660805
CHEMBL388210,CHEMBL1871,Androgen Receptor,Ki,=,34.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)cc1,7.468521082957745
CHEMBL439873,CHEMBL1871,Androgen Receptor,Ki,=,24.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,COc1cc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc1C#N,7.619788758288394
CHEMBL388421,CHEMBL1871,Androgen Receptor,Ki,=,7.8,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)cc1C(F)(F)F,8.10790539730952
CHEMBL230052,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)cc1Cl,8.823908740944319
CHEMBL230053,CHEMBL1871,Androgen Receptor,Ki,=,48.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)cc1-c1ccccc1,7.318758762624412
CHEMBL389606,CHEMBL1871,Androgen Receptor,Ki,=,8.5,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1cc(C#N)ccc1N1C(=O)[C@@H]2[C@H](O)CCN2C1=O,8.070581074285707
CHEMBL389607,CHEMBL1871,Androgen Receptor,Ki,=,4.5,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(C#N)ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c1C,8.346787486224656
CHEMBL230694,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1C(F)(F)F,8.537602002101044
CHEMBL230695,CHEMBL1871,Androgen Receptor,Ki,=,3.7,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,COc1c(C#N)ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c1C,8.431798275933005
CHEMBL390849,CHEMBL1871,Androgen Receptor,Ki,=,1.3,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1F,8.886056647693163
CHEMBL229264,CHEMBL1871,Androgen Receptor,Ki,=,2.1,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.67778070526608
CHEMBL398226,CHEMBL1871,Androgen Receptor,Ki,=,1.2,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Br,8.920818753952375
CHEMBL231014,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1C#N,8.096910013008056
CHEMBL231015,CHEMBL1871,Androgen Receptor,Ki,=,4.3,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c(F)c1F,8.366531544420413
CHEMBL394592,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c(F)c1Cl,8.522878745280337
CHEMBL394593,CHEMBL1871,Androgen Receptor,Ki,=,6.1,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,COc1c(C#N)ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c1Cl,8.214670164989233
CHEMBL231122,CHEMBL1871,Androgen Receptor,Ki,=,0.7,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,Cc1c(C#N)ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c1Cl,9.154901959985743
CHEMBL395502,CHEMBL1871,Androgen Receptor,Ki,=,8.1,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,COc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1C,8.09151498112135
CHEMBL231327,CHEMBL1871,Androgen Receptor,Ki,=,7.9,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,COc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1C(F)(F)F,8.102372908709558
CHEMBL231328,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,CCc1cc(C#N)ccc1N1C(=O)[C@@H]2[C@H](O)CCN2C1=O,7.853871964321762
CHEMBL397217,CHEMBL1871,Androgen Receptor,Ki,=,3.3,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,CCc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1C(F)(F)F,8.481486060122112
CHEMBL425646,CHEMBL1871,Androgen Receptor,Ki,=,3.2,nM,CHEMBL887415,B,Binding affinity to human AR,CHEMBL1144612,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12,8.494850021680094
CHEMBL229264,CHEMBL1871,Androgen Receptor,Ki,=,1.4,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.853871964321762
CHEMBL395483,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,CC1=C(c2ccc(C#N)c(Cl)c2C)C(=O)N2CC[C@H](O)[C@@H]12,9.301029995663981
CHEMBL390594,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@@H](O)[C@H]3[C@H]2C(C)C)ccc(C#N)c1Cl,7.638272163982407
CHEMBL229211,CHEMBL1871,Androgen Receptor,Ki,=,2.2,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@@H](O)[C@H]3[C@H]2C(F)(F)F)ccc(C#N)c1Cl,8.657577319177793
CHEMBL390593,CHEMBL1871,Androgen Receptor,Ki,=,2.3,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,CC[C@@H]1[C@@H]2[C@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,8.638272163982407
CHEMBL229210,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@@H](O)[C@H]3[C@@H]2C(F)(F)F)ccc(C#N)c1Cl,9.0
CHEMBL229160,CHEMBL1871,Androgen Receptor,Ki,=,0.7,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,CC[C@H]1[C@@H]2[C@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,9.154901959985743
CHEMBL229159,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@@H](O)[C@H]3[C@@H]2C)ccc(C#N)c1Cl,8.537602002101044
CHEMBL389250,CHEMBL1871,Androgen Receptor,Ki,=,1.9,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@H](O)[C@H]3[C@H]2C(F)(F)F)ccc(C#N)c1Cl,8.721246399047171
CHEMBL229916,CHEMBL1871,Androgen Receptor,Ki,=,1.6,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,CC[C@@H]1[C@@H]2[C@@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,8.795880017344075
CHEMBL229862,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@H](O)[C@H]3[C@H]2C)ccc(C#N)c1Cl,8.397940008672037
CHEMBL375918,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@H](O)[C@H]3[C@@H]2C(F)(F)F)ccc(C#N)c1Cl,9.045757490560675
CHEMBL229861,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,CC[C@H]1[C@@H]2[C@@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,9.045757490560675
CHEMBL229860,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C(=O)N3CC[C@H](O)[C@H]3[C@@H]2C)ccc(C#N)c1Cl,8.823908740944319
CHEMBL389077,CHEMBL1871,Androgen Receptor,Ki,=,2.2,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C[C@@H]3[C@H](O)CC[C@@H]3C2=O)ccc(C#N)c1Cl,8.657577319177793
CHEMBL229808,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,Cc1c(N2C[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.698970004336019
CHEMBL425646,CHEMBL1871,Androgen Receptor,Ki,=,3.2,nM,CHEMBL888425,B,Displacement of [3H]DHT from androgen receptor expressed in MDA-MB-453 cells,CHEMBL1145402,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12,8.494850021680094
CHEMBL394369,CHEMBL1871,Androgen Receptor,Ki,=,290.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1sccc1CO)O2)C(C)=CC(C)(C)N3,6.537602002101044
CHEMBL428922,CHEMBL1871,Androgen Receptor,Ki,=,346.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,CC/C=C(\C)c1ccsc1/C=C1\Oc2ccc(O)c(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.460923901207224
CHEMBL397920,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,CO/N=C(\C)c1ccsc1/C=C1\Oc2ccc(O)c(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.958607314841775
CHEMBL244537,CHEMBL1871,Androgen Receptor,Ki,=,1530.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1sccc1C(C)O)O2)C(C)=CC(C)(C)N3,5.815308569182401
CHEMBL397919,CHEMBL1871,Androgen Receptor,Ki,=,290.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1sccc1/C(C)=N/O)O2)C(C)=CC(C)(C)N3,6.537602002101044
CHEMBL243656,CHEMBL1871,Androgen Receptor,Ki,=,1900.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1sccc1C(O)C(F)(F)F)O2)C(C)=CC(C)(C)N3,5.721246399047171
CHEMBL395716,CHEMBL1871,Androgen Receptor,Ki,=,150.0,nM,CHEMBL896165,B,Binding affinity to AR,CHEMBL1148778,KI,COCc1ccsc1/C=C1\Oc2ccc(O)c(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.823908740944319
CHEMBL446191,CHEMBL1871,Androgen Receptor,Ki,=,1700.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,O=c1cc(C(F)(F)F)c2cc(N3CCCC3)ccc2[nH]1,5.769551078621726
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,70.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.154901959985743
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.698970004336019
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.337242168318426
CHEMBL2113293,CHEMBL1871,Androgen Receptor,Ki,=,7.6,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@H]([C@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.119186407719209
CHEMBL467888,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.823908740944319
CHEMBL395992,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@H](CCl)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.0
CHEMBL243252,CHEMBL1871,Androgen Receptor,Ki,=,70.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@H](CO)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.154901959985743
CHEMBL243251,CHEMBL1871,Androgen Receptor,Ki,=,43.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@@H](C)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.366531544420413
CHEMBL244896,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,C[C@@H]1CC[C@H](C)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.721246399047171
CHEMBL244895,CHEMBL1871,Androgen Receptor,Ki,=,72.0,nM,CHEMBL896869,B,Binding affinity to human AR,CHEMBL1148826,KI,CC1CCCN1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.142667503568731
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,1.5,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.823908740944319
CHEMBL235346,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,Cc1cc(=O)[nH]c2ccc(N(CC(C)C)CC(F)(F)F)cc12,7.920818753952375
CHEMBL235347,CHEMBL1871,Androgen Receptor,Ki,=,9.8,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@@H](CCl)N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.008773924307505
CHEMBL394194,CHEMBL1871,Androgen Receptor,Ki,=,5.4,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@H](CCl)N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.267606240177031
CHEMBL235128,CHEMBL1871,Androgen Receptor,Ki,=,112.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@H](N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1)C(F)(F)F,6.950781977329818
CHEMBL235127,CHEMBL1871,Androgen Receptor,Ki,=,9.2,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@@H](N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1)C(F)(F)F,8.036212172654444
CHEMBL235126,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(O)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,6.0
CHEMBL393280,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,COc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12,7.638272163982407
CHEMBL238332,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(Br)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.301029995663981
CHEMBL238331,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(Cl)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.301029995663981
CHEMBL238330,CHEMBL1871,Androgen Receptor,Ki,=,0.4,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.397940008672037
CHEMBL238124,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CC(C)c1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12,7.6777807052660805
CHEMBL392004,CHEMBL1871,Androgen Receptor,Ki,=,42.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCCc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12,7.376750709602099
CHEMBL238123,CHEMBL1871,Androgen Receptor,Ki,=,5.4,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12,8.267606240177031
CHEMBL238122,CHEMBL1871,Androgen Receptor,Ki,=,1.4,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,Cc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12,8.853871964321762
CHEMBL391798,CHEMBL1871,Androgen Receptor,Ki,=,24.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1ccc2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,7.619788758288394
CHEMBL3706931,CHEMBL1871,Androgen Receptor,Ki,=,3.1,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CC(=O)C(C)N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.508638306165727
CHEMBL3706930,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(Cc3ccoc3)CC(F)(F)F)ccc2[nH]1,7.853871964321762
CHEMBL3706929,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=C(N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1)C(F)(F)F,6.0
CHEMBL3706928,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCOC(=O)CN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.721246399047171
CHEMBL3706927,CHEMBL1871,Androgen Receptor,Ki,=,61.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(Cc3cccs3)CC(F)(F)F)ccc2[nH]1,7.214670164989233
CHEMBL3706926,CHEMBL1871,Androgen Receptor,Ki,=,79.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(Cc3ccccc3)CC(F)(F)F)ccc2[nH]1,7.102372908709558
CHEMBL237682,CHEMBL1871,Androgen Receptor,Ki,=,6.6,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CCO)CC(F)(F)F)ccc2[nH]1,8.18045606445813
CHEMBL237681,CHEMBL1871,Androgen Receptor,Ki,=,31.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)C(F)(F)F)ccc2[nH]1,7.508638306165727
CHEMBL391940,CHEMBL1871,Androgen Receptor,Ki,=,116.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CCC(F)(F)F)CC(F)(F)F)ccc2[nH]1,6.935542010773082
CHEMBL428026,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(Cl)Cl)CC(F)(F)F)ccc2[nH]1,8.221848749616356
CHEMBL237474,CHEMBL1871,Androgen Receptor,Ki,=,2.6,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CCCl)CC(F)(F)F)ccc2[nH]1,8.585026652029182
CHEMBL440980,CHEMBL1871,Androgen Receptor,Ki,=,1.7,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)F)CC(F)(F)F)ccc2[nH]1,8.769551078621726
CHEMBL393865,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCC(C)N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.537602002101044
CHEMBL237473,CHEMBL1871,Androgen Receptor,Ki,=,243.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CC(C)(C)CCN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,6.614393726401688
CHEMBL237472,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CC(C)(C)CN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.920818753952375
CHEMBL237262,CHEMBL1871,Androgen Receptor,Ki,=,2.9,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CC(C)N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.537602002101044
CHEMBL393864,CHEMBL1871,Androgen Receptor,Ki,=,33.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCCCN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.481486060122112
CHEMBL237261,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCCN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.920818753952375
CHEMBL217769,CHEMBL1871,Androgen Receptor,Ki,=,7.1,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCN(CC(F)(F)F)c1ccc2nc(O)cc(C(F)(F)F)c2c1,8.148741651280925
CHEMBL237259,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.045757490560675
CHEMBL393664,CHEMBL1871,Androgen Receptor,Ki,=,2.3,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)F)CC(F)(F)Cl)ccc2[nH]1,8.638272163982407
CHEMBL237045,CHEMBL1871,Androgen Receptor,Ki,=,0.5,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)F)CC(F)F)ccc2[nH]1,9.301029995663981
CHEMBL442240,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCCN(CCC)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,7.1938200260161125
CHEMBL277378,CHEMBL1871,Androgen Receptor,Ki,=,4.4,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,CCN(CC)c1ccc2nc(O)cc(C(F)(F)F)c2c1,8.356547323513812
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.698970004336019
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,151.0,nM,CHEMBL891115,B,Binding affinity to human AR,CHEMBL1147033,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.821023052706831
CHEMBL3706946,CHEMBL1871,Androgen Receptor,Ki,=,910.0,nM,CHEMBL896651,B,Binding affinity at AR,CHEMBL1149550,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1cccc(O)c1)O2)C(C)=CC(C)(C)N3,6.040958607678906
CHEMBL3706943,CHEMBL1871,Androgen Receptor,Ki,=,570.0,nM,CHEMBL896651,B,Binding affinity at AR,CHEMBL1149550,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1cccc(C)c1)O2)C(C)=CC(C)(C)N3,6.2441251443275085
CHEMBL3706942,CHEMBL1871,Androgen Receptor,Ki,=,630.0,nM,CHEMBL896651,B,Binding affinity at AR,CHEMBL1149550,KI,COCOCc1cc(F)ccc1/C=C1\Oc2ccc(O)c(OC)c2-c2ccc3c(c21)C(C)=CC(C)(C)N3,6.200659450546418
CHEMBL3706940,CHEMBL1871,Androgen Receptor,Ki,=,700.0,nM,CHEMBL896651,B,Binding affinity at AR,CHEMBL1149550,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1ccc(F)cc1CO)O2)C(C)=CC(C)(C)N3,6.154901959985743
CHEMBL1170,CHEMBL1871,Androgen Receptor,Ki,=,0.25,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,9.602059991327963
CHEMBL234394,CHEMBL1871,Androgen Receptor,Ki,=,36.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,COC(=O)[C@@H]1[C@H](O)CCN1S(=O)(=O)c1ccc(C#N)c(Cl)c1C,7.443697499232712
CHEMBL234185,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C[C@@H]3[C@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,7.853871964321762
CHEMBL391770,CHEMBL1871,Androgen Receptor,Ki,=,20.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(C)[C@@H]3[C@@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,7.698970004336019
CHEMBL233977,CHEMBL1871,Androgen Receptor,Ki,=,189.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C[C@@H]3[C@@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,6.723538195826755
CHEMBL391769,CHEMBL1871,Androgen Receptor,Ki,=,44.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(=O)[C@@H]3C[C@H](O)CN3S2(=O)=O)ccc(C#N)c1Cl,7.356547323513812
CHEMBL391768,CHEMBL1871,Androgen Receptor,Ki,=,8.2,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(=O)[C@]3(C)[C@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,8.086186147616283
CHEMBL233774,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(=O)[C@@H]3[C@@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,7.537602002101044
CHEMBL233773,CHEMBL1871,Androgen Receptor,Ki,=,0.45,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,9.346787486224656
CHEMBL229264,CHEMBL1871,Androgen Receptor,Ki,=,2.11,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.675717544702307
CHEMBL425646,CHEMBL1871,Androgen Receptor,Ki,=,3.2,nM,CHEMBL896728,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1149563,KI,N#Cc1ccc(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)c2ccccc12,8.494850021680094
CHEMBL235206,CHEMBL1871,Androgen Receptor,Ki,=,700.1,nM,CHEMBL902630,B,Binding affinity to human androgen receptor,CHEMBL1138341,KI,C[C@@](c1ccc(F)cc1F)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.154839922348055
CHEMBL1393,CHEMBL1871,Androgen Receptor,Ki,=,39.4,nM,CHEMBL902630,B,Binding affinity to human androgen receptor,CHEMBL1138341,KI,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@H]12,7.404503778174426
CHEMBL237122,CHEMBL1871,Androgen Receptor,Ki,=,8892.0,nM,CHEMBL902630,B,Binding affinity to human androgen receptor,CHEMBL1138341,KI,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)C2C1C1CC[C@@]3(CCC(=O)O3)[C@@]1(C)[C@H]1O[C@@H]21,5.0510005459730465
CHEMBL391439,CHEMBL1871,Androgen Receptor,Ki,=,590.0,nM,CHEMBL902630,B,Binding affinity to human androgen receptor,CHEMBL1138341,KI,C[C@](c1ccc(F)cc1)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.229147988357855
CHEMBL235209,CHEMBL1871,Androgen Receptor,Ki,=,849.0,nM,CHEMBL902630,B,Binding affinity to human androgen receptor,CHEMBL1138341,KI,C[C@@](c1ccc(F)cc1)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.071092309756047
CHEMBL367364,CHEMBL1871,Androgen Receptor,Ki,=,360.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(C3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,6.443697499232712
CHEMBL272574,CHEMBL1871,Androgen Receptor,Ki,=,2.41,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12C[C@@H](O)C(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@H]12,8.61798295742513
CHEMBL255331,CHEMBL1871,Androgen Receptor,Ki,=,7.18,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12C[C@H](O)C(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12,8.143875555757699
CHEMBL403039,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc([N+](=O)[O-])c4c(Br)cccc34)C(=O)[C@H]12,7.769551078621726
CHEMBL255216,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)n4nccc34)C(=O)[C@H]12,7.7447274948966935
CHEMBL446626,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)c4nsnc34)C(=O)[C@H]12,8.522878745280337
CHEMBL271261,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3c(N)ccc4nccn34)C(=O)[C@H]12,7.568636235841012
CHEMBL271262,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3c(N)ccc4ncsc34)C(=O)[C@H]12,7.769551078621726
CHEMBL403061,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,COc1cc(N2C(=O)[C@@H]3[C@H](C2=O)C2(C)CCC3(C)O2)ccc1-c1cnco1,7.920818753952375
CHEMBL403213,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3cnc(C#N)c(Cl)c3)C(=O)[C@H]12,8.397940008672037
CHEMBL403214,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc([N+](=O)[O-])c(C(F)(F)F)c3)C(=O)[C@H]12,7.769551078621726
CHEMBL257668,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)[C@H]12,8.522878745280337
CHEMBL272509,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CSc1cc(N2C(=O)[C@@H]3[C@H](C2=O)C2(C)CCC3(C)O2)ccc1C#N,8.522878745280337
CHEMBL403668,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@H]12,9.0
CHEMBL403669,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.769551078621726
CHEMBL272510,CHEMBL1871,Androgen Receptor,Ki,=,41.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(C)(O1)[C@H]1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)[C@H]12,7.3872161432802645
CHEMBL404506,CHEMBL1871,Androgen Receptor,Ki,=,410.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC12CCC(O1)[C@H]1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)[C@H]12,6.3872161432802645
CHEMBL255157,CHEMBL1871,Androgen Receptor,Ki,=,4100.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1,5.3872161432802645
CHEMBL427721,CHEMBL1871,Androgen Receptor,Ki,=,1170.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,N#Cc1ccc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)cc1C(F)(F)F,5.931814138253838
CHEMBL271925,CHEMBL1871,Androgen Receptor,Ki,=,1110.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c(C(F)(F)F)c1,5.954677021213342
CHEMBL271924,CHEMBL1871,Androgen Receptor,Ki,=,692.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c([N+](=O)[O-])c1,6.1598939055432425
CHEMBL255367,CHEMBL1871,Androgen Receptor,Ki,=,77.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,Cc1cc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)ccc1Cl,7.113509274827518
CHEMBL437214,CHEMBL1871,Androgen Receptor,Ki,=,486.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,Cc1ccc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)cc1Cl,6.313363730737707
CHEMBL270450,CHEMBL1871,Androgen Receptor,Ki,=,377.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1,6.423658649794207
CHEMBL270586,CHEMBL1871,Androgen Receptor,Ki,=,221.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(I)c(Cl)c1,6.655607726314889
CHEMBL402930,CHEMBL1871,Androgen Receptor,Ki,=,53.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Br)c2ccccc12,7.275724130399211
CHEMBL402807,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12,8.522878745280337
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,43.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,7.366531544420413
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL404315,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,CC(C)(C)OC(=O)N1CC2CC1[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21,7.3979400086720375
CHEMBL255776,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL933063,B,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL1142249,KI,O=C1[C@H]2C3CCC(C3)N2C(=O)N1c1cccc(C(F)(F)F)c1,7.6777807052660805
CHEMBL259820,CHEMBL1871,Androgen Receptor,Ki,=,910.0,nM,CHEMBL931334,B,Binding affinity to human recombinant androgen receptor expressed in SF9 cells,CHEMBL1147082,KI,COc1c(O)ccc2c1-c1ccc3c(c1/C(=C/c1cccc(C)c1F)O2)C(C)=CC(C)(C)N3,6.040958607678906
CHEMBL404512,CHEMBL1871,Androgen Receptor,Ki,=,15.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](CO)N3CC(F)(F)F,7.823908740944319
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,151.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.821023052706831
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.045757490560675
CHEMBL224263,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,C[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,9.045757490560675
CHEMBL257988,CHEMBL1871,Androgen Receptor,Ki,=,281.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](C(F)(F)F)N3CC(F)(F)F,6.55129368009492
CHEMBL401805,CHEMBL1871,Androgen Receptor,Ki,=,5.9,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](C(F)(F)F)N3CC(F)(F)F,8.229147988357855
CHEMBL256330,CHEMBL1871,Androgen Receptor,Ki,=,8.3,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCC(C(F)(F)F)N3CC(F)(F)F,8.080921907623926
CHEMBL257387,CHEMBL1871,Androgen Receptor,Ki,=,180.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,Cc1cccc([C@H]2COc3cc4[nH]c(=O)cc(C(F)(F)F)c4cc3N2CC(F)(F)F)c1,6.7447274948966935
CHEMBL257379,CHEMBL1871,Androgen Receptor,Ki,=,1.1,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,Cc1cccc([C@@H]2COc3cc4[nH]c(=O)cc(C(F)(F)F)c4cc3N2CC(F)(F)F)c1,8.958607314841775
CHEMBL404222,CHEMBL1871,Androgen Receptor,Ki,=,150.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](c1ccccc1)N3CC(F)(F)F,6.823908740944319
CHEMBL402835,CHEMBL1871,Androgen Receptor,Ki,=,1.3,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](c1ccccc1)N3CC(F)(F)F,8.886056647693163
CHEMBL404483,CHEMBL1871,Androgen Receptor,Ki,=,2.4,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,CSCC[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.619788758288394
CHEMBL256284,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](CC(F)(F)F)N3CC(F)(F)F,7.7447274948966935
CHEMBL256326,CHEMBL1871,Androgen Receptor,Ki,=,6.6,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCC(C(F)F)N3CC(F)(F)F,8.18045606445813
CHEMBL254798,CHEMBL1871,Androgen Receptor,Ki,=,32.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](CF)N3CC(F)(F)F,7.494850021680094
CHEMBL429311,CHEMBL1871,Androgen Receptor,Ki,=,2.6,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](CF)N3CC(F)(F)F,8.585026652029182
CHEMBL256126,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,N#CCC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,7.7447274948966935
CHEMBL404568,CHEMBL1871,Androgen Receptor,Ki,=,109.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,COC[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,6.962573502059376
CHEMBL402039,CHEMBL1871,Androgen Receptor,Ki,=,9.4,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,COC[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.0268721464003
CHEMBL436644,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL933554,B,Displacement of [3H]DHT from human Androgen receptor in human MDA-MB-453 cells,CHEMBL1145608,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](CO)N3CC(F)(F)F,7.657577319177793
CHEMBL258241,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,Cc1cc(=O)[nH]c2ccc3c4cc(F)ccc4oc(=O)c3c12,6.0
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.698970004336019
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,151.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.821023052706831
CHEMBL402136,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1OC2,7.568636235841012
CHEMBL450334,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1ccccc1CO3,8.096910013008056
CHEMBL257751,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,O=c1cc(C(F)(F)F)c2c(ccc3c2oc(=O)c2cccc(O)c23)[nH]1,8.522878745280337
CHEMBL403219,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c(=O)oc3c(ccc4[nH]c(=O)cc(C(F)(F)F)c43)c12,7.301029995663981
CHEMBL253535,CHEMBL1871,Androgen Receptor,Ki,=,1.3,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1c(O)cccc1OC3,8.886056647693163
CHEMBL401629,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1CO2,7.958607314841775
CHEMBL258384,CHEMBL1871,Androgen Receptor,Ki,=,1593.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,C=CCC1Oc2cccc(OC)c2-c2ccc3[nH]c(=O)cc(C)c3c21,5.797784224198868
CHEMBL253744,CHEMBL1871,Androgen Receptor,Ki,=,250.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(C)O2,6.6020599913279625
CHEMBL253746,CHEMBL1871,Androgen Receptor,Ki,=,2346.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(OC)O2,5.629671992220489
CHEMBL258190,CHEMBL1871,Androgen Receptor,Ki,=,1300.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(O)O2,5.886056647693163
CHEMBL427731,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1c(O)ccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2,8.301029995663981
CHEMBL257151,CHEMBL1871,Androgen Receptor,Ki,=,26.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,Cc1cc(=O)[nH]c2ccc3c(c12)COc1cccc(CO)c1-3,7.585026652029182
CHEMBL256947,CHEMBL1871,Androgen Receptor,Ki,=,59.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2,7.229147988357855
CHEMBL256768,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1c(OC(C)C)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,7.6777807052660805
CHEMBL256977,CHEMBL1871,Androgen Receptor,Ki,=,62.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,CCOc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1OC,7.207608310501746
CHEMBL256769,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1c(C(=O)OC(F)(F)F)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,8.0
CHEMBL427898,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1c(O)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,8.397940008672037
CHEMBL401711,CHEMBL1871,Androgen Receptor,Ki,=,8.7,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,Cc1cc(=O)[nH]c2ccc3c4c(C(=O)OC(C)(C)C)cccc4oc(=O)c3c12,8.060480747381382
CHEMBL450933,CHEMBL1871,Androgen Receptor,Ki,=,28.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1cccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12,7.552841968657781
CHEMBL258397,CHEMBL1871,Androgen Receptor,Ki,=,610.0,nM,CHEMBL930492,B,Binding affinity to human androgen receptor expressed in monkey COS7 cells by whole cell binding assay,CHEMBL1143080,KI,COc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1,6.214670164989233
CHEMBL258191,CHEMBL1871,Androgen Receptor,Ki,=,57.0,nM,CHEMBL931545,B,Binding affinity at androgen receptor,CHEMBL1145597,KI,Cc1cc(-c2cccc3cc[nH]c23)c(Cl)c2c1NC(C)(C)CC2C,7.2441251443275085
CHEMBL253745,CHEMBL1871,Androgen Receptor,Ki,=,1500.0,nM,CHEMBL931545,B,Binding affinity at androgen receptor,CHEMBL1145597,KI,COc1ccc2cc[nH]c2c1-c1cc(C)c2c(c1Cl)C(C)CC(C)(C)N2,5.823908740944319
CHEMBL429842,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL931545,B,Binding affinity at androgen receptor,CHEMBL1145597,KI,Cc1cc(-c2cc(F)c(F)c3cc[nH]c23)c(Cl)c2c1NC(C)(C)CC2C,7.301029995663981
CHEMBL257152,CHEMBL1871,Androgen Receptor,Ki,=,780.0,nM,CHEMBL931545,B,Binding affinity at androgen receptor,CHEMBL1145597,KI,Cc1cc(-c2ccc(F)c3cc[nH]c23)c(Cl)c2c1NC(C)(C)CC2C,6.107905397309519
CHEMBL806,CHEMBL1871,Androgen Receptor,Ki,=,3700.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,5.431798275933005
CHEMBL482064,CHEMBL1871,Androgen Receptor,Ki,=,370.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,O=C(c1cccc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)c1)N1CCCC1,6.431798275933005
CHEMBL482063,CHEMBL1871,Androgen Receptor,Ki,=,340.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,O=C(c1ccc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1)N1CCCC1,6.468521082957745
CHEMBL520428,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCCC1,6.958607314841775
CHEMBL481139,CHEMBL1871,Androgen Receptor,Ki,=,100.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CCN(CC)C(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C,7.0
CHEMBL480162,CHEMBL1871,Androgen Receptor,Ki,=,220.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(N)=O,6.657577319177793
CHEMBL519112,CHEMBL1871,Androgen Receptor,Ki,=,75.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)O,7.1249387366083
CHEMBL480960,CHEMBL1871,Androgen Receptor,Ki,=,170.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1CO,6.769551078621726
CHEMBL521251,CHEMBL1871,Androgen Receptor,Ki,=,180.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CCOC(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C,6.7447274948966935
CHEMBL480959,CHEMBL1871,Androgen Receptor,Ki,=,180.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,COC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,6.7447274948966935
CHEMBL479988,CHEMBL1871,Androgen Receptor,Ki,=,140.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,6.853871964321762
CHEMBL521249,CHEMBL1871,Androgen Receptor,Ki,=,270.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)cc1C(=O)N1CCCC1,6.568636235841012
CHEMBL480955,CHEMBL1871,Androgen Receptor,Ki,=,130.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc(C#N)cc2)cc1C(=O)N1CCCC1,6.886056647693163
CHEMBL520603,CHEMBL1871,Androgen Receptor,Ki,=,1300.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccccc2[N+](=O)[O-])cc1C(=O)N1CCCC1,5.886056647693163
CHEMBL481746,CHEMBL1871,Androgen Receptor,Ki,=,1800.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(CO)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,5.7447274948966935
CHEMBL480934,CHEMBL1871,Androgen Receptor,Ki,=,730.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(O)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.136677139879544
CHEMBL481939,CHEMBL1871,Androgen Receptor,Ki,=,810.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1ccc(CN(c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,6.0915149811213505
CHEMBL481107,CHEMBL1871,Androgen Receptor,Ki,=,800.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(F)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.096910013008056
CHEMBL518945,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.958607314841775
CHEMBL519780,CHEMBL1871,Androgen Receptor,Ki,=,520.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(N(CC2CCCCC2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.2839966563652006
CHEMBL481356,CHEMBL1871,Androgen Receptor,Ki,=,3400.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CC(C)N(c1ccc([N+](=O)[O-])cc1)c1cc(C(=O)N2CCCC2)n(C)c1,5.468521082957745
CHEMBL481355,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CCN(c1ccc([N+](=O)[O-])cc1)c1cc(C(=O)N2CCCC2)n(C)c1,5.698970004336019
CHEMBL481350,CHEMBL1871,Androgen Receptor,Ki,=,3600.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CN(c1ccc([N+](=O)[O-])cc1)c1cc(C(=O)N2CCCC2)n(C)c1,5.443697499232712
CHEMBL481686,CHEMBL1871,Androgen Receptor,Ki,=,2200.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(Cc2ccc(CO)cc2)c2cc(C(=O)N3CCCC3)n(C)c2)c1,5.657577319177793
CHEMBL481515,CHEMBL1871,Androgen Receptor,Ki,=,690.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(Cc2ccc(O)cc2)c2cc(C(=O)N3CCCC3)n(C)c2)c1,6.161150909262744
CHEMBL481514,CHEMBL1871,Androgen Receptor,Ki,=,350.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)c1,6.455931955649724
CHEMBL519450,CHEMBL1871,Androgen Receptor,Ki,=,490.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(CC2CCCCC2)c2cc(C(=O)N3CCCC3)n(C)c2)c1,6.309803919971486
CHEMBL516752,CHEMBL1871,Androgen Receptor,Ki,=,2700.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(c2cc(C(=O)N3CCCC3)n(C)c2)C(C)C)c1,5.568636235841012
CHEMBL481152,CHEMBL1871,Androgen Receptor,Ki,=,2700.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CCN(c1cc(C)cc(C)c1)c1cc(C(=O)N2CCCC2)n(C)c1,5.568636235841012
CHEMBL480183,CHEMBL1871,Androgen Receptor,Ki,=,6100.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(N(C)c2cc(C(=O)N3CCCC3)n(C)c2)c1,5.214670164989233
CHEMBL516610,CHEMBL1871,Androgen Receptor,Ki,=,4900.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cn1cc(Nc2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,5.309803919971486
CHEMBL444991,CHEMBL1871,Androgen Receptor,Ki,=,3100.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,Cc1cc(C)cc(Nc2cc(C(=O)N3CCCC3)n(C)c2)c1,5.508638306165727
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,3700.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.431798275933005
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,430.0,nM,CHEMBL1013140,B,Displacement of [3H]testosterone from wild type human androgen receptor,CHEMBL1155056,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,6.366531544420413
CHEMBL491,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.522878745280337
CHEMBL503676,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCc2ccccc21,8.045757490560675
CHEMBL520428,CHEMBL1871,Androgen Receptor,Ki,=,27.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCCC1,7.568636235841012
CHEMBL481139,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,CCN(CC)C(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C,8.522878745280337
CHEMBL519112,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)O,8.522878745280337
CHEMBL521251,CHEMBL1871,Androgen Receptor,Ki,=,100.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,CCOC(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C,7.0
CHEMBL480959,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,COC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,8.154901959985743
CHEMBL479988,CHEMBL1871,Androgen Receptor,Ki,=,130.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,CC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,6.886056647693163
CHEMBL521249,CHEMBL1871,Androgen Receptor,Ki,=,36.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)cc1C(=O)N1CCCC1,7.443697499232712
CHEMBL480955,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc(C#N)cc2)cc1C(=O)N1CCCC1,8.221848749616356
CHEMBL481924,CHEMBL1871,Androgen Receptor,Ki,=,49.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1C(=O)N1CCCC1,7.309803919971486
CHEMBL481746,CHEMBL1871,Androgen Receptor,Ki,=,1400.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(CO)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,5.853871964321762
CHEMBL480934,CHEMBL1871,Androgen Receptor,Ki,=,330.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(O)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.481486060122112
CHEMBL481939,CHEMBL1871,Androgen Receptor,Ki,=,130.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cc1ccc(CN(c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1,6.886056647693163
CHEMBL481107,CHEMBL1871,Androgen Receptor,Ki,=,140.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccc(F)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.853871964321762
CHEMBL518945,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,8.301029995663981
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL1013146,B,Displacement of [3H]testosterone from human recombinant androgen receptor T877A mutant expressed in LNCaP cells,CHEMBL1155056,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.0
CHEMBL514646,CHEMBL1871,Androgen Receptor,Ki,=,7400.0,nM,CHEMBL1022893,B,Displacement of radioligand from androgen receptor by fluorescence polarization assay,CHEMBL1138590,KI,C[C@@]1(C(=O)Nc2nccs2)CC2c3ccccc3C1c1ccccc12,5.130768280269024
CHEMBL474189,CHEMBL1871,Androgen Receptor,Ki,=,2900.0,nM,CHEMBL1022893,B,Displacement of radioligand from androgen receptor by fluorescence polarization assay,CHEMBL1138590,KI,CC12CC(C)(C(=O)Nc3nccs3)C(c3ccccc31)c1ccccc12,5.537602002101044
CHEMBL514630,CHEMBL1871,Androgen Receptor,Ki,=,9300.0,nM,CHEMBL1022893,B,Displacement of radioligand from androgen receptor by fluorescence polarization assay,CHEMBL1138590,KI,CC12CC(C)(C(=O)Nc3nncs3)C(c3ccccc31)c1ccccc12,5.031517051446064
CHEMBL229264,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,7.853871964321762
CHEMBL229808,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(N2C[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.221848749616356
CHEMBL484919,CHEMBL1871,Androgen Receptor,Ki,=,0.8,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\OC[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,9.096910013008056
CHEMBL520174,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\OC[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl,9.522878745280337
CHEMBL484726,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\O[C@@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl,9.522878745280337
CHEMBL484727,CHEMBL1871,Androgen Receptor,Ki,=,0.2,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\O[C@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl,9.698970004336019
CHEMBL521329,CHEMBL1871,Androgen Receptor,Ki,=,2.3,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\O[C@H](C(F)(F)F)[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,8.638272163982407
CHEMBL484728,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\O[C@@H](C(F)(F)F)[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,9.522878745280337
CHEMBL483745,CHEMBL1871,Androgen Receptor,Ki,=,0.7,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\O[C@@H](C(C)C)[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,9.154901959985743
CHEMBL483746,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\NC[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,8.0
CHEMBL519169,CHEMBL1871,Androgen Receptor,Ki,=,1.9,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\N(C)C[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,8.721246399047171
CHEMBL483941,CHEMBL1871,Androgen Receptor,Ki,=,19.0,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(/N=C2\N(C(N)=O)C[C@@H]3[C@H](O)CCN23)ccc(C#N)c1Cl,7.721246399047171
CHEMBL482549,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(N2C(NC#N)N3CC[C@H](O)[C@H]3[C@@H]2C)ccc(C#N)c1Cl,7.769551078621726
CHEMBL229860,CHEMBL1871,Androgen Receptor,Ki,=,1.6,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,Cc1c(N2C(=O)N3CC[C@H](O)[C@H]3[C@@H]2C)ccc(C#N)c1Cl,8.795880017344075
CHEMBL229861,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL996725,B,Displacement of [3H[DHT from androgen receptor endogenously expressed in human MDA-MB-453 cells,CHEMBL1138465,KI,CC[C@H]1[C@@H]2[C@@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,9.045757490560675
CHEMBL522172,CHEMBL1871,Androgen Receptor,Ki,=,1500.0,nM,CHEMBL1103121,B,Inhibition of AR,CHEMBL1154969,KI,CC(C)CNc1cc(CCc2cccc3ccccc23)nc(NCc2cccc3ccccc23)n1,5.823908740944319
CHEMBL103,CHEMBL1871,Androgen Receptor,Ki,=,35.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,7.455931955649724
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,4.7,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.327902142064282
CHEMBL1164379,CHEMBL1871,Androgen Receptor,Ki,=,10.4,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2ccsc2)cc1,7.982966660701219
CHEMBL1163602,CHEMBL1871,Androgen Receptor,Ki,=,2.3,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,N#Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2ccsc2)cc1,8.638272163982407
CHEMBL1163604,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2ccccc2)cc1,7.7447274948966935
CHEMBL1163595,CHEMBL1871,Androgen Receptor,Ki,=,4523.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1ccc(NC(CC(=O)c2ccc(C)cc2)c2ccccc2)cc1,5.344573412254082
CHEMBL1163643,CHEMBL1871,Androgen Receptor,Ki,=,490.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1cc(C(CC(=O)c2ccc(C)cc2)Nc2ccc([N+](=O)[O-])cc2)cc(OC)c1OC,6.309803919971486
CHEMBL1163975,CHEMBL1871,Androgen Receptor,Ki,=,1531.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1cc(C(CC(=O)c2cccc(C)c2)Nc2ccc([N+](=O)[O-])cc2)cc(OC)c1OC,5.81502480930174
CHEMBL1165799,CHEMBL1871,Androgen Receptor,Ki,=,3178.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1cc(C(CC(=O)c2cccc(F)c2)Nc2ccc([N+](=O)[O-])cc2)cc(OC)c1OC,5.497846107128639
CHEMBL1163976,CHEMBL1871,Androgen Receptor,Ki,=,65.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1cccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2cccc(F)c2)c1,7.187086643357144
CHEMBL1164485,CHEMBL1871,Androgen Receptor,Ki,=,51.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1cccc(F)c1,7.292429823902063
CHEMBL1163598,CHEMBL1871,Androgen Receptor,Ki,=,96.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2cccc(F)c2)cc1,7.017728766960431
CHEMBL1163597,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1cccc(Cl)c1,6.958607314841775
CHEMBL1163645,CHEMBL1871,Androgen Receptor,Ki,=,124.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1cccc(Br)c1,6.906578314837764
CHEMBL1163646,CHEMBL1871,Androgen Receptor,Ki,=,63.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccccc1,7.200659450546418
CHEMBL1163644,CHEMBL1871,Androgen Receptor,Ki,=,30.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(F)cc1,7.522878745280337
CHEMBL1163746,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(Cl)cc1,7.7447274948966935
CHEMBL1163747,CHEMBL1871,Androgen Receptor,Ki,=,39.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(Br)cc1,7.4089353929735005
CHEMBL1165642,CHEMBL1871,Androgen Receptor,Ki,=,417.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(-c2ccccc2)cc1,6.379863945026242
CHEMBL1163902,CHEMBL1871,Androgen Receptor,Ki,=,1010.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(C2CCCCC2)cc1,5.995678626217357
CHEMBL1163620,CHEMBL1871,Androgen Receptor,Ki,=,283.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1cccc(F)c1)c1ccc(N2CCOCC2)cc1,6.548213564475709
CHEMBL1163717,CHEMBL1871,Androgen Receptor,Ki,=,493.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1ccc(F)cc1)c1cccc(Cl)c1,6.30715308072277
CHEMBL1163625,CHEMBL1871,Androgen Receptor,Ki,=,1314.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1ccc(C(F)(F)F)cc1)c1cccc(F)c1,5.8814046347762385
CHEMBL1163822,CHEMBL1871,Androgen Receptor,Ki,=,883.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,N#Cc1cccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2ccc(C(F)(F)F)cc2)c1,6.054039296422431
CHEMBL1163899,CHEMBL1871,Androgen Receptor,Ki,=,320.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2ccc(C(F)(F)F)cc2)cc1,6.494850021680094
CHEMBL1164856,CHEMBL1871,Androgen Receptor,Ki,=,636.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1ccc(C(F)(F)F)cc1)c1ccc(Cl)cc1,6.196542884351587
CHEMBL1164858,CHEMBL1871,Androgen Receptor,Ki,=,115.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)C2CCCCC2)cc1,6.939302159646388
CHEMBL1165483,CHEMBL1871,Androgen Receptor,Ki,=,37.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)C2CCCCC2)cc1,7.431798275933005
CHEMBL1164752,CHEMBL1871,Androgen Receptor,Ki,=,35.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1ccc(Br)cc1,7.455931955649724
CHEMBL1163480,CHEMBL1871,Androgen Receptor,Ki,=,45.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1ccc(Cl)cc1,7.346787486224656
CHEMBL1163481,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1ccc(F)cc1,7.1938200260161125
CHEMBL1163485,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1cccc(F)c1,7.1938200260161125
CHEMBL1163484,CHEMBL1871,Androgen Receptor,Ki,=,406.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,COc1cccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)C2CCCCC2)c1,6.391473966422806
CHEMBL1163529,CHEMBL1871,Androgen Receptor,Ki,=,140.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1ccc(Cl)c(Cl)c1,6.853871964321762
CHEMBL1165353,CHEMBL1871,Androgen Receptor,Ki,=,74.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,O=C(CC(Nc1ccc([N+](=O)[O-])cc1)C1CCCCC1)c1ccccc1,7.130768280269024
CHEMBL1164339,CHEMBL1871,Androgen Receptor,Ki,=,203.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2cccc([N+](=O)[O-])c2)c2cccc(F)c2)cc1,6.692503962086787
CHEMBL1163588,CHEMBL1871,Androgen Receptor,Ki,=,322.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc(F)cc2)c2cccc(F)c2)cc1,6.492144128304169
CHEMBL1163585,CHEMBL1871,Androgen Receptor,Ki,=,1214.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)CC(Nc2ccc(F)c(F)c2)c2cccc(F)c2)cc1,5.915781313260761
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,8.4,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.075720713938118
CHEMBL1165497,CHEMBL1871,Androgen Receptor,Ki,=,24.2,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)C[C@@H](Nc2ccc([N+](=O)[O-])cc2)c2cccc(F)c2)cc1,7.616184634019569
CHEMBL1164158,CHEMBL1871,Androgen Receptor,Ki,=,342.0,nM,CHEMBL1169306,B,Displacement of [3H]DHT from human androgen receptor after 16 hrs by scintillation counting,CHEMBL1165993,KI,Cc1ccc(C(=O)C[C@H](Nc2ccc([N+](=O)[O-])cc2)c2cccc(F)c2)cc1,6.465973893943865
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL1208812,CHEMBL1871,Androgen Receptor,Ki,=,21.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CNC[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.6777807052660805
CHEMBL1210840,CHEMBL1871,Androgen Receptor,Ki,=,20.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CN1C(=O)[C@]2(C)O[C@](C)(C1=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.698970004336019
CHEMBL1210841,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12O[C@](C)(C(=O)N(CC3CC3)C1=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.301029995663981
CHEMBL1210843,CHEMBL1871,Androgen Receptor,Ki,=,3600.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(C)[N+]1([O-])C(=O)[C@]2(C)O[C@](C)(C1=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,5.443697499232712
CHEMBL1210908,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(C)N1C(=O)[C@]2(C)O[C@](C)(C1=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.853871964321762
CHEMBL1210909,CHEMBL1871,Androgen Receptor,Ki,=,37.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(O)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.431798275933005
CHEMBL1210910,CHEMBL1871,Androgen Receptor,Ki,=,3.7,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CON1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.431798275933005
CHEMBL1209903,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCCN1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.853871964321762
CHEMBL1209904,CHEMBL1871,Androgen Receptor,Ki,=,84.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.075720713938118
CHEMBL1209905,CHEMBL1871,Androgen Receptor,Ki,=,39.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(C)C(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.4089353929735005
CHEMBL1209906,CHEMBL1871,Androgen Receptor,Ki,=,36.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(C(=O)C3CC3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.443697499232712
CHEMBL1209970,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(C(=O)c3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.638272163982407
CHEMBL1209973,CHEMBL1871,Androgen Receptor,Ki,=,5.7,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCOC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.244125144327509
CHEMBL1210033,CHEMBL1871,Androgen Receptor,Ki,=,6.6,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCCOC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.18045606445813
CHEMBL1210842,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(C)OC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.958607314841775
CHEMBL1210907,CHEMBL1871,Androgen Receptor,Ki,=,176.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCNC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,6.75448733218585
CHEMBL1209971,CHEMBL1871,Androgen Receptor,Ki,=,98.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CC(C)NC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.008773924307505
CHEMBL1209972,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(C(=O)Nc3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.3979400086720375
CHEMBL1210034,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(C(=O)Nc3ccc(F)cc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.537602002101044
CHEMBL1210035,CHEMBL1871,Androgen Receptor,Ki,=,56.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(S(C)(=O)=O)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.251811972993799
CHEMBL1210036,CHEMBL1871,Androgen Receptor,Ki,=,16.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,CCS(=O)(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.795880017344075
CHEMBL1210090,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(S(=O)(=O)c3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.920818753952375
CHEMBL1208805,CHEMBL1871,Androgen Receptor,Ki,=,32.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(S(=O)(=O)c3ccc(F)cc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.494850021680094
CHEMBL1210091,CHEMBL1871,Androgen Receptor,Ki,=,93.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(S(=O)(=O)c3ccccn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.031517051446065
CHEMBL1210783,CHEMBL1871,Androgen Receptor,Ki,=,9.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(c3cccc(C(N)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.045757490560675
CHEMBL1210150,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(c3cccc(S(N)(=O)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.657577319177793
CHEMBL1210151,CHEMBL1871,Androgen Receptor,Ki,=,9.4,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(c3cccc(S(C)(=O)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.0268721464003
CHEMBL1210152,CHEMBL1871,Androgen Receptor,Ki,=,3.5,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(c3cc(Cl)ncn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.455931955649724
CHEMBL1210214,CHEMBL1871,Androgen Receptor,Ki,=,6.1,nM,CHEMBL1212404,B,Displacement of [3H]DHT from AR in human MDA-MB-453 cells,CHEMBL1208719,KI,C[C@]12CN(c3ncccn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.214670164989233
CHEMBL1270149,CHEMBL1871,Androgen Receptor,Ki,=,1100.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OC[C@H](O)CO)c(C)c1,5.958607314841775
CHEMBL1270253,CHEMBL1871,Androgen Receptor,Ki,=,1800.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OC[C@@H](O)CO)c(C)c1,5.7447274948966935
CHEMBL403670,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OC[C@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1,6.0
CHEMBL272502,CHEMBL1871,Androgen Receptor,Ki,=,1100.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OC[C@H](O)CO)c(C)c1)c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1,5.958607314841775
CHEMBL272304,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1,6.0
CHEMBL403885,CHEMBL1871,Androgen Receptor,Ki,=,1100.0,nM,CHEMBL1273732,B,Binding affinity to androgen receptor,CHEMBL1268942,KI,CCC(CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1,5.958607314841775
CHEMBL258191,CHEMBL1871,Androgen Receptor,Ki,=,57.0,nM,CHEMBL1648958,B,Binding affinity to androgen receptor,CHEMBL1641544,KI,Cc1cc(-c2cccc3cc[nH]c23)c(Cl)c2c1NC(C)(C)CC2C,7.2441251443275085
CHEMBL1644759,CHEMBL1871,Androgen Receptor,Ki,=,900.0,nM,CHEMBL1648958,B,Binding affinity to androgen receptor,CHEMBL1641544,KI,Cc1cc(-c2cccc3cc[nH]c23)c(Cl)c2c1NC(C)(C)[C@H](O)[C@H]2C,6.045757490560675
CHEMBL1644761,CHEMBL1871,Androgen Receptor,Ki,=,915.0,nM,CHEMBL1648958,B,Binding affinity to androgen receptor,CHEMBL1641544,KI,Cc1cc(-c2cccc3cc[nH]c23)c(Cl)c2c1NC(C)(C)C(O)C2(C)C,6.0385789059335515
CHEMBL1644765,CHEMBL1871,Androgen Receptor,Ki,=,400.0,nM,CHEMBL1648958,B,Binding affinity to androgen receptor,CHEMBL1641544,KI,Cc1cc(-c2cccc3cc[nH]c23)c(Cl)c2c1NC(C)(C)[C@@H](O)[C@H]2C,6.3979400086720375
CHEMBL1672549,CHEMBL1871,Androgen Receptor,Ki,=,2550.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,CC[C@@H](C)n1cc(-c2ccc(C#N)cc2)c2ccc(NS(C)(=O)=O)cc21,5.5934598195660445
CHEMBL1672548,CHEMBL1871,Androgen Receptor,Ki,=,1740.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,CC[C@H](C)n1cc(-c2ccc(C#N)cc2)c2ccc(NS(C)(=O)=O)cc21,5.7594507517174005
CHEMBL1672547,CHEMBL1871,Androgen Receptor,Ki,=,648.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,CC(C)n1cc(-c2ccc(C#N)c(F)c2)c2ccc(NS(C)(=O)=O)cc21,6.188424994129407
CHEMBL1672546,CHEMBL1871,Androgen Receptor,Ki,=,490.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,COc1cc(-c2cn(C(C)C)c3cc(NS(C)(=O)=O)ccc23)ccc1C#N,6.309803919971486
CHEMBL1672541,CHEMBL1871,Androgen Receptor,Ki,=,403.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,Cc1cc(-c2cn(C(C)C)c3cc(NS(C)(=O)=O)ccc23)ccc1C#N,6.39469495385889
CHEMBL1672544,CHEMBL1871,Androgen Receptor,Ki,=,2590.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,CCn1cc(-c2ccc(C#N)cc2)c2ccc(NS(C)(=O)=O)cc21,5.586700235918748
CHEMBL391231,CHEMBL1871,Androgen Receptor,Ki,=,676.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,C[C@](c1ccc(F)cc1F)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.170053304058364
CHEMBL235206,CHEMBL1871,Androgen Receptor,Ki,=,211.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,C[C@@](c1ccc(F)cc1F)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.675717544702307
CHEMBL1672542,CHEMBL1871,Androgen Receptor,Ki,=,220.0,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,CC(c1ccc(F)cc1)(c1c[nH]c2c(NS(C)(=O)=O)cccc12)C1CC1,6.657577319177793
CHEMBL1672540,CHEMBL1871,Androgen Receptor,Ki,=,68.9,nM,CHEMBL1680620,B,Displacement of [3H]methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL1671834,KI,COc1ccc(C(c2ccccc2)c2c[nH]c3ccccc23)cc1,7.161780778092374
CHEMBL1672635,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL1679746,B,Displacement of fluorescent-tagged R1881 from androgen receptor after 4 hrs by fluorometric assay,CHEMBL1671840,KI,Cc1c(N[C@@H](c2nnc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl,8.154901959985743
CHEMBL386630,CHEMBL1871,Androgen Receptor,Ki,=,29.0,nM,CHEMBL1679746,B,Displacement of fluorescent-tagged R1881 from androgen receptor after 4 hrs by fluorometric assay,CHEMBL1671840,KI,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,7.537602002101044
CHEMBL27769,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL1679746,B,Displacement of fluorescent-tagged R1881 from androgen receptor after 4 hrs by fluorometric assay,CHEMBL1671840,KI,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.0
CHEMBL1682441,CHEMBL1871,Androgen Receptor,Ki,=,1430.0,nM,CHEMBL1687061,B,Binding affinity to AR,CHEMBL1681726,KI,C[C@H]1c2c(cc(F)c(-c3cccc4cc[nH]c34)c2F)NC(C)(C)[C@@H]1O,5.844663962534938
CHEMBL1762210,CHEMBL1871,Androgen Receptor,Ki,=,430.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,CCO/N=C1/c2c(cc(F)c(-c3cccc4c(C)c[nH]c34)c2F)NC(C)(C)C1O,6.366531544420413
CHEMBL1760023,CHEMBL1871,Androgen Receptor,Ki,=,2800.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,CO/N=C1/c2c(cc(F)c(-c3cccc4c(C)c[nH]c34)c2F)NC(C)(C)C1O,5.552841968657781
CHEMBL1762209,CHEMBL1871,Androgen Receptor,Ki,=,290.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,Cc1c[nH]c2c(-c3c(F)cc4c(c3F)/C(=N/OC(C)(C)CO)CC(C)(C)N4)cccc12,6.537602002101044
CHEMBL1762204,CHEMBL1871,Androgen Receptor,Ki,=,1500.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,Cc1c[nH]c2c(-c3c(F)cc4c(c3F)/C(=N/OC(C)C)CC(C)(C)N4)cccc12,5.823908740944319
CHEMBL1762203,CHEMBL1871,Androgen Receptor,Ki,=,90.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,CC1(C)C/C(=N\OC(C)(C)C)c2c(cc(F)c(-c3cccc4c(Cl)c[nH]c34)c2F)N1,7.045757490560675
CHEMBL1762202,CHEMBL1871,Androgen Receptor,Ki,=,1000.0,nM,CHEMBL1762870,B,Binding affinity to androgen receptor,CHEMBL1759905,KI,Cc1c[nH]c2c(-c3c(F)cc4c(c3F)/C(=N/OC(C)(C)C)CC(C)(C)N4)cccc12,6.0
CHEMBL1782494,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786227,B,Binding affinity to wild type androgen receptor by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1cccc2ccccc12)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782494,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786228,B,Binding affinity to androgen receptor W741L mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1cccc2ccccc12)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782494,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786234,B,Binding affinity to androgen receptor W741C mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1cccc2ccccc12)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782495,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786227,B,Binding affinity to wild type androgen receptor by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1Cc1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782495,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786228,B,Binding affinity to androgen receptor W741L mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1Cc1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782495,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786234,B,Binding affinity to androgen receptor W741C mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1Cc1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782496,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786227,B,Binding affinity to wild type androgen receptor by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1-c1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782496,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786228,B,Binding affinity to androgen receptor W741L mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1-c1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782496,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1786234,B,Binding affinity to androgen receptor W741C mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1-c1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782495,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1785912,B,Binding affinity to androgen receptor T877A mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1Cc1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782496,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1785912,B,Binding affinity to androgen receptor T877A mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1ccccc1-c1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1782494,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL1785912,B,Binding affinity to androgen receptor T877A mutant by competitive binding assay,CHEMBL1782015,KI,C[C@](O)(CS(=O)(=O)c1cccc2ccccc12)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.698970004336019
CHEMBL1801012,CHEMBL1871,Androgen Receptor,Ki,=,1058.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nccs1)[C@@H](c1ccccc1)c1ccc(O)cc1,5.975514332300833
CHEMBL1801008,CHEMBL1871,Androgen Receptor,Ki,=,1034.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nccs1)[C@@H](c1ccccc1)c1ccc(O)c(F)c1,5.985479461242076
CHEMBL1801006,CHEMBL1871,Androgen Receptor,Ki,=,370.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nccs1)[C@@H](c1ccccc1)c1ccc(O)c(Br)c1,6.431798275933005
CHEMBL1800981,CHEMBL1871,Androgen Receptor,Ki,=,993.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nncs1)[C@@H](c1ccccc1)c1ccc(O)c(F)c1,6.0030507515046185
CHEMBL1800984,CHEMBL1871,Androgen Receptor,Ki,=,2341.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nccs1)[C@H]1c2ccccc2Oc2cc(O)ccc21,5.630598586303376
CHEMBL1800985,CHEMBL1871,Androgen Receptor,Ki,=,696.0,nM,CHEMBL1805660,B,Binding affinity to androgen receptor by fluorescence polarization assay,CHEMBL1799968,KI,CC(C)(C(=O)Nc1nncs1)[C@H]1c2ccccc2Oc2cc(O)ccc21,6.157390760389438
CHEMBL1800985,CHEMBL1871,Androgen Receptor,Ki,=,696.0,nM,CHEMBL1914152,B,Displacement of fluorescently labeled ligand from androgen receptor by fluorescence polarization assay,CHEMBL1909630,KI,CC(C)(C(=O)Nc1nncs1)[C@H]1c2ccccc2Oc2cc(O)ccc21,6.157390760389438
CHEMBL1801012,CHEMBL1871,Androgen Receptor,Ki,=,1058.0,nM,CHEMBL1914152,B,Displacement of fluorescently labeled ligand from androgen receptor by fluorescence polarization assay,CHEMBL1909630,KI,CC(C)(C(=O)Nc1nccs1)[C@@H](c1ccccc1)c1ccc(O)cc1,5.975514332300833
CHEMBL2181925,CHEMBL1871,Androgen Receptor,Ki,=,1170.0,nM,CHEMBL2188777,B,Displacement of [3H]-methyltrienolone from human androgen receptor overexpressed in HEK293 cells by microbeta counting assay,CHEMBL2177005,KI,O=c1[nH]c2cc(/C=C3\c4ccccc4COc4cc(F)ccc43)ccc2n1[C@H]1C[C@H]2COCCN2C1,5.931814138253838
CHEMBL2346976,CHEMBL1871,Androgen Receptor,Ki,=,2200.0,nM,CHEMBL2352665,B,Displacement of [3H]R1881 from full length androgen receptor in human LNCAP cells,CHEMBL2346572,KI,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,5.657577319177793
CHEMBL2426624,CHEMBL1871,Androgen Receptor,Ki,=,243.0,nM,CHEMBL2428205,B,Binding affinity to androgen receptor (unknown origin) by fluorescence polarization assay,CHEMBL2424628,KI,CC(C(=O)Nc1nncs1)[C@@H](c1ccccc1)c1ccc2c(cnn2-c2ccc(F)cc2)c1,6.614393726401688
CHEMBL2426636,CHEMBL1871,Androgen Receptor,Ki,=,2513.0,nM,CHEMBL2428205,B,Binding affinity to androgen receptor (unknown origin) by fluorescence polarization assay,CHEMBL2424628,KI,CCCC(c1ccc2c(cnn2-c2ccc(F)cc2)c1)C(C)(C)C(=O)Nc1nncs1,5.599807511407424
CHEMBL384467,CHEMBL1871,Androgen Receptor,Ki,=,1410.0,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,5.85078088734462
CHEMBL131,CHEMBL1871,Androgen Receptor,Ki,=,2520.0,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO,5.598599459218455
CHEMBL3120320,CHEMBL1871,Androgen Receptor,Ki,=,418.0,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,CS(=O)(=O)Nc1cccc(C=C2c3ccccc3CCc3ccccc32)c1,6.3788237182249645
CHEMBL3120319,CHEMBL1871,Androgen Receptor,Ki,=,5.98,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,C/C(=C1/c2ccccc2COc2ccccc21)c1cccc(NS(C)(=O)=O)c1,8.223298816011589
CHEMBL3120318,CHEMBL1871,Androgen Receptor,Ki,=,9.74,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,CC/C(=C1/c2ccccc2COc2ccccc21)c1cccc(NS(C)(=O)=O)c1,8.011441043121385
CHEMBL3120317,CHEMBL1871,Androgen Receptor,Ki,=,239.0,nM,CHEMBL3122503,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL3120138,KI,CC/C(=C1\c2ccccc2OCc2cccc(OC)c21)c1cccc(NS(C)(=O)=O)c1,6.621602099051863
CHEMBL3132980,CHEMBL1871,Androgen Receptor,Ki,=,2300.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.638272163982407
CHEMBL3132979,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.522878745280337
CHEMBL3132978,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1Cl)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.522878745280337
CHEMBL3132977,CHEMBL1871,Androgen Receptor,Ki,=,600.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,6.221848749616356
CHEMBL3132976,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.522878745280337
CHEMBL3132975,CHEMBL1871,Androgen Receptor,Ki,=,7000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.154901959985743
CHEMBL3132974,CHEMBL1871,Androgen Receptor,Ki,=,4000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.3979400086720375
CHEMBL3132973,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.522878745280337
CHEMBL3133004,CHEMBL1871,Androgen Receptor,Ki,=,200.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,6.698970004336019
CHEMBL3133003,CHEMBL1871,Androgen Receptor,Ki,=,1400.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.853871964321762
CHEMBL3133002,CHEMBL1871,Androgen Receptor,Ki,=,12000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,4.920818753952375
CHEMBL3133001,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.522878745280337
CHEMBL3133000,CHEMBL1871,Androgen Receptor,Ki,=,1700.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.769551078621726
CHEMBL3132999,CHEMBL1871,Androgen Receptor,Ki,=,2000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O,5.698970004336019
CHEMBL3132998,CHEMBL1871,Androgen Receptor,Ki,=,3000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.522878745280337
CHEMBL3132997,CHEMBL1871,Androgen Receptor,Ki,=,56000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,4.251811972993799
CHEMBL3132996,CHEMBL1871,Androgen Receptor,Ki,=,11000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,4.958607314841775
CHEMBL3132995,CHEMBL1871,Androgen Receptor,Ki,=,400.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1Cl)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,6.3979400086720375
CHEMBL3132994,CHEMBL1871,Androgen Receptor,Ki,=,2200.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1Cl)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.657577319177793
CHEMBL3132993,CHEMBL1871,Androgen Receptor,Ki,=,32000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,4.494850021680094
CHEMBL3132992,CHEMBL1871,Androgen Receptor,Ki,=,2300.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.638272163982407
CHEMBL3132991,CHEMBL1871,Androgen Receptor,Ki,=,3600.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC(C)C[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.443697499232712
CHEMBL3132990,CHEMBL1871,Androgen Receptor,Ki,=,4100.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.3872161432802645
CHEMBL3132989,CHEMBL1871,Androgen Receptor,Ki,=,2700.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.568636235841012
CHEMBL3132988,CHEMBL1871,Androgen Receptor,Ki,=,2500.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.6020599913279625
CHEMBL3132987,CHEMBL1871,Androgen Receptor,Ki,=,10000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.0
CHEMBL3132986,CHEMBL1871,Androgen Receptor,Ki,=,13000.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,4.886056647693163
CHEMBL3132985,CHEMBL1871,Androgen Receptor,Ki,=,1900.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.721246399047171
CHEMBL3132984,CHEMBL1871,Androgen Receptor,Ki,=,2100.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.6777807052660805
CHEMBL3132983,CHEMBL1871,Androgen Receptor,Ki,=,2100.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.6777807052660805
CHEMBL3132981,CHEMBL1871,Androgen Receptor,Ki,=,1300.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.886056647693163
CHEMBL3132982,CHEMBL1871,Androgen Receptor,Ki,=,4100.0,nM,CHEMBL3135862,B,Displacement of fluorescein-CSSRFESLFAGEKESR from human androgen receptor-LBD after 1 hr by fluorescence polarization assay,CHEMBL3132744,KI,CC[C@H](C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)O,5.3872161432802645
CHEMBL3588960,CHEMBL1871,Androgen Receptor,Ki,=,68.0,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)COC)cc1F,7.167491087293763
CHEMBL3589387,CHEMBL1871,Androgen Receptor,Ki,=,126.1,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCOCC3)cc1F,6.899284913426918
CHEMBL3589385,CHEMBL1871,Androgen Receptor,Ki,=,14.1,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,N#Cc1ccc(N2C(=O)[C@]3(CCOC3)N(c3ccc(C(N)=O)c(F)c3)C2=S)cc1C(F)(F)F,7.85078088734462
CHEMBL3589383,CHEMBL1871,Androgen Receptor,Ki,=,11.9,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,COC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,7.924453038607469
CHEMBL3589382,CHEMBL1871,Androgen Receptor,Ki,=,215.4,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@]23CCOC3)cc1F,6.666754301038037
CHEMBL3589381,CHEMBL1871,Androgen Receptor,Ki,=,18.4,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,7.735182176990463
CHEMBL3589380,CHEMBL1871,Androgen Receptor,Ki,=,33.8,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C23CCOC3)cc1F,7.471083299722345
CHEMBL3183409,CHEMBL1871,Androgen Receptor,Ki,=,34.7,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,7.459670525209126
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,28.2,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.549750891680639
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,160.2,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.795337488251781
CHEMBL3588965,CHEMBL1871,Androgen Receptor,Ki,=,43.3,nM,CHEMBL3592213,B,Partial agonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)CO)cc1F,7.363512103646634
CHEMBL3588959,CHEMBL1871,Androgen Receptor,Ki,=,95.3,nM,CHEMBL3592213,B,Partial agonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]2C)cc1F,7.020907099361674
CHEMBL3589391,CHEMBL1871,Androgen Receptor,Ki,=,481.8,nM,CHEMBL3592213,B,Partial agonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]2C)cc1F,6.317133204337676
CHEMBL3589390,CHEMBL1871,Androgen Receptor,Ki,=,257.0,nM,CHEMBL3592213,B,Partial agonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2C)cc1F,6.590066876668706
CHEMBL3588968,CHEMBL1871,Androgen Receptor,Ki,=,575.6,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2CCC(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C2=S)cc1F,6.239879214735432
CHEMBL3588967,CHEMBL1871,Androgen Receptor,Ki,=,584.6,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(COC)COC)cc1F,6.233141188978582
CHEMBL3588964,CHEMBL1871,Androgen Receptor,Ki,=,235.9,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CCOC(=O)CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NC)c(F)c1,6.6272720591144045
CHEMBL3588963,CHEMBL1871,Androgen Receptor,Ki,=,514.5,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)COCc2ccccc2)cc1F,6.288614620901548
CHEMBL3588962,CHEMBL1871,Androgen Receptor,Ki,=,797.6,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]2(C)COC)cc1F,6.098214854696401
CHEMBL3588961,CHEMBL1871,Androgen Receptor,Ki,=,40.6,nM,CHEMBL3592212,B,Antagonist activity at androgen receptor (unknown origin),CHEMBL3588823,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@]2(C)COC)cc1F,7.391473966422806
CHEMBL3590187,CHEMBL1871,Androgen Receptor,Ki,=,40.0,nM,CHEMBL3592008,B,Displacement of [3H]methyltrienolone from androgen receptor in human prostate cancer cells,CHEMBL3588838,KI,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,7.3979400086720375
CHEMBL3605919,CHEMBL1871,Androgen Receptor,Ki,=,232.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(F)ccc1-c1c(CN(C)Cc2ccccc2)[nH]c2c(NS(C)(=O)=O)cc(C(C)C)cc12,6.634512015109101
CHEMBL3605921,CHEMBL1871,Androgen Receptor,Ki,=,4140.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(F)ccc1-c1c(CN(C)Cc2ccccc2)[nH]c2c(N)cc(F)cc12,5.3829996588791005
CHEMBL3605922,CHEMBL1871,Androgen Receptor,Ki,=,6120.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1ccc(F)cc1-c1c[nH]c2c(NC(C)=O)cccc12,5.213248577854438
CHEMBL3605923,CHEMBL1871,Androgen Receptor,Ki,=,4060.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(NS(C)(=O)=O)c2[nH]c(C)c(-c3ccccc3)c2c1,5.391473966422806
CHEMBL3605924,CHEMBL1871,Androgen Receptor,Ki,=,1120.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(NS(C)(=O)=O)c2[nH]c(C)c(-c3cc(F)ccc3OC)c2c1,5.950781977329818
CHEMBL3605925,CHEMBL1871,Androgen Receptor,Ki,=,355.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,CS(=O)(=O)Nc1cccc2cc[nH]c12,6.449771646944906
CHEMBL3605926,CHEMBL1871,Androgen Receptor,Ki,=,231.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(F)ccc1-c1c(CN(C)Cc2ccccc2)[nH]c2c(NS(C)(=O)=O)cc(C(C)(C)C)cc12,6.636388020107855
CHEMBL3605927,CHEMBL1871,Androgen Receptor,Ki,=,684.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(F)ccc1-c1c(Cc2ccccc2)[nH]c2c(NS(C)(=O)=O)cc(C(C)C)cc12,6.164943898279883
CHEMBL3605928,CHEMBL1871,Androgen Receptor,Ki,=,905.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1ccc(F)cc1-c1c(-c2ccccc2)[nH]c2c(NS(C)(=O)=O)cccc12,6.043351420794797
CHEMBL3605929,CHEMBL1871,Androgen Receptor,Ki,=,1130.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1cc(F)ccc1-c1c(C)[nH]c2c(NS(C)(=O)=O)cc(F)cc12,5.94692155651658
CHEMBL3605930,CHEMBL1871,Androgen Receptor,Ki,=,697.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1ccc(Cl)cc1-c1c[nH]c2c(NS(C)(=O)=O)cccc12,6.15676722190199
CHEMBL3605932,CHEMBL1871,Androgen Receptor,Ki,=,91.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,CS(=O)(=O)Nc1cccc2c(-c3cccc(Cl)c3)c[nH]c12,7.040958607678906
CHEMBL3605933,CHEMBL1871,Androgen Receptor,Ki,=,401.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,COc1ccccc1-c1c[nH]c2c(NS(C)(=O)=O)cccc12,6.396855627379818
CHEMBL3605934,CHEMBL1871,Androgen Receptor,Ki,=,496.0,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,CS(=O)(=O)Nc1cccc2c(-c3ccc(F)cc3)c[nH]c12,6.304518323509802
CHEMBL1276308,CHEMBL1871,Androgen Receptor,Ki,=,5.95,nM,CHEMBL3607225,B,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay,CHEMBL3603837,KI,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C,8.22548303427145
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,64.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.1938200260161125
CHEMBL3623114,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@@H]1O)[C@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@H]12,8.096910013008056
CHEMBL3623115,CHEMBL1871,Androgen Receptor,Ki,=,1600.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1C(=O)O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,5.795880017344075
CHEMBL3623116,CHEMBL1871,Androgen Receptor,Ki,=,23.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CC(C)OC(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.638272163982407
CHEMBL3623117,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CN(C(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12)c1ccccc1,7.301029995663981
CHEMBL3623118,CHEMBL1871,Androgen Receptor,Ki,=,31.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1N)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.508638306165727
CHEMBL3623119,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CCC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.522878745280337
CHEMBL3623120,CHEMBL1871,Androgen Receptor,Ki,=,50.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CNS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.301029995663981
CHEMBL3623121,CHEMBL1871,Androgen Receptor,Ki,=,31.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CC(C)NC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,7.508638306165727
CHEMBL3623122,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CN1CCN(OC(=O)N[C@@H]2C[C@]3(C)O[C@]2(C)[C@@H]2C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)[C@@H]23)CC1,8.154901959985743
CHEMBL3623123,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1NS(C)(=O)=O)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.920818753952375
CHEMBL3623124,CHEMBL1871,Androgen Receptor,Ki,=,10.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1ccccc1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,8.0
CHEMBL3623125,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1ccccc1F)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,9.0
CHEMBL3623126,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,C[C@]12O[C@@](C)(C[C@H]1NS(=O)(=O)c1cccnc1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,8.698970004336019
CHEMBL3623127,CHEMBL1871,Androgen Receptor,Ki,=,1.7,nM,CHEMBL3624233,B,Displacement of [3H]-DHT from androgen receptor in human MDA-MB-453 cells after 90 mins by TopCount analysis,CHEMBL3621143,KI,CCS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.769551078621726
CHEMBL3764446,CHEMBL1871,Androgen Receptor,Ki,=,5.21,nM,CHEMBL3767965,B,Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method,CHEMBL3763123,KI,Cc1c(N[C@@H]2COC[C@@]2(C)O)ccc(C#N)c1Cl,8.283162276700475
CHEMBL3765823,CHEMBL1871,Androgen Receptor,Ki,=,16.9,nM,CHEMBL3767965,B,Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method,CHEMBL3763123,KI,Cc1c(N[C@@H]2CCCC[C@@]2(C)O)ccc(C#N)c1Cl,7.772113295386326
CHEMBL3765171,CHEMBL1871,Androgen Receptor,Ki,=,0.68,nM,CHEMBL3767965,B,Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method,CHEMBL3763123,KI,Cc1c(N[C@@H]2CCC[C@]2(C)O)ccc(C#N)c1Cl,9.167491087293763
CHEMBL3764185,CHEMBL1871,Androgen Receptor,Ki,=,2.03,nM,CHEMBL3767965,B,Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method,CHEMBL3763123,KI,Cc1c(N[C@@H]2CCC[C@@]2(C)O)ccc(C#N)c1Cl,8.692503962086787
CHEMBL166444,CHEMBL1871,Androgen Receptor,Ki,=,0.4,nM,CHEMBL3767965,B,Displacement of [3H]-methyltrienolone from androgen receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method,CHEMBL3763123,KI,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.397940008672037
CHEMBL3902310,CHEMBL1871,Androgen Receptor,Ki,=,5.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,CNC(=O)[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](F)[C@@H]2C1,8.301029995663981
CHEMBL3921315,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,CNC(=O)[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,8.522878745280337
CHEMBL3893320,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@@]3(C(N)=O)S2(=O)=O)cc1C(F)(F)F,8.522878745280337
CHEMBL3949176,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](F)[C@@H]2C1,8.096910013008056
CHEMBL3920247,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H](CN(c3ccc(C#N)c(C(F)(F)F)c3)S1(=O)=O)[C@H]1C[C@H](O)[C@@H]2C1,8.522878745280337
CHEMBL3917372,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@H]3S2(=O)=O)cc1C(F)(F)F,8.522878745280337
CHEMBL3987109,CHEMBL1871,Androgen Receptor,Ki,=,12.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,N#Cc1ccc(N2C[C@@H]3[C@@H]([C@@H]4C=C[C@H]3C4)S2(=O)=O)cc1C(F)(F)F,7.920818753952375
CHEMBL3926358,CHEMBL1871,Androgen Receptor,Ki,=,3.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,8.522878745280337
CHEMBL3898284,CHEMBL1871,Androgen Receptor,Ki,=,2.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H]3C=C[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,8.698970004336019
CHEMBL3935242,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H]3CC[C@@H](C3=O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,8.096910013008056
CHEMBL3907304,CHEMBL1871,Androgen Receptor,Ki,=,106.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H]3CC[C@@H](C3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,6.97469413473523
CHEMBL3907304,CHEMBL1871,Androgen Receptor,Ki,=,48.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@@H]3CC[C@@H](C3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.318758762624412
CHEMBL3939272,CHEMBL1871,Androgen Receptor,Ki,=,28.0,nM,CHEMBL3869525,B,Displacement of [3H]DHT from androgen receptor in human MDA-MB-453 cells,CHEMBL3868609,KI,C[C@@]12[C@H]3C[C@H]([C@H](O)C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O,7.552841968657781
CHEMBL6874,CHEMBL1871,Androgen Receptor,Ki,=,26.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,KI,CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1,7.585026652029182
CHEMBL4447539,CHEMBL1871,Androgen Receptor,Ki,=,22.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,KI,CC1(C)CCc2cc3c(cc2N1)NC(C#N)C=C3C(F)(F)F,7.657577319177793
CHEMBL4548397,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL4371127,B,Inhibition of human androgen receptor,CHEMBL4371002,KI,CC1(C)CCc2cc3c(cc2N1)NC(F)C=C3C(F)(F)F,7.958607314841775
CHEMBL3183409,CHEMBL1871,Androgen Receptor,Ki,=,1452.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,5.838033383635925
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,509.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.293282217663242
CHEMBL1738889,CHEMBL1871,Androgen Receptor,Ki,=,3.8,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.42021640338319
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,3641.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.438779321066056
CHEMBL4539953,CHEMBL1871,Androgen Receptor,Ki,=,71.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.1487416512809245
CHEMBL4521365,CHEMBL1871,Androgen Receptor,Ki,=,252.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.598599459218455
CHEMBL4527176,CHEMBL1871,Androgen Receptor,Ki,=,490.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.309803919971486
CHEMBL4449952,CHEMBL1871,Androgen Receptor,Ki,=,204.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.690369832574101
CHEMBL4542153,CHEMBL1871,Androgen Receptor,Ki,=,326.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.486782399932061
CHEMBL4527241,CHEMBL1871,Androgen Receptor,Ki,=,382.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.417936637088291
CHEMBL4530573,CHEMBL1871,Androgen Receptor,Ki,=,68.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(Cl)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.167491087293763
CHEMBL4469605,CHEMBL1871,Androgen Receptor,Ki,=,115.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.939302159646388
CHEMBL4436972,CHEMBL1871,Androgen Receptor,Ki,=,273.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.5638373529592435
CHEMBL4438211,CHEMBL1871,Androgen Receptor,Ki,=,170.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.769551078621726
CHEMBL4451795,CHEMBL1871,Androgen Receptor,Ki,=,135.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1cc(-c2ccccc2)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.8696662315049934
CHEMBL4447959,CHEMBL1871,Androgen Receptor,Ki,=,133.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.876148359032914
CHEMBL4585987,CHEMBL1871,Androgen Receptor,Ki,=,720.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cccc(F)c21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.142667503568731
CHEMBL4590504,CHEMBL1871,Androgen Receptor,Ki,=,156.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.806875401645538
CHEMBL4474118,CHEMBL1871,Androgen Receptor,Ki,=,253.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.596879478824182
CHEMBL4483663,CHEMBL1871,Androgen Receptor,Ki,=,315.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.501689446210399
CHEMBL4567476,CHEMBL1871,Androgen Receptor,Ki,=,332.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1cc(F)c2ccccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.478861916295964
CHEMBL4475563,CHEMBL1871,Androgen Receptor,Ki,=,62.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2c(F)cc(-c3ccc(F)cc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.207608310501746
CHEMBL4520679,CHEMBL1871,Androgen Receptor,Ki,=,86.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2c(F)c(-c3ccccc3)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.0655015487564325
CHEMBL4439702,CHEMBL1871,Androgen Receptor,Ki,=,84.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2c(-c3ccccc3)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.075720713938118
CHEMBL4448937,CHEMBL1871,Androgen Receptor,Ki,=,995.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,CCOC(=O)c1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccccc12,6.002176919254275
CHEMBL4542693,CHEMBL1871,Androgen Receptor,Ki,=,294.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(I)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.531652669587842
CHEMBL4456781,CHEMBL1871,Androgen Receptor,Ki,=,316.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.500312917381596
CHEMBL4460567,CHEMBL1871,Androgen Receptor,Ki,=,124.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.906578314837764
CHEMBL4442857,CHEMBL1871,Androgen Receptor,Ki,=,547.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,6.262012673666569
CHEMBL4554646,CHEMBL1871,Androgen Receptor,Ki,=,47.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2ccc([N+](=O)[O-])cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.327902142064282
CHEMBL4586748,CHEMBL1871,Androgen Receptor,Ki,=,433.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc([N+](=O)[O-])ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.363512103646634
CHEMBL4474096,CHEMBL1871,Androgen Receptor,Ki,=,212.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.673664139071248
CHEMBL4456765,CHEMBL1871,Androgen Receptor,Ki,=,419.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.377785977033705
CHEMBL4446471,CHEMBL1871,Androgen Receptor,Ki,=,2080.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.681936665037238
CHEMBL4444904,CHEMBL1871,Androgen Receptor,Ki,=,267.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.573488738635424
CHEMBL4584527,CHEMBL1871,Androgen Receptor,Ki,=,78.0,nM,CHEMBL4411915,B,Displacement of [3H]-mibolerone from recombinant wild-type GST-tagged androgen receptor LBD (unknown origin) after 16 hrs by scintillation counting analysis,CHEMBL4411271,KI,CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1,7.107905397309519
CHEMBL2346976,CHEMBL1871,Androgen Receptor,Ki,=,5000.0,nM,CHEMBL4668333,B,Inhibition of androgen receptor LBD domain (unknown origin),CHEMBL4665673,KI,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,5.301029995663981
CHEMBL2346976,CHEMBL1871,Androgen Receptor,Ki,=,2200.0,nM,CHEMBL4668334,B,Inhibition of full length androgen receptor (unknown origin),CHEMBL4665673,KI,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1,5.657577319177793
CHEMBL4297185,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,KI,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,7.958607314841775
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,86.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.0655015487564325
CHEMBL3183409,CHEMBL1871,Androgen Receptor,Ki,=,93.0,nM,CHEMBL4710579,B,Inhibition of androgen receptor (unknown origin),CHEMBL4706566,KI,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F,7.031517051446065
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,3641.29,nM,CHEMBL4726226,B,Displacement of [3H]-mibolerone from GST-tagged human AR-LBD expressed in HEK293 cells,CHEMBL4725256,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.438744731561981
CHEMBL4584527,CHEMBL1871,Androgen Receptor,Ki,=,267.0,nM,CHEMBL4726226,B,Displacement of [3H]-mibolerone from GST-tagged human AR-LBD expressed in HEK293 cells,CHEMBL4725256,KI,CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1,6.573488738635424
CHEMBL4444904,CHEMBL1871,Androgen Receptor,Ki,=,78.0,nM,CHEMBL4726226,B,Displacement of [3H]-mibolerone from GST-tagged human AR-LBD expressed in HEK293 cells,CHEMBL4725256,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.107905397309519
CHEMBL4865865,CHEMBL1871,Androgen Receptor,Ki,=,8.4,nM,CHEMBL4820464,B,Binding affinity to wild-type androgen receptor in human LNCaP cells assessed as inhibition constant incubated for 24 hrs by Cheng-Prusoff equation analysis,CHEMBL4819022,KI,CN1CCC(Oc2ccc(N3C(=S)N(c4cnc(C#N)c(C(F)(F)F)c4)C(=O)C34CCC4)cc2)CC1,8.075720713938118
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL4820464,B,Binding affinity to wild-type androgen receptor in human LNCaP cells assessed as inhibition constant incubated for 24 hrs by Cheng-Prusoff equation analysis,CHEMBL4819022,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.769551078621726
CHEMBL409,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.958607314841775
CHEMBL125663,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,C[C@@](O)(COc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1,8.221848749616356
CHEMBL469759,CHEMBL1871,Androgen Receptor,Ki,=,0.54,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,C[C@@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(I)c1,9.267606240177031
CHEMBL511130,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,CC(=O)Nc1ccc(OC[C@@](C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1,8.397940008672037
CHEMBL4754501,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,C[C@@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,8.397940008672037
CHEMBL5184779,CHEMBL1871,Androgen Receptor,Ki,=,1.4,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,Cc1c(N2C(=O)C3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.853871964321762
CHEMBL401805,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](C(F)(F)F)N3CC(F)(F)F,7.7447274948966935
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL5127804,B,Binding affinity to Androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5126525,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.0
CHEMBL5170697,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL5127815,B,Binding affinity to recombinant human Androgen receptor assessed as inhibition constant by competitive binding assay,CHEMBL5126525,KI,CCc1c(C)c2c3c(Cl)cc(=O)[nH]c3ccc2n1CC(F)(F)F,9.045757490560675
CHEMBL1200436,CHEMBL1871,Androgen Receptor,Ki,=,62.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O,7.207608310501746
CHEMBL390728,CHEMBL1871,Androgen Receptor,Ki,=,17.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,7.769551078621726
CHEMBL436784,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,8.337242168318426
CHEMBL5187916,CHEMBL1871,Androgen Receptor,Ki,=,8.7,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,CC(C)(C)OC(=O)c1cccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C(F)(F)F)c43)c12,8.060480747381382
CHEMBL227088,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,C[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,9.045757490560675
CHEMBL467888,CHEMBL1871,Androgen Receptor,Ki,=,6.5,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.187086643357144
CHEMBL5170587,CHEMBL1871,Androgen Receptor,Ki,=,1.0,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,N#Cc1ccc(N2CCC[C@@H]2[C@@H](O)C(F)(F)F)cc1C(F)(F)F,9.0
CHEMBL484726,CHEMBL1871,Androgen Receptor,Ki,=,0.3,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,Cc1c(/N=C2\O[C@@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl,9.522878745280337
CHEMBL197595,CHEMBL1871,Androgen Receptor,Ki,=,4.6,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KI,C[C@@H]1CN(c2ccc(C#N)c(C(F)(F)F)c2)[C@@H](C)CN1C(=O)Nc1ccc(C(F)(F)F)nc1,8.337242168318426
CHEMBL5189325,CHEMBL1871,Androgen Receptor,Ki,=,7.0,nM,CHEMBL5140903,B,Binding affinity to human Androgen receptor measured by fluorescence polarization assay,CHEMBL5137058,KI,Cc1c(N[C@@H](c2ccc(-c3ccc(C#N)cc3)o2)[C@H](C)O)ccc(C#N)c1Cl,8.154901959985743
CHEMBL229861,CHEMBL1871,Androgen Receptor,Ki,=,0.9,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,KI,CC[C@H]1[C@@H]2[C@@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,9.045757490560675
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,11.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.958607314841775
CHEMBL124881,CHEMBL1871,Androgen Receptor,Ki,=,365.0,nM,CHEMBL5140915,B,Binding affinity to Androgen receptor (unknown origin),CHEMBL5137058,KI,C[C@@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.437707135543525
CHEMBL125236,CHEMBL1871,Androgen Receptor,Ki,=,4.0,nM,CHEMBL5140919,B,Displacement of [3H]mibolerone from Androgen receptor (unknown origin) measured by liquid scintillation counting method,CHEMBL5137058,KI,CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1,8.397940008672037
CHEMBL1738889,CHEMBL1871,Androgen Receptor,Ki,=,0.55,nM,CHEMBL5140919,B,Displacement of [3H]mibolerone from Androgen receptor (unknown origin) measured by liquid scintillation counting method,CHEMBL5137058,KI,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,9.259637310505756
CHEMBL233773,CHEMBL1871,Androgen Receptor,Ki,=,0.45,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3S2(=O)=O)ccc(C#N)c1Cl,9.346787486224656
CHEMBL229264,CHEMBL1871,Androgen Receptor,Ki,=,3.2,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,Cc1c(N2C(=O)[C@@H]3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,8.494850021680094
CHEMBL5186356,CHEMBL1871,Androgen Receptor,Ki,=,73.0,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,CCCCc1ccc(OC(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc([N+](=O)[O-])c5ccccc45)C(=O)N32)cc1,7.136677139879544
CHEMBL362566,CHEMBL1871,Androgen Receptor,Ki,=,18.0,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)cc1C(F)(F)F,7.7447274948966935
CHEMBL5186213,CHEMBL1871,Androgen Receptor,Ki,=,2.4,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,C[C@@]12O[C@@](C)(C[C@H]1O)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12,8.619788758288394
CHEMBL5189989,CHEMBL1871,Androgen Receptor,Ki,=,14.0,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,CC(C)N1C[C@@]2(C)O[C@](C)(C1)[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]12,7.853871964321762
CHEMBL5194764,CHEMBL1871,Androgen Receptor,Ki,=,8.0,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,CNC(=O)[C@]12C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@H]1[C@H]1C[C@H](F)[C@@H]2C1,8.096910013008056
CHEMBL3932464,CHEMBL1871,Androgen Receptor,Ki,=,1.7,nM,CHEMBL5140924,B,Displacement of [3H]DHT from Androgen receptor expressed in human MDA-MB-453 cells,CHEMBL5137058,KI,CCS(=O)(=O)N[C@@H]1C[C@@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12,8.769551078621726
CHEMBL518945,CHEMBL1871,Androgen Receptor,Ki,=,110.0,nM,CHEMBL5140945,B,Binding affinity to wild-type Androgen receptor (unknown origin),CHEMBL5137058,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,6.958607314841775
CHEMBL518945,CHEMBL1871,Androgen Receptor,Ki,=,6.0,nM,CHEMBL5140957,B,Binding affinity to bicalutamide-resistant Androgen receptor T878A mutant (unknown origin),CHEMBL5137058,KI,Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1,8.221848749616356
CHEMBL5272485,CHEMBL1871,Androgen Receptor,Ki,=,5.6,nM,CHEMBL5235779,B,Antagonist activity at androgen receptor (unknown origin) assessed as inhibition constant,CHEMBL5233269,KI,COC(=O)c1ccc(C2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@]23CCOC3)cc1F,8.2518119729938
CHEMBL4584527,CHEMBL1871,Androgen Receptor,Ki,=,78.06,nM,CHEMBL5239289,B,Binding affinity to GST tagged AR LBD (unknown orign) by radioligand binding assay,CHEMBL5236610,KI,CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1,7.10757145305477
CHEMBL4444904,CHEMBL1871,Androgen Receptor,Ki,=,267.39,nM,CHEMBL5239289,B,Binding affinity to GST tagged AR LBD (unknown orign) by radioligand binding assay,CHEMBL5236610,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.572854838757011
CHEMBL4444904,CHEMBL1871,Androgen Receptor,Ki,=,267.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.573488738635424
CHEMBL5408162,CHEMBL1871,Androgen Receptor,Ki,=,91.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1c2ccccc2c2ccccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,7.040958607678906
CHEMBL5435897,CHEMBL1871,Androgen Receptor,Ki,=,729.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1c2ccccc2c2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.137272471682025
CHEMBL5398983,CHEMBL1871,Androgen Receptor,Ki,=,194.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1c2ccccc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.7121982700697735
CHEMBL5403067,CHEMBL1871,Androgen Receptor,Ki,=,249.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1c2ccccc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.603800652904264
CHEMBL5395016,CHEMBL1871,Androgen Receptor,Ki,=,810.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1c2ccc(F)cc2c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.0915149811213505
CHEMBL5420396,CHEMBL1871,Androgen Receptor,Ki,=,3615.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc2ccc(F)cc2n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.44189169836945
CHEMBL5417717,CHEMBL1871,Androgen Receptor,Ki,=,1476.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nnc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.830913642512977
CHEMBL63560,CHEMBL1871,Androgen Receptor,Ki,=,509.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.293282217663242
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Ki,=,3641.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.438779321066056
CHEMBL4297185,CHEMBL1871,Androgen Receptor,Ki,=,4231.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1,5.3735569746687055
CHEMBL1738889,CHEMBL1871,Androgen Receptor,Ki,=,38.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.42021640338319
CHEMBL5419739,CHEMBL1871,Androgen Receptor,Ki,=,724.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.140261433802853
CHEMBL5408185,CHEMBL1871,Androgen Receptor,Ki,=,1399.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cc1nc2cc(F)c(F)cc2[nH]1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.854182285508172
CHEMBL5408573,CHEMBL1871,Androgen Receptor,Ki,=,883.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1,6.054039296422431
CHEMBL5435483,CHEMBL1871,Androgen Receptor,Ki,=,913.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2cccc(F)c21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.039529222465701
CHEMBL5408265,CHEMBL1871,Androgen Receptor,Ki,=,1589.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.798876102792621
CHEMBL5435893,CHEMBL1871,Androgen Receptor,Ki,=,493.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2c(C(F)(F)F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.30715308072277
CHEMBL5436377,CHEMBL1871,Androgen Receptor,Ki,=,474.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cnc2cccc(C(F)(F)F)c21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.324221658325914
CHEMBL5427747,CHEMBL1871,Androgen Receptor,Ki,=,318.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc(F)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.497572880015568
CHEMBL5432213,CHEMBL1871,Androgen Receptor,Ki,=,755.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc(Cl)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.1220530483708115
CHEMBL5409022,CHEMBL1871,Androgen Receptor,Ki,=,757.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.120904120499928
CHEMBL5422780,CHEMBL1871,Androgen Receptor,Ki,=,644.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc(C#N)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.1911141326401875
CHEMBL5426070,CHEMBL1871,Androgen Receptor,Ki,=,424.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc([N+](=O)[O-])c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.372634143407268
CHEMBL5438541,CHEMBL1871,Androgen Receptor,Ki,=,137.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1ncc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.863279432843593
CHEMBL5437180,CHEMBL1871,Androgen Receptor,Ki,=,172.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc2c(F)cccc2n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.764471553092451
CHEMBL5429413,CHEMBL1871,Androgen Receptor,Ki,=,12325.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc2c(C(F)(F)F)cccc2n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,4.909213072050733
CHEMBL5393959,CHEMBL1871,Androgen Receptor,Ki,=,605.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(F)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.2182446253475305
CHEMBL5421024,CHEMBL1871,Androgen Receptor,Ki,=,1343.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.871923987331284
CHEMBL5426016,CHEMBL1871,Androgen Receptor,Ki,=,3006.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(Cl)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,5.52201102374911
CHEMBL5440684,CHEMBL1871,Androgen Receptor,Ki,=,26302.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(Br)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,4.580011226569585
CHEMBL5426565,CHEMBL1871,Androgen Receptor,Ki,=,3268.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(I)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,5.4857179521396215
CHEMBL5399091,CHEMBL1871,Androgen Receptor,Ki,=,796.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1nc(C=O)c2cc(F)ccc21)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1,6.099086932262331
CHEMBL4442857,CHEMBL1871,Androgen Receptor,Ki,=,547.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12,6.262012673666569
CHEMBL5421919,CHEMBL1871,Androgen Receptor,Ki,=,332.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1cc(F)c2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.478861916295964
CHEMBL5419937,CHEMBL1871,Androgen Receptor,Ki,=,1006.0,nM,CHEMBL5340021,B,Displacement of [3H]mibolerone from GST-tagged wild type AR ligand binding domain (unknown origin) incubated for 16 hrs by scintillation counting analysis,CHEMBL5338730,KI,C[C@](O)(Cn1ncc2c(C(F)(F)F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.997402019280091
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,20.0,nM,CHEMBL1111209,B,Agonist activity at androgen receptor ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-DBD by luciferase reporter gene assay,CHEMBL1154793,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.698970004336019
CHEMBL6,CHEMBL1871,Androgen Receptor,EC50,=,0.14,nM,CHEMBL2329799,B,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL2321830,EC50,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1,9.853871964321762
CHEMBL2323511,CHEMBL1871,Androgen Receptor,EC50,=,0.14,nM,CHEMBL2329799,B,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL2321830,EC50,COc1ccc2c(c1)c(C)c(CCC(=O)NS(C)(=O)=O)n2C(=O)c1ccc(Cl)cc1,9.853871964321762
CHEMBL2323507,CHEMBL1871,Androgen Receptor,EC50,=,0.15,nM,CHEMBL2329799,B,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL2321830,EC50,COc1ccc2c(c1)c(C)c(CCC(=O)O)n2C(=O)c1ccc(Cl)cc1,9.823908740944319
CHEMBL2323490,CHEMBL1871,Androgen Receptor,EC50,=,0.1,nM,CHEMBL2329799,B,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL2321830,EC50,COc1ccc2c(c1)c(CC(=O)NS(=O)(=O)C(F)(F)F)cn2C(=O)c1ccc(Cl)cc1,10.0
CHEMBL2337505,CHEMBL1871,Androgen Receptor,EC50,=,4800.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl,5.318758762624412
CHEMBL2337506,CHEMBL1871,Androgen Receptor,EC50,=,640.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,N#Cc1ccc(N2CCC(O)C2)cc1Cl,6.1938200260161125
CHEMBL2337506,CHEMBL1871,Androgen Receptor,EC50,=,4700.0,nM,CHEMBL2339065,B,Agonist activity at wild type Androgen receptor in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,N#Cc1ccc(N2CCC(O)C2)cc1Cl,5.327902142064282
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,15.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,7.823908740944319
CHEMBL2337512,CHEMBL1871,Androgen Receptor,EC50,=,5100.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1,5.292429823902063
CHEMBL2337511,CHEMBL1871,Androgen Receptor,EC50,=,10000.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1,5.0
CHEMBL2337510,CHEMBL1871,Androgen Receptor,EC50,=,10000.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1,5.0
CHEMBL2337509,CHEMBL1871,Androgen Receptor,EC50,=,20.0,nM,CHEMBL2339064,B,Agonist activity at Androgen receptor T877A mutant in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(F)cc1,7.698970004336019
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,6.2,nM,CHEMBL2339065,B,Agonist activity at wild type Androgen receptor in human LNCaP-hr cells assessed as prostate specific antigen secretion measured after 3 days by enzyme-immunoassay,CHEMBL2331321,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.207608310501746
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,49.0,nM,CHEMBL2395387,B,Displacement of [3H]R1881 from AR in human MDA-MB-453 cells,CHEMBL2390857,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.309803919971486
CHEMBL409,CHEMBL1871,Androgen Receptor,EC50,=,31.0,nM,CHEMBL2395387,B,Displacement of [3H]R1881 from AR in human MDA-MB-453 cells,CHEMBL2390857,EC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,7.508638306165727
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,915.0,nM,CHEMBL2395386,B,Displacement of [3H]R1881 from AR in human LNCaP cells after 2 hrs by scintillation counting analysis,CHEMBL2390857,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.0385789059335515
CHEMBL2105738,CHEMBL1871,Androgen Receptor,EC50,=,670.0,nM,CHEMBL2395386,B,Displacement of [3H]R1881 from AR in human LNCaP cells after 2 hrs by scintillation counting analysis,CHEMBL2390857,EC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,6.173925197299173
CHEMBL409,CHEMBL1871,Androgen Receptor,EC50,=,1400.0,nM,CHEMBL2395386,B,Displacement of [3H]R1881 from AR in human LNCaP cells after 2 hrs by scintillation counting analysis,CHEMBL2390857,EC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.853871964321762
CHEMBL3221237,CHEMBL1871,Androgen Receptor,EC50,=,144.0,nM,CHEMBL3222680,B,Agonist activity at human AR expressed in African green monkey CV1 cells after 17 hrs by ARE-driven luciferase reporter gene assay,CHEMBL3217624,EC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,6.84163750790475
CHEMBL3238273,CHEMBL1871,Androgen Receptor,EC50,=,689.0,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccccc1)C(=O)N1CCc2c(C#N)cccc21,6.161780778092375
CHEMBL3238274,CHEMBL1871,Androgen Receptor,EC50,=,2.5,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21,8.602059991327963
CHEMBL3238275,CHEMBL1871,Androgen Receptor,EC50,=,37.4,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1cccc(F)c1)C(=O)N1CCc2c(C#N)cccc21,7.42712839779952
CHEMBL3238276,CHEMBL1871,Androgen Receptor,EC50,=,14.8,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccccc1F)C(=O)N1CCc2c(C#N)cccc21,7.8297382846050425
CHEMBL3238277,CHEMBL1871,Androgen Receptor,EC50,=,3.4,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(Cl)cc1)C(=O)N1CCc2c(C#N)cccc21,8.468521082957745
CHEMBL3238278,CHEMBL1871,Androgen Receptor,EC50,=,275.0,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1cccc(Cl)c1)C(=O)N1CCc2c(C#N)cccc21,6.560667306169737
CHEMBL3238279,CHEMBL1871,Androgen Receptor,EC50,=,6.1,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccccc1Cl)C(=O)N1CCc2c(C#N)cccc21,8.214670164989233
CHEMBL3238280,CHEMBL1871,Androgen Receptor,EC50,=,0.34,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(Br)cc1)C(=O)N1CCc2c(C#N)cccc21,9.468521082957745
CHEMBL3238281,CHEMBL1871,Androgen Receptor,EC50,=,1.8,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(C(F)(F)F)cc1)C(=O)N1CCc2c(C#N)cccc21,8.744727494896694
CHEMBL3238282,CHEMBL1871,Androgen Receptor,EC50,=,8.6,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1,8.065501548756432
CHEMBL3238283,CHEMBL1871,Androgen Receptor,EC50,=,6.8,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COC(=O)c1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1,8.167491087293763
CHEMBL3238284,CHEMBL1871,Androgen Receptor,EC50,=,7.2,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(-c2cocn2)cc1)C(=O)N1CCc2c(C#N)cccc21,8.142667503568731
CHEMBL3238285,CHEMBL1871,Androgen Receptor,EC50,=,1.8,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(C#N)cc1)C(=O)N1CCc2c(C#N)cccc21,8.744727494896694
CHEMBL3238286,CHEMBL1871,Androgen Receptor,EC50,=,1.7,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccccc1C(F)(F)F)C(=O)N1CCc2c(C#N)cccc21,8.769551078621726
CHEMBL3238287,CHEMBL1871,Androgen Receptor,EC50,=,0.15,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccccc1C#N)C(=O)N1CCc2c(C#N)cccc21,9.823908740944319
CHEMBL3238288,CHEMBL1871,Androgen Receptor,EC50,=,0.074,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(F)cc1C#N)C(=O)N1CCc2c(C#N)cccc21,10.130768280269024
CHEMBL3238289,CHEMBL1871,Androgen Receptor,EC50,=,0.4,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(F)cc1Br)C(=O)N1CCc2c(C#N)cccc21,9.397940008672037
CHEMBL3238290,CHEMBL1871,Androgen Receptor,EC50,=,1.1,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,Cc1cc(F)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,8.958607314841775
CHEMBL3238291,CHEMBL1871,Androgen Receptor,EC50,=,0.06,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(C#N)cc1Br)C(=O)N1CCc2c(C#N)cccc21,10.221848749616356
CHEMBL3238292,CHEMBL1871,Androgen Receptor,EC50,=,0.039,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(C#N)cc1F)C(=O)N1CCc2c(C#N)cccc21,10.4089353929735
CHEMBL3238293,CHEMBL1871,Androgen Receptor,EC50,=,7.6,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COc1cc(C#N)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,8.119186407719209
CHEMBL3238294,CHEMBL1871,Androgen Receptor,EC50,=,17.1,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COc1cc(Cl)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21,7.767003889607846
CHEMBL3238295,CHEMBL1871,Androgen Receptor,EC50,=,2.9,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(F)c1,8.537602002101044
CHEMBL3233069,CHEMBL1871,Androgen Receptor,EC50,=,0.61,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(Cl)c1,9.214670164989233
CHEMBL3233070,CHEMBL1871,Androgen Receptor,EC50,=,0.28,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(Cl)cc1F)C(=O)N1CCc2c(C#N)cccc21,9.55284196865778
CHEMBL3233071,CHEMBL1871,Androgen Receptor,EC50,=,0.25,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(Cl)cc1Cl)C(=O)N1CCc2c(C#N)cccc21,9.602059991327963
CHEMBL3233072,CHEMBL1871,Androgen Receptor,EC50,=,0.11,nM,CHEMBL3243252,B,Agonist activity at human AR expressed in CV1 cells after 17 hrs by luciferase reporter gene assay,CHEMBL3232788,EC50,C[C@](O)(COc1ccc(Br)cc1F)C(=O)N1CCc2c(C#N)cccc21,9.958607314841775
CHEMBL3326466,CHEMBL1871,Androgen Receptor,EC50,=,0.3,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC(F)(F)C[C@@H]12,9.522878745280337
CHEMBL3326465,CHEMBL1871,Androgen Receptor,EC50,=,26.0,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC(=O)C[C@@H]12,7.585026652029182
CHEMBL3326464,CHEMBL1871,Androgen Receptor,EC50,=,1.4,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2C[C@@H](F)C[C@@H]12,8.853871964321762
CHEMBL3326462,CHEMBL1871,Androgen Receptor,EC50,=,9.7,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2C[C@H](O)C[C@@H]12,8.013228265733755
CHEMBL3326461,CHEMBL1871,Androgen Receptor,EC50,=,0.16,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@@H](F)[C@@H]12,9.795880017344075
CHEMBL3326460,CHEMBL1871,Androgen Receptor,EC50,=,1.5,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](F)[C@@H]12,8.823908740944319
CHEMBL3326459,CHEMBL1871,Androgen Receptor,EC50,=,7.1,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@H]1CCN2N=C(c3ccc(C#N)c(Cl)c3C)[C@@H](OC)[C@H]12,8.148741651280925
CHEMBL3326458,CHEMBL1871,Androgen Receptor,EC50,=,0.4,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@@H](O)[C@@H]12,9.397940008672037
CHEMBL3326457,CHEMBL1871,Androgen Receptor,EC50,=,0.93,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,COCCO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12,9.031517051446064
CHEMBL3326456,CHEMBL1871,Androgen Receptor,EC50,=,4.5,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,Cc1c(C2=NN3CC[C@H](O)[C@H]3[C@@H]2OC(C)C)ccc(C#N)c1Cl,8.346787486224656
CHEMBL3326455,CHEMBL1871,Androgen Receptor,EC50,=,1.0,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CCO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12,9.0
CHEMBL3326454,CHEMBL1871,Androgen Receptor,EC50,=,0.5,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12,9.301029995663981
CHEMBL3326453,CHEMBL1871,Androgen Receptor,EC50,=,978.0,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,Cc1c(C2=NN3CC[C@H](O)[C@H]3[C@@H]2O)ccc(C#N)c1Cl,6.009661145212398
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,0.13,nM,CHEMBL3371979,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells by androgen-specific response element-driven luciferase reporter gene assay,CHEMBL3351728,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.886056647693163
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,0.18,nM,CHEMBL3385881,B,Agonist activity at human androgen receptor expressed in HEK293 cells by luciferase reporter gene assay,CHEMBL3352412,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.744727494896694
CHEMBL570898,CHEMBL1871,Androgen Receptor,EC50,=,2.5,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,N#Cc1ccc(N2CCCC2)c2ccccc12,8.602059991327963
CHEMBL570897,CHEMBL1871,Androgen Receptor,EC50,=,41.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,O=[N+]([O-])c1ccc(N2CCCC2)c2ccccc12,7.3872161432802645
CHEMBL3402221,CHEMBL1871,Androgen Receptor,EC50,=,0.19,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1CCCN1c1ccc(C#N)c2ccccc12,9.721246399047171
CHEMBL3402223,CHEMBL1871,Androgen Receptor,EC50,=,21.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,CC1(C)CCCN1c1ccc(C#N)c2ccccc12,7.6777807052660805
CHEMBL3402224,CHEMBL1871,Androgen Receptor,EC50,=,0.24,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,CC[C@H]1CCCN1c1ccc(C#N)c2ccccc12,9.619788758288394
CHEMBL3402225,CHEMBL1871,Androgen Receptor,EC50,=,2.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,CC(C)[C@H]1CCCN1c1ccc(C#N)c2ccccc12,8.698970004336019
CHEMBL3402226,CHEMBL1871,Androgen Receptor,EC50,=,21.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,N#Cc1ccc(N2CCC[C@@H]2C(N)=O)c2ccccc12,7.6777807052660805
CHEMBL3402227,CHEMBL1871,Androgen Receptor,EC50,=,160.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,N#Cc1ccc(N2CCC[C@@H]2C#N)c2ccccc12,6.795880017344075
CHEMBL3402228,CHEMBL1871,Androgen Receptor,EC50,=,0.25,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1[C@@H](O)CCN1c1ccc(C#N)c2ccccc12,9.602059991327963
CHEMBL3402229,CHEMBL1871,Androgen Receptor,EC50,=,0.32,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1[C@H](O)CCN1c1ccc(C#N)c2ccccc12,9.494850021680094
CHEMBL3402230,CHEMBL1871,Androgen Receptor,EC50,=,2.2,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1C(=O)CCN1c1ccc(C#N)c2ccccc12,8.657577319177793
CHEMBL3402231,CHEMBL1871,Androgen Receptor,EC50,=,1.2,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1[C@@H](CO)CCN1c1ccc(C#N)c2ccccc12,8.920818753952375
CHEMBL3402232,CHEMBL1871,Androgen Receptor,EC50,=,45.0,nM,CHEMBL3404788,B,Modulation of androgen receptor (unknown origin) expressed in Cos7 cells assessed as luciferase activity after 24 hrs,CHEMBL3399980,EC50,C[C@H]1[C@@H](C(C)(C)O)CCN1c1ccc(C#N)c2ccccc12,7.346787486224656
CHEMBL409,CHEMBL1871,Androgen Receptor,EC50,=,971.0,nM,CHEMBL3418492,B,Displacement of [3H]R1881 from androgen receptor in human LNCAP cells,CHEMBL3414506,EC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,6.012780770091995
CHEMBL2105738,CHEMBL1871,Androgen Receptor,EC50,=,845.0,nM,CHEMBL3418492,B,Displacement of [3H]R1881 from androgen receptor in human LNCAP cells,CHEMBL3414506,EC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,6.073143291050307
CHEMBL2105738,CHEMBL1871,Androgen Receptor,EC50,=,405.0,nM,CHEMBL3418493,B,Displacement of [3H]R1881 from androgen receptor in human PC3 cells,CHEMBL3414506,EC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,6.392544976785331
CHEMBL409,CHEMBL1871,Androgen Receptor,EC50,=,4300.0,nM,CHEMBL3418493,B,Displacement of [3H]R1881 from androgen receptor in human PC3 cells,CHEMBL3414506,EC50,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.366531544420413
CHEMBL3764446,CHEMBL1871,Androgen Receptor,EC50,=,73.7,nM,CHEMBL3767969,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay,CHEMBL3763123,EC50,Cc1c(N[C@@H]2COC[C@@]2(C)O)ccc(C#N)c1Cl,7.132532512140949
CHEMBL3765823,CHEMBL1871,Androgen Receptor,EC50,=,4.88,nM,CHEMBL3767969,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay,CHEMBL3763123,EC50,Cc1c(N[C@@H]2CCCC[C@@]2(C)O)ccc(C#N)c1Cl,8.311580177997289
CHEMBL3765171,CHEMBL1871,Androgen Receptor,EC50,=,0.0398,nM,CHEMBL3767969,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay,CHEMBL3763123,EC50,Cc1c(N[C@@H]2CCC[C@]2(C)O)ccc(C#N)c1Cl,10.400116927926312
CHEMBL3764185,CHEMBL1871,Androgen Receptor,EC50,=,0.499,nM,CHEMBL3767969,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay,CHEMBL3763123,EC50,Cc1c(N[C@@H]2CCC[C@@]2(C)O)ccc(C#N)c1Cl,9.30189945437661
CHEMBL166444,CHEMBL1871,Androgen Receptor,EC50,=,0.013,nM,CHEMBL3767969,B,Agonist activity at human androgen receptor expressed in mouse C2C12 cells cotransfected with GRE/ARE reporter plasmid assessed as receptor transactivation after 48 hrs by luciferase reporter gene assay,CHEMBL3763123,EC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,10.886056647693163
CHEMBL3819469,CHEMBL1871,Androgen Receptor,EC50,=,2.884,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2ccc(Cl)o2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.540004743952608
CHEMBL3818882,CHEMBL1871,Androgen Receptor,EC50,=,5.623,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2ccc(Cl)s2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.250031916490597
CHEMBL3819080,CHEMBL1871,Androgen Receptor,EC50,=,0.2512,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2ccco2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,9.599980364934842
CHEMBL3818235,CHEMBL1871,Androgen Receptor,EC50,=,0.5012,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2cocn2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,9.299988937677888
CHEMBL3819595,CHEMBL1871,Androgen Receptor,EC50,=,5.888,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2cscn2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.230032198670557
CHEMBL3818438,CHEMBL1871,Androgen Receptor,EC50,=,10.47,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(c2nccs2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,7.980053318321158
CHEMBL3819111,CHEMBL1871,Androgen Receptor,EC50,=,19.95,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2ccc(Cl)s2)C(F)(F)F)cc1C(F)(F)F,7.700057099977233
CHEMBL3818412,CHEMBL1871,Androgen Receptor,EC50,=,2.512,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2ccc(Cl)o2)C(F)(F)F)cc1C(F)(F)F,8.599980364934842
CHEMBL3819324,CHEMBL1871,Androgen Receptor,EC50,=,1.995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2nccs2)C(F)(F)F)cc1C(F)(F)F,8.700057099977233
CHEMBL3818942,CHEMBL1871,Androgen Receptor,EC50,=,1.995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2cscn2)C(F)(F)F)cc1C(F)(F)F,8.700057099977233
CHEMBL3818634,CHEMBL1871,Androgen Receptor,EC50,=,1.259,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2ccco2)C(F)(F)F)cc1C(F)(F)F,8.899974269892137
CHEMBL3818224,CHEMBL1871,Androgen Receptor,EC50,=,1.259,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(c2cocn2)C(F)(F)F)cc1C(F)(F)F,8.899974269892137
CHEMBL3818069,CHEMBL1871,Androgen Receptor,EC50,=,15.85,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C#CC2CC2)C(F)(F)F)ccc(C#N)c1Cl,7.79997073344623
CHEMBL3817985,CHEMBL1871,Androgen Receptor,EC50,=,79.43,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C#CC(C)(C)C)C(F)(F)F)ccc(C#N)c1Cl,7.100015437450609
CHEMBL3818688,CHEMBL1871,Androgen Receptor,EC50,=,3.981,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(CC(C)(C)C)C(F)(F)F)ccc(C#N)c1Cl,8.400007822415901
CHEMBL3818258,CHEMBL1871,Androgen Receptor,EC50,=,79.43,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C(C)(C)C)C(F)(F)F)ccc(C#N)c1Cl,7.100015437450609
CHEMBL3818497,CHEMBL1871,Androgen Receptor,EC50,=,0.1995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C2CC2)C(F)(F)F)ccc(C#N)c1Cl,9.700057099977233
CHEMBL3818208,CHEMBL1871,Androgen Receptor,EC50,=,0.7943,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C(C)C)C(F)(F)F)ccc(C#N)c1Cl,9.100015437450608
CHEMBL3819094,CHEMBL1871,Androgen Receptor,EC50,=,1.995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CCC(O)(c1ccc(C#N)c(Cl)c1C)C(F)(F)F,8.700057099977233
CHEMBL3819002,CHEMBL1871,Androgen Receptor,EC50,=,19.95,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C(F)(F)F)C(F)(F)F)ccc(C#N)c1Cl,7.700057099977233
CHEMBL3818919,CHEMBL1871,Androgen Receptor,EC50,=,3.162,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)(C)CC(O)(c1ccc(C#N)c(Cl)c1Cl)C(F)(F)F,8.500038134403809
CHEMBL3818549,CHEMBL1871,Androgen Receptor,EC50,=,3.162,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)CC(O)(c1ccc(C#N)c(Cl)c1Cl)C(F)(F)F,8.500038134403809
CHEMBL3819640,CHEMBL1871,Androgen Receptor,EC50,=,0.631,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CCC2)C(F)(F)F)c(Cl)c1Cl,9.199970640755865
CHEMBL3818619,CHEMBL1871,Androgen Receptor,EC50,=,0.1995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CC2)C(F)(F)F)c(Cl)c1Cl,9.700057099977233
CHEMBL3818367,CHEMBL1871,Androgen Receptor,EC50,=,0.7943,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)C(O)(c1ccc(C#N)c(Cl)c1Cl)C(F)(F)F,9.100015437450608
CHEMBL3819015,CHEMBL1871,Androgen Receptor,EC50,=,2.512,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CCC(O)(c1ccc(C#N)c(Cl)c1Cl)C(F)(F)F,8.599980364934842
CHEMBL3818405,CHEMBL1871,Androgen Receptor,EC50,=,63.1,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(O)(c1ccc(C#N)c(Cl)c1Cl)C(F)(F)F,7.199970640755866
CHEMBL3817881,CHEMBL1871,Androgen Receptor,EC50,=,3.162,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CCCC2)C(F)(F)F)cc1Cl,8.500038134403809
CHEMBL3819102,CHEMBL1871,Androgen Receptor,EC50,=,1.585,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CCC2)C(F)(F)F)cc1Cl,8.79997073344623
CHEMBL3818577,CHEMBL1871,Androgen Receptor,EC50,=,0.3981,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CC2)C(F)(F)F)cc1Cl,9.400007822415901
CHEMBL3819599,CHEMBL1871,Androgen Receptor,EC50,=,158.49,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)(C)C(O)(c1ccc(C#N)c(Cl)c1)C(F)(F)F,6.799998134593398
CHEMBL3818620,CHEMBL1871,Androgen Receptor,EC50,=,3.981,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)C(O)(c1ccc(C#N)c(Cl)c1)C(F)(F)F,8.400007822415901
CHEMBL3818757,CHEMBL1871,Androgen Receptor,EC50,=,19.95,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C#N)ccc(C(O)(CC(C)(C)C)C(F)(F)F)c1C,7.700057099977233
CHEMBL3818854,CHEMBL1871,Androgen Receptor,EC50,=,1.585,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C#N)ccc(C(O)(C2CC2)C(F)(F)F)c1C,8.79997073344623
CHEMBL3819417,CHEMBL1871,Androgen Receptor,EC50,=,12.59,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C#N)ccc(C(O)(C(C)C)C(F)(F)F)c1C,7.899974269892137
CHEMBL3818033,CHEMBL1871,Androgen Receptor,EC50,=,2511.89,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C#N)ccc(C(C)(O)C(F)(F)F)c1C,5.59999938302362
CHEMBL3817997,CHEMBL1871,Androgen Receptor,EC50,=,39.81,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,C/C=C(\C)C(O)(c1ccc(C#N)c(C(F)(F)F)c1)C(F)(F)F,7.400007822415902
CHEMBL3818136,CHEMBL1871,Androgen Receptor,EC50,=,31.62,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,C=C(C)C(O)(c1ccc(C#N)c(C(F)(F)F)c1)C(F)(F)F,7.50003813440381
CHEMBL3818420,CHEMBL1871,Androgen Receptor,EC50,=,12.59,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,C=CC(O)(c1ccc(C#N)c(C(F)(F)F)c1)C(F)(F)F,7.899974269892137
CHEMBL3819393,CHEMBL1871,Androgen Receptor,EC50,=,1.585,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CCC2)C(F)(F)F)cc1C(F)(F)F,8.79997073344623
CHEMBL3819048,CHEMBL1871,Androgen Receptor,EC50,=,0.1585,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C2CC2)C(F)(F)F)cc1C(F)(F)F,9.79997073344623
CHEMBL3818652,CHEMBL1871,Androgen Receptor,EC50,=,10000.0,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(CO)C(F)(F)F)cc1C(F)(F)F,5.0
CHEMBL3818826,CHEMBL1871,Androgen Receptor,EC50,=,7.943,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CC(C)C(O)(c1ccc(C#N)c(C(F)(F)F)c1)C(F)(F)F,8.100015437450608
CHEMBL3818789,CHEMBL1871,Androgen Receptor,EC50,=,3.981,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,CCC(O)(c1ccc(C#N)c(C(F)(F)F)c1)C(F)(F)F,8.400007822415901
CHEMBL3818723,CHEMBL1871,Androgen Receptor,EC50,=,15.85,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,N#Cc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1C(F)(F)F,7.79997073344623
CHEMBL3819648,CHEMBL1871,Androgen Receptor,EC50,=,0.1995,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C2CCC2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,9.700057099977233
CHEMBL3818706,CHEMBL1871,Androgen Receptor,EC50,=,0.03162,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C2CC2)C(F)(F)F)ccc(C#N)c1C(F)(F)F,10.500038134403809
CHEMBL3819303,CHEMBL1871,Androgen Receptor,EC50,=,0.2512,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C(C)C)C(F)(F)F)ccc(C#N)c1C(F)(F)F,9.599980364934842
CHEMBL3818542,CHEMBL1871,Androgen Receptor,EC50,=,1.585,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(O)(C(F)(F)F)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.79997073344623
CHEMBL3819041,CHEMBL1871,Androgen Receptor,EC50,=,3.981,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(C)(O)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.400007822415901
CHEMBL3818555,CHEMBL1871,Androgen Receptor,EC50,=,15.85,nM,CHEMBL3820557,B,Modulation of human androgen receptor expressed in African green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,CHEMBL3817832,EC50,Cc1c(C(C)(C)C(O)C(F)(F)F)ccc(C#N)c1C(F)(F)F,7.79997073344623
CHEMBL299499,CHEMBL1871,Androgen Receptor,EC50,=,9500.0,nM,CHEMBL4017717,B,Antagonist activity at full length human androgen receptor expressed in mammalian expression system measured after 22 to 24 hrs by luciferase reporter gene assay,CHEMBL4017455,EC50,N=C(Nc1ccc(I)cc1)NC12CC3CC(CC(C3)C1)C2,5.022276394711152
CHEMBL271227,CHEMBL1871,Androgen Receptor,EC50,=,17050.0,nM,CHEMBL4017717,B,Antagonist activity at full length human androgen receptor expressed in mammalian expression system measured after 22 to 24 hrs by luciferase reporter gene assay,CHEMBL4017455,EC50,CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(c4cccnc4)=CC[C@@H]32)C1,4.768275616671484
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,420.0,nM,CHEMBL4017717,B,Antagonist activity at full length human androgen receptor expressed in mammalian expression system measured after 22 to 24 hrs by luciferase reporter gene assay,CHEMBL4017455,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.376750709602099
CHEMBL4084182,CHEMBL1871,Androgen Receptor,EC50,=,12680.0,nM,CHEMBL4017717,B,Antagonist activity at full length human androgen receptor expressed in mammalian expression system measured after 22 to 24 hrs by luciferase reporter gene assay,CHEMBL4017455,EC50,N=C(NCCCOc1ccc(F)cc1)Nc1ccc(Cl)cc1,4.896880746454286
CHEMBL4092687,CHEMBL1871,Androgen Receptor,EC50,=,28130.0,nM,CHEMBL4017717,B,Antagonist activity at full length human androgen receptor expressed in mammalian expression system measured after 22 to 24 hrs by luciferase reporter gene assay,CHEMBL4017455,EC50,COc1ccc(NC(=N)NCCCOc2ccc(F)cc2)cc1,4.550830267834799
CHEMBL4090028,CHEMBL1871,Androgen Receptor,EC50,=,0.19,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.721246399047171
CHEMBL4092535,CHEMBL1871,Androgen Receptor,EC50,=,0.29,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.537602002101044
CHEMBL4071751,CHEMBL1871,Androgen Receptor,EC50,=,810.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,6.0915149811213505
CHEMBL4100278,CHEMBL1871,Androgen Receptor,EC50,=,1000.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,Cc1c(N2C(=O)C[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,6.0
CHEMBL4085514,CHEMBL1871,Androgen Receptor,EC50,=,150.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@@H]1N(c2ccc(C#N)c(Cl)c2)C(=O)C[C@]1(C)O,6.823908740944319
CHEMBL4072533,CHEMBL1871,Androgen Receptor,EC50,=,6.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.221848749616356
CHEMBL4067691,CHEMBL1871,Androgen Receptor,EC50,=,8.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,8.096910013008056
CHEMBL4088914,CHEMBL1871,Androgen Receptor,EC50,=,4.7,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.327902142064282
CHEMBL4059588,CHEMBL1871,Androgen Receptor,EC50,=,24.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(OC)c1,7.619788758288394
CHEMBL4087902,CHEMBL1871,Androgen Receptor,EC50,=,23.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1C,7.638272163982407
CHEMBL4074501,CHEMBL1871,Androgen Receptor,EC50,=,1.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O,9.0
CHEMBL4101232,CHEMBL1871,Androgen Receptor,EC50,=,3.6,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O,8.443697499232712
CHEMBL4101935,CHEMBL1871,Androgen Receptor,EC50,=,220.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@H]1[C@@H](O)[C@H](Cc2ccccc2)C(=O)N1c1ccc(C#N)c(Cl)c1,6.657577319177793
CHEMBL4100995,CHEMBL1871,Androgen Receptor,EC50,=,0.39,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC[C@H]1[C@@H](O)[C@H](C)C(=O)N1c1ccc(C#N)c(Cl)c1,9.4089353929735
CHEMBL4077666,CHEMBL1871,Androgen Receptor,EC50,=,30.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@H]1[C@@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1,7.522878745280337
CHEMBL4082265,CHEMBL1871,Androgen Receptor,EC50,=,10000.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@@H]1[C@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1,5.0
CHEMBL4063939,CHEMBL1871,Androgen Receptor,EC50,=,12.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@H]1[C@@H](O)C(F)(F)C(=O)N1c1ccc(C#N)c(Cl)c1,7.920818753952375
CHEMBL4093265,CHEMBL1871,Androgen Receptor,EC50,=,170.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,CC(C)C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1,6.769551078621726
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,3.0,nM,CHEMBL4021500,B,Agonist activity at human AR expressed in African green monkey COS7 cells after 24 hrs by luciferase reporter gene assay,CHEMBL4020736,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,8.522878745280337
CHEMBL4061510,CHEMBL1871,Androgen Receptor,EC50,=,17.8,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)c2c1CCC2,7.7495799976911055
CHEMBL4087256,CHEMBL1871,Androgen Receptor,EC50,=,573.2,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1,6.241693818274693
CHEMBL4065842,CHEMBL1871,Androgen Receptor,EC50,=,37.3,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cc1cc(-c2ccc(C#N)n2C)ccc1O,7.428291168191312
CHEMBL4079377,CHEMBL1871,Androgen Receptor,EC50,=,94.8,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cc1cc(O)ccc1-c1ccc(C#N)n1C,7.023191662661934
CHEMBL4103641,CHEMBL1871,Androgen Receptor,EC50,=,391.0,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,CCc1cc(-c2ccc(C#N)n2C)ccc1O,6.407823242604133
CHEMBL4068562,CHEMBL1871,Androgen Receptor,EC50,=,1517.7,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)c(F)c1,5.81881406587177
CHEMBL4095883,CHEMBL1871,Androgen Receptor,EC50,=,0.34,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1F,9.468521082957745
CHEMBL4062016,CHEMBL1871,Androgen Receptor,EC50,=,909.5,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)c(Cl)c1,6.041197296600497
CHEMBL4088158,CHEMBL1871,Androgen Receptor,EC50,=,1.7,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1Cl,8.769551078621726
CHEMBL4073399,CHEMBL1871,Androgen Receptor,EC50,=,15.2,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1C(F)(F)F,7.818156412055227
CHEMBL4100251,CHEMBL1871,Androgen Receptor,EC50,=,233.0,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1[N+](=O)[O-],6.632644078973981
CHEMBL4066319,CHEMBL1871,Androgen Receptor,EC50,=,29.7,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)cc1C#N,7.527243550682788
CHEMBL4087674,CHEMBL1871,Androgen Receptor,EC50,=,1450.3,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,COC(=O)c1cc(O)ccc1-c1ccc(C#N)n1C,5.838542153028249
CHEMBL4095364,CHEMBL1871,Androgen Receptor,EC50,=,0.14,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1c(F)cc(O)cc1F,9.853871964321762
CHEMBL4091403,CHEMBL1871,Androgen Receptor,EC50,=,229.1,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1cc(F)c(O)cc1F,6.6399749108106025
CHEMBL4069026,CHEMBL1871,Androgen Receptor,EC50,=,980.0,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1ccc(O)c(F)c1F,6.008773924307505
CHEMBL4104046,CHEMBL1871,Androgen Receptor,EC50,=,5.3,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1c(F)cc(O)cc1C#N,8.275724130399212
CHEMBL4074555,CHEMBL1871,Androgen Receptor,EC50,=,0.17,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)ccc1-c1c(Cl)cc(O)cc1Cl,9.769551078621726
CHEMBL4072730,CHEMBL1871,Androgen Receptor,EC50,=,34.6,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cc1c(O)ccc(-c2ccc(C#N)n2C)c1C,7.460923901207224
CHEMBL4073869,CHEMBL1871,Androgen Receptor,EC50,=,1644.6,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(C#N)cc(Br)c1-c1ccc(O)cc1,5.783939714076858
CHEMBL4088572,CHEMBL1871,Androgen Receptor,EC50,=,1341.7,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,Cn1c(-c2ccc(O)cc2)cc(C(F)(F)F)c1C#N,5.872344580224793
CHEMBL4060340,CHEMBL1871,Androgen Receptor,EC50,=,1136.4,nM,CHEMBL4040335,B,Agonist activity at human androgen receptor expressed in African green monkey CV-1 cells after 17 hrs by ARE luciferase reporter gene assay,CHEMBL4038318,EC50,CCn1c(C#N)ccc1-c1ccc(O)cc1F,5.944468774949102
CHEMBL4564335,CHEMBL1871,Androgen Receptor,EC50,=,15200.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccc(Cl)cc1N1CCN(C(=O)[C@@H]2C[C@@H]2c2ccc(F)cc2)CC1,4.818156412055227
CHEMBL4553882,CHEMBL1871,Androgen Receptor,EC50,=,1700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccc(Cl)cc1N1CCN(C(=O)[C@H]2C[C@H]2c2ccc(F)cc2)CC1,5.769551078621726
CHEMBL4517379,CHEMBL1871,Androgen Receptor,EC50,=,2700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccc(Cl)cc1N1CCN(C(=O)C2CC2c2ccc(F)cc2)CC1,5.568636235841012
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,1100.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.958607314841775
CHEMBL4437961,CHEMBL1871,Androgen Receptor,EC50,=,7900.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1C1CC2CCC(C1)N2C(=O)CSCc1c(C)noc1C,5.102372908709558
CHEMBL4437961,CHEMBL1871,Androgen Receptor,EC50,=,7700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1C1CC2CCC(C1)N2C(=O)CSCc1c(C)noc1C,5.113509274827518
CHEMBL4436931,CHEMBL1871,Androgen Receptor,EC50,=,7200.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(S(=O)(=O)CSCc2c(C)noc2C)CC1,5.142667503568731
CHEMBL4556937,CHEMBL1871,Androgen Receptor,EC50,=,2900.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)[C@H]2C[C@H]2c2ccccc2)CC1,5.537602002101044
CHEMBL4436888,CHEMBL1871,Androgen Receptor,EC50,=,12700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)/C=C\c2ccccc2)CC1,4.896196279044043
CHEMBL4440255,CHEMBL1871,Androgen Receptor,EC50,=,16100.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)CS(=O)(=O)Cc2c(C)noc2C)CC1,4.79317412396815
CHEMBL4462835,CHEMBL1871,Androgen Receptor,EC50,=,20300.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)C#Cc2ccccc2)CC1,4.692503962086787
CHEMBL4470403,CHEMBL1871,Androgen Receptor,EC50,=,14400.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)CCCc2ccccc2)CC1,4.841637507904751
CHEMBL4462787,CHEMBL1871,Androgen Receptor,EC50,=,13700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)CSCc2ccccc2)CC1,4.863279432843593
CHEMBL4454790,CHEMBL1871,Androgen Receptor,EC50,=,10800.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(CCSCc2c(C)noc2C)CC1,4.966576244513051
CHEMBL4593239,CHEMBL1871,Androgen Receptor,EC50,=,16600.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1cccc(N2[C@H](C)CN(C(=O)CSCc3c(C)noc3C)C[C@@H]2C)c1,4.779891911959945
CHEMBL4581526,CHEMBL1871,Androgen Receptor,EC50,=,14700.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1noc(C)c1CSCC(=O)N1C[C@@H](C)N(c2ccccc2)[C@@H](C)C1,4.8326826652518236
CHEMBL4440641,CHEMBL1871,Androgen Receptor,EC50,=,3100.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1C[C@@H](C)N(C(=O)CSCc2c(C)noc2C)[C@@H](C)C1,5.508638306165727
CHEMBL4561103,CHEMBL1871,Androgen Receptor,EC50,=,11100.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCCN(C(=O)CSCc2c(C)noc2C)CC1,4.954677021213342
CHEMBL4581378,CHEMBL1871,Androgen Receptor,EC50,=,18400.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N(C)CCN(C)C(=O)CSCc1c(C)noc1C,4.735182176990463
CHEMBL4574668,CHEMBL1871,Androgen Receptor,EC50,=,11100.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1noc(C)c1CSCC(=O)N1CCN(c2cccc3ccccc23)CC1,4.954677021213342
CHEMBL4513309,CHEMBL1871,Androgen Receptor,EC50,=,12600.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1noc(C)c1CSCC(=O)N1CCN(c2ccccc2F)CC1,4.8996294548824375
CHEMBL4556818,CHEMBL1871,Androgen Receptor,EC50,=,12000.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1noc(C)c1CSCC(=O)N1CCN(c2ccccc2C#N)CC1,4.920818753952375
CHEMBL4465239,CHEMBL1871,Androgen Receptor,EC50,=,14500.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1ccccc1N1CCN(C(=O)CSCc2c(C)noc2C)CC1,4.838631997765025
CHEMBL1352525,CHEMBL1871,Androgen Receptor,EC50,=,7300.0,nM,CHEMBL4432909,B,Antagonist activity at androgen receptor in human C4-2-PSA-rl cells incubated for 24 hrs in presence of androgen R1881 by dual-glo luciferase reporter gene assay,CHEMBL4431378,EC50,Cc1cccc(N2CCN(C(=O)CSCc3c(C)noc3C)CC2)c1C,5.136677139879544
CHEMBL4591875,CHEMBL1871,Androgen Receptor,EC50,=,190.0,nM,CHEMBL4479399,B,Inhibition of DHT-induced androgen receptor transactivation in human LNCaP cells after 24 hrs by luciferase reporter gene assay relative to control,CHEMBL4477236,EC50,C[C@]12CC[C@H](n3ccnc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,6.721246399047171
CHEMBL4539707,CHEMBL1871,Androgen Receptor,EC50,=,470.0,nM,CHEMBL4479399,B,Inhibition of DHT-induced androgen receptor transactivation in human LNCaP cells after 24 hrs by luciferase reporter gene assay relative to control,CHEMBL4477236,EC50,C[C@]12CC[C@H]3[C@@H](C[C@@H](n4ccnc4)C45CC4CC[C@]35C)[C@@H]1CC=C2n1cnc2ccccc21,6.327902142064282
CHEMBL4541575,CHEMBL1871,Androgen Receptor,EC50,=,1650.0,nM,CHEMBL4479399,B,Inhibition of DHT-induced androgen receptor transactivation in human LNCaP cells after 24 hrs by luciferase reporter gene assay relative to control,CHEMBL4477236,EC50,C[C@]12CC[C@H](OCc3ccncc3)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,5.782516055786093
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,180.0,nM,CHEMBL4479399,B,Inhibition of DHT-induced androgen receptor transactivation in human LNCaP cells after 24 hrs by luciferase reporter gene assay relative to control,CHEMBL4477236,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,6.7447274948966935
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,61.8,nM,CHEMBL4820469,B,Agonist activity at VP16-AR F877L mutant (unknown origin) transfected in human HepG2 cells cotransfected with ARE-LUC incubated for 48 hrs by steady-glo luciferase reporter gene assay,CHEMBL4819022,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,7.209011524911184
CHEMBL4869652,CHEMBL1871,Androgen Receptor,EC50,=,649.0,nM,CHEMBL4820469,B,Agonist activity at VP16-AR F877L mutant (unknown origin) transfected in human HepG2 cells cotransfected with ARE-LUC incubated for 48 hrs by steady-glo luciferase reporter gene assay,CHEMBL4819022,EC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)cc3)C2=S)cnc1C#N,6.187755303199631
CHEMBL4860547,CHEMBL1871,Androgen Receptor,EC50,=,838.0,nM,CHEMBL4820469,B,Agonist activity at VP16-AR F877L mutant (unknown origin) transfected in human HepG2 cells cotransfected with ARE-LUC incubated for 48 hrs by steady-glo luciferase reporter gene assay,CHEMBL4819022,EC50,COc1cc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCN(C)CC4)nc3)C2=S)cnc1C#N,6.076755981369724
CHEMBL4862827,CHEMBL1871,Androgen Receptor,EC50,=,45.0,nM,CHEMBL4820469,B,Agonist activity at VP16-AR F877L mutant (unknown origin) transfected in human HepG2 cells cotransfected with ARE-LUC incubated for 48 hrs by steady-glo luciferase reporter gene assay,CHEMBL4819022,EC50,N#Cc1ncc(N2C(=O)C3(CCC3)N(c3ccc(OC4CCNCC4)cc3)C2=S)cc1Cl,7.346787486224656
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,11390.0,nM,CHEMBL5106963,B,Agonist activity at full length androgen receptor F877L mutant (unknown origin) expressed in PC-3 cells assessed as transcriptional activity,CHEMBL5104187,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,4.9434762759209
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,1070.0,nM,CHEMBL5106964,B,Agonist activity at full length androgen receptor F876L/T877A mutant (unknown origin) expressed in PC-3 cells assessed as transcriptional activity,CHEMBL5104187,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.97061622231479
CHEMBL386630,CHEMBL1871,Androgen Receptor,EC50,=,1.9,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.721246399047171
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,0.14,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.853871964321762
CHEMBL166444,CHEMBL1871,Androgen Receptor,EC50,=,0.11,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.958607314841775
CHEMBL1229684,CHEMBL1871,Androgen Receptor,EC50,=,50.0,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC,7.301029995663981
CHEMBL5197302,CHEMBL1871,Androgen Receptor,EC50,=,9.2,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21,8.036212172654444
CHEMBL5192080,CHEMBL1871,Androgen Receptor,EC50,=,4.8,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CCCCCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@H]3[C@H]([C@@H](C)C[C@]12C)[C@H]1CCC(=O)C=C1C[C@H]3C,8.318758762624412
CHEMBL2177238,CHEMBL1871,Androgen Receptor,EC50,=,0.9,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(C)c1ccc(O)cc1,9.045757490560675
CHEMBL2177230,CHEMBL1871,Androgen Receptor,EC50,=,0.8,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CN1C(=S)N(c2ccc(Cl)c(Cl)c2)C(=O)[C@@]1(C)c1ccc(O)cc1,9.096910013008056
CHEMBL5185723,CHEMBL1871,Androgen Receptor,EC50,=,3.99,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(O)c1ccccc1,8.399027104313252
CHEMBL5184779,CHEMBL1871,Androgen Receptor,EC50,=,0.7,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1c(N2C(=O)C3[C@H](O)CCN3C2=O)ccc(C#N)c1Cl,9.154901959985743
CHEMBL1288321,CHEMBL1871,Androgen Receptor,EC50,=,27.0,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21,7.568636235841012
CHEMBL401805,CHEMBL1871,Androgen Receptor,EC50,=,23.0,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](C(F)(F)F)N3CC(F)(F)F,7.638272163982407
CHEMBL1367504,CHEMBL1871,Androgen Receptor,EC50,=,8960.0,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1cc(O)nc2ccc(S(=O)(=O)Nc3ccc(O)cc3)cc12,5.047691990337874
CHEMBL436784,CHEMBL1871,Androgen Receptor,EC50,=,0.2,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.698970004336019
CHEMBL4090028,CHEMBL1871,Androgen Receptor,EC50,=,0.19,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl,9.721246399047171
CHEMBL4092535,CHEMBL1871,Androgen Receptor,EC50,=,0.29,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F,9.537602002101044
CHEMBL4088914,CHEMBL1871,Androgen Receptor,EC50,=,4.7,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.327902142064282
CHEMBL3818555,CHEMBL1871,Androgen Receptor,EC50,=,15.8,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1c(C(C)(C)C(O)C(F)(F)F)ccc(C#N)c1C(F)(F)F,7.801342913045577
CHEMBL3819041,CHEMBL1871,Androgen Receptor,EC50,=,3.98,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1c(C(C)(O)C(F)(F)F)ccc(C#N)c1C(F)(F)F,8.400116927926312
CHEMBL3818224,CHEMBL1871,Androgen Receptor,EC50,=,1.26,nM,CHEMBL5127802,B,Modulation of Androgen receptor (unknown origin),CHEMBL5126525,EC50,N#Cc1ccc(C(O)(c2cocn2)C(F)(F)F)cc1C(F)(F)F,8.899629454882437
CHEMBL3221237,CHEMBL1871,Androgen Receptor,EC50,=,0.65,nM,CHEMBL5127803,B,Modulation of human Androgen receptor transfected in African green monkey COS cells,CHEMBL5126525,EC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12,9.187086643357144
CHEMBL390728,CHEMBL1871,Androgen Receptor,EC50,=,4.0,nM,CHEMBL5127811,B,Agonist activity at human Androgen receptor transfected in African green monkey CV-1 cells by Luciferase reporter gene assay,CHEMBL5126525,EC50,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,8.397940008672037
CHEMBL5170697,CHEMBL1871,Androgen Receptor,EC50,=,3.6,nM,CHEMBL5127816,B,Activation of Androgen receptor-mediated transcription (unknown origin) in African green monkey CV-1 cells incubated for 40 hrs by Luciferase reporter gene assay,CHEMBL5126525,EC50,CCc1c(C)c2c3c(Cl)cc(=O)[nH]c3ccc2n1CC(F)(F)F,8.443697499232712
CHEMBL5207694,CHEMBL1871,Androgen Receptor,EC50,=,10.0,nM,CHEMBL5127822,B,Agonist activity at Androgen receptor (unknown origin),CHEMBL5126525,EC50,Cc1cc(Cl)cc2c1OCC(=O)NC2C(=O)Nc1ccc([N+](=O)[O-])cc1,8.0
CHEMBL5203846,CHEMBL1871,Androgen Receptor,EC50,=,25.0,nM,CHEMBL5127822,B,Agonist activity at Androgen receptor (unknown origin),CHEMBL5126525,EC50,O=C1COc2c(Cl)cc(Cl)cc2C(C(=O)Nc2ccc(C(F)(F)F)cc2)N1,7.6020599913279625
CHEMBL27769,CHEMBL1871,Androgen Receptor,EC50,=,0.1,nM,CHEMBL5140897,B,Agonist activity at human Androgen receptor measured by CALUX bioassay,CHEMBL5137058,EC50,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,10.0
CHEMBL390728,CHEMBL1871,Androgen Receptor,EC50,=,4.0,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21,8.397940008672037
CHEMBL436784,CHEMBL1871,Androgen Receptor,EC50,=,0.2,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1,9.698970004336019
CHEMBL5187916,CHEMBL1871,Androgen Receptor,EC50,=,1.1,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,CC(C)(C)OC(=O)c1cccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C(F)(F)F)c43)c12,8.958607314841775
CHEMBL227088,CHEMBL1871,Androgen Receptor,EC50,=,1.1,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,C[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F,8.958607314841775
CHEMBL467888,CHEMBL1871,Androgen Receptor,EC50,=,7.1,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1,8.148741651280925
CHEMBL484726,CHEMBL1871,Androgen Receptor,EC50,=,0.2,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,EC50,Cc1c(/N=C2\O[C@@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl,9.698970004336019
CHEMBL5183180,CHEMBL1871,Androgen Receptor,EC50,=,17.0,nM,CHEMBL5140901,B,Agonist activity at human Androgen receptor expressed in human MDA-MB-453 cells cotransfected with MMTV-Luc assessed as transactivation modulation of AR measured by luciferase reporter assay,CHEMBL5137058,EC50,CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cncnc5)C[C@H]4[C@@H]3CC[C@@H]12,7.769551078621726
CHEMBL3402228,CHEMBL1871,Androgen Receptor,EC50,=,0.32,nM,CHEMBL5140906,B,Agonist activity to human Androgen receptor in African green monkey COS-7 cells measured by luciferase reporter assay,CHEMBL5137058,EC50,C[C@H]1[C@@H](O)CCN1c1ccc(C#N)c2ccccc12,9.494850021680094
CHEMBL4060271,CHEMBL1871,Androgen Receptor,EC50,=,0.29,nM,CHEMBL5140906,B,Agonist activity to human Androgen receptor in African green monkey COS-7 cells measured by luciferase reporter assay,CHEMBL5137058,EC50,Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1Cl,9.537602002101044
CHEMBL5209205,CHEMBL1871,Androgen Receptor,EC50,=,2.5,nM,CHEMBL5140916,B,Agonist activity at Androgen receptor (unknown origin) measured by androgen response element luciferase assay,CHEMBL5137058,EC50,C[C@](O)(CCOc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21,8.602059991327963
CHEMBL229861,CHEMBL1871,Androgen Receptor,EC50,=,1.8,nM,CHEMBL5140920,B,Agonist activity at Androgen receptor (unknown origin),CHEMBL5137058,EC50,CC[C@H]1[C@@H]2[C@@H](O)CCN2C(=O)N1c1ccc(C#N)c(Cl)c1C,8.744727494896694
CHEMBL4088914,CHEMBL1871,Androgen Receptor,EC50,=,4.7,nM,CHEMBL5140920,B,Agonist activity at Androgen receptor (unknown origin),CHEMBL5137058,EC50,CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1,8.327902142064282
CHEMBL5193931,CHEMBL1871,Androgen Receptor,EC50,=,0.34,nM,CHEMBL5140929,B,Agonist activity at human Androgen receptor expressed in African green monkey CV-1 cells measured by ARE-luciferase assay,CHEMBL5137058,EC50,N#Cc1ccc(-c2ccc(O)cc2F)[nH]1,9.468521082957745
CHEMBL5193931,CHEMBL1871,Androgen Receptor,EC50,=,1206.0,nM,CHEMBL5140930,B,Activation of human Androgen receptor N/C (N-terminal/C-terminal) interaction,CHEMBL5137058,EC50,N#Cc1ccc(-c2ccc(O)cc2F)[nH]1,5.9186526921958675
CHEMBL1082407,CHEMBL1871,Androgen Receptor,EC50,=,1100.0,nM,CHEMBL5140970,B,Antagonist activity at Androgen receptor in human LNCaP C4-2 cells transfected with PSA6.1-luc and pRL-TK measured by luciferase gene reporter assay,CHEMBL5137058,EC50,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.958607314841775
CHEMBL4564335,CHEMBL1871,Androgen Receptor,EC50,=,1700.0,nM,CHEMBL5140970,B,Antagonist activity at Androgen receptor in human LNCaP C4-2 cells transfected with PSA6.1-luc and pRL-TK measured by luciferase gene reporter assay,CHEMBL5137058,EC50,Cc1ccc(Cl)cc1N1CCN(C(=O)[C@@H]2C[C@@H]2c2ccc(F)cc2)CC1,5.769551078621726
CHEMBL1565119,CHEMBL1871,Androgen Receptor,EC50,=,8.0,nM,CHEMBL5149353,B,Agonist activity at human AR expressed in CHO-K1 cells,CHEMBL5143733,EC50,C[C@]12CC[C@H]3[C@@H](C[C@H](F)C4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,8.096910013008056
CHEMBL2105738,CHEMBL1871,Androgen Receptor,EC50,=,10410.0,nM,CHEMBL5239287,B,Induction of degradation of full length Androgen receptor (unknown origin),CHEMBL5236610,EC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,4.982549270489464
CHEMBL5184863,CHEMBL1871,Androgen Receptor,EC50,=,1000.0,nM,CHEMBL5239294,B,Induction of degradation of AR LBD in human LNCaP cells,CHEMBL5236610,EC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)NCCOCCOC(=O)CC12CC3CC(CC(C3)C1)C2,6.0
CHEMBL5279873,CHEMBL1871,Androgen Receptor,EC50,=,2000.0,nM,CHEMBL5239294,B,Induction of degradation of AR LBD in human LNCaP cells,CHEMBL5236610,EC50,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)NCCOCCOCCOCCOC12CC3CC(CC(C3)C1)C2,5.698970004336019
CHEMBL4862963,CHEMBL1871,Androgen Receptor,EC50,=,3.6,nM,CHEMBL5334775,B,Induction of androgen receptor degradation in human VCaP cells incubated for 24 hrs by Western blot analysis,CHEMBL5331127,EC50,N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6cc7c(cc6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)nn3)CC2)cc1Cl,8.443697499232712
CHEMBL5404267,CHEMBL1871,Androgen Receptor,EC50,=,0.6,nM,CHEMBL5334775,B,Induction of androgen receptor degradation in human VCaP cells incubated for 24 hrs by Western blot analysis,CHEMBL5331127,EC50,C[C@H]1CC2(CCN(c3ccc(C(=O)N4CCN(C5CN(c6ccc7c(c6)C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)CC4)cc3)CC2)CN1c1ccc(C#N)c(Cl)c1,9.221848749616356
CHEMBL4862963,CHEMBL1871,Androgen Receptor,EC50,=,5.5,nM,CHEMBL5334779,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by Western blot analysis,CHEMBL5331127,EC50,N#Cc1ccc(O[C@H]2CC[C@H](NC(=O)c3ccc(N4CCC(CN5CCN(c6cc7c(cc6F)C(=O)N(C6CCC(=O)NC6=O)C7=O)CC5)CC4)nn3)CC2)cc1Cl,8.259637310505756
CHEMBL5404267,CHEMBL1871,Androgen Receptor,EC50,=,0.6,nM,CHEMBL5334779,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by Western blot analysis,CHEMBL5331127,EC50,C[C@H]1CC2(CCN(c3ccc(C(=O)N4CCN(C5CN(c6ccc7c(c6)C(=O)N(C6CCC(=O)NC6=O)C7=O)C5)CC4)cc3)CC2)CN1c1ccc(C#N)c(Cl)c1,9.221848749616356
CHEMBL5407635,CHEMBL1871,Androgen Receptor,EC50,=,2840.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.546681659952963
CHEMBL5404028,CHEMBL1871,Androgen Receptor,EC50,=,3210.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,CCc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.493494967595128
CHEMBL5402908,CHEMBL1871,Androgen Receptor,EC50,=,4760.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,CC(C)c1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.3223930472795065
CHEMBL5414716,CHEMBL1871,Androgen Receptor,EC50,=,3880.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,COc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccnnc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.411168274405792
CHEMBL5412123,CHEMBL1871,Androgen Receptor,EC50,=,3310.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,C[C@]12CC[C@H](NC(=O)c3ccnnc3)CC1=CCC1C2CC[C@]2(C)C(n3cnc([N+](=O)[O-])c3)=CCC12,5.480172006224281
CHEMBL5425503,CHEMBL1871,Androgen Receptor,EC50,=,5720.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccncc6F)CC[C@]5(C)C4CC[C@]23C)cn1,5.242603971206975
CHEMBL5409426,CHEMBL1871,Androgen Receptor,EC50,=,2600.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc([N+](=O)[O-])cc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.585026652029182
CHEMBL5420162,CHEMBL1871,Androgen Receptor,EC50,=,1560.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(C#N)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.806875401645538
CHEMBL5411468,CHEMBL1871,Androgen Receptor,EC50,=,1370.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(S(C)(=O)=O)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.863279432843593
CHEMBL5400213,CHEMBL1871,Androgen Receptor,EC50,=,1280.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6)CC[C@]5(C)C4CC[C@]23C)cn1,5.892790030352131
CHEMBL5413706,CHEMBL1871,Androgen Receptor,EC50,=,1680.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,Cc1cn(C2=CCC3C4CC=C5C[C@@H](NC(=O)c6ccc(F)cc6F)CC[C@]5(C)C4CC[C@]23C)cn1,5.774690718274137
CHEMBL2105738,CHEMBL1871,Androgen Receptor,EC50,=,14400.0,nM,CHEMBL5335599,B,Induction of androgen receptor degradation in human LNCaP cells incubated for 24 hrs by ELISA,CHEMBL5331145,EC50,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12,4.841637507904751
CHEMBL89136,CHEMBL1871,Androgen Receptor,Kd,=,1.4,nM,CHEMBL648321,B,Dissociation constant against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL1144953,KD,CCCCN(CCCC)c1ccc(/C=C2\C(=O)ON=C2c2ccccc2)cc1,8.853871964321762
CHEMBL89437,CHEMBL1871,Androgen Receptor,Kd,=,1.4,nM,CHEMBL648321,B,Dissociation constant against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL1144953,KD,O=C1ON=C(c2ccccc2F)/C1=C/c1ccc(N2CCCC2)cc1,8.853871964321762
CHEMBL330478,CHEMBL1871,Androgen Receptor,Kd,=,1.4,nM,CHEMBL648321,B,Dissociation constant against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL1144953,KD,O=C1ON=C(c2ccc(F)cc2)/C1=C/c1ccc(N2CCCC2)cc1,8.853871964321762
CHEMBL315964,CHEMBL1871,Androgen Receptor,Kd,=,1.4,nM,CHEMBL648321,B,Dissociation constant against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL1144953,KD,O=C1ON=C(c2ccc(O)cc2)/C1=C/c1ccc(N2CCCC2)cc1,8.853871964321762
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.61,nM,CHEMBL829227,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 273 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.214670164989233
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.52,nM,CHEMBL830052,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 278 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.2839966563652
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.56,nM,CHEMBL830053,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 283 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.2518119729938
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.68,nM,CHEMBL830054,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 288 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.167491087293763
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.74,nM,CHEMBL830055,B,Dissociation constant value of the radiolabeled compound against the androgen receptor 293 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.130768280269024
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.99,nM,CHEMBL830056,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 298 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.00436480540245
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,1.21,nM,CHEMBL829224,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 303 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.91721462968355
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,1.51,nM,CHEMBL829225,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 308 K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.821023052706831
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,1.95,nM,CHEMBL829226,B,Dissociation constant for [3H]R-1881 binding to human androgen receptor at 310K,CHEMBL1142733,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,8.709965388637482
CHEMBL166444,CHEMBL1871,Androgen Receptor,Kd,=,0.6,nM,CHEMBL1116293,B,Binding affinity to androgen receptor,CHEMBL1157104,KD,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C,9.221848749616356
CHEMBL4444904,CHEMBL1871,Androgen Receptor,Kd,=,1300.0,nM,CHEMBL4668336,B,Inhibition of androgen receptor AF1 domain (141 to 486 residues) (unknown origin) incubated for 30 mins by steady-state fluorescence emission spectroscopy,CHEMBL4665673,KD,C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1,5.886056647693163
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Kd,=,40200.0,nM,CHEMBL5045075,B,Binding affinity to human AR LBD (663 to 920 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by biolayer interferometry assay,CHEMBL5042532,KD,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,4.39577394691553
CHEMBL5085066,CHEMBL1871,Androgen Receptor,Kd,=,75870.0,nM,CHEMBL5045110,B,Binding affinity to human AR LBD (663 to 920 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant in presence of DHT by biolayer interferometry assay,CHEMBL5042532,KD,CN(C)S(=O)(=O)Nc1ccc(OCc2ccccc2)cc1,4.119929915935932
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Kd,=,295400.0,nM,CHEMBL5045110,B,Binding affinity to human AR LBD (663 to 920 residues) expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant in presence of DHT by biolayer interferometry assay,CHEMBL5042532,KD,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,3.5295895090240696
CHEMBL5177079,CHEMBL1871,Androgen Receptor,Kd,=,10050.0,nM,CHEMBL5106956,B,Binding affinity to full length androgen receptor (unknown origin) assessed as dissociation constant at 5 uM measured after 15 mins by biolayer interferometry assay,CHEMBL5104187,KD,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)cc3)n2)cc1C(F)(F)F,4.997833938243493
CHEMBL5203294,CHEMBL1871,Androgen Receptor,Kd,=,8990.0,nM,CHEMBL5106956,B,Binding affinity to full length androgen receptor (unknown origin) assessed as dissociation constant at 5 uM measured after 15 mins by biolayer interferometry assay,CHEMBL5104187,KD,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1C(F)(F)F,5.046240308266771
CHEMBL5201101,CHEMBL1871,Androgen Receptor,Kd,=,20480.0,nM,CHEMBL5106956,B,Binding affinity to full length androgen receptor (unknown origin) assessed as dissociation constant at 5 uM measured after 15 mins by biolayer interferometry assay,CHEMBL5104187,KD,N#Cc1ccc(-n2ccc(CC(=O)Nc3ccc(F)nc3)n2)cc1Cl,4.688670047696207
CHEMBL1082407,CHEMBL1871,Androgen Receptor,Kd,=,6520.0,nM,CHEMBL5106956,B,Binding affinity to full length androgen receptor (unknown origin) assessed as dissociation constant at 5 uM measured after 15 mins by biolayer interferometry assay,CHEMBL5104187,KD,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F,5.185752404268079
CHEMBL386630,CHEMBL1871,Androgen Receptor,Kd,=,0.4,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KD,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O,9.397940008672037
CHEMBL27769,CHEMBL1871,Androgen Receptor,Kd,=,0.25,nM,CHEMBL5140896,B,Binding affinity to human Androgen receptor,CHEMBL5137058,KD,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12,9.602059991327963
CHEMBL717,CHEMBL1871,Androgen Receptor,Kd,=,1.0,nM,CHEMBL5140898,B,Agonist activity at human Androgen receptor,CHEMBL5137058,KD,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C,9.0
